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ABSTRACT 
SYNTHETIC, STRUCTURAL, AND STABILITY STUDIES OF METAL 
COMPLEXES OF CROSS-BRIDGED TETRAAMINE MACROCYCLES 
BY
WEIJUN NIU 
University o f  New Hampshire, September, 2003
Cross-bridging of tetraazamacrocyclic ligands with an ethylene unit forms a 
family of bicyclic tetraamine ligands originally designed and synthesized by the 
Weisman-Wong research group to selectively complex small metal ions such as Li+ in a 
m-folded configuration. Cu(II), Ga(HI), and In(lll) complexes of these cross-bridged 
ligands have potential radiometal-based pharmaceutical applications. It has been 
generally accepted that high kinetic stability of a metal complex is important to realize 
this potential. Cu(II) complexes of eight cross-bridged tetraazamacrocyclic ligands have 
been synthesized and structurally characterized. Their relative kinetic stabilities were 
evaluated by monitoring acid-promoted dissociation processes using UV-Vis 
spectroscopy. The copper complex of a dicarboxylate pendant-armed cross-bridged 
cyclam (ligand 7) was the most inert, consistent with its superior in vivo stability. This is 
also in accord with the fact that copper fits best in this ligand as indicated by the largest 
Nax-Cu-Nax bond angle of this complex compared to any other six-coordinate Cu(II) 
complexes of cross-bridged ligands. Ga(lII) and In(III) complexes of three of the ligands
xxxi
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have also been prepared and characterized. The indium complex of cross-bridged cyclen 
with the poorest fit in the solid-state showed the lowest inertness as indicated by its 
partial decomplexation in water. By contrast, gallium complexes of cross-bridged cyclam 
(ligand 1) and a di carboxyl ate pendant-armed cross-bridged cyclen have been found to be 
stable in acidic D2O (pD =1.07) for more than seven months. Thus we were able to 
investigate the possible solution structures of the Ga(III) complex with ligand 1 in acidic 
D2O using NMR techniques. Zn(Il), Cd(II) and Hg(II) complexes o f the eight cross­
bridged ligands have been synthesized and whenever appropriate, structurally 
characterized. Comparison of their solid-state structures suggested the selectivity o f this 
family of cross-bridged ligands for Zn(II) ion based on its best fit inside the cleft formed 
by the cross-bridged ligands. The solution structures of these metal complexes were also 
investigated using NMR spectroscopy. In addition, the kinetic stabilities of selected 
Zn(II), Cd(II) and Hg(II) complexes were studied. As with copper and indium complexes, 
the Zn(II) complex of cross-bridged cyclam is more inert than that of cross-bridged 
cyclen. These results indicate that cross-bridged cyclam and its derivatives have more 
potential for radiopharmaceutical applications than related cross-bridged cyclen and its 
derivatives.
xxxii
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CHAPTER I
GENERAL INTRODUCTION
Macrocyclic ligands are ring compounds whose structures can allow several of 
their donor atoms to bind to a single metal.1 They are divided into two major classes. 
One features the oxygen donors, such as the crown ethers and oxygen-based 
cryptands.2,3 The other contains nitrogen donor sites.4,5 Compared to their acyclic 
analogues, macrocyclic complexes typically have higher kinetic inertness as well as 
higher thermodynamic stability.5,6 Among macrocyclic complexes, metal complexes of 
cyclic tetraamines and their derivatives have played an important role in a variety of
7 8 9 10research areas. These areas include coordination chemistry, ’ cancer therapy, ’ contrast 
agents,11 catalysis,7 enzyme mimics,12,13 supramolecular chemistry,14,15,16 and molecular 
switches.17
This doctoral research focuses on the coordination chemistry of eight bicyclic 
tetraamine ligands with a bridging ethylene connecting nonadjacent nitrogens (Figure 
1.1). These ligands were originally designed by our research group for selective 
complexation with small metal ions such as lithium(I) and copper(II) .18,19 The metals 
used for complexation here include Cu(II), Ga(III), In(III), Zn(II), Cd(II) and Hg(II). 
Since ligands 1-4 are ethylene-cross-bridged cyclam and cyclen and ligands 5-8 are 
carboxylate and carbamoyl derivatives of ethylene-cross-bridged cyclam and cyclen,
1
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Figure 1.1 Cross-bridged ligands studied in this research.
literature work on the coordination chemistry of cyclam, cyclen, and their derivatives 
including carboxylate and carbamoyl derivatives will be discussed.
1. Coordination Chemistry of Cyclam, Cyclen and their Derivatives and Potential 
Applications of these Complexes.
1.1 General Information on Coordination Chemistry of cyclam and cyclen.
A family of macrocyclic tetraamines is shown in Figure 1.2. 1,4,8,11- 
tetraazacyclotetradecane (cyclam, 14-ane-N4) (9 in Figure 1.3) and 1,4,7,10- 
tetraazacyclododecane (cyclen, 12-ane-N4) (10 in Figure 1.3) have been the most 
studied of macrocyclic tetraamines. The 14-membered cyclam and its derivatives are 
fairly flexible.
According to Bosnich, they can potentially adopt any of the five coordinated 
configurations (I to V in Figure 1.4) in their metal complexes featuring two five-
2
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Figure 1.2 A family of macrocyclic tetraamines.
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Figure 1.3 Cyclam and Cyclen.
membered and two six-membered chelate rings.7’20’21 Both c/s-folded and tran^-isomers 
are possible for the three configurations I, II and V. In their complexes with specific 
cations, cyclam and its derivatives may prefer one configuration over the others.22(a'd) 
For example, the preferred low-energy configuration of cyclam and its derivatives in 
their Cu(II) complexes is the trans-ffl.22(a'e) By contrast, the metallation of N', N", N'", 
N""-tetramethylcyclam (Me4Cyclam) by transition metal ions typically leads to five- 
coordinate trans-I type isomers.22(a‘e) Only very recently, several Cu(II) complexes of 
this ligand in a trans-lll configuration have been structurally characterized ,22(c‘e) The 12- 
membered cyclen and its derivatives may adopt any of the four coordinated 
configurations (I, II, III (IV) and V in Figure 1.5) in their metal complexes, giving four
3
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Figure 1.6 The metal-to-ligand bondlengths and bite angles that produce the 
minimum-strain energy structures for chelate rings of sizes five and six with saturated 
chelate rings containing nitrogen donors.
five-membered chelate rings. The available crystal structures indicate that the trans-1 
configuration is dominant.223 Consistently, MM calculations have shown that the trans- 
l l l  configuration of coordinated cyclen and its derivatives are at much higher energy 
than the trans-1 configuration.223 The minimum-strain geometries (MM calculation) for
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chelate rings of sizes five and six, involving neutral nitrogen donors, are shown in 
Figure 1.6.
Metal ions complexed by cyclam, cyclen and their derivatives comprise almost 
all the transition metals. Only the most relevant metal complexes will be discussed here.
1.2 Zinc(II) Complexes of Cyclen, Cyclam and their Derivatives.
One important metal cation is Zn2+ because of its biological relevance. A search 
of the Cambridge Crystallographic Database revealed a total of 58 X-ray structures of 
zinc complexes with cyclam and its derivatives. Most of these have the favored trans-III 
ligand configuration with a coordination number of six23(a"^  or five24(a~el  The structure of 
a six-coordinate Zn(II) complex of cyclam ( l l ) 23(a) is shown in Figure 1.7. The
S(2IV_y
Figure 1.7 The X-ray structure of [Zn(cyclam)(NCS)2] (11) (Zn is disordered over 
two sites.).
coordination geometry around this Zn(II) center is pseudo-octahedral. The five- 
coordinate Zn(II) complex of meso-5,12-dimethyl-cyclam (12)24^  has a distorted square 
pyramidal geometry (Figure 1.8). The adopting of a frans-configuration is indicated by
CI10)
5
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similar values of the N(l)-Zn-N(3) angle of 153.7(4)° and N(2)-Zn-N(4) angle of 











0 ( 2 )
Figure 1.8 The X-ray structure of [Zn(5,12-dimethyl-cyclam)(Cl)](C104) (12).
N', N", N '", N'"'-tetramethylcyclam (Me4Cyclam) complexes of Zn(II) have a 
five-coordinate trans-l configuration.25^  The X-ray structure of such a Zn(II) complex 
(13) is presented in Figure 1.9.25(a) The Zn(II) center in 13 has square-pyramidal 
geometry around it. Variable-temperature 13C NMR spectral studies of 13 in 
nitromethane solution demonstrated the presence of a dynamic process (Scheme l .l) .25(a)
By contrast, only six cis-Y  structures are known and all of them are Zn(II) 
complexes of cyclam derivatives.26^  The X-ray structure of a dimeric Zn(II) Xylyl- 
bicyclam complex (14) in such a c/s-folded (V) configuration is shown in
6
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Figure 1.9 The X-ray structure of [Zn(Me4Cyclam)(Cl)](C104) (13), 
Me4Cyclam = N', N", N"', N""-tetramethylcyclam.
i-x




Figure 1.10 The X-ray structure of a dimeric Zn(II) Xylyl-bicyclam complex (14).
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Figure 1.10.26(a) Here, each distorted octahedral Zn(II) center is coordinated by four 
nitrogen atoms from the macrocycle and a bidentate acetate. The adopting of such a cis- 
configuration is indicated by the N(l)-Zn-N(8) angle of 174.67(4)° in the axial position 
and N(4)-Zn-N(ll) angle of 105.32(10)° in the equatorial position. In aqueous solution, 
the major configurations of this Zn(II) complex are cis-V/trans-1 as indicated by detailed 
1D and 2D NMR studies.26(a)
The coordination chemistry of Zn(II) complexes of cyclam and its derivatives has 
been explored in bioinorganic chemistry. In 1985, Ito and co-worker reported that 
carbon dioxide was fixed by the Zn(II)-cyclam complex in MeOH (Scheme 1.2).23W
in MeOH
16
Scheme 1.2 Carbon dioxide fixation by the Znn-cyclam complex in MeOH.
”74-The solid-state structure of 16 showed that pseudo-octahedral Zn is surrounded by 
cyclam in a trans-III configuration with two oxygen atoms from a pair of Me0 C02  
occupying the axial positions. The MeOC02  bridges two neighboring [Zn(cyclam)J2+
8
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units to give a linear chain structure along the axis. More interestingly, it was found that
Zn(II) complex 15 was the most effective in uptake of carbon dioxide among Ni(II),
01Co(II), Cu(II) and Zn(II) complexes of cyclam. This research stimulated other research 
groups to use cyclen or cyclam complexes of Zn(II) to mimic the active centers in Zn(II) 
enzymes.
The Zn(II) complex of a phenol C-pendant-armed cyclam (19 in Scheme 1.3) 
was reported by Kimura and his coworkers as a possible mimic of the anion inhibition in 
Carbonic Anhydrase. They were able to obtain the X-ray structure of the penta- 
coordinated Zn(II) complex 19.28 The coordination geometry around Zn(II) is square 






Scheme 1.3 The formation of the Zn(II) complex of a phenol pendant-armed cyclam.
There are numerous structural reports of zinc complexes with cyclen and its 
pendant-armed derivatives in the literature, almost all of these have the trans-1 ligand 
configuration with all four amine substituents on the same side of the macrocycle as 
zinc.,4’15’29(a'n'1 Their coordination number is generally five or sixI4,15’29(a'm) but a higher
9
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coordination number o f seven is also found.30(a’c) An X-ray structure of a 5-coordinate 
Zn(II) complex of cyclen, [Zn(cyclen)-im-Zn(cyclen)](C104)3 (20) (im = imidazolate) 













Figure 1.11 The X-ray structure of [Zn(cyclen)-Imidazolate-Zn(cyclen)] (20).
HN N.
h n _ _ n h
21
B r2i
Figure 1.12 The X-ray structure of complex [Zn(II)21(H20)]2+.
The X-ray structure of a 6-coordinate Zn(II) complex with a pendant-armed cyclen 
derivative (ligand 21) is shown in Figure 1.12.29(fl  The Zn(II) atom in this complex is 
octahedrally coordinated by four nitrogen atoms, one carbonyl oxygen from the pendant 
arm and the water oxygen. An example of a seven-coordinate Zn(II) complex is the X-
10
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ray structure of [Zn(II)22]2+ (Figure 1.13).30(a) The zinc ion is seven-coordinated by the 
four nitrogen atoms of the macrocycle and three N atoms of the pyrazole groups. The 
coordination polyhedron of 22 may be approximately described as a pentagonal 
bipyramid. Zn(II) complexes of parent cyclen (10) prefer the coordination number 
five.29(a)’(d)’(h'',', Studies of Zn(II) with cyclen and its derivatives have been carried out 
mainly by Kimura and his coworkers. These Zn(II) complexes have been extensively 
examined as models for Zn(II) enzymes such as Alkaline Phosphatase (AP), 
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Figure 1.14 The pKa values for Lr-Zn-OH22+==^  t _Zn—OH+ + Hr.
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Since it is well established that the Znn-OH' and/or Zn-OR' are the most critical 
reactants with substrates in Zn(II) enzymes, Kimura’s group has been quite interested in 
how coordination influences the Zn(II) lewis acidity which promotes proton dissociation 
from [Znn-OH2]2+ or [Zn^-OHR]24. The pKa values of [Znn-OH2]2+ complexes (23, 24, 
and 25 in Figure 1.14) of three cyclic tetraamines are significantly higher than those for 
CA (~7) and carboxypeptidase A (CPA) (~6). In fact, few model complexes showed 
such low pKa values of Zn-bound H2O. Hence, Kimura surmised since the Zn11 ion alone 
can not generate sufficent Zn(II)-OH~ species at a physiological pH, this generation 
may be possible only in the presence of nearby complementary strong bases such as 
carboxylates within the active sites.
3OOC,
h n/ \









hn ~/  \
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Scheme 1.4 The equilibrium between the carboxylate-bound and the carboxylate- 
unbounded forms of Zn(II) complexes of carboxylate pendant-armed cyclens.
Acetate is another anionic inhibitor of CA. Zn(II) complexes of carboxymethyl- 
ligand 26, carboxyethyl- ligand 27, and carboxypropyl pendant-armed cyclen 28 
(Scheme 1.4) were thus prepared by Kimura’s group.34 As shown in Scheme 1.4, in 
acidic solution, all these Zn2+ complexes exist in equilibrium between the carboxylate-
12
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bound and the carboxylate-unbound forms. 28a has the lowest pKa value (8.7) because 
the seven-membered chelate ring from the carboxylate arm is not stable. OH' can thus 
easily displace it to give 28b. In fact, the solid-state structure of 28a shows a dimeric 
Zn(II) complex, 29 (Figure 1.15), which is in equilibrium with the monomeric species 
28a in aqueous solution. The reactivity order in 4-nitrophenyl acetate (NA) hydrolysis at 
pH 9.3 was found to be 28 »  27 > 26. This is consistent with the fact that 28a has the 
lowest pKa value.
Figure 1.15 The solid-state structure of 29.
The neutral inhibitors of CA include weak acids such as sulfonamides, 
carboxamides and alcohols. Such inhibitors with high pKa values may bind either as 
neutral molecules or as deprotonated anions to the active zinc center. To understand the 
effect of weak inhibitor alcohols on the Zn(II) center at the alkaline phosphatase active 
center, Kimura’s group synthesized the Zn(ll) complexes of an alcohol pendant-armed 
cyclen (30 in Scheme 1.5). The X-ray structure of 30 indicated a distorted square 
pyramidal geometry. An overall reaction mechanism for NA hydrolysis catalyzed by 30 
proposed by this group is shown in Scheme l.S.29^
13
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33
Scheme 1.5 An overall reaction mechanism for 4-nitrophenyl acetate 
hydrolysis catalyzed by an alcohol pendant-armed cyclen zinc(II) complex.
Scheme 1.6 The reaction of 34 with bis(4-nitrophenyl) phosphate yielded a 
"phosphoryl-transfer" intermediate 36 which was isolated.
14
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The Zn(II) complex of a benzyl alcohol pendant-armed cyclen (34 in Scheme 
1.6) was also synthesized and characterized by Kimura’s group.36 The crystal structure 
o f the zinc(II)-bound alkoxide species 35 with a pK\, of 6.5 at 25°C showed the alkoxide 
closely bounded at the fifth coordination site. The direct reaction of this zinc(II) complex 
35 with bis(4-nitrophenyl) phosphate yielded a “phosphoryl-transfer” intermediate 36 
which was isolated.
^ h 2 H 0  H2N ^ n
o A  “n A  OH° V
Yc=o = 1645 cm'1 (in D20 )  yc=0 = 1576 cm'
n o 2
h N I N
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Scheme 1.7 Zn(II) complexes of carboxamide pendant-armed cyclens (Type one).
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Interestingly, carboxamides are substrates for CPA but inhibitors for CA. 
Different modes of recognition of carboxamides by CA and CPA were mimicked by
with either the carbonyl oxygen (37 in Scheme 1.7) or water molecule bound to Zn(II) 
were characterized by their IR and UV spectral data. The solid-state structure of 41 
confirmed this assignment. Species 37, 40 and 42 represent the first models for 
demonstrating Zn(II)-facilitated carboxamide deprotonation. Consistent with the 
assumption that no Zn(II)-OH‘ was produced from them, none of the species in Scheme 
1.7 were able to catalyze NA hydrolysis.
Scheme 1.8 Zn(II) complexes of carboxamide pendant-armed cyclens (Type two).
In the second type of amide-pendant-armed cyclen Zn(II) complexes 44 and 47,
using various carboxamide-pendant cyclens.37 Zn2+ complexes of neutral carboxamides
r f L J k
44 45 46
yc=0 = 1624 cm"1 (in D20 )  yc=0 = 1624 cm'1 (in D20 )  
n O
p * a = 7 .48  I # ___
47 48
2 _ p
monodeprotonation also occurred but the products were the Zn -OH’ species 45 and 48 
(Scheme 1.8) since the yc=0 (in D2O) before (1624 cm'1) and after deprotonation (1624
16
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cm'1) were the same. The observed catalytic NA hydrolysis by this second type of
amide-pendant-armed cyclen Zn(II) complexes also indicated the presence of active 
Zn2+-OH species. The authors thus proposed that the model complexes in Scheme 1.7 
may present an explanation for why the amide is not hydrolyzed by CA. On the other 
hand, if  the interaction between the amide and Zn(II) center is weaker, as is the case of 
the second class of model complexes (Scheme 1.8), the Zn2+-OH‘ species is more 
favorably formed at neutral pH. This second type of amide-pendant-armed Zn(II) 
complexes may provide such a CPA model.
jj 1) dansyl chloride
H /  K2C 0 3
N  I N  2 3
in CH3CN | H  Zn11
„N  Nlt NaC104 m
X 2C104' H2° ’ PH 7
Nh
N(CH3)2 •N(ch3)2





50*2C104‘ 51-C104' 49-5 HC1
Scheme 1.9 The synthesis of a protonated ligand 49-5HC1.
To mimic the aromatic sulfonamide inhibitor of CA, the Zn(II) complex of an 
aromatic sulfonamide-pendant cyclen (49) was synthesized in two steps.29(c) The first 
step, the reaction of 50 with dansyl chloride in the presence of K2CO3, yielded 51, the 
Zn(II) complex of 49. Then demetalization of 51 and purification in 6M HC1 produced 
49 as its 5 HC1 salt (Scheme 1.9). Interestingly, ligand 49 is an effective zinc(II)- 
fluorophore. At pH 7.3, the zinc(II)-dependent fluorescence of 49 was not affected by
17
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the presence of large excess of other biologically important metal ions such as Na+, K+, 
Ca2+, and Mg2+.
van Eldik’s group performed a detailed kinetic study of the catalytic activity o f 
the Zn(II) complex of cyclen (52 in Figure 1.16) with respect to the hydration of CO2 
and dehydration of HCO3'.38 Subsequently, an attempt to fix carbon dioxide by alcohol 
(ROH) to dialkyl carbonate (ROCOOR) in the presence of a base failed.29(a) During this 
study, they were able to obtain the X-ray structure of [Zn(cycl en)EtOH] (CIO^ (53 in 
Figure 1.16), which is five-coordinate with the four nitrogen donor atoms from the 
macrocycle and the oxygen of the coordinated ethanol. The coordination geometry 
around Zn(II) in 53 is distorted square pyramidal.
■OH HOCH2CH3
52 53
Figure 1.16 Cation parts of two Zn(II) cyclen complexes.
HO
Figure 1.17 The structure of a ternary zinc(II) complex, 54.
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Kimura’s group has been interested in the selective recognition of nucleosides 
such as thymidine by Zn(II) complexes of cyclen derivatives.29(d),29(e)’39(a"e) In 1993, they 
found that complex [Zn*cyclen(H2 0 )](C104)2 reacted with AZT (3'-azido-3'- 
deoxythymidine) in slightly basic solution to form a ternary Zn(II) complex.29(d) The 
crystal structure o f this ternary zinc (II) complex showed that four nitrogen donors from 
cyclen and deprotonated Na in AZT coordinated to Zn(II) (54 in Figure 1.17). The 
coordination geometry around Zn(II) is again a distorted square pyramid. Such a
1 13structure might be maintained in solution as indicated by its H and C NMR spectra in 
d6-DMSO and its solution UV absorption spectra. Several Zn(II) complexes of lipophilic 
cyclen derivatives (Figure 1.18) were also investigated as carriers for extraction of 
imide-containing nucleosides and nucleotides. Among these Zn(II) complexes, the most 
lipophilic Zn(II) complex, 58 extracted thymidine most effectively from an aqueous 
solution into chloroform.39(b) 58 almost quantitatively extracted more lipophilic 
thymidine derivatives such as AZT into chloroform.
o h 2
V R 55: R= n-C3H7
JN- • — ■ ■56: R= n-C8H17 
Znn I 57: R= n-C12H25
HN Nh  58:R=n-C16H33
Figure 1.18 Lipophilic Zn(II) cyclen derivative complexes.
More recently, Kimura and his coworkers found that Zn(II) complexes of cyclen 
derivatives with the pendant bis[(l -naphthyl)methyl] or bis[(4 -quinolyl)methyl] group 
(59 or 60 in Figure 1.19) formed the strongest binding thymine-Zn(II)-cyclen derivative
19
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complexes.39^  They believed that this increased binding was the result of the double n-
n stacking interactions between the two naphthalene rings and the zinc-bound N(3')- 





X= OH2 or OH- 
59
X= OH2 or OH- 
60




O '  N® O
\  i
61: X= CH 
63: X= N
in solid state and in aprotic solvents
62: X= CH 
64: X= N  
in protic solvents
Figure 1.20 Ternary Zn(II) complexes of two pendant-armed cyclen derivatives 
and deprotonated 1 -methylthymine.
the ternary zinc(II) complex of N',N"'-bis[(l-naphthyl)methyl] cyclen and N(3')- 
deprotonated 1 -methylthymine (61 in Figure 1.20) showed that such an interaction did 
not exist in the solid state whereas !H NMR studies in protic and aprotic solvents
20
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indicated that these double n-n  stacking interactions between the two naphthalene rings 
and the zinc-bound N(3')-deprotonated 1 -methylthymine existed in protic solvents.39(f) 
The authors thus deduced that this ternary Zn(II) complex formed as 61 (or 63) in solid 
or in aprotic solvents and as 62 (or 64) in protic solvents (Figure 1.20).
H^ o
/  \
N N' v - TT, 






Figure 1.21 The structure of [Zn(DOTAM)] (65).
66 67
Figure 1.22 The structures of a seven-coordinated Zn(II) complex of ligand 66 
(complex 67).
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There are few reported examples featuring carboxylate and carbamoyl 
derivatives of cyclam and cyclen complexing with Zn(II). A Zn(II) complex of an 
octadentate ligand DOT AM (1,4,7,10-tetrakis(acetamido)-l ,4,7,10-cyclododecane) (65 
in Figure 1.21) was synthesized and structurally characterized by Wainwright’s group.40 
In this complex, zinc(II) is hexa-coordinated by four amino nitrogens of cyclen and two 
carbonyl oxygens of non-adjacent amides. More recently, a new pendant amide- 
derivative of cyclen (66) and its Zn(II) complex were synthesized and characterized by 
Kimura and coworkers.30(c) The X-ray structure of this Zn(II) complex (67 in Figure 
1.22) revealed a 7-coordinated Zn(II) center with four nitrogens of cyclen and three 
carbonyl oxygens of amides. In 2002, a rare structural example of a Zn(II) complex with 
a deprotonated amide (41 in Scheme 1.7) was published by Kimura et al. 29(g) Its solid- 
state structure showed that Zn(II) is penta-coordinate with four nitrogens from the cyclen 
ring and one deprotonated amide nitrogen from the pendant arm.
Several Zn(II) complexes of carboxylate derivatives of macrocyclic tetraamines 
have been reported.23(d)’23(g),30(b)’41 The zinc(II) complex of a cyclen derivative, ligand 
D02A (68 in Figure 1.23) was prepared by Wainwright’s group.41 No solid-state 
structure of [Zn(D02A)J has been reported. From 13C{'H} NMR studies in neutral D2O, 
it was concluded that this Zn(II) complex has a time-averaged C2v symmetrical cis- 
octahedral structure. The X-ray structure of a Zn(II) complex of a tetrasubstituted cyclen 
derivative, [Zn(H2DOTA)J (69 in Figure 1.23) was reported by Riesen and his 
coworkers.23(d) The Zn(II) center staying on a C2 axis has a pseudo-octahedral 
coordination geometry with a coordinated cis-1 ligand. The X-ray structure of 
[Zn(H2TETA)]°4H20  (70 in Figure 1.24) revealed a trans-lll octahedral arrangement of
22
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the four planar amino nitrogen donors and of the two axial carboxylate oxygens around 
Zn(II). H2TETA is a tetraacetate derivative of cyclam. A similar X-ray structure to that 
of [Zn(H2TETA)]"4H2 0  was also reported on the Zn(II) complex of dicarboxylate­
armed macrocyclic tetraamine derivative (71 in Figure 1.24).23(g)















68 (D02A) [Zn(H2DOTA)] (69) [Zn(H2DOTA)] (69)
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Figure 1.24 The X-ray structure of [Zn(H2TETA)] (70) and ligand 71.
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1.3 Cd(II) and Hg(II) Complexes of Cyclen, Cyclam and their Derivatives.
There are less than twenty well-characterized Cd(II) complexes of cyclam, 
cyclen and their derivatives in the literature. The majority are eight-coordinated Cd(II) 
complexes with t etra-N - sub stituted cyclam and cyclen derivatives.40,42(a'e) A good
NH2
72
Figure 1.25 The structure of [Cd(DOTAM)]2+(72).
example is the structure of a Cd(Il) complex of an octadentate ligand DOTAM (72 in 
Figure 1.25)40 In this complex, Cd(II) is encapsulated by the four nitrogen atoms of the 
macrocyclic ring and by the four oxygen atoms of the amide groups. The coordination 
geometry around Cd(II) is a distorted square-antiprism with two sets of Cd-O bond 
lengths. In D20  or DMF-Jg, both this Cd(II) complex and Zn(II) complex (65 in Figure 
1.21) undergo a nondissociative Bailar-twist for a dynamic process (Scheme 1.10) as
j-----ft  ^ j
Lo—
N / N
1— N T '
H?N
Scheme 1.10 Helicity reversal in the approximately square anti-prismatic Zn(II) and 
Cd(II) complexes of ligand DOTAM in solution.
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revealed by variable temperature ^C ^H } NMR studies. When the equilibration in 
Scheme 1.10 occurs faster than the NMR time scale, the carbons atoms at A and B will 
be equivalent. Several other Cd(II) complexes have the coordination number six43(a'e:> 
including a Cd(II) complex of cis-6,13,-Dimethyl-1,4,8,11 -tetraazacyclotetradecane-
6,13-diamine with a cw-folded (V) configuration (73 in Figure 1.26).43(a) The 
coordination polyhedron of this Cd(II) complex can best be described as a pseudo-
\/NH'
N N 
H i  J h
H ,N
^ N ( 6 )  C(12)!?
Cd^ 4 > X C(8)
N (1 )\ 1N(2)
L
K(C(10) 
o ' .1 C(11) ^
73
Figure 1.26 The X-ray structure of the Cd(II) complex of L (73) ( L = 6,13- 
Dimethyl-1,4,8,11 -tetra-azacyclotetradecane-6,13-diamine.
Figure 1.27 The X-ray structure of [Cd3(cyclam)3(C0 3)](C104)4 (74).
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octahedron. The solid-state structure of [Cd3(cyclam)3(C0 3 )](C104)4 (74 in Figure 1.27) 
showed a ds-I configuration of coordinated cyclam. The complex contains three 
independent [Cd(cyclam)]2+ units. Each unit has a distorted octahedral geometry of the 
cis-CdN402 set. Yet in CD3CN solution, it adopted a trans-I configuration as supported 
by ID and 2D ’H, i3C and 15N NMR studies 43(b) The rest of these 6 -coordinate Cd(II) 
complexes have the trans-1 coordinated ligand configuration.43^ '6’ Several Cd(II) 
complexes with coordination number five are also available.443’4415 These include a square 
pyramidal Cd(II) complex of cyclen, [{Cd(cyclen)} {Pt(CH3)2(bpy)}](ClC>4)2 (75 in 








Figure 1.28 The X-ray stmcture of [ {Cd-cyclen} {Pt(CH3)2(bpy)}](C104)2 (75).
Only several examples of Hg(II) complexes with cyclam, cyclen and their 
derivatives are available in the literature,45(a'c) including a pseudo-octahedral Hg(II) 
complex of a cyclam derivative in a c/s-folded (I) configuration (76 in Figure 1.29)45c 
In contrast to the Cd(II) complex with the same ligand (73), the Hg (II) complex o f cis-
26
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6,13-Dimethyl-1,4,8,11 -tetraazacyclotetradecane-6,13-diamine is an out-of cavity 
complex (77 in Figure 1.30)45b in which two separate molecular units co-exist. The first 
unit (77a in Figure 1.30) has two mercury ions chelated at the opposite sides o f the 
macrocycle and the second (77b in Figure 1.30) has the Hg(II) bound to each pendant 









Figure 1.30 The X-ray structure of the Hg(II) complex of L (77) ( L = 6,13- 
Dimethyl- 1,4,8,11 -tetra-azacyclotetradecane-6,13-diamine.
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1.4 Co(III) Complexes of Cyclen and its Derivatives.
Co(III) complexes are interesting because of their slow ligand-exchange 
reactions and particular affinity for nitrogen donors. Co(III) complexes of cyclen and its 
derivatives, as well as other polyamines, have also been studied as models for the active 
sites of Co(III) phosphate monoesterases, diesterases, and thiesterases.46(a"c) In 1993, 
Chin and his coworkers reported studies on the kinetics and mechanism of nitrile 
hydration catalyzed by a Co(III) cyclen complex, [Co(cyclen)(OH2)2](C104)3 (78 in 
Figure 1.31). Under mild conditions, 78 catalytically hydrated nitriles to amides at pH 7.
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Figure 1.31 Three Co(III) complexes 78, 79 and 80.
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The mechanism of this process involved a three-step cycle (Scheme 1.11)47 However, 
addition of 79 to benzonitrile yielded an isolable Co(III) complex of chelated 
benzonitrile (80) without any catalytic turnover. The authors believed that the two 
methyl groups in 80 prohibited the equilibrium between the bidentate and monodentate 
amide Co(III) complexes in Scheme 1.11. This led to the loss of catalytic hydration of 
benzonitrile by 79. This work clearly indicates that it is important for an enzyme model 
complex to have two cA-coordinating sites available in order to have catalytic activity. 
In the past ten years, Buckingham and his coworkers have explored the coordination 
chemistry of Co(III) cyclen and 1-methyl-cyclen (Mecyclen) complexes.48^  Treatment 
of [Co(Mecyclen)Cl2]Cl with S-alanine (S-AlaOH) gave a mixture of six 
[Co(Mecyclen)(S-AlaO)]2+ isomers out of eight possible isomers of this octahedral 
Co(III) complex (Figure 1.32).48(a) Using both cation ion exchange chromatography and 
recrystallization, five isomers (81, 82, 83, 84, 85) were isolated and structurally assigned 
through a combination of nOe and COSY 'H NMR spectroscopies in d6-DMSO solvent. 
The presence of separate N-H resonances was critical for the structural assignments by 
the *H NMR method. The X-ray structures of 81, 82 and 84 further confirmed these 
assignments. As shown for 81 in Figure 1.32, all three structures exhibited distorted 
octahedral coordination geometry around Co(III). One oxygen donor and one nitrogen 
donor from the chelating S-alanine and two secondary amine nitrogen donors from the 
cis-folded Mecyclen constituted the equatorial position and the two remaining amine 
nitrogen donors including the tertiary amine nitrogen donor took the axial positions. This 
group was also able to isolate and structurally characterize three cw-folded 
[Co(cyclen)(S-AlaO)]2+ (86, 87, 88) out of four possible isomers (Figure 1.33).48(f)
29
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81: syn(Me), 82: syn(Me), 83: syn(Me), jyn(Me),
syn(N),anti(0) anti(N),syn(0) syn(N),syn(0) anti(K),anti(0)
Me Me Me Me
84: anti(Me), 85: a«;i(Me), anti(Me), anti{Me),
syn(N),anti(Q) anti(N),syn(0) ^«(N),5>>n(0) anti(N),anti(0)
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Figure 1.33 The four possible configurational isomers of [Co(cyclen)(S-AlaO)] 2+
The separation and characterization of these isomers enabled the authors to investigate 
pathways for proton exchange at a coordinated secondary amine center (Scheme 1.12). 
The NHfND exchange rate constants (Scheme 1.13) for various NH protons in these 
isomers were obtained by following the decay of amine NH  signals as a function of time
30
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H
M— NR jR2 + OH'
M— NR iR2 + OH'
H
Scheme 1.12 Stepwise mechanism for proton exchange and inversion at a 
coordinated secondary amine center.
H % - H O D  e +DOD ?
M—NR]R2+ OD' „  M— NR jR2 t  > M -N R jR2 + OD'
Scheme 1.13 N/7/ND exchange at a coordinated secondary amine center.
by !H NMR using dilute DC1 solutions or D20  buffers at 25°C. The second-order rate 
constants of isomerization (Scheme 1.12) were monitored by the growth or decay of the
appropriate N Me signal. Ratios of these two rate constants suggested that the two
equatorial secondary amine centers in the coordinated cyclen were very susceptible to 
inversion. Interestingly, when equilibrium was reached at 25°C (1 ~ 0.1M), the 81: 82: 
83 ratios were 73:21:6 and the 86: 87: 88 ratios were 63:32:5.
1.5 Complexes of Cyclen, Cyclam and their Derivatives with Cu(II)
Copper(II) complexes of cyclen, cyclam and their derivatives commonly adopt 
six-coordinate elongated rhombic or tetragonal octahedral structure, or five-coordinate 
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A search of the Cambridge Crystallographic Database revealed hundreds o f X- 
ray structures of copper complexes with cyclam and its derivatives. The most common 
configuration is the most-stable rrans-III.22(a"c)’50(a~m) Here only selected references are 
listed with more discussed later. As expected, the majority of these Cu(II) complexes 
have a coordination number of six or five.22(a'c)’50(a'h) For example, complex cation 
[Cu(Cyclam)(MeCN)2]2+ (89) has a coordination number of six as revealed by its solid- 
state structure (Figure 1.34).50(a) The Cu(II) atom is coordinated by four nitrogen donors
Figure 1.34 The X-ray structure of [Cu(Cyclam)(MeCN)2]2+ (89).
from cyclam in the equatorial position and two weakly-coordinated acetonitriles in axial 
position of a distorted octahedral geometry. The X-ray structure of a five-coordinate 
Cu(II) complex with Me4cyclam is shown in Figure 1.35.22(d) The Cu(II) atom in this 
complex (90) has a slightly distorted square-pyramidal geometry. Several four- 
coordinate copper(II) complexes with cyclam derivatives have been structurally 
characterized. 50(l~m) These include a Cu complex of trans-6,\ 3-Diammonio-5,7,12,14- 
tetramethyl-cyclam (ligand 91) (Figure 1.36).50n Here, Cu(II) only coordinates to four
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Figure 1.35 The molecular structure of [Cu(Me4Cyclam)Br]Br (90).
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Figure 1.36 The molecular structure of a Cu(II) complex with trans-6,13- 
Diammonio-5,7,12,14-tetramethyl-cyclam (ligand 91).
cyclam nitrogen donors in a square-planar geometry whereas two primary amine groups 
from this potential hexadentate ligand are both protonated. Some Cu(II) complexes of 
cyclam and its derivatives with a trans-1 configuration have also been reported.50(g),51<-a‘h) 
For example, the X-ray structure (92) in Figure 1.37 features an azide bridging dinuclear
33
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Cu(II) complex of Me4cyclam. Very interestingly, in the presence of excess ligand, 
Cu(II) complex 92 comproportionated and isomerized to yield the trans-III isomer and 
copper metal in alkaline aqueous solutions.
92
Figure 1.37 The molecular structure of [Cu2(Me4Cyclam)2(l ,3-p-N3)]3+ (92).
93 0 (1 )
Figure 1.38 The molecular structure of [Cu(II)C193]+.
Several X-ray structures of copper(II) complexes with cyclam and its derivatives 
have also been found to adopt a trans-II configuration50(,l),52(a’d) including a Cu(II)
34
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
complex of ligand 93 in Figure 1.38.50(n) In this structure, Cu(II) is coordinated by four 
nitrogen donors from the macrocycle and one terminal chloride to form a square 
pyramidal geometry.
Several examples of the rarer cz's-folded Cu(II) cyclam complexes have also been 
reported.26(b),53(a'd) These include the X-ray structure of [Cu(tet bXo-SCeHUCC^)] (94) in 
Figure 1.39 (tet b = rac-5,7,7,12,14,14-Hexamethyl-cyclam and 0 -SC6H4CO2 = o- 
mercaptobenzoate). In this five-coordinate Cu(II) complex, coordinated ligand tet b 
adopted a c/s-folded (V) configuration. This is indicated by the N(l)-Cu-N(3) angle of 
170.8(4)° in the axial position and N(2)-Cu-N(4) angle of only 103.5(4)° in the 




Figure 1.39 The molecular structure of [Cu(tet b)(o-SC6H4C 02)] (94).
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There are more than thirty reported X-ray structures of Cu(II) complexes with 
cyclen and its derivatives. The majority of these adopt the trans-l configuration with a 
coordination number o f five or six.54^  The X-ray structure of a six-coordinate Cu(II) 
complex of a pyridylmethyl pendant-armed cyclen derivative (ligand 95) is shown in 
Figure 1.40.54(m) In this structure, Cu(II) is coordinated by four-nitrogen donors from the
Ct61
Figure 1.40 The X-ray structure of [Cu(II)95]2+.
Me4Cyclen
Figure 1.41 The X-ray structure of [Cu(Me4Cyclen)(H20)]2+ (96).
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cyclen ring and two nitrogen atoms of the four pyridyl groups. It has a severely-distorted 
octahedral geometry around the Cu(II) atom. The X-ray structure of a five-coordinate 
[Cu(Me4cyclen)H20]2+ (96) is shown in Figure 1.41.54(m) The copper atom has a square 
pyramidal geometry. An interesting Cu(II) complex of a bicyclic cyclen derivative 




Figure 1.42 The X-ray structure of [Cu(Cage L)]2+ (97).
et al..55 The five-coordinate Cu(II) atom is fully coordinated by this pentadentate 
macrocycle, adopting a trigonal bipyramidal coordination geometry.
CI6) C(B!
H O O C ^N  NC'COOH
HOOC^/N N^/CO O H
H4dota 0 ( 2 )
98
Figure 1.43 The X-ray structure of [Cu(H2dota)] (98).
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Only six-coordinate Cu(II) complexes of carboxylate-armed cyclen derivatives 
have their ligands in the c/s-I configuration. 56(a'c-) Those include a Cu(II) complex of a 
tetracarboxylate-substituted ligand H4dota (complex 98 in Figure L43).56(c) The 
coordination geometry of this complex is a pseudo-octahedron as evidenced by the 
N(ax)-Cu-N(ax) angle of only 152.6(3)° and the larger N(eq)-Cu-N(eq) angle o f 
105.0(3)°.
Compared to the relatively few Zn(II) complexes, numerous Cu(II) complexes 
featuring carboxylate and carbamoyl derivatives of cyclam have been 
reported. 5°w’53(d),57(a"o) In X-ray structures of most of these, all four nitrogen donor atoms 
from the macrocycle and two oxygen donors from the trans-III ligand generally 
coordinate to Cu(II) center in a distorted octahedral geometry.57^ ’^  This is illustrated by 
the X-ray of a Cu(II) complex of a dicarboxylate-functionalized cyclam (ligand 99 in 
Figure 1.44).50(l-> This structure shows that the coordinated ligand 99 adopts a trans-III
NH n T^C02H
99 \
Figure 1.44 The X-ray structure of complex [Cu(II)99](C104)2.
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[Cu(II)99] (C104)2
Scheme 1.14 Structural rearrangement [Cu(II)99](C104)2 in aqueous solution.
configuration and the Cu(II) atom is in trans-octahedral geometry as defined by the 
apical positions of two carboxylate arms. This Cu(II) atom is coordinated by the four 
nitrogen atoms of the macrocycle in the equatorial plane and the two carbonyl oxygens 
at the apical positions. Thus the two carboxylate groups from the macrocycle are in the 
protonated form while coordinating to the Cu(II) atom. The electronic spectra of this 
Cu(II) complex at different pH values are different. Specifically, it exhibited a broad 
band at 622 nm in aqueous solution whereas in 0.1 M HCIO4, this band shifted to 595 
nm. Such a change in electronic spectra can be explained by the equilibrium in Scheme 
1.14. A tetraamide-armed cyclam derivative (ligand 100) complex of Cu(II) (Figure 
1.45) showed a similar coordination geometry.57(a) Several Cu(II) complexes with 
carboxylate derivatives of cyclen have been structurally characterized.54(e),56<a'd)’58 Unlike 
complex 98 in Figure 1.43, the crystal structure of a Cu(II) complex with a trisubstituted 
carboxylate derivative of cyclen [Cu(HD03A)J (101 in Figure 1.46) revealed that this
co
coordinated cyclen derivative had an intermediate structure between trans-1 and cis-1. 
This is indicated by the pseudo-axial N-Cu-N bond angle of 138.5(1)° and pseudo- 
equatorial N-Cu-N angle of 115.5(2)°.
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Figure 1.46 The X-ray structure of [Cu(HD03A)] (101).
60Cu(II), 61Cu(II), 62Cu(II), 64Cu(II) and 67Cu(II) complexes have applications as 
radiopharmaceuticals.59 For success, their in vivo stability is a very important factor.59 
This requires their very high thermodynamic stability and especially kinetic inertness to 
avoid transchelation with in vivo biological ligands such as transferrin. For this purpose, 
Cu(II) complexes of cyclam or cyclen derivatives have been investigated.58,59 The 
possible relationship between their structures and in vivo stability were also studied.58,59 
The metabolic studies of Cu-64-labeled methanephosphonate derivatives of cyclen
40
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^  ""'I 102a (D02P): X, Y = H
V N 102b (D03P): X = H, Y = GH2PO(OH)2
(HO)2OP~V \ ____/ \  102c (D04P): X, Y = CH2PO(OH)2
Figure 1.47 Methanephosphonate derivatives of cyclen.
(102a, 102b and 102c in Figure 1.47) in rat liver by Anderson and her research group 
suggested that the D02P ligand (102a in Figure 1.47) may be the most promising of 
these because its complex was stable in rat serum out to 24 hours and had the most
optimal clearance through blood and liver among these three ligands.60 The authors
believed that this was due to the hexa-coordinate Cu(II)-D02P complex. This ligand 
may be used as a bifunctional chelator for copper radionuclides in radiotherapy.
1.6 Complexes of Cyclen, Cyclam and their Derivatives with Ga(III) and In (III).
C O
Both Ga(III) and In(III) are generally considered hard metal ions. Indium(III) 
has an ionic radius of 94 pm in six-coordinate complexes and gallium(III) has an ionic 
radius of 76 pm. Therefore, In(III) is slightly softer than Ga(III) and can also be 
considered a borderline metal ion. Ga(III) prefers to coordinate to harder oxygen donor 
ligands whereas In(III) prefers neutral nitrogen or negative sulfur donors. In the 
preparation of Ga(III) and In(III) coordination complexes, a problem that always exists 
is that the precipitation of Ga(OH)3 and In(OH)3 may occur more quickly than the 
complexation of Ga(III) or In(III) with ligands.59
The Ga(III) and In(III) complexes of macrocyclic tetraamines are potential 
precursors in III-V semiconductor epitaxy and porous hybrid materials.61^  Some
41
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organometallic complexes of Ga(III) and In(III) with cyclam and cyclen have been 
reported for this purpose.61(a),61(b),62(a"d) For example, an X-ray structure of 
[(CH3)GaCyclam]Cl2 (103 in Figure 1.48) showed that this six-coordinated Ga(III) is 
coordinated by four amino nitrogens from cyclam with the common trans-III geometry 
and one methyl and one weakly bonded chloride trans to it.62(a) Several gallium 
phosphate complexes of cyclam have been characterized as building blocks in the 
construction of mesoporous materials. Cyclam in these gallium complexes again adopts 








Figure 1.48 The X-ray structure of [(CH3)GaCycl am]Cl2 (103).
No well-characterized gallium and indium halide complexes of 
tetrazamacrocycles cyclam and cyclen have been reported. In 1981, Taylor et al. 
reported 1:2 In(III) complexes with cyclam. These In(III) complexes were formulated as 
[In(cyclam)2][InX4]3 (X=halide) but characterized only by In(III) and halogen elemental 
analyses.64 CHN elemental analyses of [In(cyclam)2] [InCfrJs, however, failed and no 
structural evidence was provided.
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104a: m=0, R= H 
104b: m=0, R =CH2COOH 
104c: m =l, R= H _
104d: m = l, R = -C H 2- < Q > -N 0 2
Figure 1.49 Cyclen and cyclam derivatives tested for potential metal-based 
radiopharmaceutical application by Kaden et al.
Ga(III) and In(III) complexes of pendant-armed cyclam and cyclen derivatives 
are of interest60 also because of their potential radiopharmaceutical application. 
66Ga(III), 67Ga(III), 68Ga(III), lu In(III), H3mIn(III), 86Y(III) and 86Y(III) are the relevant 
radioisotopes. Four carboxymethylated cyclen and cyclam derivatives shown in Figure 
1.49 (104a-104d) were synthesized by Kaden et al. The stability of their 151In(III) 
complexes in blood serum was measured and it was demonstrated that the In(III) 




Figure 1.50 The X-ray structure of an In(III) complex of a cyclen derivative, 
ligand 104a.
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complex (Figure 1.50) showed that the In(III) was hepta-coordinated by the four 
nitrogen atoms and the three carboxylate groups of ligand 104a, which adopted a trans-I 
configuration. The X-ray structure of the In(III) complex of 104c is very similar to that 
of 104a but it is less compact and symmetrical, which may cause have lowered the 
stability of this complex in serum.
Peptide HN
105 106
Figure 1.51 Two cyclen derivatives for bioconjugation towards potential metal-based 
radiopharmaceutical application.
More recently, the same research group found that both 67Ga(III) and 90Y- 
labelled cyclen-derivatized somatostatin analogue (ligand 105 in Figure 1.51) showed
66 67high in vivo stability and superb tumor-targeting properties. The Ga(III) complex of 
this cyclen-derivatized somatostatin analogue had much faster in vivo kidney clearance 
and higher tumor-targeting ability than the 90Y complex. The authors believed that the 
differences in the coordination chemistry of these two complexes caused the differences 
in biological behavior. In the X-ray structure (Figure 1.52) of the Ga(III) complex of a 
model ligand (106 in Figure 1.51), the Ga(III) center is hexa-coordinated by this en ­
folded macrocyclic ligand. The amide oxygen and one deprotonated carboxylate group 
are not coordinated to the metal. This structural feature likely contributed to the 
favorable handling of the radiopeptide by the kidneys. By contrast, in the structure
44
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Figure 1.53 The X-ray structure of an Y(III) complex of 
a cyclen derivative, ligand 106.
(Figure 1.53) of the Y(III) complex of this model ligand, the Y(III) center was octa- 
coordinated by all four amine nitrogens, the amide oxygen and all three carboxylate
45
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groups. Assuming that the Y(III) complex of the original cyclen-derivatized somatostatin 
analogue (105 in Figure 1.51) had the same coordination geometry, this would force the 
chelator closer to the peptide and thus introduce steric strain, possibly disturbing the 
proper spatial arrangement of the targeting peptide. Besides this research by Kaden’s 
group, several pendant-armed derivatives of cyclam and cyclen have been also 
investigated by others for this purpose.67(a)’67(b-) However, fully characterized Ga(III) and 
In(III) complexes of pendant-armed cyclam and cyclen derivatives are still rare.
2. Coordination Chemistry of Cross-bridged Tetraazamacrocyclic Ligands
An important concept in macrocyclic chemistry is the ligand/cation size match 
selectivity, which means that a macrocyclic ligand may complex best with metal ions 
that fits best into the cavity of the macrocycles. Macrocyclic polyamines such as cyclam 
and cyclen have thus been structurally reinforced for this purpose. Wainwright made a 
structural modification to the parent cyclam and cyclen ligands in which two adjacent 
nitrogens were bridged with an ethylene unit (Figure 1.54). This adjacent-bridging 
ethylene increased the tendency towards trans-coordination of transition metal
ions. 68(a),68(b)
H. /  \  M
Figure 1.54 Adjacent-bridged cyclam and cyclen.
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2.1 Ethylene Cross-bridged Tetraazamacrocyclic Ligands.
Cross-bridging of tetraazamacrocyclic ligands with an ethylene unit formed a 
new family ofbicyclic tetraamine ligands (Figure 1.55) which were first designed and
m=l, n=l, R = H, ligand 1 m=l, n=l, R = Me, ligand 107
m=0, n=0, R = H, ligand 2 m=0, n=0, R = Me, ligand 108
m=l, n=l, R = Bn, ligand 3 m=0, n=l, R = Me, ligand 109
m=0, n=0, R = Bn, ligand 4 m=0, n = l, R = H, ligand 110
m=l, n-1, R =CH2CONH2, ligand 5 
m=0, n=0, R =CH2CONH2, ligand 6 
m=l, n=l, R =CH2COOH, ligand 7 
m=0, n=0, R =CH2COOH, ligand 8
Figure 1.55 Cross-bridged ligands used to form metal complexes.
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Scheme 1.15 General synthetic route to make cross-bridged ligands.
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synthesized by Weisman, Wong and coworkers.18,19 A typical procedure of making these 
cross-bridged ligands is shown in Scheme 1.15,69(a),69(b) by which ligands 1, 3 and 7 were
nr\
synthesized. Ligand 108 was also produced by a less efficient route (Scheme 1.16). 
Ligand 2 has also been synthesized using the much less efficient Schmidtchen method
Q P
HjCP  kH  7 - f  H’> Q ,  B2H6 “ P n  M
Cl Cl
u 'N N ° N k  N\
H \  I CH3 \  / CH3 \ ____/  L H 3
108














3 .  H +
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Scheme 1.17 An alterative method to sythesize ligand 2.
(Scheme 1.17).71 Cross-bridging cyclam or cyclen with an ethylene was anticipated to 
result in a higher kinetic inertness of metal complexes than those of the parent cyclam or 
cyclen complexes as a consequence of the highly-favored cA-folded (cis-V) ligand 
coordination mode. This binds a metal cation within a ligand’s molecular cleft using all 
four convergent nitrogen lone pairs (Figure 1.56) and deters common decomplexation 
pathways. Consistent with the design by Weisman, Wong and coworkers, this family of
48
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ligands (Figure 1.55), as shown by the Wong/Weisman group and others, yielded very
Competition NMR experiment studies indicated that the binding of Li (I) to ligand 107 
was about 10,000 times better than Na(I).18,19 Another common property of these cross­
bridged ligands is their strong basicity.
Figure 1.56 Cz's-folded configuration (V) adopted by cross-bridged 
ligands in their metal complexes.
To date, the metal ions successfully complexed with these ethylene cross-bridged 
ligands include Li(I), Cu(II), Cu(I), Ni(II), Co(II), Co(III), Fe(II), Fe(III), Mn(II), 
Mn(III), Ga(III), In(III), Pd(II) and Zn(II).76 All structural and spectral studies of metal 
complexes of cross-bridged ligands in the literature have affirmed this single 
coordination mode in which octahedral, trigonal bipyramidal, square pyramidal and 
tetrahedral geometries were observed. To describe the “fit” of a metal ion within the 
cavity formed by a coordinated cross-bridged ligand, the axial bond angle between the 
non-bridged nitrogen atoms through the metal ion, the Nax-M-Nax bond angle (Figure 
1.57) as well as the Neq-M-Neq bond angle are very useful. In five- or six-coordinate 
metal complexes, the closer the Nax-M-Nax angle is to linearity, the better of the metal
72 75stable complexes with many many group as well as first-row transition metal cations.
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Figure 1.57 Equatorial and axial nitrogen atoms are labled as Neq and 














Figure 1.58 The X-ray structure of a Cu(II) complex of ligand 1.
ion fits inside a cross-bridged ligand’s cavity. Our research group has reported the 
syntheses and characterization of Cu(II) complexes of ligands 1, 3, 5 and 7.18,69 The X- 
ray structures of [Cu(l)(C104)]C104 (Figure 1.58), [Cu(1)C1]C1(H20)3 and
[Cu(3)C1]C1(H20) (Figure 1.59) all exhibit five-coordinate Cu(II). The coordination 
geometries of [Cu(l)(C104)]C104 and [Cu(1)C1]C1(H20)3 lie between the idealized
50
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Figure 1.59 The X-ray structure of a Cu(II) complex of ligand 3.
Figure 1.60 The X-ray structure of a Cu(II) complex of ligand 7-2H.
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square pyramidal and the trigonal bipyramidal. The most striking crystal structure is that 
of a six-coordinated Cu(II) complex of deprotonated ligand 7, [Cu®(7-2H)Na(H20 )  
C104]2(H20) (Figure 1.60). This is currently the only structurally-characterized metal 
complex of any pendant-armed cross-bridged ligand in the literature. Here, Cu(II) 
coordinates to a distorted octahedral N4O2 donor set from 7 and is fully engulfed within 
the cavity formed as indicated by the Nax-Cu-Nax bond angle o f 179.7(3)°. The synthesis
72and characterization of two six-coordinated Zn(II) complexes of ligand 1 and four six- 
coordinated Ga(III) and In(III) complexes of ligands 1 and 2 in this thesis were
77 73 74communicated recently. In contrast to what was claimed in Busch’s work, ’ these 
Zn(II) complexes of ligand 1 were readily synthesized in the protic solvent methanol. 
The structures of [Zn® 1 (OH2Xp-Cl)ZnCl3], dimeric [Zn®l(p,-C1)]2C12(CH3 0 H)4 (Figure 
1.61) and [GaCl2*l]Cl all present slightly distorted octahedral coordination geometries 
whereas [InBr2*2]Br (Figure 1.62) has a more distorted octahedral geometry as 














Figure 1.61 The X-ray structure of the dimeric Zn(Il) complex of ligand 1.
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Figure 1.62 The X-ray structure of an In(III) complex of ligand 2.
Figure 1.63 The X-ray structure of [Cu(II)Cl® 107]
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Since 1998, Busch and his coworkers have reported the syntheses and structural 
characterization of several Mn(II), Mn(III), Fe(II), Fe(III), Co(II), Co(III), Ni(II), Cu(I), 
Cu(II) and Pd(II) complexes of ligands 1, 2, 3, 4,107 and 108. A common feature for the 
syntheses of these complexes was the use of an aprotic solvent, anhydrous MeCN or 
DMF. The X-ray structure of the six-coordinate M nCh'lO? showed a distorted 
octahedral geometry.73 It was noted that the kinetic stability o f Cu(II) complex of 107 
was at least eight orders of magnitude larger than that of Cu(II) complex of Me4cyclam. 
Meztcyclam is the closest unbridged analogue of 107. The X-ray structure of a Cu(II) 
complex of 107, [Cu(II)CM07]PF6 was later shown to be penta-coordinate (Figure 
1.63).74 Busch’s group also communicated the solid-state structures of a rare tetra-
q C3Q
Figure 1.64 The X-ray structure of [Cu(I)*3]+.
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coordinated [Cu(I)*3]PF6 (Figure 1.64) and penta-coordinated [Pd(II)Cl*107]Cl(H2O) in 
















Figure 1.65 The X-ray structure of [Cu(II)(MeCN)®3]+.
severely-distorted tetrahedral geometry with both benzyl groups folded toward the metal 
ion. In 2000, they detailed the syntheses and characterization of Mn(II) and Fe(II) 
complexes of ligands 107 and 108.75 These six-coordinate complexes include 
MnCl2*107, MnCl2*108, FeCl2*107 and FeCl2*108. The structural data (Table 1.1, vide 
infra) of these complexes revealed that the 14-membered macrobicycle in 107 engulfed 
the metal ion more fully than that of 12-membered macrobicycle in 108. To study the 
kinetic stability of the paramagnetic complex, MnCl2*9, its protonation in 1 M DC1 was 
monitored by measuring the integrated intensity of the protonated 107 in ]H NMR
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spectra as a function of time. The dissociation of 107 from Mn(II) had a rate that is 12 
orders of magnitude slower than the rate of water exchange from the hydrated Mn(II) 
ion. In 2001, the syntheses and characterization of Mn(III) and Fe(III) complexes of 
ligands 107 and 108 were also reported. These Mn(III) and Fe(III) complexes were 
produced from the oxidation of respective Mn(II) and Fe(II) complexes. In aqueous 
solution, as suggested by conductance measurement, [MnCl2*107]PF6 was presented as 
[Mn(H2O)2*107]3+. Titration data of this complex provided pATa’s o f 1.6(2) and 5.87(2), 
which were larger than the first two pXa’s of [Mn»(H20)6]3+ (0.82 and 0.94 respectively). 
X-ray structures of six-coordinated Ni(II) complexes, [Ni(H20)2*107] CI2,
[Ni(acac)®107][Ni(acac)3]THF and [Ni(acac)*108][Ni(acac)3]THF were also reported.81 
The latter two Ni(II) complexes are the rare published examples of any metal ion that is 
hexa-coordinated by four nitrogen donors from a cross-bridged ligand as well as two 
donors from a bidentate ligand.
Figure 1.66 A cross-bridged ligand, 111.
In 2002, the structures of six-coordinated CoCl2*107, CoCl2*108 and 
[CoCl2*108]PF6 were reported.82 Even more recently, they synthesized and structurally 
characterized Mn(CF3SC>3)2#3, MnCl2®4, FeCl2*4, [ 1 •FeCl(p-0)ClFe* 1 ]C^EtCfb and
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[2«FeCl(^-0)ClFe®2]Cl2(H20)2.83 The metal centers in these metal complexes all were 
found to adopt the distorted octahedron coordination geometry. A structural modified 
cross-bridged ligand 111 (Figure 1.66) was also synthesized by Busch’s group. X-ray 
structures of five-coordinate metal complexes, [CoCl• 11 l^CoCLt),82 [NiCM ll]PF6,81 
and [CuCM 1 1 ]PF674 have been reported. A summary of the Nax-Cu-Nax bond angles and 
the Neq-Cu-Neq bond angles of the complexes reported by both Busch and us is listed in 
Table 1.1.
As discussed above, due to their high kinetic stabilities, metal complexes of
• 84cross-bridged ligands have potential application in areas including radiopharmaceutical
85 86and oxidation catalysis research ’ .
Studies by our collaborator, Dr. Carolyn Anderson and her group at Washington 
University have revealed that the 64Cu(II) complex of the dicarboxylate-armed ligand, 7 
has high in vivo stability.84 This Cu(II) complex is much more stable in vivo than the 
64Cu(II) complex of 1,4,8,11 -tetraazacclotetradecane-1,4,8,11 -tetraacetic acid (TETA). It 
survived in serum for days and showed fast clearance from all tissues and organs in 
normal rats. This indicates that bioconjugated ligand 7 derivatives labeled with copper 
radionuclides may well have potential applications in diagnostic imaging and targeted 
radiotherapy. The Busch group has been interested in the oxidation catalysis application 
of their metal complexes.75,80,85,86 They reported that MnCl2*107 reacted with oxidizing 
agents to form the Mn(IV)*107 complex. Unlike the metalloporphyrins, in the presence 
of MnCl2*9 at pH 10, significant oxidation of carbamazepine was observed to produce 
the sole product, epoxide, in 7.3 % yield using H2O2 as the oxidizing agent. Under the 
same conditions, the hydrogen abstraction reaction with 1,4-cyclohexadiene to form
57
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1.1 Comparison of the 'fit' of metal ions inside cross-bridged ligands.








MnCl2*107 Severely distorted Oh 158.0(2)° 75.6 (2)° 75
MnCl2.108 Severely distorted Oj, 144.0(2)° 73.7 (2)° 75
Mn(CF3S 03)?3 Distorted O], 165.25 (10)° 79.40(14)° 83
MnCl2®4 Severely distorted Oj, 144.30(6)° 74.56 (8)° 83 '
[MnCl2"107]PF6 Distorted Oj, 170.1 (2)° 81.7(7)° 80
[MnCl2-108]PF6 Severely distorted Oh 155.01 (11)° 81.29(11)° 80
FeCl2 >107 Distorted Oj, 161.88 (5)° 78.36 (5)° 75
FeCl2 408 Severely distorted 0 |, 145.78 (7)° 77.31 (7)° 75
FeCl2.4 Severely distorted 0|, 147.71 (8)° 76.92 (9)° 83
[l-FeCl(n-0)ClFe‘l]C l2(H20 ) 3 Distorted Of, 159.6 (2)° 79.2 (2)° 83
[> FeCl((j.-0)ClFe*2]Cl2(H2O)2 Severely distorted Oj, 146.8 (2)° 77.7 (2)° 83
CoCl2*107 Distorted Oh 172.4 (2)° 81.11 (13)° 82
CoC12*108 Severely distorted Oj, 149.81 (9)° 80.86 (8)° 82
[CoC12-108]PF6 Distorted Oj, 168.8(4)° 87.2 (4)° 82
[Ni(H2O)2*107]Cl2 Distorted Oh 175.39(5)° 85.56 (5)° 81
[Ni(acac) ®9][Ni(acac)3]THF Distorted Oh 174.56(10)° 84.84 (9)° 81
[Ni(acac) ” 108][N i(acac)3]THF Distorted Oj, 161.58(13)° 81.61 (13)° 81
[CuC14]Cl(H20 )3 Halfway between SP and TBPY 176.9 (2)° 87.8 (2)° 69(a)
[Cu(C104)*l]C104 Halfway between SP and TBPY 179.7(3)° 88.5 (3)° 69(a)
[CuCl *3]C1(H20 ) Distorted SP 176.0(2)° 86.1 (1)° 69(a)
[Cu *3]p f 6 Severely distorted Tj 171.85 (5)° 85.17(5)° 78
[Cu(CH3CN)®3](PF6)2 Distorted SP 177.34 (9)° 86.96(10)° 78
[CuC1®107]PF6 Halfway between SP and TBPY 175.16(13)° 85.30(12)° 74




[Zn®l(p-01)]2C12(CH30H )4 Distorted Oh 168.7 (3)° 84.5 (2)° 72
[GaClfl]Cl Distorted Oh 169.33 (7)° 84.17(7)° 77
[InBrf 2]Br Severely distorted Oj, 143.95(12)° 76.78 (12)° 77
ax
N m =l, n=T, R =  H, ligand 1 
m=0, n=0, R = H, ligand 2 
m =l, n=l, R =  Bn, ligand 3 
m=0, n=0, R = Bn, ligand 4
m =l, n=l, R = Me, ligand 107 
m=0, n=0, R = Me, ligand 108
58
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.











[PdCM07]PF6(H2O)2 Distorted SP 171.65(11)° 80.12(10)° 79
[CuBrllO]C104 Distorted SP 176.3 (2)° OO N> 0 88
[CoCl* l l l ] 2(CoCl4) Distorted TBPY 175.0 (6)° 89.3 (5)° 82
[CuCM11]PF6 Distorted TBPY 175.14(8)° 87.51 (8)° 74





m =l, n= l, R = CH2COOH, ligand 7 
m =l, n=l, R = Me, ligand 107 




benzene in 63.2% yield. These results revealed that this Mn(IV)*107 complex is a 
selective catalyst which showed moderate catalytic activity in oxygen transfer and much 
higher catalytic activity in hydrogen abstraction reactions. This is relevant to the
7 c  Oft o c  o z
development of bleaching agent technology. ’ ’ ’
07
An alterative procedure to make ligand 110 was reported by Springborg et al.. 
Reaction of 1,4,7-triazacyclononane with tris(3 -chloropropyl)amine afforded the inside 
monoprotonated form of the tricyclic amine 1,4,8,12-tetraazatricyclo[6.6.3.24,12] 
nonadecane, which was then treated with concentrated boiling hydrochloric acid to cause 
a slow cleavage of one trimethylene bridge to give triprotonated ligand 110 salt in 40% 
yield (Scheme 1.18). In 2001, they also reported the synthesis and X-ray structure of a 
five-coordinated Cu(II) complex, [CuBr*110]ClC>4.88
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Scheme 1.18 An alterative method to synthesize ligand 110.
2.2 Other Cross-bridged Tetraazamacrocyclic Ligands.
Very recently, Springborg reviewed the coordination chemistry of cross-bridged 
tetraazamacrocyclic ligands.76 Springborg et al. have used the reaction of the ditosylate 
of 1,3-propane diol with cyclen {tram ditosylated) to prepare three tri-methylene cross­
bridged ligands, 112, 113 and 114 (Figure 1.67). Cu(II), Co(II), Co(III) and Ni(II) 
complexes of 112 and 114 have been synthesized and characterized by his group.
j  n " h O - h  r ^ i . H) Ch d c v i>
112 113 114
Figure 1.67 Trimethylene cross-bridged ligands.
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Figure 1.68 The X-ray structure of a Cu(II) complex of ligand 114.
In 1997, Springborg and his coworkers reported two Cu(II) complexes, 
[CuBr*112]C104 and [CuI*112]I. As shown by their crystal structures, the coordination 
geometry of [CuBr»112]C104 can be described as being halfway between trigonal 
bipyramidal and square pyramidal whereas the coordination geometry of [CuI*112]I is a 
distorted trigonal bipyramid.89 In a basic carbonate buffer, [CuBr*112]ClC>4 existed as 
[CuOH»112]+, which reacted with carbonate to form a trinuclear Cu(II) complex, 
[(Cu*112)3(p3-C0 3 )](C104)4(H2 0 )2.90 Their work further revealed that the cleavage of 
copper(II) nitrogen bonds in a penta-coordinated [CuBr*112]ClC>4, has a half-life of 130 
hours in 5 N HC1.88 More recently, [CuBr*114]C104 was synthesized and shown to have
OQ
a trigonal bipyramidal geometry (Figure 1.68).
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Two dinuclear Ni(II) complexes, [(Ni»112)2(p-Br)2](ClC>4)2 and [(Ni»112)2(p- 
C1)2](C104)2 were also synthesized and characterized. The dinuclear structure of 
[(Ni*112)2(p-Cl)2](C104)2, which is similar to that of dinuclear [Zn°l(p-Cl)]2Cl2 
(CH3OH)4 (Figure 1.61), was determined by a single-crystal X-ray analysis.91 [Ni(p- 
Br)2*112](C104)2 was formed from the reaction of anhydrous NiBr2 with 112 in 
anhydrous DMF. In dilute aqueous solution, both Ni(II) complexes exist as [Ni 
(H2 0 )2*112]2+ which was isolated as [Ni(H2 0 )2*112]S2CV2H2 0 . Two additional Ni(II) 
complexes, [Ni(t]2-N0 2 )*112]PF6 and [Ni(r|2-N03 )®112]PF6 were obtained by the 
reaction of [N iC H ^ O ^ 'lO ^ C ^ I^ O  with nitrite and nitrate respectively. The 
coordination geometry about Ni(II) in all five of these complexes is a distorted 
octahedron. In contrast to the use of anhydrous conditions in the synthesis of 
[(Ni*112)2(p-Br)2](ClC>4)2, [Ni(r|2-N0 3 )*114]N0 3 was obtained using the hydrated salt
on
and 114 with ethanol as the reaction solvent. The authors found that maintenance of 
excess metal ions was crucial to the high yields of this purple complex which was 
structurally characterized as a six-coordinated chelated nitrate complex. In the syntheses 
of five-coordinate [NiCl*114]Cl and [NiBr*114]Br each with a trigonal bipyramidal 
coordination geometry, methoxyethanol was found to be the optimal reaction solvent. 
Treatment of [NiCl*114]Cl with dilute perchlorate acid yielded the blue chelated 
perchlorate complex, [Ni(r|2-C104)*114]C104.
Springborg and his coworkers also prepared several Co(II) complexes o f ligand 
114.88 The reaction of CoCl2*6H2 0  with free ligand in methoxyethanol produced a high 
yield (83%) of [CoCl*114]Cl, which has a trigonal bipyramidal geometry. The crystal 
structure of this complex is similar to that of [CuBr*114]Br. Complex [CoCl®114]Cl
62
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
formed a five-coordinate [CoCl*114]+ in 12M HC1 and a six-coordinate [CoXY*114]n+ 
(X, Y = Cf or MeOH and n = 0, 1 or 2) in MeOH. Both a six-coordinate pale green 
diaqua complex, [Co(H20 )2* 1 and a four-coordinated pink
[Co*114][ZnCl4] were isolated from two different aqueous solutions. The proposed 
structure of the pale green complex as the six-coordinated [Co(H2 0 )2* 114](C1C>4)2*H20 
was based upon spectral data. The X-ray of [Co*114][ZnCl4] (Figure 1.69) revealed a
Figure 1.69 The X-ray structure of a Co(II) complex o f ligand 114.
distorted tetrahedral coordination, which was also observed in [Zn*114][ZnCl4]. The 
high flexibility of this ligand is indicated by the dramatic change of the bond angle 
between the two non-bridging nitrogen atoms at Co(II), which is 126.22(11)° in four- 
coordinate [Co*114][ZnCl4] and is 173.08(9)° in five-coordinate [Co*114Cl]Cl. Very
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[CoCl-114]Cl Distorted TBPY 173.08 (9)° 87.78 (6)° 88
[C o .ll4 (r |2-C 0 3)]AsF6 Distorted Otl 176.8(3)° 103.0(2)° 92
[Co(ti2-S 04)-114]A sF6(H20 ) Distorted 0 )t 176.02(15)° 103.69 (15)° 92
[Co(t|2-HC 03)"l 14](ZnBr4)(H20 ) Distorted Oh 177.7 (4)° 103.4 (4)° 92
[(Ni-112)2(p-Cl)2](C104)2 Distorted Oh 166.2 (2)° 94.3 (2)° 91
[Ni(r|2-N02)*112]PF4 Distorted Oh 170.0(2)° 99.0 (2)° 91
[Ni(r|2-N 03)412]PF4 Distorted Oh 170.14 (9)° 98.46 (8)° 91
[Ni(H20 )2»112]S20 6(H20 ) 2 Distorted Oh 168.43 (5)° 94.88 (5)° 91
[NiC1414]Cl Distorted TBPY 173.87(12)° 87.90 (8)° 88
[NiBr414]Br Distorted TBPY 174.15 (8)° 87.95 (6)° 88
[Ni(ri2-N 03)*114]N03 Distorted Oh 176.5 (2)° 105.9 (2)° 88
[Ni(t12-C104)*114]C104 Distorted Oh 177.34(10)° 106.41 (9)° 88
[CuBr412]C104 Halfway between SP and TBPY 170.5 (4)° 99.0 (3)° 89
[CuM12]l Distorted TBPY 170 (2)° 103 (2)° 89
t(Cu* 112)3(p3-C 0 3)](C104)4(H20 ) 2 Distorted TBPY 169.0 (2)° 98.0 (2)° 90
[CuBi»114]Br Distorted TBPY 174.8(2)° 88.12 (12)° 88
interestingly, unlike most polyamine Co(II) complexes, [Co*114][ZnCl4] is not oxidized 
to a Co(III) complex by air. A purple Co(III) complex, [Co(r|2-C0 3 )* 114] Cl was thus 
prepared by the reaction of 114 with a Co(III) compound, [Co(py)3(r|2-C03)Cl] in 
ethanol.92 When this reaction was carried out in perchloric acid, a blue complex [Co(r|2- 
HC0 3 )»114][ZnBr4]”H20  was isolated. This is a rare example of a complex with a
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chelated bound hydrogen carbonate. While in H2SO4, a turquoise Co(III) complex, 
[Co(r|2-S04) *114] AsF6*H20  was obtained. The Nax-Cu-Nax bond angles and the Neq- 
Cu-Ngq bond angles of the complexes reported by Springborg are summarized in Table 
1.2.
The kinetic inertness of these metal complexes of ligands 112 and 114 were 
studied in 5 N HC1 by Springborg. Data for these acid decomplexations are shown in 
Table 1.3. For comparison, the kinetic data of acidic decomplexation of [CuCl*110]+ in 
5N FIC1 is also included. The rate of cleavage in these metal complexes of 114 increased 
in the order Ni(II) < Cu(II) < Zn(II) < Co(II).
Table 1.3 Kinetic data for the acid decomplexation of metal complexes of some cross­
bridged ligands in 5N HC1 reported by Springborg.
Complex ^ c le a v a g  J  S AH/Y3 mol'1 AS/1 moF’K'1 Ref.
[Cu»112Cl]+ 1.48(2) x 10'b 89(6) -60(14) 91
[Cu’llO C lf 1.79(5) x 10"b 93(4) -42(9) 91
[Cu*114Cl]+ 2.28(6) x 1 O'7 121(4) 32(14) 91
[NM12(H20 )2]+ 1.7(9) x 1 O’9 110(5) -45(15) 88
[Ni*114Cl]+ 1.4(6) x 1 O'9 126(6) 8(17) 91
[Co*114]+ 1.12(2 ) x 10'4 84(2) -39(15) 91
[Zn*114]+ 1.60(6) x 1 O'4 82(2) -44(7) 91
The synthesis of tetra-, penta-, hepta-93,94,95 and octa-methylene96,97,98 cross­
bridged ligands (Figure 1.70) have been also reported. Their coordination chemistry has 
been unexplored so far.
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n -(c h 2) - n
n -{ch2)7N
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H
n=0 and 1
Figure 1.70 Tetra-, penta-, hepta-, octa-methylene cross-bridged ligands.
3. General Aspects of this Dissertation.
As mentioned above, this doctoral dissertation research has focused on the 
synthesis and characterization of Cu(II), Ga(III), In(III), Zn(II), Cd(II) and Hg(II) 
complexes of eight cross-bridged ligands (Figure 1.1). In order to synthesize their metal 
complexes, these eight ligands were prepared according to procedures that were 
originally worked out by other research group members. Metal complexes were then
13 isynthesized and characterized by elemental analyses, IR (KBr), proton and C{ H} 
NMR (or electronic spectra) and other spectroscopic techniques as well as single crystal 
X-ray structural analyses where appropriate. The investigation of the kinetic stability in 
acidic aqueous solution of selected complexes was then carried out.
Because of their potential radiopharmaceutical application, our research group 
have been interested in Cu(II), Ga(III) and In(III) complexes of these cross-bridged 
ligands, especially those with pendant-arms. In the past several years, we have 
cooperated with Dr Carolyn Anderson’s research group in the medical school at
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Washington University, St. Louis, on the synthesis of novel cross-bridged tetraamines, 
their metal complexes, assays of their kinetic stability, and the evaluation of their 
efficacy as carriers o f cancer diagnostic and therapeutic copper, gallium, and indium 
radionuclides. As a result of the high basicity and consequent proton-sponge behavior of
18 81 84these cross-bridged ligands, ’ ’ determination of the thermodynamic stability 
constants of their metal complexes in aqueous solution is problematic.81,84 Studies of 
their kinetic stability are however possible. By studying their relative kinetic stabilities, 
we hoped to select the best candidate ligands for stable radionuclide carriers. In aqueous 
solution, the kinetic stability of a metal complex is reflected by the rate constant of its 
acidic decomplexation process. If pseudo-first-order reaction conditions are adopted, a 
complex’s kinetic stability is directly related to the half-life of this decomplexation 
process. Therefore, the best candidate ligands for stable radionuclide carriers are those 
forming the longest half-life metal complexes in acidic aqueous solution.
Since Ga(III) and In(III) are diamagnetic, the kinetic stabilities o f their 
complexes in acidic solution can thus be readily evaluated by using NMR techniques. 
NMR techniques can not be used to monitor kinetic stability of Cu(II) complexes. 
Different d-d electronic transition maxima are expected for complexed and decomplexed 
Cu(II), so acidic decomplexation can be followed spectrophotometrically in the UV-Vis 
region (370-800 nm).
We are also interested in Zn(II), Cd(II) and Hg(II) complexes of these ligands for 
several reasons. As shown in this introduction, macrocyclic tetraamine Zn(II) complexes 
can play an important role in bioinorganic chemistry. ' Coordination chemistry of 
these cz',s-folded cross-bridged tetraamine Zn(II) complexes may provide useful basic
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information for entry into this field. Zn(II), Cd(II) and Hg(II) are in the Group 2B triad 
o f J-metals. They range from the smallest zinc(II) (six-coordinate ionic radius 88 pm) of 
borderline hardness through cadmium(II) (ionic radius 109 pm) to the soft mercury(II) 
(ionic radius 116 pm), presenting a useful series for studying variations in coordination 
preferences. The well-known propensity of Hg(II) to adopt lower coordination numbers 
may also provide alternate ligand binding modes. The diamagnetic nature of these 
Zn(II), Cd(II), and Hg(II) complexes renders them amenable to NMR spectroscopic 
studies. In acidic aqueous solution, their NMR spectra can be used to deduce the 
decomplexation rates. Their kinetic stabilities can then be correlated to the fit o f a metal
1 13 1ion in a cross-bridged ligand as shown by their solid-state structures. H and C{ H} 
NMR spectra of these Zn(II), Cd(II) and Hg(II) complexes can also help identify the 
solution structures. For robust Cd(II) and Hg(II) complexes, additional structural insight
1 13could also be obtained from observations of H and C coupling to their NMR-active 
isotopes (I = 1/2: 1HCd, 12.75% natural abundance, 13Cd, 12.26%; and 199Hg, 
16.84%).99'103
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CHAPTER II
Zn(II), Cd(II) AND Hg(II) COMPLEXES OF CROSS-BRIDGED
TETRAAZAM ACROCYCLIC LIGANDS 1-4
1. Synthesis and Characterization of Zn(II), Cd(II) and Hg(II) Complexes.
1.1 General Synthetic Methods.
Twenty Zn(II), Cd(II) and Hg(II) complexes of the parent and N, N'-Dibenzyl- 
substituted cross-bridged ligands (1, 2, 3, 4 in Figure 2.1) were synthesized and 
characterized by their IR, ]H and 13C NMR spectral data as well as CHN elemental
Figure 2.1 Cross-bridged ligands 1-4.
analyses. An additional complex, ( H g C b V ^  (135) was isolated unexpectedly but only 
characterized by its X-ray structure. In general, these metal complexes were prepared by 
refluxing a methanol or MeCN solution of the appropriate metal salt and an equivalent 
amount of cross-bridged ligand for a period from several hours to several days. Crystals
N C ph
Ph-JV N
1 2 3 4
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of the resulting complexes suitable for X-ray analyses were typically obtained by diethyl 
ether diffusion into a solution of the crude product in methanol, Me0 H/H2 0  mixture, or
72chloroform. As mentioned in our previous communication, specific reaction conditions 
are metal- and ligand-dependent.
1.2 Synthesis of Zn(II) and Cd(II) Complexes.
Zn(II) and Cd(II) complexes of ligands 1 and 2 were readily formed in MeOH in 
reasonable yields (64% - 98%) even when hydrated Zn(II) and Cd(II) salts were used as 
reactants.
However, attempted complexation of metal hydrate salts of Zn(II) and Cd(II) with 
ligands 3 and 4 yielded mainly protonated ligands as indicated by the presence of a broad 
NH stretch of R3NH+ between 2450 and 2700 cm'1 in the IR spectra and a protonated NH  
resonance of RaNH+ at 8 larger than 9 in the ]H NMR spectra of the products. For 
example, the unsuccessful complexation product of Zn(C104)2*6H2 0  with ligand 3 is a 
monoprotonated 3. Its IR (KBr) spectrum is shown in Figure 2.2(a). For comparison, the 
IR (KBr) spectrum of ZnCl2*3 is shown in Figure 2.2(b). The obvious difference 
between these two spectra is the presence of medium intensity band around 2600 cm'1 
indicated by an arrow in Figure 2.2(a). In this spectrum, there is also a strong and broad 
perchlorate band around 1100 cm'1. This indicates that this monoprotonated ligand is 
probably [H3]+[C1C>4]'. The ]H NMR spectrum of monoprotonated 3 obtained from this 
failed complexation was also compared to that of ZnCl2*3 in the same solvent, J^-DMSO 
(Figure 2.3). Clearly, the downfield singlet at 8 10.4 of the monoprotonated 3 can be 
seen. There are several possible explanations for this problem. One is that the basicity of
70
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Figure 2.2(a) The IR (KBr) spectrum of monoprotonated 3 obtained from the failed 
complexation of Zn(C104)2*6H2 0  with ligand 3.
b o o400Q 3600 3 2 0 0  2800 2400 2 0 0 0  1BOO 3 000 1400 1200 lOOO BOO
tfovenumber*
Figure 2.2(b) The IR (KBr) spectrum of ZnCl2*3 .
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3.0 2 . 5  2.08.5
Figure 2.3 The JH NMR spectra of monoprotonated 3 obtained from the failed 
complexation of Zn(C104)2*6H2 0  with ligand 3 and ZnCl2*3 . The top one is that of 
monoprotonated 3 in J^-DMSO and the bottom one is that of ZnCl2*3 in tfg-DMSO.
ligand 3 is higher than that of ligand 1 and the basicity of ligands 4 is probably higher 
than that of ligand 2. The other is that the precipitating of protonated ligands 3 and 4 from 
the reaction solvent prevented successful complexation. Since ligand 1 (or 2) has two 
secondary amine nitrogen donors whereas ligand 3 (or 4) only has four tertiary amine 
nitrogen donors, Zn(II) and Cd(II) complexes of ligand 1 (or 2) may also be 
thermodynamically more stable than related Zn(II) complexes of ligand 3 (or 4).104
In the complexation of ZnCh with ligand 3, methanol was originally used as the 
solvent. But the reaction products were unpredictable due to the formation of ZnCl2*3 
(119), Zn*3 (p-Cl)2-ZnCl2 (120) and protonated 3 (minor). An aprotic reaction solvent 
(CH3CN) and anhydrous reaction conditions were then used to successfully make
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ZnCl2*3 and Zn-3 (|n-Cl)2-ZnCl2 in reasonable yields (88% and 92% respectively). In the 
synthesis of ZnCh‘4, when methanol was used as the reaction solvent, CHN analyses of 
the white precipitate formed at the end of the reaction had a varied composition of 
(ZnCl2)i.2-i.7*4 . This is probably due to the presence of varying amounts o f both ZnCl2*4 
and (ZnCl2)2*4 . Interestingly, we were able to purifity ZnCE‘4 (124) from this mixture by 
redissolving it in CHCI3. This is due to the much higher solubility of ZnCl2*4 in 
chloroform.
1.3 Synthesis of Hg(II) Complexes.
Attempted complexation of HgC^ with ligand 3 (and ligand 4) yielded white 
precipitates which had poor solubility even in polar NMR solvents such as Jg-DMSO, 
CD3CN and D2O. Evidence for formation of the Hg(II) complexes of ligand 3 (and ligand 
4) was the similarity of their IR spectra to these of Zn(II) and Cd(II) analogues. However, 
due to their poor solubility, no further characterization was carried out.
In contrast to our observation that Zn(II) and Cd(II) complexes were formed by 
the reactions of hydrated salts of Zn(II) and Cd(II) with either ligand 1 or ligand 2, 
attempted complexation of Hg(N0 3 )2*H2 0  with ligand 1 failed as indicated by the fact 
that the 1H and 13C{!H} NMR spectra of the product in D2O were the same as these of 
protonated 1. This indicated that in the synthesis of Hg(II) complexes of ligand 1, the 
presence of water inhibited the complexation. Anhydrous HgCE was thus used to react 
with stoichiometric amount of 1 in methanol to form the complex [HgCl2(p -l)]2 (133) in 
a reasonable yield (68%).
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In an attempted synthesis of HgCl2*2 (134), (HgCl2)6*(2)4 (135) precipitated 
unexpectedly from the refluxing reaction solution of an equivalent amount of ligand 2 
and HgCfr. Complex (HgCl2)6“(2)4 was characterized by its X-ray structure. An 
interesting feature of this complex is that all chlorides remain coordinated to Hg(II) 
(Figure 2.41 and Figure 2.42, vide infra). Subsequently, under anhydrous reaction 
conditions and equivalents amounts of the two reactants in anhydrous methanol, a clear 
solution formed after reflux. Cooling of this solution to room temperature did not provide 
any crystals or precipitate. Diethyl ether diffusion into this solution yielded HgCl2*2 as 
colorless crystals which was fully characterized by its CHN elemental analyses and X-ray 
structure (Figure 2.40, vide infra). Since the only significant change in reaction condition 
was the anhydrous reaction conditions, we believe the formation of (HgCl2)6*(2)4 was due 
to the presence of excess HgCfr. Even though equivalent amounts of HgCh and 2 were 
used, the actual amount of HgCh was in excess of 2 because of two possible reasons. One 
is the absorbing of moisture into 2 and the other is the presence of small amount of 
organic impurity (< 4%) in 2. Since complex (HgCl2)6*(2)4 has a poor solubility in 
MeOH, it precipitated out from the reaction solution. To test this hypothesis, a 1.5:1 
mixture of HgCl2 (58.7 mg, 0.216 mmol) and 2 (29.3 mg, 0.148 mmol) were dissolved in 
methanol. Refluxing of this solution followed by cooling to room temperature yielded 
colorless crystals (40.1 mg). CHN elemental analyses of these crystals indicated the 
composition of (HgCl2)n(2)6 (or (HgCl2)i.83(2)) (Table 2.1). Its 'H and ^C-^H} NMR 
spectra in CD3CN indicated the presence of only one coordinated 2 species on the NMR 
time scale. This clearly indicated that any excess HgCh in the reaction solution could
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cause its co-precipitating with HgCl2*2 . The formation of (HgCl2)6*(2)4 and 
(HgCl2)n*(2)6 are also consistent with the high affinity of Hg(II) for chloride.
Table 2.1 CHN elemental results of (HgCl2)n(2)6 (or (HgCl2)i.83(2) ).
Anal. C (%) H(%) N(%)
Calcd. 17.26 3.19 8.05
Found 17.52 and 17.47 3.19 and 3.18 8.00 and 8.02
1.4 Comparison of the Solubility of Metal Complexes.
Zn(II) and Cd(II) complexes of parent cross-bridged ligands, 1 and 2, are freely 
soluble in water. Except for [Zn«l(OH2)(p-Cl)ZnCl3] (115), these are also freely soluble 
in methanol. Their solubility in other organic solvents depends on the counter anion. 
Zn(II) and Cd(II) complexes with perchlorate or nitrate anions have a better solubility 
than those with chloride counter anions in acetonitrile. [Zn*l(p-Cl)]2Cl2 is slightly 
soluble in acetonitrile whereas ZnCb‘2 is not soluble in this solvent at all. Compared to 
Zn(II) and Cd(II) complexes of ligands 1 and 2, complexes of the more hydrophobic 
ligands, 3 and 4 have much poorer solubility in protic solvent such as H2O and CH3OH. 
Two Hg(II) complexes, [HgCl2( p - l )]2 (133) and HgCl2*2 (134), have better solubility in 
MeOH and water than complexes of ligands 3 and 4 but are not as soluble as Zn(II) and 
Cd(II) complexes of ligands 1 and 2.
2. Spectral Data.
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2.1 Infrared Spectra.
As mentioned above, the IR spectral data are useful in the characterization of 
these Zn(II), Cd(II) and Hg(II) complexes. In the presence of acidic proton source such as 
water, the failure o f a complexation with 1, 2, 3 or 4 was indicated by the presence of 
broad and medium-intensity vnh of R3NH+ varying from 2450 cm'1 to 2700 cm'1. This is 
consistent with the absence of this band in the IR (KBr) spectra of the twenty-one 
characterized Zn(II), Cd(II) and Hg(II) complexes of ligands 1-4. The different 
coordination modes of the ZnCl2 and CdCl2 complexes of ligand 1 compared to that of 
[HgCl2(p - l )]2 can also be inferred from their solid-state infrared spectra. All the Zn and 
Cd complexes of ligands 1 and 2 have N-H stretches appearing between 3186 and 3292 
cm'1 (Table 2.2). By contrast, in the IR spectrum (KBr) of [HgCl2(|a-T)]2 (133), a broad
Table 2.2 Comparison of NH stretches in the IR spectra of Zn(II), Cd(II) and Hg(II) 
complexes of ligands 1 and 2 .
Complex v n h  (cm'1) Complex v n h  (cm'1)
rZn*l(OH2)(p-Cl)ZnCl3l 3264, 3252 fZn*l(p-Cl)l2Cl2 3216
Zn«l(C104)2 3286 Zn*l(N03)2 3255
[Zn-2(0H2)21(C104)2 3198,3173 ZnCl2*2 3186
Zn*2(N03)2 3199,3173 Cd*l(N03)2 3259
CdCl2*l 3248, 3220 Cd*l(C104)2 3284
CdCl2®2 3248 Cd*2(C104)2 3260
[Cd®2(r)2-N 03)2] 3292 HgCl2*2 3240
(HgCl2)6-(2)4 3262 [HgCl2(p -l)l2 3078
N-H stretching band of medium intensity appeared at lower frequency (3078 cm'1) which 
was shifted to around 2497 cm'1 upon deuteration. This lower-energy stretch can be 
attributed to the extensive intra-cleft hydrogen bonding between the N-i7 and the tertiary
76
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Figure 2.4 The IR (KBr) spectra of HgCl2*2 (top), (H gC f^V ^^ (middle), and 
(HgCl2)n«(2)6 (bottom).
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This NH stretch is also very useful in the determination of whether HgCl2*2 
formed since HgCl2*2 has an NH stretch at 3240 cm'1 whereas (HgCl2)6®(2)4 and 
(HgCl2)n*(2)6 presents a broad NH stretch at 3262 cm'1 and 3275 cm'1 respectively 
(Figure 2.4). It seems that the increased ratio of HgCb to 2 increased the NH stretch 
frequency.
2.2 Solution *H and ^C fH } NMR Spectra.
Compared to the complicated NMR spectra of metal cyclam (or cyclen) 
complexes reported previously due to mixtures of isomers in equilibria,25(a),43(b'l’45<a)’48(a'l) 
the ]H and 13 C{lH} NMR spectra of all these Zn(ll), Cd(II) and Hg(II) complexes 
showed only one type of complexed cross-bridged ligand on the NMR timescale because 
of the cfr-folded (V) ligand configuration (Figure 1.56). Interestingly, such a czs-folded 
configuration of one coordinated cyclam unit was believed to play an important role in 
the recognition of a Zn(II) Xylyl-bicyclam complex by an HIV coreceptor.26(a)
The 13C{!H} NMR spectra of all characterized Zn(II), Cd(II) and Hg(II) 
complexes of ligands 1 and 3 indicate their actual or averaged C2 symmetry in solution at 
room temperature. Complexes o f ligands 2 and 4 exhibit a higher-order C2V symmetry as 
their ^ C l’H} NMR spectra contain only three carbon resonances from a total of 10 
carbons in ligand 2 and eight carbon resonances from a total of 24 carbons in ligand 4. In 
either D2O or CD3OD, the exchange between the secondary amine hydrogens from 
coordinated 1 or 2 and deuterium was observed for all their Zn(II), Cd(II) and Hg(II) 
complexes (Scheme 2.1).
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Lj and L2 are ancillary ligands
v— N.
n = 1, ligand 1
n -  0 , ligand 2
N-H complex N-D complex
Scheme 2.1 The N///NZ) exchange observed for Zn(II), Cd(II) and Hg(II) 
complexes of ligands 1 and 2 in D20  or CD3OD.
(a) Zinc Complexes of Ligands 1-4. In methanol, different proton spectra of 
these three zinc complexes of ligand 1 (Figure 2.5) were observed for the distinct 
counterions C104\  NO3', and Cf, suggesting full or partial retention of the respective 
anion within zinc’s first coordination sphere.72’74 For all three, three multiplets from 5 1.4 
to 5 2.7 show very similar patterns. The ’H NMR spectra of Zn®l(C104)2 (117) and 
Zn*l(N03)2 (118) are reasonably similar to each other whereas the proton spectrum of 
[Zn«l(|i-Cl)]2Cl2 (116) is significantly different from them. For example, there is a triplet 
of triplets at 8 3.48 in the proton spectrum of [Zn*l(p-Cl)]2Cl2 (116) whereas no 
resonance was observed from 8 3.40 to 8 3.60 for either Zn*l(C104)2 (117) or Zn*l(N03)2 
(118). This difference can be explained by that fact that the chloride anion should have a 
stronger coordinating interaction with the Zn(II) center than either the perchlorate or 
nitrate in a weakly coordinating solvent like methanol. This is consistent with the
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2 .6 2 2 2 .04 ,0
Figure 2.5 Comparison of *H NMR spectra of three Zn(II) complexes of 1 in CD3OD. 
Top: [Zn*l(p-Cl)]2Cl2 (0.017 M), middle: Zn*l(N03)2 (0.020 M), bottom: Zn*l(C104)2 
(0.020 M).
1
13C{1H} NMR spectrum of [Zn»l(p-Cl)]2Cl2 in CD3OD also differing from those of 
Zn*l(C104)2 and Zn*l(N03)2 (Figure 2.6). For example, the chemical shift difference in 
the most downfield 13C resonance between Zn*l(C104)2 and [Zn*l(p-Cl)]2Cl2 is 1.05 
ppm.
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Figure 2.6 Comparison of i3C{'H} NMR spectra of three Zn(II) complexes of 1 in 
CD3OD. Top one: [Zn*l(p-Cl)]2Cl2 (0.017 M); middle: Zn*l(N03)2 (0.020 M); and 
bottom: Zn*l(C104)2 (0.020 M).
Only very limited detailed ’H and 13C NMR spectral analyses of the metal 
complexes of cyclam, cyclen and their derivatives exist in the literature. One major 
problem is the difficulty of analyzing complicated mixtures of possible configurational 
isomers in either cis or trans forms (Figure 1.4 and Figure 1.5) in dynamic equilibria or 
slow exchange.26(a-)’43(b')’48^a",') By contrast, resonances in the *H and 13C{1H} NMR spectra 
of [Zn*l(p-Cl)]2Cl2 in CD3OD, especially using the 500 MHz NMR spectrometer, can be 
fully interpreted using a combination of the NH7ND exchange (Scheme 2.1), 2D
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gCOSY and 2D [’h , 13C] gHSQC NMR experiments. In the proton NMR spectrum of the 
N-H complex (Scheme 2.1), we would expect to see coupling between the amine 
hydrogen and hydrogens on the carbon a  to it. In the N-D complex, of course, such a 
coupling would disappear. It was also anticipated that the chemical shift of the carbon a 




Figure 2.7 A 2D ['H^H] gCOSY spectrum of [Zn*l(p-Cl)]2Cl2 (0.050 M N-H 
complex) in CD3OD.
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In its proton NMR spectrum, the broad lowest-field resonance at 8 3.69 assigned to the 
axial N-H  protons disappeared upon standing for days at room temperature due to this 
NH/ND exchange in CD3OD solvent (vide infra). A doublet of pentets to the highest field 
at 5 1.53 can be assigned to the equatorial proton of the p-methylene ($-CHeqR) in the 
six-membered chelate ring. The dtt at 8 2.31 can be assigned to the axial proton of this 
same p-methylene (p-CH tf^). As indicated by its 2D [ ^ H ]  gCOSY and [‘H ^C ] 
gHSQC NMR spectra (Figure 2.7 and Figure 2.8), these two resonances are coupled to
n  |
each other and they are also correlated to the resonance at 8 22.66 in the C{ H} NMR 
spectrum which can be assigned to this P carbon (labeled B in Table 2.3, vide infra).
F 2
( p p ®):
0 . 5 -;
1 . 0 - i
F I  ( p p m )
Figure 2.8 A 2D [’H ^C ] gHSQC NMR spectrum of [Zn*l(ju-Cl)]2Cl2 (0.050 M N-D 
complex) in CD3OD.
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The ^C^H } spectrum of [Zn*l(p-Cl)]2Cl2 in CD3OD consists of six resonances 
between 8 20 and 60 for both the N-H complex and the N-D complex (Figure 2.6). The 
chemical shifts of two 13C resonances (8  48.49 ppm overlapped with the solvent peak and 
5 42.60 ppm) shift upfield (8 48.35 and 42.51 ppm) upon deuteration. These two 
resonances can thus be assigned to the two carbons a  to the secondary amine nitrogens in 
ligand 1. 2D []H,13C] gHSQC NMR data show that the l3C resonance at 8 42.51 couples 
to the proton resonance at 8 3.52. The spin pattern of this proton resonance also changed 
from a triplet o f triplets to a triplet of doublets upon N77/ND exchange (Figure 2.9) . As
1 . a2 . 2 z . o2. 42 . 63 . G3 . 6 3 . 43 . S
Figure 2.9 Comparison of ]H NMR spectra of the NH complex (top) and the ND 
complex (bottom) of [Zn*l(p-Cl)]2Cl2 in CD3OD.
can be seen in the 2D [^H^H] gCOSY spectrum (Figure 2.7), these protons are coupled
to those at 5 2.30 (P~-CHHax). We thus assigned them as the protons at the A position in
1 ^ligand 1. They are also coupled to the proton resonance at 8 2.88 and the C resonance at
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8 48.49 in the 2D [!H,I3C] gHSQC spectrum (Figure 2.8). Both the resonance at 8 2.88 
(a broad doublet) and at 8 3.52 can thus be assigned to the protons on carbon A (Table 
2.3, vide infra). Thus the 13C resonance at 8 48.49 can be identified as this carbon A. This 
assignment agrees with the NMR data since this resonance at 5 48.49 shows a
1 Xshift upon NZ//ND exchange. As the C resonance at 8 42.60 is also significantly 
affected by the NiZ/NZ) exchange, it can be assigned to carbon E which in turn is coupled 
to the multiplet between 8 2.92 and 8 3.06 (four protons at position E). The proton 
multiplet at 8 2.70-2.78 (XX' of AA'XX') corresponds to the protons at F. This resonance 
is also coupled only to the AA' multiplet (8 3.22-3.33). These two proton resonances only 
correlate to the 13C resonance at 8 52.0 as revealed by the 2D ^ H ^ C ] gHSQC spectrum, 
indicating the resonance at 8 52.0 belonging to carbon F. The proton multiplet between 
8 2.92 and 3.06 (E position) only couples to the dd's at 5 3.16 and 2.48. This indicates 
that the resonances at 8 3.16 and 2.48 belong to the protons at the D position which in 
turn correlates with the C resonance at 8 60.0. We can then assign this C resonance to 
the D position. The proton resonance at 8 2.31 is also coupled to the multiplet from 
8 3.22 to 3.32 which integrates for four protons. Two of these four protons are assignable 
to the F protons. The other two then are attached to the C methylene, showing coupling
l
with the broad doublet at 8 2.82. They further correlate with the C resonance at 8 59.77. 
We can therefore assign the proton doublet at 8 2.82, the multiplet from 8 3.22 to 3.32, 
and the l3C resonance at 8 59.7 to the C methylene. Final assignments of all these 
resonances are listed in Table 2.3.
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Table 2.3 The assignment of proton and 13C{!H} NMR spectra of 0.050 M [Zn0l(p,- 










J h h  (Hz) 8 in
13C
NMR
T/NCH2CH2CH2N n  -fir 3.77 br t (2 H) ~ 9
h n c f 2c h 2c h 2n A 3.52 tt (2 H) 13.2,3.0 48.49
h n c / / 2c h 2c h 2n A 2.88 d (2 H) ~ 13
HNCH2C772CH2N B 2.31 dtt (2 H) 16.5, 13.5,3.0 22.66
h n c h 2c / /2c h 2n B 1.53 dp (2 H) 16.5, 3.0
HNCH2CH2Ci72N C 3.22-3.32 m (2 H) 59.77
HNCH2CH2Ci/2N C 2.82 d (2 H) ~ 12
NCi72CH2NH D 3.16 dd (2 H) 12.8, 5.5 60.04
n c / / 2c h 2n h D 2.48 dd (2 H) 12.5, 4.0
NCH2CF2NH E 2.92-3.06 m (4 H) 42.60
NCiT2Ci/2N F 3.22-3.32 AA' (2 H)
n c / / 2c / /2n F 2.70-2.78 XX' (2 H) 51.98
B
1
Similar to their methanol spectra, significantly different 'H  NMR spectra (Figure 
2.10(a)) were observed for the counterions CIO4", NO3", and Cl' in acetonitrile. Similarly, 
this is consistent with the different NMR spectrum of [Zn*l(p-Cl)]2Cl2 in
CD3CN compared to those of Zn®l(C104)2 and Zn®l(N03)2 (Figure 2.10(b)). The 13C 
resonance with the largest chemical shift difference between Zn*l(NC>3)2 and [Zn®l(p- 
C1)]2C12 is the most downfield one. This difference is 1.17 ppm.
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Figure 2.10(a) Comparison of 'H NMR spectra of the three Zn(II) complexes of 1 in 
CD3CN. Top: [Zn*l(p-Cl)]2Cl2 (0.017 M); middle: Zn*l(C104)2; and bottom: 
Zn*l(N03)2.
In dilute (< 0.15M) D20  solution, all zinc complexes of ligand 1 give identical ]H 
NMR (Figure 2.11) and ^Cl'H} NMR spectra regardless of counterion, suggesting a
2"fcommon solution species, most likely [Zn*l(D20 )2] , which is related to the X-ray 
structure of [Zn*l(OH2)(p-Cl)ZnCl3] (115) (Figure 2.26, vide infra). There is no 
detectable difference between their proton NMR spectra and the largest chemical shift 
difference is 0.05 ppm in their 13C{]H} NMR spectra. This is consistent with the fact that 
water is a better coordinating solvent than either acetonitrile or methanol resulting in full 
counterion dissociation. The broad lowest-field proton resonance at 5 3.50 assigned to the
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Figure 2.10(b) Comparison of 13C{'H} NMR spectra of three Zn(II) complexes of 1 in 
CD3CN. Top: [Zn»l(p-Cl)]2Cl2 (0.017 M); middle: Zn* 1(0 0 4 )2; and bottom: 
Zn*l(N03)2.
T




Figure 2.11 Comparison of ’H NMR spectra of the four Zn(II) complexes of 1 in D2O. 
Top: [Zn*l(p-Cl)]2Cl2; second: Zn*l(N0 3)2; third: Zn* 1(0 0 4 )2; bottom: 
[Zn*l(OH2)(p-Cl)ZnCl3]. The singlet resonance marked with the asterisk belongs to 
reference CH3CN.
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axial N -H protons disappeared upon standing due to NHfND exchange with the solvent
(vide infra). The resonance at 5 2.16-2.32 can again be assigned to the axial proton of the
P-methylene in the six-membered chelate ring (p-CHH ax). A doublet of pentets at the
highest field at 6 1.56 belongs to the equatorial proton of this p-methylene (p-C H //e?).
This is confirmed by their coupling with each other as revealed by 2D ['H,'H] gCOSY.
The i3C{’H} spectrum consists of six well-resolved resonances between 8 20 and 60. The
1 ^proton resonances at 5 2.16-2.32 and 8 1.56 are coupled to the C resonance at 8 21.81
] 3which is again assigned to carbon B. The chemical shifts of two C resonances (8 48.49 
and 41.34 ppm) shift upfield (48.35 and 41.22 ppm) upon deuteration. These two 
resonances can thus be assigned to the two carbons a  to axial N-H  (either A or E). 
However, because of the overlapping of eighteen proton resonances within 8 2.81-3.20, 
no further assignments of all six carbon resonances could be made.
Similar to these three Zn(II) complexes of ligand 1, in methanol different proton 
spectra of zinc complexes of ligand 2 (Figure 2.12(a)) were also observed for the 
counterions CIOT, NCfr and Cf, again suggesting full or partial retention of the 
respective anion within zinc’s first coordination sphere. The *H NMR spectra of 
[Zn*2 (0 H2)2](C104)2 (122) and Zn*2(N03)2 (123) are somewhat similar to each other 
whereas that of ZnCl2*2 (121) is significantly different. For example, there is a triplet of 
doublets at 8 3.15 in the proton spectrum of ZnCl2*2 whereas no resonance was observed 
from 8 3.01 to 8 3.50 for the others. This is also consistent with the 13C{'H} NMR 
spectrum of ZnCl2*2 in CD3OD which is obviously not the same as those of 
[Zn*2(0 H2)2](C104)2 and Zn*2(N03)2 (Figure 2.12(b)). Assignments of proton and 13C
89
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Figure 2.12(a) Comparison of *H NMR spectra o f the three Zn(II) complexes of 2 in 
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Figure 2.12(b) C o m p a r i s o n  o f  13C { ! H }  N M R  s p e c t r a  o f  t h e  t h r e e  Z n ( I I )  c o m p l e x e s  o f  
2 i n  CD3OD ( t h e  N - D  c o m p l e x e s ) .  T o p :  Z n C l 2 *2 ; m i d d l e :  Z n » 2 (N C > 3) 2 ; b o t t o m :  
Z n * 2 ( C 1 0 4 ) 2 . T h e  r e s o n a n c e s  o f  2 a r e  l a b e l e d  b y  d o t s .
N M R  r e s o n a n c e s  o f  Z n C l 2 * 2  i n  C D 3O D  w e r e  a l s o  m a d e  f e a s i b l e  u s i n g  a  c o m b i n a t i o n  o f  
NH/N D  e x c h a n g e ,  2 D  [ ' H . ’ H ]  C O S Y ,  a n d  2 D  [ ! H , 13C ]  H M Q C  N M R  e x p e r i m e n t s .
M l
Figure 2.13 C o m p a r i s o n  o f  ]H NMR s p e c t r a  of NH c o m p l e x  ( t o p )  a n d  ND c o m p l e x  
( b o t t o m )  ofZnCl2«2 i n  C D 3O D .
9 1
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The broad lowest-field resonance at 8 3.9 in its proton spectrum can be assigned 
to the N-H protons since it disappeared upon standing due to NiT/ND exchange with the 
solvent. Two resonances at 8 3.54 and 2.74 belong to the protons on the carbon adjacent 
to axial NH (carbon at a in Table 2.4, vide infra) since their splitting patterns simplified 
upon N///ND exchange (Figure 2.13). 2D ^H^H] COSY NMR data (Figure 2.14(a))
_ jkd
F2 
( p p m j
3 . 1 
3 . Z 
3 . 3 - 3  
3. 4- 
3 . 5 
3 . S- 
3 . 7- 
3 . 8-
e P
3 . 5  3 . 4  3 . 3  3 . 2  3 . 1  3 . 0  2 . 9  Z . S  2 . 7  2 . 6  2 . S
F I  ( p p m )
Figure 2.14(a) A 2D [‘H^H] COSY spectrum of ZnCl2«2 (N-D complex) in CD3OD.
reveal that the doublet of doublets at 8 3.54 couples to those at 8 3.15 and 2.74 while the 
resonance at 8 2.74 (ddd) couples to those at 8 3.15, 2.82 and 2.74. All three carbon 
resonances were assigned using 2D [’H ^C ] HMQC NMR data (Figure 2.14(b)). These 
data indicate that the 13C resonance at 8 57.26 correlates to the protons at 8 3.15 and 2.82,
92
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Figure 2.14(b) A 2D [!H,13C] HMQC NMR spectrum of ZnCl2*2 (N-D complex) in 
CD3OD.
while the ,3C resonance at 8 51.77 couples to the proton singlet at 8 2.93. Finally, the 
resonance at 8 51.21 correlates to the proton resonances at 8 3.54 and 2.74. A full 
assignment of these resonances is shown in Table 2.4.














HNC//2CH2N a 3.54 dd (4 H) 14.8,7.2 51.21
h n c # 2c h 2n a 2.74 ddd (4 H) 14.6, 11.6, 5.9
HNCH2Cif2N b 3.15 td (4 H) 11.7, 7.4 57.26
HNCH2Cif2N b 2.82 dd (4 H) 11.7,5.9
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Figure 2.15(a) Comparison of ]H NMR spectra of the three Zn(II) complexes of 2 in 
D2O (N-D complexes). Top: ZnCl2*2 ; middle: Zn*2 (C104)2; bottom: Zn*2(NC>3)2.
In dilute (< 0.1 OM) D2O solution, all zinc complexes of ligand 2 give identical 'H 
(Figure 2.15(a)) and ^C ^H } NMR spectra (Figure 2.15(b)) regardless of counterion,
Oi | t
suggesting a common solution species, most likely [Zn*2(D2 0 )2] . The proton singlet at 
5 2.94 of the N-D complex corresponds to those on the cross-bridged ethylene (position c 
in Table 2.4), correlating with the 13C resonance at 5 50.67 (position c) as revealed by a 
2D [1H,13C] gHSQC spectrum. Two proton resonances at 6 3.56 and 2.74 must be 
attached to the protons on the carbon adjacent to NH (a position) since the splitting 
pattern of these simplified upon complete NH7NZ) exchange. They are also coupled with
each other as revealed by a 2D ['H^H] gCOSY. These also correlate to the 1JC resonance13/
at 5 50.34 as revealed by the 2D []H,I3C] gHSQC spectrum. Thus the J3C resonance at13,
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8 50.34 can be assigned the carbon at position a. The remaining 13C resonance at 8 56.36 
can then be assigned to carbon b.
1 .. : _________________________________u
' ’ ‘ ' ' ' ’ ' ’57.0 ' 56.0 S 5.0 Sa.b 53.0 52.0 S! .O 50.0 ilV.O
L ...............................................
................ 57.o' ‘ ’ 56.0 55.6 S<i.O 55.0 52.8 3 1.6 30.0 49.0
I . 1
57.0 50.0 53.0 54.0 33.0 37..O 51.0
(ppm)
50.0 49.0
Figure 2.15(b) C o m p a r i s o n  o f  13C { ' H }  N M R  s p e c t r a  o f  t h e  t h r e e  Z n ( I I )  c o m p l e x e s  o f  
2 i n  D 2 O  ( N - D  c o m p l e x e s ) .  T o p :  Z n C l 2 *2 ; m i d d l e :  Z n » 2 ( C l Q 4 ) 2 ; b o t t o m :  Z n * 2 (N C > 3 ) 2 .
In the proton NMR spectra of the two Zn(II) complexes of ligand 3, the presence 
of an AX splitting pattern of the benzyl methylene is consistent with an actual or 
averaged C2 symmetry. For example, the proton NMR spectrum of ZnCl2»3 (119) in D2O 
showed an AX pattern at 8 4.24 and 3.93 (Figure 2.16). Both the methylenes in the two 
benzyl groups as well as the cross-bridged ethylene in ligand 4 also appear as singlets in 
the proton NMR spectra of ZnCl2*4 (124) at 8 4.62 and at 8 2.86 respectively (Figure
2.17). This is consistent with an actual or averaged C2v symmetry o f ZnCl2*4 in CDCI3 
solution.
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(ppm)
Figure 2.16 T h e  p r o t o n  NMR s p e c t r u m  o f  Z n C l 2 * 3  i n  D 2 O .  T h e  AB o f  t h e  b e n z y l  
m e t h y l e n e  i s  m a r k e d  b y  t w o  a r r o w s .
Figure 2.17 T h e  p r o t o n  N M R  s p e c t r u m  o f  Z n C l 2 * 4  i n  CDCI3. T h e  b e n z y l  m e t h y l e n e  
s i n g l e t  i s  m a r k e d  b y  a n  a r r o w  a n d  t h e  c r o s s - b r i d g i n g  e t h y l e n e  s i n g l e t  i s  m a r k e d  b y  a  d o t .
( b )  Cadmium Complexes of L i g a n d s  1-4. B e c a u s e  t h e  d 10 n a t u r e  o f  C d ( I I )  
l e a d s  t o  r a p i d  m e t a l - l i g a n d  e x c h a n g e  r a t e s ,  t h e r e  h a s  b e e n  a  r e l a t i v e  p a u c i t y  o f  1 1 I ,H 3 C d  
c o u p l i n g  d a t a  w i t h  ]H  a n d  13C  r e s o n a n c e s  i n  C d ( I I )  c o m p l e x e s . 102 I t  i s  t h e r e f o r e  
s i g n i f i c a n t  t h a t  1 H C d  a n d  113C d  d o u b l e t  s a t e l l i t e s  a r e  c l e a r l y  d i s c e m a b l e  f o r  s e v e r a l
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1 Tproton and C resonances of our Cd(II) complexes of ligands 1 and 2. These coupling 
constants vary from 6.4 Hz to 14.6 Hz. The presence of only a single doublet satellite 
indicates the overlap of in Cd and 113Cd satellites and is consistent with the literature 
data.102 This is caused by the similar magnetogyric ratios of H1Cd and n 3Cd, -5.9330 x 
10~7 and -5.6720 x 10'7 rad/Ts, respectively.
An instructive comparison of proton NMR spectra of ZnCl2*2 (121), CdCh‘2 
(129) and HgCl2*2 (134) in CD3OD (Figure 2.18) reveals that for CdCl2*2 , the doublet
Z n (II)
AMA.




Figure 2.18 Comparison of *H NMR spectra of the three Zn(II), Cd(II) and Hg(II) 
complexes of 2 in CD3OD (N-D complexes). Top: ZnCl2*2 ; middle: CdCl2*2 ; bottom: 
HgCl2*2 . The peaks labeled with asterisks are assigned to bridging ethylene protons. The 
metal-}H coupling satellites are marked with arrows.
satellite around the singlet at 5 2.86 assignable to the cross-bridging CH2CH2 is a result
1 111113 3of H and ’ Cd coupling. This J  coupling constant is 11.8 Hz. Similarly, the proton 
NMR spectrum of CdCl2*4 (132) in CDCI3 (Figure 2.19) also has a doublet satellite
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around the cross-bridging CH2CH2 singlet at 5 2.80. A coupling constant of 11.6 Hz is 
found here. In the proton spectrum of CdCl2®4 in CDCI3, the singlet at 5 4.66 belonging
Figure 2.19 The proton NMR spectrum of CdCl2*4 in CDCI3. The benzyl methylene 
singlet is marked by a dot and the doublet satellite around cross-bridging ethylene singlet 
is marked by two arrows. For clarity, only § 2.4-4.8 region is shown.
to the methylene in the N,N'-dibenzyl arms does not show any satellites. Since a reported 
Karplus-type relationship between the 3J  (m ,113Cd, *H) and Cd-N-C-H dihedral angle 
likely applies here, the averaged coupling constant may be too small for observation.106 
In contrast to this, in the l3C{1H} NMR spectra of both CdCl2*3 and CdCl2*4, the tertiary 
carbon from the benzene ring show J  coupling constant of 6 and 5 Hz respectively with 
m ’113Cd.
For the Cd(II) complexes of ligands 1 and 2 in D2O solution, the specific 
counterion has a major effect on their aqueous solution proton spectra (Figure 2.20 and 
Figure 2.21), again indicative of association of these counterions at the metal's first 
coordination sphere. These observations are different from their Zn(II) analogues’ 
behavior, As shown in Figure 2.20, the !H NMR spectrum of CdCl2*l (125) in D2O is 
significantly different from these of Cd»l(N03)2 (126) and Cd*l(ClC>4)2 (127) which have 
very similar spectra. This indicates that even in D20 , CdCl2*l has partially or fully
98
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Figure 2.20 Detailed comparison of *H NMR spectra of the three Cd(II) complexes of 
1 in D20. Top: CdCl2»l; middle: Cd*l(N03)2, bottom: Cd*l(C104)2.
3.70 3.00 3.50 3.40 3.3o' '  3.20 ' 3.00 2.90 ’ 2.BO 2.70
3.70 3.00 3.50 3.40 3.30 3.20 3.10 3.00 2.90 2.80 2.70
Figure 2.21 Detailed comparison of NMR spectra of the three Cd(II) complexes (all 
N-D complexes) of 2 in D20 . Top: CdCl2*2; middle: [Cd*2(p2~N03)2]; bottom: 
Cd*2(C104)2.
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coordinated Cl' whereas Cd*l(N03)2 and Cd* 1(0 0 4 )2  share a common solution species, 
most likely [Cd®l(D20 )2]2+. ]H and NMR spectra of a 1:1 mixture of 0.10 M
CdCl2#l and 0.10 M Cd*l(N03)2 in D20  (Figure 2.22(a) and Figure 2.22(b)) showed a
Figure 2.22(a) The ’H NMR spectrum of a 1:1 mixture of 0.10 M CdCl2*l and 0.10 M 
Cd*l(N03)2 in D20  (> 85% N-D complex). The reference CH3CN is marked by a dot.
Figure 2.22(b) The 13C{!H} NMR spectrum of a 1:1 mixture of 0.10 M CdCl2*l and 
0.10 M Cd*l(N03)2 in D20  (N-D complex).
time-averaged spectrum whose signals lie between those of 0.10 M CdCl2*l and those of 
0.10 M Cd®l(NC>3)2 in D20. After addition of 10 equivalents ofNaCl into this mixture, 
its ]H and ^ C l’H} NMR spectra are again similar to these of 0.10 M CdCl2*l (Figure
100
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2.23). 13C { 1H }  N M R  c h e m i c a l  s h i f t s  o f  t h e s e  C d ( I I )  c o m p l e x e s  ( a l l  N - D  c o m p l e x e s )  a r e  
l i s t e d  i n  Table 2.5.
*
Figure 2.23 T h e  ]H NMR s p e c t r u m  o f  t h e  m i x t u r e  o b t a i n e d  b y  t h e  a d d i t i o n  o f  10 
e q u i v a l e n t s  o f N a C l  i n t o  a  1:1 m i x t u r e  o f  0.10 M C d C T ’ l  a n d  0.10 M C d * l ( N C > 3 )2  i n  
D 2 O  ( >  8 5 %  N - D  c o m p l e x ) .  T h e  r e f e r e n c e  C H 3 C N  i s  m a r k e d  b y  a n  a s t e r i s k .
T able 2 . 5  C o m p a r i s o n  o f  ' H  a n d  13C { ] H }  N M R  d a t a  o f  C d ( I I ) * l  c o m p l e x e s  ( a l l  N - D  
c o m p l e x e s )  i n  D 2 O .
Complex 'H NMR in the 
8 2.7 -3.3 region
UC{'H} NMR data 
5
0 .10M CdCl2*l 3.20 (td, 2H), 
2.71-2.85 (no peak)
59.69, 58.55, 49.82, 49.26, 
40.93, 22.93
0.10M Cd*l(N03)2 3.15-3.30 (no peak), 
2.71-2.85 (m, 2H)
60.23, 58.65, 49.94, 49.84, 
40.88, 22.88
0.13M Cd»l(C104)2 3.15-3.30 (no peak), 
2.71-2.86 (m, 2H)
60.29, 58.71,49.96, 49.91, 
40.91,22.89
0.10M CdCl2*l + 
0.10 M Cd*l(N03)2
3.15 (td, 2H), 
2.71-2.85 (no peak)
59.96, 58.64, 49.89, 49.53, 
40.92, 22.92
0.010M CdCl2*l 3.16 (td, 2H), 
2.71-2.85 (no peak)
59.95, 58.64, 49.89, 49.51, 
40.94, 22.94
0.10M Cd(II)«l + 10 
equivalents NaCl
3.23 (td, 2H), 
2.71-2.85 (no peak)
59.37, 58.36, 49.69, 48.99, 
40.88, 22.87
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The U3Cd chemical shift has been found to be very sensitive to the number and 
types of donor atoms, coordination number and geometry. It also shows a wide chemical 
shift range (~1100 ppm) .1051'3’6'1 It has been reported that the deshielding of 113Cd increases 
in the order O < N < S and I < Br < Cl. Only ligands with higher donor ability than water 
will provide positive chemical shifts relative to that of [Cd(H2 0 )6]2+. 113Cd NMR 
spectra105(c)’106 have thus been used to elucidate the possible solution structures of Cd(II) 
coordination compounds. 113Cd NMR spectra of our three Cd(II) complexes of ligand 1 in 
D2O were recorded using 3 M CdS04  in D2O at -3 ppm as an external reference. 105(e-) The 
chemical shifts of 0.10 M CdCF'l, 0.10 M Cd®l(N03)2, and 0.13 M Cd«l(C104)2 are 
found to be 326, 262 and 267 ppm respectively. The solution and solid-state 113Cd NMR 
spectral studies o f Cd(a,a'-bipyridyl)2X2 (X=C1 and H2O) have revealed that the chemical 
shift difference between a N4-Cd(II)-Cl2 species and N4-Cd(II)-(OH2)2 species is -78 
ppm.107 The 113Cd NMR spectral studies also showed that the chemical shift difference is 
-35 ppm if a coordinated chloride in a Cd(II) complex is substituted by a coordinated 
water.105(c) From our data, the chemical shift difference between 0.10 M CdC b'l and 0.10 
M Cd*l(N03)2 (or 0.13 M Cd* 1(0 0 4 )2) is -64 (or -59) ppm. These data are thus 
consistent with the hypothesis that in D2O, CdCb®! has partially coordinated CF around 
its Cd(II) center with the number of coordinated chloride between one and two. Such an 
intermediate value is probably the result of the fast equilibria among [Cd»l(OH2)(Cl)]+, 
[Cd*l(0)2] and [Cd®l(OH2)2]2+.
A recent report of a cadmium cyclam complex (74 in Figure 1.27) assigned the 
highest-field multiplet (doublet of triplet of triplets) to the axial proton of the 
p-methylene within the six-membered chelate rings.43(b) This is inconsistent with our
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observations here as spectra of all our synthesized Zn(II) and Cd(II) complexes in several 
solvents indicated the assignment to be the equatorial proton instead. This may suggest a 
non-chair solution conformation for the six-membered chelate ring as coordinated cyclam 
is more flexible than complexes of cross-bridged cyclam.43(b)
A combination of N///ND exchange, 2D ['H^H] gCOSY and 2D [ 'H ^ C ] 
gHSQC NMR experiments again enabled us to assign the !H and ^C-^H} NMR spectra 
of CdCl2*2 in CD3OD. In the proton spectrum, the resonance at 8 3.49-3.55 belongs to 
the protons on the carbons adjacent to NH (position a in Table 2.4) as the spin pattern of 
these two resonances simplified upon complete N///ND exchange. The 2D ['H^H] 
gCOSY NMR spectrum (Figure 2.24) reveals that the singlet resonance at 8 2.86 does
a A i A
( PPi*») 
1 . 5 -
QC£S£ 3 8 1
6 .0  5 .5  S.O 4 .5  4 .0  3 5 3 .0  2 . 5
F l (ppm )
. 0 1 . S
Figure 2.24 A 2D [’H,]H] gCOSY spectrum ofCdCl2*2 (N-D complex) in CD3OD.
103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
not show any strong coupling to any other resonances so this can be assigned to that o f 
the cross-bridging CH2CH2. The satellites around this singlet are from the coupling 
between these protons and m,U3Cd. All three carbon resonances were readily assigned by 
using 2D []H,13C] gHSQC NMR (Figure 2.25). The 13C resonance at 8 57.82 correlates
Figure 2.25 A 2D [’H ^C ] gHSQC NMR spectrum of CdCl2*2 (N-D complex) in 
CD3OD.
to the proton multiplet at 8 3.28-3.38 and one of the two proton resonances between 
8 2.65-2.82. The 13C resonance at 8 57.82 can thus be assigned to carbon b. The 13C 
resonance at 8 49.45 belonging to carbon c correlates to the proton singlet at 8 2.86. 
Finally, the remaining 13C resonance at 8 51.72 can be assigned to the carbons at a, which 
is in turn coupled to the proton multiplet between 8 3.49-3.55 as well as part of the 
resonances between 8 2.65-2.82.
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(c) Mercury Complexes of Ligands 1 and 2. Complex [HgCl2(p -l)]2 (133)
s t a r t e d  d e c o m p l e x a t i o n  i n  D 2 O  i m m e d i a t e l y  a f t e r  i t  w a s  d i s s o l v e d .  N o n e t h e l e s s  b o t h
p r o t o n  a n d  ^ C ^ H }  N M R  d a t a  i n  D2O o r  CD3OD c a n  b e  o b t a i n e d  w h i c h  s h o w  o n l y  o n e
c o o r d i n a t e d  s p e c i e s  w i t h  r e t e n t i o n  o f  t h e  l i g a n d ' s  C2 s y m m e t r y .  S i z e a b l e  13C - 199H g
11couplings of 25-52 Hz are observed as satellites in four o f the six C resonances in 
CD3OD. This suggests a slow exchange between coordinated 1 and free 1 in CD3OD. We 
believe that in methanol the same structure is maintained as that in the solid-state (Figure 
2.39, vide infra).
Again, both proton and l3C couplings to 199Hg are clearly observed in both of the 
'H and ^C^H } NMR spectra of HgCl2®2 (134) in D2O or CD3OD at ambient 
temperature. A 3J  coupling constant of 44 Hz between !H and 199Hg is observed for the 
cross-bridging CH2CH2 in the *H NMR spectrum in CD3OD (Figure 2.18). Compared to 
the analogues coupling constant of 12 Hz between JH and 111,113Cd for CdCl2*2 (Figure
2.18), this coupling constant is significantly larger. This is consistent with literature data 
for heavy metals.102 Considering the liability of most Hg(II)-polyamine complexes, there 
is a real paucity o f such data in the literature.99'103
Similar to HgCl2®2 , complex (HgCl2)6*(2)4 (135) shows a C2V symmetry in da-
1 -a 1
D M S O  due to the presence of only three carbon resonances in its C{ H} N M R  
spectrum. This implies that even though both the cationic unit [Hg*2 (p-Cl)]22+ and the 
anionic unit [Hg*2Cl(p-Cl)(HgCl3)]~ exist in the solid-state, they must be in fast 
exchange in D M S O  on the N M R  time scale. This exchange does not include the 
dissociation of the ligand from Hg(II) as evidenced by the presence of 13C - 199H g  
couplings in all three carbon resonances in o ^ - D M S O .  In CD3CN, the presence of a
105
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proton singlet at 5 2.81 belonging to cross-bridging CH2CH2 also indicates a C2V 
symmetry. However, four carbon resonances including two at 5 50.46 and 50.34 appeared 
in its NMR spectrum in CD3CN. This can be due to the presence of a mixture of
the N-H complex (5 50.46) and the N-D complex (5 50.34) and is consistent with the 
detection of HOD in this CD3CN solvent as indicated by the presence of a 1:1:1 triplet 
(3H) at 5 2.21 and also the integrated area of only about 1.2-1.5 NH  protons at 5 3.09- 
3.30 in its *H NMR spectrum.
2.3 N-fir/N-D Exchange in D2O and CD3 OD.
N-H/N-D exchange was observed at the secondary N-H sites for all Zn(II), Cd(II) 
and Hg(II) complexes of cross-bridged ligands 1 and 2 in D2O and CD3OD (Scheme 2.1). 
Generally, the resonances of protons adjacent to the axial N-H sites lose their coupling 
with the N-H proton upon complete deuteration. The chemical shifts of the carbons 
adjacent to these axial N-H sites also show a detectable upheld shift. For example, the 
13C{’H} NMR spectrum of a NH/ND mixture of CdCl2*2 (129) has five peaks at 5 57.81 
(b in N-H complex), 57.79 (b in N-D complex), 51.71 (a in N-H complex), 51.59 (a in
1 3N-D complex), and 49.47 (c in both N-H complex and N-D complex) instead of three C 
resonances for this C2V complex. As mentioned above, these changes have been useful in 
assigning the respective resonances in their NMR spectra in D2O and CD3OD.
The NH/ND exchange rates of all detectable Zn(II) and Cd(II) complexes of 
ligands 1 and 2 follow a pseudo-first-order reaction rate. This exchange is so fast for the 
Hg(II) complexes that only the N-D complexes were detected by ]H NMR spectroscopy 
recorded within 30 minutes. If we assume that this exchange also follows a pseudo first-
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order rate law and that the detection limit for the NH  proton resonance in their NMR 
spectra is five percent, the upper limit of the half-lives for this exchange is 0.12 hour. The 
half-lives for the NiT/ND exchange in all Zn(II), Cd(II) and Hg(II) complexes o f ligands 
1 and 2 are summarized in Table 2.6. As shown, these rates follows the order: Hg(II) 
complexes of ligand 1 (or ligand 2) > Cd(II) complexes of ligand 1 (or ligand 2) > Zn(II) 
complexes of ligand 1 (or ligand 2). However, due to the possible different pD values o f 
these complexes in D2O and CD3OD even at the same starting concentration of the metal 
complex, these kinetic data are only the preliminary results. A more thorough 
investigation of a Nif/ND exchange will require buffered D2O solutions.29®
Table 2.6 Half-lives for the NTT/ND exchange in Zn(II), Cd(II) and Hg(II) complexes of 
ligands 1 and 2 in D2O or CD3OD at room temperature.
Metal complex C (mol/L) Solvent ti/2 (hours)
ZnCl2*l 0.070 D20 2.4 x 104
ZnCl2°l no data d 2o 5.3 x 104
ZnCl2*l 0.0165 CD3OD 65
Zn(C104)2«l no data CD3OD 6.5 x 104
CdCl2*l no data d 2o 327
Cd(N03)2*l 0.029 d 2o 257
Cd(N03)2*l 0.062 d 2o 245
Cd(C104)2*l 0.132 d 2o 65
[HgCl2*ll2 saturated d 2o < 0.12
[HgCl2*l]2 saturated CD3 0 D < 0.12
ZnCl2*2 0.0187 d 2o 17
ZnCl2*2 0.0066 CD3 0 D 29
Zn(N03)2*2 0.018 CD3 0 D 23
Zn(C104)2*2 0.023 CD3 0 D 2000
Zn(C104)2*2 0.020 CD3 0 D 2583
CdCl2*2 0.45 d 2o 0.43
CdCl2*2 0.022 CD30D 3.0
CdCl2*2 no data CD30D 7.8
Cd(N03)2*2 0.020 CD3 0 D 13.5
Cd(C104)2®2 0.020 CD3 0 D 14.7
HgCl2*2 saturated d 2o < 0.12
HgCl2*2 saturated CD3 0D < 0.12
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3. X-ray Structural Data.
Thirteen X-ray structures of these Zn(II), Cd(II) and Hg(II) complexes of ligands 
1-4 have been determined. A summary of relevant bond distances and angles for each of 
these is listed in Tables 2.7 (a-o).
As mentioned in the Chapter I, the fit o f a metal ion within the cavity formed by a 
coordinated cross-bridged ligand can be best gauged by the axial bond angle between the 
non-bridging nitrogen atoms at the metal ion, Nax-M-Nax (Figure 1.25).
3.1 The Five Z n ( I I )  Complexes:
Zn»l(OH2)(p-Cl-ZnCl3) (115). This complex has cross-bridged ligand 1 in the 
distorted diamond lattice [2323]/[2323] cw-folded conformation (Figure 2.26).108 The 
Zn(II) center adopts a near-octahedral coordination geometry. It is coordinated by four 
amine nitrogens from 1, one coordinated H2O, as well as one bridging chloride. The axial 
N(2)-Zn-N(4) angle of 173.5(2)° and equatorial N(l)-Zn-N(3) angle of 84.9(2)° reflect a 
reasonably good fit of an octahedral Zn(II) inside 1. Consistent with literature data, the 
secondary N(ax)-Zn bondlength of 2 .121(6)A is marginally shorter than the tertiary 
N(eq)-Zn bondlength of 2.140(5)A.269a),29(g) For comparison, most zinc complexes of 
cyclam and its derivatives have the trans-UI ligand configuration.23(a~k) Only five cw-V 
structures are known and all of them are cyclam derivatives.26^  These have secondary 
amine N-Zn distances ranging from 2.07 to 2.19A and N(ax)-Zn-N(ax) angles between 
168 and 174°. Not surprisingly, without cross-bridging, their folded N(eq)-Zn-N(eq)
108














Figure 2.26 X-ray structure of [Zn»l(OH2)(fi-Cl)ZnCl3] (115) showing atomic 










Figure 2.27 Hydrogen bonding interactions in the crystal structure of 
[Zn*l(OH2)(g-Cl)ZnCl3] (115).
1 0 9
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angles have obtuse values of 102-108°. A ZnCb complex of the N,N’-dimethyl derivative 
of 1 has also been communicated though without full structural detail.73
Table 2.7(a) Selected Bond Distances (A) and Bond Angles (deg) in [Zn®l(OH2) 
(g-Cl)ZnCl3] (115) (Hydrogen bonding interactions are included.).
Zn(l)-N(l) 2.141(5) Zn(l)-N(2) 2.119(6)
Zn(l)-N(3) 2.140(5) Zn(l)-N(4) 2.123(6)
Zn(l)-0(1) 2.170(5) Zn(l)-Cl(l) 2.629(2)
Zn(2)-Cl(l) 2.309(2) H(Ol)—C1(4A) 2.48(4)
H(02)—Cl(2) 2.41(2) H(2)—Cl(3) 2.70(3)
H(2)—Cl(l) 2.92(6) H(4)—C1(2A) 2.84(4)
N(2)-Zn(l)-N(4) 173.5(2) N(2)-Zn(l)-N(3) 85.0(2)
N(4)-Zn(l)-N(3) 90.1(2) N(2)-Zn(l)-N(l) 90.5(2)
N(4)-Zn(l)-N(l) 84.7(2) N(3)-Zn(l)-N(l) 84.9(2)
N(2)-Zn(l)-0(1) 92.4(2) N(4)-Zn(l)-0(1) 92.4(2)
N(3)-Zn(l)-0(1) 177.2(2) N(l)-Zn(l)-0(1) 94.1(2)
N(2)-Zn(l)-Cl(l) 90.16(16) N(4)-Zn(l)-Cl(l) 93.93(2)
N(3)-Zn(l)-Cl(l) 92.91(2) N(l)-Zn(l)-Cl(l) 177.38(14)
0(1)-Zn(l)-Cl(l) 88.24(14) 0 ( 1 )-H (01 )-Cl(4 A) 153(7)
0 ( 1 )-H(02)-Cl(2) 158(6) N(2)-H(2)-C1(3) 154(6)
N(2)-H(2)-C1(1) 115(5) N(4)-H(4)-C1(2A) 137(5)
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Ancillary ligands in this complex include one water as well as a bridging chloride 
from the ZnCfr2' counterion. The inter- and intra-molecular hydrogen bonding 
interactions from two such units result in a pseudo-dimeric structure (Figure 2.27). The 
distances of these hydrogen bonds range from 2.25 to 2.63 A while the Zn(l)-Cl(l) bond 
is quite long at 2.629(2)A. The Zn(II)-OH2 of 2.170 (5) A is within the average Zn- 0  
bondlength of 2.097 ± 0.049 A for a 6-coordinate Zn(II) species.109 Only two previous 
reports were found in the Cambridge Crystallographic Database with this Zn(H2 0 )(p- 
Cl-ZnCfr) structural motif. One contains triethanolamine and the other has pyridine-2- 
carbaldehyde as co-ligands.110’111 There are two reports of 6 -coordinate Zn(II) complexes 
of cyclam and its derivatives with coordinated water.23ti)’23(1) However, the two ancillary 
ligands including H2O are found in the trans position. Since the significance of labile cis- 
coordination sites at Zn(II) centers for catalytic chemistry has often been invoked,29^ ’112 
the potential biomimetic reactivity at this type of complex is clearly worthy of study.
[Zn»l(p-Cl)]2Cl2*4CH3 0 H (116). This meso dimer contains both enantiomers of the 
[Zn*l]2+ core bridged by two chlorides (Figure 2.28). The distance between the two 
Zn(II) centers is 3.715 A. The coordination geometry around each Zn(II) center is a 
distorted octahedron since the N(ax)-Zn-N(ax) angle is compressed from linearity to 
168.7(3)° and the N(eq)-Zn-N(eq) angle from 90° to 84.5(2)°. Again, the secondary 
N(ax)-Zn bonds are slightly shorter (2.133(5)A) than the tertiary N(eq)-Zn (2.185(4)A). 
The N-H hydrogens are also engaged in hydrogen bonding with the methanol solvent 
molecules (Figure 2.29). All bridging Zn-Cl bonds have identical lengths of 2.5265(13) 
A. For polyamine complexes of zinc, there has been only one other chloride-bridged zinc
111
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Figure 2.28 Structure of the [Zn*l(g-Cl)]22+ dimer in [Zn* 1 ( ja -C l^ C b ^ C ^ O H  














Figure 2.29 Hydrogen bonding interactions in the crystal structure of 
[Zn*l(n-Cl)]2Cl2*4CH3OH (116).
112
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113complex reported. This five-coordinate ZnCl2*triazacyclononane dimer features rather 
unsymmetrical bridging Zn-Cl bonds of 2.714A and 2.292A respectively. The structure 
of monomeric tran$-ZnCh°cyclam is also known with the ligand in the common trans-III 
configuration. This has long axial Zn-Cl bondlengths o f 2.664A and secondary N-Zn 
bonds of 2.090 A and 2.103 A.23(h)
Table 2.7(b) Selected Bond Distances (A) and Bond Angles (deg) in 
[Zn»l(ji-Cl)]2Cl2(CH30H)4 (116) (Hydrogen bonding interactions are included.).
Zn(l)-N(l) 2.133(5) Zn(l)-N(1B) 2.133(5)
Zn(l)-N(2) 2.185(4) Zn(l)-N(2B) 2.185(4)
Zn(l)-Cl(l) 2.5265(13) Zn(l)-C1(1A) 2.5265(13)




N( 1 )-Zn( 1 )-Cl( 1 A) 96.51(14) 
N(2B)-Zn( 1 )-Cl( 1 A) 179.59(11) 
Cl( 1 A)-Zn( 1 )~C1( 1) 85.36(6) 
N(l)-H(l)-0(1) 143(5)
N( 1 )-Zn( 1 )-N (2B) 83.51(18)
N(1B)-Zn(l)-N(2) 83.51(18)
N (1 B)-Zn( 1 )-N(2B) 88.10(18) 
N( 1 B)-Zn( 1 )-Cl( 1 A) 91.83(14) 
N(2)-Zn( 1 )-Cl( 1 A) 95.05(12) 
Zn( 1 )-Cl( 1 )-Zn( 1 A) 94.64(6)
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[Zn* 1 (p,—Cl)]2CI2 (116a). [Zn®l(p-Cl)]2Cl2 was obtained when acetonitrile was used as
• 2"bthe reaction solvent. This meso dimer also contains both enantiomers of the [Zn®l] core 
bridged by two chlorides (Figure 2.30). The N(ax)-Zn-N(ax) angle of 168.4(3)° is the 
same as that in [Zn*l(p-Cl)]2Cl2*4CH30H. Without the participation of hydrogen- 
bonding MeOH in this X-ray structure, this dimer becomes rather unsymmetrical with 
bridging Zn-Cl bonds of 2.483(2)A and 2.515(2)A respectively. The distance between the 
two Zn(II) centers is 3.60A. This X-ray structure confirms that the formation of such a 




Figure 2.30 Structure of [Z n*l(p -C l)]2Cl2 (116a), showing atomic labeling scheme. 
Hydrogens bonded to carbons are omitted for clarity.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 2.7(c) Selected Bond Distances (A) and Bond Angles (deg) in [Zn®l(|i-Cl)]2Cl2 
(116a) (Hydrogen bonding interactions are included.).
Zn(l)-N(l) 2.171(5) Zn(l)-N(2) 2 .111(6)
Zn(l)-N(3) 2.166(6) Zn(l)-N(4) 2.171(5)
Zn(l)-Cl(l) 2.4829(18) Zn(l)-C1(1A) 2.515(2)
H(N2)—Cl(l) 2.91(7) H(N2)—Cl(2) 2.50(7)
H(N4)—Cl(l) 2 .88(6) H(N4)—Cl(2) 2..70(6)
N(2)-Zn(l)-N(4) 168.3(2) N(l)-Zn(l)-N(2) 88.3(2)
N(l)-Zn(l)-N(3) 83.4(2) N(l)-Zn(l)-N(4) 83.0(2)
N(2)-Zn(l)-N(3) 82.8(2) N(3)-Zn(l)-N(4) 88.3(3)
N(l)-Zn(l)-Cl(l) 178.50(16) N(2)-Zn(l)-Cl(l) 92.86(17)
N(3)-Zn(l)-Cl(l) 95.80(15) N(4)-Zn(l)-Cl(l) 95.73(18)
N (1 )-Zn( 1 )-Cl (1 A) 95.26(16) N(2)-Zn( 1 )-Cl( 1 A) 95.12(17)
N(3)-Zn(l)-C1(1A) 177.58(17) N(4)-Zn(l)-C1(1A) 93.5(2)
Cl( 1 A)-Zn( 1 )-Cl( 1) 85.56(6) N(2)- H(N2)-C1(1) 113(5)
N(2)- H(N2)-C1(2) 146(6) N(4)- H(N4)-C1(1) 124(6)
N(4)- H(N4)-C1(2) 138(6)
Zn®3 (jJ.-Cl)2-ZnCl2 (120). Here Zn(II) coordinates to four nitrogen donors from ligand 3 
within its molecular cleft with slightly longer benzyl N(ax)-Zn bonds of 2.272(5)A
115
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Figure 2.31 X-ray structure of Zn®3 (p-Cl)2-ZnCl2 (120) showing atomic labeling 
scheme. Hydrogens bonded to carbons are omitted for clarity.
compared to the N(eq)-Zn bonds of 2.124(5)A (Figure 2.31). The N(ax)-Zn-N(ax) angle 
of 171.1(2)° is similar to those in the three Zn(II) complexes of ligand 1. A doubly- 
bridging ZnCU2' counterion completes the pseudo-octahedral metal coordination sphere. 
While the doubly chloride-bridged Z^CU 2' anion unit has been found in X-ray structures 
of twenty-nine compounds,114(a'^ this variation represents the only structural form for 
ZnCb amine complexes. As can be expected, the octahedral zinc's Zn(l)-(p-Cl) bonds, 
2.518(1) A long, are substantially weaker than the pseudo-tetrahedral Zn(2 )-(p-Cl) bonds 
at 2.3422(6) A. A Cambridge Crystallographic Database search showed that no previous 
report was found for Zn(II) complexes of any mono, di, tri or tetra N-benzylated cyclam 
derivatives. Very recently, the X-ray structure of a Zn(II) nitrate complex of a tri N-
116
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benzylated cyclam derivative with a trans-1 configuration was reported.43(d) The range 
Zn-N bondlengths to the tertiary amine nitrogens here is 2.109(2)-2.306(2) A.
Table 2.7(d) Selected Bond Distances (A) and Bond Angles (deg) in 
Zn*3(p-Cl)2-ZnCl2 (120).
Zn(l)-N(1A) 2.124(5) Zn(l)-N(l) 2.124(5)
Zn(l)-N(2) 2.272(5) Zn(l)-N(2A) 2.272(5)
Zn(l)-C1(1A) 2.5183(15) Zn(l)-Cl(l) 2.5183(15)
Zn(2)-C1(2A) 2.2211(19) Zn(2)-Cl(2) 2.2211(19)
Zn(2)-C1(1A) 2.3422(16) Zn(2)-Cl(l) 2.3422(16)
N(1A)-Zn(l)-N(l) 83.5(3) N( 1 A)-Zn( 1 )-N(2) 82.87(19)
N(l)-Zn(l)-N(2) 90.45(19) % > 1 N 1 2 NJ > 90.45(19)
N(l)-Zn(l)-N(2A) 82.87(19) N(2)-Zn(l)-N(2A) 171.1(2)
N(1A)-Zn(l)-C1(1A) 96.88(3) N( 1 )-Zn( 1 )-Cl( 1 A) 171.28(15)
N(2)-Zn( 1 )-Cl( 1 A) 98.25(13) N (2 A)-Zn( 1 )-Cl( 1 A) 88.41(13)
N(1A)-Zn(l)-Cl(l) 171.28(15) N(l)-Zn(l)-Cl(l) 96.88(14)
N(2)-Zn(l)-Cl(l) 88.41(13) N (2 A)-Zn( l)-Cl(l) 98.25(13)
Cl( 1 A)-Zn( 1 )-Cl( 1) 84.04(7) C1(2A)-Zn(2)-Cl(2) 118.73(10)
Cl(2 A)-Zn(2)-Cl( 1 A) 113.85(6) Cl(2)-Zn(2)-Cl( 1 A) 107.65(6)
Cl(2a)-Zn(2)-Cl( 1) 107.65(6) Cl(2)-Zn(2)-Cl(l) 113.85(6)
Cl( 1 A)-Zn(2)-Cl( 1) 92.06(8) Zn(2)-Cl(l)-Zn(l) 91.95(5)
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[Zn®2(H20 )2](0 0 4 )2  (122). The smaller cross-bridged cyclen, ligand 2, is clearly a
poorer fit for the six-coordinate Zn(II) (Figure 2.32) than cross-bridged cyclam, ligand 1.
N2 2
zm
Figure 2.32 X-ray structure of [Zn*2(H20)2](0 0 4 )2  (122) showing atomic labeling 
scheme. Hydrogens bonded to carbons are omitted for clarity.
This is manifested in the increased protrusion of the cation out from the ligand cleft as the 
N(ax)-Zn-N(ax) angle is compressed to only 156.8(3)°. Contrary to previous literature 
data,26(a)’29(s:) the secondary N(ax)-Zn and tertiary N(eq)-Zn distances are essentially the 
same at 2.133(5)A and 2.139(4)A respectively. Although there are numerous structural 
reports of zinc complexes with cyclen and its pendant-armed derivatives in the literature, 
almost all of these have the trans-l ligand configuration with all four amine substituents 
on the same side of the macrocycle as zinc.29(a~1) In contrast, only two examples of cis-1
118
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ligand configuration are available. These have pseudo-octahedral geometry with N(ax)-
Zn-N(ax) angles of 153-154° and equatorial N-Zn-N angles of 108-109°.23(d)’115
Table 2.7(e) Selected Bond Distances (A) and Bond Angles (deg) in
[Zn*2(H20)2](C104)2(122).
Zn(l)-0(1) 2.123(4) Zn(l)-0(1A) 2.123(4)
Zn(l)-N(2) 2.133(5) Zn(l)-N(2A) 2.133(5)
Zn(l)-N(l) 2.139(4) Zn(l)-N(1A) 2.139(4)
0(1 )-Zn( 1 )-N(2 A) 100.1(2) 0 ( 1 A)-Zn( 1 )-N(2) 100 .1(2 )
0(1)-Zn(l)-N(2) 96.7(2) 0(1 A)-Zn(l)-N(2A) 96.7(2)
0(1)-Zn(l)-N(1A) 95.34(16) 0(1A)-Zn(l)-N(l) 95.34(16)
0(1)-Zn(l)-N(l) 175.83(18) 0 ( 1 A)-Zn( 1 )-N( 1 A) 175.83(18)
0(1)-Zn(l)-0(1A) 86.5(2) N(2)-Zn(l)-N(2A) 156.8(3)
N(2)-Zn(l)-N(l) 83.40(18) N(2A)-Zn( 1 )-N( 1 A) 83.40(18)
N(2)-Zn( 1 )-N (1 A) 79.26(18) N (2 A)-Zn( 1 )-N( 1) 79.26(18)
N(l)-Zn(l)-N(1A) 83.08(19)
The favored coordination number of these cyclen Zn(II) complexes is five29(a)’(d),(h' 
whereas six is found in the cross-bridged cyclen complex, [Zn(H20 )2»2](Cl04 )2. The 
coordination geometry around Zn(II) center is again a pseudo-octahedron. Two ds-aqua
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ligands complete the metal coordination sphere. Literature data of the X-ray structure of 
(trimethyltriazacyclononane)triaquozinc(II) nitrate revealed a cis-N 3 O 3  coordination 
set.110 However, no polyamine zinc complex structure with a cis-N 4 O 2  donor geometry 
has been reported. Two fo's-phenanthroline complexes of Zn(II) with similar cfs-aqua 
ligands are known.116,117 These have Zn-0 distances ranging from 2.04 to 2.14 A 
compared to 2.123(4) A here. Their N(ax)-Zn-N(ax) angles are less strained at 162-169° 
and their Zn-N bondlengths range from 2.14 to 2.21 A.








CI18SCI15) CI21)CI16I CI20IcntiCI17I cun
CII2)
Figure 2.33 X-ray structure of ZnCh‘4 (124) showing atomic labeling scheme. 
Hydrogens bonded to carbons are omitted for clarity.
the coordination geometry around this Zn(II) center is a pseudo-octahedron as evidenced 
by the N(ax)-Zn-N(ax) angle of only 152.6(1)° and the constrained N(eq)-Zn-N(eq) angle
120
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of 77.61(8)°. For comparison, the corresponding angles for Zn»3 (p-C l2ZnCl2) are 
171.1(2)° and 83.5(3)° respectively. The two terminal chlorides here are 2.36-2.39A 
away from zinc and they subtend an obtuse Cl-Zn-Cl angle of 95.50(3)°. Again, a 
Cambridge Crystallographic Database search revealed no previous report for Zn(II) 
complexes of any mono, di, tri or tetra N-benzylated cyclen derivative.
Table 2.7(f) Selected Bond Distances (A) and Bond Angles (deg) in ZnCl2’4  (124).
Zn(l)-N(l) 2.241(2) Zn(l)-N(2) 2.231(2)
Zn(l)-N(3) 2 .201 (2 ) Zn(l)-N(4) 2.231(2)
Zn(l)-Cl(l) 2.3874(7) Zn(l)-Cl(2) 2.3603(7)
N(3)-Zn(l)-N(l) 152.61(9) N(3)-Zn(l)-N(4) 77.98(8)
N(3)-Zn(l)-N(2) 81.44(9) N(4)-Zn(l)-N(2) 77.61(8)
N(4)-Zn(l)-N(l) 81.04(9) N(2)-Zn(l)-N(l) 77.00(9)
N(3)-Zn(l)-Cl(2) 95.37(7) N(4)-Zn(l)-Cl(2) 92.44(6)
N(2)-Zn(l)-Cl(2) 169.96(6) N(l)-Zn(l)-Cl(2) 102.95(7)
N(3)-Zn(l)-Cl(l) 101.04(7) N(4)-Zn(l)-Cl(l) 172.07(6)
N(2)-Zn(l)-Cl(l) 94.46(6) N(l)-Zn(l)-Cl(l) 97.31(7)
Cl(2)-Zn(l)-Cl(l) 95.50(3)
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3.2 The Five Cd(II) Complexes:
CdCl2®l (125). The structure of this complex confirms the significantly poorer fit 
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Figure 2.34 X-ray structure of C dC ^'l (125) showing atomic labeling scheme. 
Hydrogens bonded to carbons are omitted for clarity.
angle of 151.5(5)° and N(eq)-Cd-N(eq) angle of 71.5(5)°. Its two Cd-Cl distances are 
similar at 2.570(2)A and 2.580(1)A respectively. Again, the secondary N(ax)-Cd bonds 
averaging 2.33A are shorter than the tertiary N(eq)-Cd average of 2.48A. A pentacyclic 
hexaamine complex of CdCl2 has been reported having the same C/.S-N4CI2 donor set.118(a) 
This contains shorter Cd-Cl bonds of 2.468(1 )A, similar secondary N-Cd distances of 
2.369(2)A, and longer tertiary N-Cd bondlengths of 2.625(2)A. However, its respective
122
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N(ax)-Cd-N(ax) and N(eq)-Cd-N(eq) angles are even more severely distorted at
121.51(1)° and 59.8(1)°.




































A cyclam derivative, 6,13,-Dimethyl-1,4,8,11 -tetraazacyclotetradecane-6,13- 
diamine, also adopts a ds-folded configuration in its Cd(II) complex (73 in Figure 
1.26).43(a) It has a very distorted N(ax)-Cd-N(ax) angle o f 141.03° and a less distorted 
N(eq)-Cd-N(eq) angle of 91.73°. The distances between its four cyclam nitrogen atoms
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and Cd range from 2.41 lA to 2.422 A. The structures o f two tetramethyl-cyclam 
complexes of Cd adopt the familiar trans-1 ligand configuration with tertiary N-Cd 
distances of 2.34-2.38A, axial N-Cd-N angles in the ranges 156-157°, and equatorial 
angles of 129°.43(c)
CdCl2®2 (129). With the smaller cross-bridged cyclen 2, the cation protrudes even 





Figure 2.35 X-ray structure of CdCl2*2 (129) showing atomic labeling scheme. 
Hydrogens bonded to carbons are omitted for clarity.
distorted this 6-coordinated geometry is away from an idealized octahedral geometry. 
Similar to those of CdCh’l, the terminal Cl-Cd bondlengths average 2.525A while the 
secondary N(ax)-Cd and tertiary N(eq)-Cd distances average 2.36A and 2.47A
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respectively. Four CdC^ complexes have been reported having the same CW-N4CI2 donor 
set_118(a-d) jkgjj. Cd-Cl bonds vary from 2.468 A to 2.533 A. Only two Cd complexes o f 
the parent ligand cyclen have had their structures determined 44(a) Both of these feature 
the ligand in a trans-1 configuration with Cd-N bonds ranging from 2.28 to 2.38A.
Table 2.7(h) Selected Bond Distances (A) and Bond Angles (deg) in CdCl2*2 
(129).
Cd(l)-N(l) 2.468(2) Cd(l)-N(2) 2.388(2)
Cd(l)-N(3) 2.456(2) Cd(l)-N(4) 2.367(2)
Cd(l)-Cl(l) 2.4924(6) Cd(l)-Cl(2) 2.5328(6)
N(2)-Cd(l)-N(4) 137.57(7) N(l)-Cd(l)-N(2) 70.63(7)
N(l)-Cd(l)-N(3) 71.02(7) N(l)-Cd(l)-N(4) 74.73(7)
N(2)-Cd(l)-N(3) 74.33(7) N(3)-Cd(l)-N(4) 71.31(7)
N(l)-Cd(l)-Cl(l) 96.95(5) N(2)-Cd(l)-Cl(l) 106.87(6)
N(3)-Cd(l)-Cl(l) 165.99(5) N(4)-Cd(l)-Cl(l) 100.87(6)
N(l)-Cd(l)-Cl(2) 163.43(5) N(2)-Cd(l)-Cl(2) 101.08(6)
N(3)-Cd(l)-Cl(2) 94.14(5) N(4)-Cd(l)-Cl(2) 105.46(6)
Cl(2)-Cd(l)-Cl(l) 99.24(2)
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[Cd»2(Tf-N03)2] (131). This structure contains a nominally eight-coordinate 
cadmium(II) fully coordinated to ligand 2 as well as two chelating nitrate counterions 













Figure 2.36 X-ray structure of [Cd*2(r]2-NC>3)2] (131) showing atomic labeling scheme.
with a coordination number of eight. All its Cd-N distances are within 2.37-2.39 A. Two 
identical bidentate nitrates here have Cd- 0  distances of 2.533 A and 2.541 A. Again, the
126
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Table 2.7(i) Selected Bond Distances (A) and Bond Angles (deg) in [Cd*2(r|2-N03)23
(130).
Cd(l)-N(l) 2.393(4) Cd(l)-N(2) 2.377(5)
Cd(l)-N(3) 2.393(5) Cd(l)-N(4) 2.369(5)
Cd(l)-0(1) 2.533(11) Cd(l)-0(2) 2.390(9)
Cd(l)-0(4) 2.511(9) Cd(l)-0(5) 2.517(10)
N(2)-Cd(l)-N(4) 138.80(19) N(l)-Cd(l)-N(2) 72.96(18)
N(l)-Cd(l)-N(3) 72.40(17) N(l)-Cd(l)-N(4) 74.13(19)
N(2)-Cd(l)-N(3) 74.25(17) N(3)-Cd(l)-N(4) 72.69(18)
N(l)-Cd(l)-0(1) 91.6(4) N(2)-Cd(l)-0(1) 120.9(3)
N(3)-Cd(l)-0(1) 154.3(3) N(4)-Cd(l)-0(1) 83.9(3)
N(l)-Cd(l)-0(2) 110.6(4) N(2)-Cd(l)-0(2) 81.1(2)
N(3)-Cd(l)-0(2) 153.1(3) N(4)-Cd(l)-0(2) 134.2(3)
N(l)-Cd(l)-0(4) 152.9(2) N(2)-Cd(l)-0(4) 134.1(3)
N(3)-Cd(l)-0(4) 110.4(4) N(4)-Cd(l)-0(4) 81.0(3)
N(l)-Cd(l)-0(5) 155.5(3) N(2)-Cd(l)-0(5) 85.8(3)
N(3)-Cd(l)-0(5) 90.5(4) N(4)-Cd(l)-0(5) 118.2(3)
0(l)-C d(l)-0(2) 51.1(4) 0(l)-C d(l)-0(4) 75.0(6)
0(l)-C d(l)-0(5) 110.1(5) 0(2)-Cd(l)-0(4) 79.5(5)
0(2)-Cd(l)-0(5) 77.0(5) 0(4)-Cd(l)-0(5) 49.4(3)
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axial N-Cd-N angle of 138.8° and equatorial N-Cd-N angle of 72.4° indicate the poor 
cation fit inside the ligand cleft. Two other polyamine Cd(NC>3)2 complexes also have this 
type o f N4O4 coordination sphere.119,120 One of them is a pentacyclic hexaamine complex 
of Cd(N03)2119 which has N-Cd-N angles even more distorted at 121.1 and 59.6° 
respectively. This Cd(II) complex also has a more unsymmetrical chelating nitrate with 
Cd- 0  distances of 2.331 A and 2.592 A.












Figure 2.37 X-ray structure of CdCl2*3 (128) showing atomic labeling scheme. 
Hydrogens bonded to carbons are omitted for clarity.
axial N-Cd-N at 158.51(13)° and equatorial N-Cd-N of75.10(14)° (Figure 2.37). All Cd- 
N distances are within 2.40-2.44A and the Cd-Cl bonds are 2.5268(8)A long. The X-ray
128
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 2 .7 0  Selected Bond Distances (A) and Bond Angles (deg) in CdCl2*3
(128).
Cd(l)-N(l) 2.404(3) Cd(l)-N(2) 2.439(3)
Cd(l)-N(1A) 2.404(3) Cd(l)-N(2A) 2.439(3)
Cd(l)-Cl(l) 2.5268(8) Cd(l)-C1(1A) 2.5268(8)
N (2)-Cd( 1 )-N (2 A) 158.51(13) N(l)-Cd(l)-N(2) 74.79(10)
N(l)-Cd(l)-N(1A) 75.10(14) N( 1 )-Cd( 1 )-N(2 A) 88.09(10)
N(2)-Cd( 1 )-N( 1 A) 88.09(10) N( 1 A)-Cd( 1 )-N(2 A) 74.79(10)
N(l)-Cd(l)-Cl(l) 94.46(7) N(2)-Cd(l)-Cl(l) 101.44(7)
N(1A)-Cd(l)-Cl(l) 163.67(8) N (2 A)-Cd( 1 )-Cl( 1) 92.61(7)
N( 1 )-Cd( 1 )-Cl( 1 A) 163.67(8) N(2)-Cd( 1 )-Cl(l A) 92.61(7)
N(1 A)-Cd( 1 )-Cl(l A) 94.46(8) N (2 A)-Cd( 1 )-Cl( 1 A) 101.44(7)
Cl( 1 A)-Cd( 1 )-Cl( 1) 98.27(4)
structure of a Cd(II) chloride complex with (1,4,8,11 -tetrakis(2-naphthylmethyl)- 
1,4,8,11 -tetraazacyclotetradecane) has a square-pyramidal geometry in which Cd(II) is 
coordinated by four nitrogen donors from trans-1 ligand and one terminal chloride. The 
Cd-N distances are between 2.34-2.37A and the Cd-Cl bonds are 2.46A long.44(b) The X- 
ray structure of a cadmium nitrate complex of 1,8-N,N'-dibenzylated cyclam derivative 
features a six-coordinated Cd(II) center. The dibenzylated cyclam in this complex has a
129
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trans-l configuration.43® The bondlengths between the Cd(II) center and two tertiary 
amine nitrogens of 2.3718(16) and 2.3692(16) A are basically the same as those in 
CdCb-S. A similar Cd(II) complex of a 1,4-N,N”-dibenzylated cyclam derivative 
incorporating the ligand in a trans-l configuration has also been reported.43®
CdCl2®4 (132). The geometry of this complex is quite similar to both CdCl2®2 and 
CdCl2®3 with the axial N-Cd-N at 137.95(11)° and equatorial N-Cd-N of 69.77(11)° 




Figure 2.38 X-ray structure of CdCl2®4 (132) showing atomic labeling scheme.
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Table 2.7(k) Selected Bond Distances (A) and Bond Angles (deg) in CdCl2®4
(132).
Cd(l)-N(l) 2.445(2) Cd(l)-N(2) 2.463(2)
Cd(l)-N(1A) 2.445(2) Cd(l)-N(2A) 2.463(2)
Cd(l)-Cl(l) 2.5056(7) Cd(l)-C1(1A) 2.5056(7)
N(2)-Cd(l)-N(2A) 137.95(11) N(l)-Cd(l)-N(2) 71.73(8)
N(l)-Cd(l)-N(1A) 69.77(11) N( 1 )-Cd( 1 )-N(2 A) 74.03(7)
N(2)-Cd( 1 )-N(l A) 74.03(8) N( 1 A)-Cd( 1 )-N(2 A) 71.73(8)
N(l)-Cd(l)-Cl(l) 96.45(6) N(2)-Cd(l)-Cl(l) 96.98(6)
N(1A)-Cd(l)-Cl(l) 165.21(6) N (2 A)-Cd( l)-Cl(l) 110.51(6)
N( 1 )-Cd( 1 )-Cl( 1 A) 165.21(6) N(2)-Cd(l)-C1(1A) 110.51(6)
N(1 A)-Cd( 1 )-Cl( 1 A) 96.45(6) N(2 A)-Cd( 1 )-Cl( 1 A) 96.98(6)
Cl( 1 A)-Cd( 1 )-Cl( 1) 97.73(4)
3.3 The Three Hg(II) Complexes:
[HgCl2(p-l) ] 2  (133). As shown by its solid-state structure (Figure 2.39), this 
structure represents the first confirmation of an exo-coordination mode for a cross­
bridged tetraamine. This is a dimeric Hg(II) complex in which each ligand bridges two 
Hg(II) centers by using only the secondary amine nitrogens. The geometry around each 
cation can be described as highly-distorted tetrahedral with a small Cl-Hg-Cl angle of 
103.45(8)° and large N-Hg-N angle of 138.2(2)°. The Hg-N bondlengths are 2.237(8)A
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Figure 2.39 X-ray structure of [HgCl2(p -l)]2 (133). The top one is an ORTEP view and 
the bottom one shows the intramolecular hydrogen bonding.
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and 2.264(8)A while the Hg-Cl distances are 2.522(3)A and 2.572(2)A. The two Hg(II) 
centers are 4.26A apart. Each metal is also positioned only 3.23A away from one chloride 
of the adjacent HgCl2 moiety. Since three literature examples of long Hg-Cl bond 
distances between 3.301 A and 3.385 A are known,121(a'c) an alternative description of 
these as distorted trigonal bipyramidal Hg(II) coordination spheres is also feasible.
Table 2.7(1) Selected Bond Distances (A) and Bond Angles (deg) in [HgCl2(p -l)]2 
(133).
Hg(l)-N(l) 2.237(8) Hg(lA)-N(lA) 2.237(8)
Hg(l)-N(3A) 2.264(8) Hg(lA)-N(3) 2.237(8)
Hg(l)-Cl(l) 2.572(2) Hg(lA)-Cl(lA) 2.572(2)
Hg(l)-Cl(2) 2.522(3) Hg(lA)-Cl(2A) 2.522(3)
N( 1 )-Hg( 1 )-N(3 A) 138.2(3) N(1A)-Hg(l)-N(3) 138.2(3)
N(l)-Hg(l)-Cl(2) 105.8(2) N( 1 A)-Hg( 1 A)-C1(2 A) 105.8(2)
N(3A)-Hg(l)-Cl(2) 102.9(2) N(3)-Hg(lA)-Cl(2A) 102.9(2)
N(l)-Hg(l)-Cl(l) 101.74(19) N( 1 A)-Hg( 1 A)-C1( 1 A) 101.74(19)
N(3 A)-Hg(l )-Cl( 1) 100.3(2) N (3 )-Hg( 1 A)-C1( 1 A) 100.3(2)
Cl(2)-Hg(l)-Cl(l) 103.45(8) Cl(2 A)-Hg( 1 A)-C1( 1 A) 103.45(8)
N( 1 A)-Hg( 1 )-Cl( 1 A) 96.45(6) N(2A)-Hg(l)-C1(1A) 96.98(6)
Cl( 1 A)-Hg( 1 )-Cl( 1) 97.73(4)
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Both ligand secondary N-H hydrogens lie inside the ligand cleft and are stabilized 
by transannular hydrogen-bonding (calculated H***N distances of 2.07-2.48 A) with the 
tertiary N lone pairs. Again the distorted [2323]/[2323] diamond lattice czs-folded ligand 
configuration is adopted. A Hg(II) complex of cyclam shows a square-pyramidal 
geometry in which Hg(II) is coordinated by four amine nitrogen donors from a trans-l 
cyclam and one terminal chloride.45(a) The Hg-N bondlengths in this complex vary from 
2.277 A to 2.421 A, which are all longer than those in [HgCl2(p-l)]2- The counterion for 
this cationic mercury cyclam complex is HgCU '. Though not strictly analogous, a 
structure of a diamine derivative of cyclam bridging two HgCB units has also been 
reported (77 in Figure 1.30).45(b)
HgCl2®2 (134). Contrary to the favored formation of mercuric complexes with low 
coordination numbers,122 the X-ray structure of HgCl2*2 features a severely distorted Oh 
geometry. This structure contains two independent 1:1 complexes with very similar 
bonding details. Only one of these will be discussed here (Figure 2.40). It features the 
most distended metal cation within a cross-bridged tetraamine ligand cleft we have 
observed to date. The axial N-Hg-N angle is only 133.4(3)° and equatorial N-Hg-N angle 
is down to 66.7(3)°. The two secondary amine N(ax)-Hg bonds are 2.398(11)A and 
2.418(9)A while the tertiary amine N(eq)-Hg distances are further lengthened to 
2.556(6)A and 2.572(7)A. One of the two terminal cA-chlorides is disordered over two 
sites (Cl(l) and Cl(lA)). The Hg-Cl distances are 2.547(11)A and 2.568(9)A, relatively 
long for terminal Hg-Cl bondlengths which are typically between 2.32-2.54A. No X-ray 
structure of Hg(II) complexes with either cyclen or its derivatives has yet been reported.
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Figure 2.40 An ORTEP view of the X-ray structure of HgCl2*2 (123) showing one 
disordered terminal chloride.
Of the three HgCh complexes of macrocyclic tetraamines and their derivatives in the 
Cambridge Crystallographic Database ,45^ '45^ ’m  only one has a cA-folded ligand 
conformation 45(c) Without a cross-bridging ethylene, this hexamethyl-cyclam complex 
has an axial N-Hg-N angle of 156.53° and equatorial N-Hg-N angle of 89.45°. Its 
secondary amine N(ax)-Hg bonds are corresponding shorter at only 2.275A.
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Table 2.7(m) Selected Bond Distances (A) and Bond Angles (deg) in HgCl2*2
(134).
Hg(l)-N(l) 2.568(9) Hg(l)-N(2) 2.418(9)
Hg(l)-N(3) 2.572(7) Hg(l)-N(4) 2.398(11)
Hg(l)-Cl(l) 2.556(6) Hg(l)-C1(1A) 2.547(11)
Hg(l)-Cl(2) 2.541(3) C1(1)-C1(1A) 0.750(13)
N(2)-Hg(l)-N(4) 133.4(3) N(l)-Hg(l)-N(2) 71.8(3)
N(l)-Hg(l)-N(3) 66.7(3) N(l)-Hg(l)-N(4) 70.4(4)
N(2)-Hg(l)-N(3) 70.9(4) N(3)-Hg(l)-N(4) 69.8(5)
N(l)-Hg(l)-Cl(l) 92.3(2) N(2)-Hg(l)-Cl(l) 107.3(3)
N(3)-Hg(l)-Cl(l) 158.7(3) N(4)-Hg(l)-Cl(l) 100.4(3)
N( 1 )-Hg( 1 )-Cl( 1 A) 100.0(3) N(2)-Hg(l)-Cl(l A) 95.3(4)
N(3 )-Hg( 1 )-Cl( 1 A) 163.0(4) N (4)-Hg( 1 )-Cl( 1 A) 117.1(5)
N(l)-Hg(l)-Cl(2) 161.5(2) N(2)-Hg(l)-Cl(2) 103.4(3)
N(3 )-Hg( 1 )-Cl(2) 94.8(2) N(4)-Hg( 1 )-Cl(2) 103.9(3)
Cl(2)-Hg( 1 )-Cl( 1 A) 98.2(3) Cl(2)-Cd(l)-Cl(l) 106.08(18)
Cl( 1 A)-Hg( 1 )-Cl( 1) 16.9(3) Cl(l A)-Cl(l)-Hg (1) 80.9(10)
Cl(l )-Cl( 1 A)-Hg( 1) 82.2(11)
(HgCl2)6»(2)4 (135). This structure contains two independent ligand 2-coordinated 
Hg(II) centers (Figure 2.41 and Figure 2.42). Stoichiometrically, the ratio of the cationic
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Figure 2.41 Structure of the cationic [Hg*2(p-Cl)]22+ part of (HgCl2)6®(2)4 (135), 
showing atomic labeling scheme.
ass
Figure 2.42 X-ray Structure of the anionic [Hg»2Cl(p-Cl)(HgCl3)]~ part of 
(HgCl2)6«(2)4 (135), showing atomic labeling scheme.
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Hg(II) unit in Figure 2.41 to the anionic Hg(II) unit in Figure 2.42 is 2:1. So 
(HgCl2)6*(2)4 can be better expressed by the formula [Hg*2(p-Cl)]2[Hg»2(Cl)(p- 
Cl)(HgCl3)]2. Similar to HgCl2®2 and [HgCl2(p-l)]2, there is no uncoordinated ionic 
chloride present in this structure. The most interesting part of this is the cationic Hg(II) 
center (Figure 2.41). This is the only example of a dimeric mercury(II) complex of any 
macrocyclic ligand bridged by one or two ancillary ligands. The axial N-Hg-N angle is 
138.82(14)° and equatorial N-Hg-N angle is 71.63(13)°. The two secondary amine N(ax)- 
Hg bonds are 2.407(4)A and 2.444(4)A while the tertiary amine N(eq)-Hg distances are 
slightly lengthened to 2.481(3)A and 2.516(4)A. The distance between Hg and its 
bridging chloride is 2.7693(11)A. The most closely-related structure in the literature is 
the dimeric [Hg»L(p-Cl)Cl]2 (L = 2-(2-pyridyl)quinoxaline).124 The distances between 
two five-coordinate Hg(II) centers and one of two bridging chlorides are 2.500(4) A and 
2.742(3) A. The anionic Hg(II) unit (Figure 2.42) in (HgCl2)6*(2)4 shows a Hg(II) center 
coordinated by four amine nitrogens from ligand 2, one terminal chloride, and one 
bridging chloride from HgCl42'. The N(ax)-Hg-N(ax) angle of 135.50(14)° and N(eq)- 
Hg-N(eq) angle of 69.50(12)° reflect an even poorer fit of Hg(II) in the coordinated 2 in 
this unit than in the cationic Hg(II) unit.
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Table 2.7(h) Selected Bond Distances (A) and Bond Angles (deg) in cationic [Hg«2(p-





















N(7)-Hg(3 )-Cl(6 A) 89.71(9) 
N(5)-Hg(3 )-Cl(6 A) 158.98(9) 
Hg(3)-Cl(6)-Hg(3A) 92.02(3)
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Table 2.1(6) Selected Bond Distances (A) and Bond Angles (deg) in anionic 
[Hg-2Cl(g-Cl)(HgCl3) r  part of (HgCl2)6*(2)4 (135).
Hg(l)-N(l) 2.481(3) Hg(l)-N(2) 2.407(4)
Hg(l)-N(3) 2.516(4) Hg(l)-N(4) 2.444(4)
Hg(l)-Cl(l) 2.6271(11) Hg(l)-Cl(2) 2.5059(10)
Hg(2)-Cl(l) 2.6439(11) Hg(l)-Cl(3) 2.5275(11)
Hg(2)-Cl(5) 2.4287(13) Hg(2)-Cl(4) 2.4233(12)
N(2)-Hg(l)-N(4) 135.50(14) N(l)-Hg(l)-N(2) 74.07(13)
N(l)-Hg(l)-N(4) 71.63(13) N(2)-Hg(l)-N(3) 70.71(13)
N(3)-Hg(l)-N(4) 73.01(13) N(l)-Hg(l)-N(3) 69.50(12)
N(2)-Hg(l)-Cl(2) 108.40(10) N(4)-Hg(l)-Cl(2) 99.50(9)
N(l)-Hg(l)-Cl(2) 162.84(9) N(3)-Hg(l)-Cl(2) 94.94(9)
N(2)-Hg(l)-Cl(l) 105.86(10) N(4)-Hg(l)-Cl(l) 103.81(10)
N(l)-Hg(l)-Cl(l) 97.76(9) N(3)-Hg(l)-Cl(l) 167.24(9)
Cl(2)-Hg(l)-Cl(l) 97.79(4) Cl(4)-Hg(2)-Cl(5) 129.32(4)
Cl(4)-Hg(2)-Cl(3) 110.77(4) Cl(5)-Hg(2)-Cl(3) 100.93(5)
Cl(4)-Hg(2)-Cl(l) 97.21(4) Cl(5)-Hg(2)-Cl(l) 105.75(4)
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3.4 Summary of Structural Data.
With only a single exception, Zn(II), Cd(II), and Hg(II) complexes of these cross­
bridged ligands 1-4 feature full r]4-N-coordination of the metal cations within the 
bicyclic tetraamine ligands’ cleft in addition to two czs-ancillary ligands. A comparison 
of axial N-M-N angles and the equatorial N-M-N angles is listed in Table 2.8. Clearly, 
cross-bridged cyclam ligands 1 and 3 provide a better fit for octahedral Zn(II) than the 
smaller cross-bridged cyclen ligands 2 and 4. This is best gauged by the axial N-Zn-N 
angles of between 169-174° for the former and 153-157° for the latter. A secondary 
indicator of this fit is the equatorial N-Zn-N angle which is between 84-85° for 
complexes of 1 and 3 but compressed to between 78-83° for 2 and 4 (Table 2.8). The e n ­
folded coordination conformation of 1 clearly favors smaller cations like Zn(II) compared 
to its cyclen analogue 2.
Comparing structural data of ligand 2 complexes of ZnCl2, CdCl2, and HgCfj, the 
increased misfit of the two larger cations from the ligand cleft can be seen within their 
respective axial N-M-N angles: Zn (153-157°), Cd (137-139°), and Hg (133-139°). 
Parallel trends in the equatorial N-M-N angles are also observed: Zn (83°), Cd (70-72°), 
and Hg (67-72°). Concurrently the N(ax)-M distances increase from Zn (2.13A) to Cd 
(2.32-2.40A) to Hg (2.40-2.42A) while the N(eq)-M bonds similarly lengthen from Zn 
(2.14A) to Cd (2.44-2.50A) to Hg (2.56-2.57A). The ramification of this increasingly 
poor fit can be found directly in the decreased kinetic inertness of the respective complex 
in aqueous solution. These results provide confirmation of our original design of these 
cross-bridged ligands for selective complexation of small metal ions.
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Table 2.8 Comparison of Zn(II), Cd(II) and Hg(II) fit inside cross-bridged ligand clefts.
Complex Axial N-M-N angle Equatorial N-M-N angle
[Zn*l(OH2)(p-Cl)ZnCl3l (115) 173.5 (2) 84.9 (2)
fZn*l(g-Cl)l2Cl2*4CH3OH (116) 168.7 (3) 84.5 (2)
fZn‘l(ir-C l)l2Cl2 (116a) 168.3 (2) 83.4 (2)
Zn*3( p-Cl)2-ZnCl2 (120) 171.1 (2) 83.5(3)
[Zn*2(H20 )2KC104)2 (122) 156.8 (3) 83.08 (19)
ZnCl2*4 (124) 152.61 (9) 77.61 (8)
CdCl2*l (125) 151.5 (6) 71.5(4)
CdCl2*2 (129) 137.57(7) 71.02 (7)
[Cd-2(Ti2-N 03)2l (131) 138.80(19) 72.40(17)
CdCl2*3 (128) 158.51 (13) 75.10(14)
CdCl2-4 (132) 137.95(11) 69.77(11)
HgCl2*2 (134) 133.4 (3) 66.7 (3)
[Hg*2(p-Cl)]22+ part of 
(HgCl2)6-(2)4(134)
138.82(14) 71.63 (13)
[Hg*2Cl(p-Cl)(HgCl3)] ’ part of 
(HgCl2)6-(2)4(134)
135.50(14) 69.50(12)
m =l, n= l, R = H, ligand 1 
m=0, n=0, R = H, ligand 2 
m = l, n = l, R = Bn, ligand 3 
m=0, n=0, R = Bn, ligand 4
For the Zn and Cd complexes of ligand 1, cross-bridged cyclam, only inside- 
cavity metal complexes formed. So why can't Hg(II) fit into the molecular cleft of ligand 
1? That this is not simply a kinetic phenomenon can be inferred from the observation that 
prolonged heating of either the reagents or the exo-[HgCl2(p-l)]2 complex in methanol 
did not result in formation of any such product. In the literature, there is no report of any 
simple macrocyclic tetraamine Hg(II) complex in which the tetraamine only coordinates 
in an rj’-mode to the Hg(II) center.45(a),45(c)’123 It is likely that the transannular H-bonding
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within this ligand cleft may be favored over a badly distended Hg(II) cation. The 
formation of dimeric Hg(II) centers that are doubly bridged by chlorides may also 
increase the preference for such a structure. Similarly, in the literature, a hexadentate 
diamine derivative of cyclam is fully coordinated to a Cd(II) center in its complex (73 in 
Figure 1.26)43(a) By contrast, in its mercury complex, at each end of the ligand, one 
nitrogen donor from the macrocyclic ring and one nitrogen from the amine arm together 
bridge a HgCl2 unit to form dimercuric species (77 in Figure 1.30).45(b)
The X-ray structures of all three Hg(II) complexes of ligands 1 and 2 have 
showed no uncoordinated chloride. This confirms the propensity o f Hg(II) to bind 
chloride rather than nitrogen and is consistent with literature precedents.45(b) This is also 
in agreement with the absence of any uncoordinated chloride in the lattice of any 
polyamine HgCb complexes in the Cambridge Crystallographic Database.
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CHAPTER III
Zm(II), Cd(II) AND Hg(II) COMPLEXES OF PENDANT-ARMED
CROSS-BRIDGED TETRAAMINES LIGANDS 5-8
1. General Comments on the Synthesis and Characterization of Zn(II), C d(II) 
and Hg(II) Complexes of Ligands 5-8.
Thirteen Zn(II), Cd(II) and Hg(II) complexes of N,N'-dipendant-armed cross­
bridged ligands, 5, 6, 7 and 8 (Figure 3.1) were synthesized and characterized by their 
IR (KBr), ]H and I3C{]H} NMR spectral data, and CHN elemental analyses.
nC c o n h iO c O N H , *C C O O H  NCCOOH
5 6 7 8
Figure 3.1 Pendant-armed cross-bridged ligands 5-8
Complexes [Cd«(8-2H)](NaC104) (147) and [Hg*(7-2H)](K2HgCl4) (148) were also 
characterized by chloride elemental analysis. Additional useful information to confirm 
the formation of Cd(II) and Hg(II) complexes of ligands 5-8 is from the observation of
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!H-m ’113Cd, 13C-m ’113Cd, 'H -^H g , or 13C-199Hg coupling satellites in their !H or
NMR spectra.
In general, these metal complexes were prepared by refluxing a methanol 
solution of the appropriate metal salt and an equivalent amount of a cross-bridged ligand 
for a period of several hours to several days. Crystals of the resulting complexes suitable 
for X-ray analyses were typically obtained by diethyl ether diffusion into a solution of 
the crude product in methanol. Interestingly, attempted crystallization of [Hg»(7- 
2H)](K2HgCl4) (148) from water yielded crystals whose structure actually showed a 
composition of [Hg»(7-2H)]2(HgCl2)3 (148a).
1.1 Synthesis of Zn(II) and Cd(II) Complexes of Ligands 5 and 6.
Zn(II) and Cd(II) complexes of diacetamide-armed cross-bridged ligands 5 and 6 
were synthesized from the reactions of 5 (and 6) with a hydrated metal salt in refluxing 
methanol. Diethyl ether diffusion into these methanol solutions produced crystals of 
these metal complexes. In the synthesis of [Zn*5](C104)2 (136), the relative low purified 
yield (20%) was caused by the presence of about five percent organic impurity in ligand 
5. Several recrystallizations yielded this pure Zn(II) complex as needle-shaped crystals, 
on which X-ray analyses and CHN elemental analyses were carried out. Similarly, 
Cd(C104)2 complex of 5 can be purified. The formation of the Cd(C104)2 complex of 5
1 ‘X 1was indicated by the presence of doublet satellites around several C{ H} resonances in 
its ^C l'H } NMR spectrum in D2O due to m,I13Cd-13C coupling. This will be discussed 
in detail in the NMR spectral discussion part. However, no CHN elemental analysis of 
this Cd(II) complex was obtained.
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1.2 Synthesis of Zn(II), Cd(II) and Hg(II) Complexes of Ligands 7 and 8.
Ligands 7 and 8 are N,N'-dicarboxylate-armed derivatives of parent cross­
bridged cyclam (1) and cyclen (2) respectively. Unlike ligands 1-6, equivalents of a base 
are necessary to neutralize these acidic protons in order to form metal complexes.
In the presence of an equivalent amount of aqueous sodium hydroxide, the 
reaction of a hydrated Zn(II) or Cd(II) salt with either ligand 7 or 8 yielded a clear 
solution. Diethyl ether diffusion into this solution yielded Zn(II) and Cd(II) complexes 
of ligands 7 and 8 as either crystals or micro-crystalline solid. CHN elemental analyses 
of both [Zn»(7-2H)](NaNC>3) (142) and [Cd»(7-2H)](NaN0 3 ) (146) indicated the 
presence of sodium hydroxide in these two complexes, consistent with the fact that their 
aqueous solutions are basic (>9) when tested by pH paper. The complex [Hg»(7- 
2H)](K2HgCl4) (148) was formed even when an equivalent each of HgCl2 and 7®(TFA)2 
were used as reactants. Again, the preferred formation of such a complex is due to the 
high affinity of Hg(II) for chloride. Unlike HgCl2 complexes of ligands 1 and 2, [Hg*(7- 
2H)](K2HgCl4) (148) has good solubility in water and methanol. Resulting crystals 
grown from water were found by X-ray diffraction to be [Hg*(7-2H)]2(HgCl2)3. 
Presumably because of the good solubility of potassium chloride in water, [Hg*(7- 
2H)](K2HgCl4) (148) apparently crystallized out as [Hg*(7-2H)]2(HgCl2)3 (148a) 
instead. These are the first examples for Cd(II) and Hg(II) complexes of carboxylate­
armed macrocyclic tetraamines. Even though good-quality crystals of [Cd®(7- 
2H)](NaC104) (145) and [Cd*(7-2H)](NaNC>3) (146) were formed readily, neither of 
their crystal structures was structurally solved.
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2. Spectral Data.
2.1 Infrared Spectra.
Typically two amide carbonyl bands ranging from 1650 to 1689 cm’1 are found 
in the 1R spectra (KBr) of Zn(II) and Cd(II) complexes of the amide-armed cross­
bridged ligands 5 and 6 (Table 3.1). In addition to these two strong bands, medium-to-
Table 3.1 Comparison of C=0 stretches in the IR spectra of Zn(II), Cd(II) and Hg(II) 
complexes of ligands 5-8.
Complex vc=o (cm'1) Complex vc=o (cm'1)
[Zn*51(C104)2 1673, 1659 fZn-61(C104)2 1682, 1663
[Zn«61(N03)2 1683, 1656 Cd*6(C104)2 1689, 1658
f Cd*6(ri1 -N 03)1(N03) 1656, 1650 [Zn*(7-2H)](NaC104) 1616, 1592
fZn*(7-2H)l(NaN03) 1618, 1596 [Zn»(8-2H)](NaC104) 1617 (br)
[Zn*(8-2H)l(NaN03) 1645, 1611 [ Cd»(7-2H)l(NaC104) 1633, 1586
[Cd*(7-2H)l(NaN03) 1619, 1594 f Cd*(8-2H)l(NaC104) 1615, 1595
[Hg-(7-2H)l(K2HgCl4) 1611, 1590
weak bands around 1600 cm’1 in these complexes can be assigned to NH or OH bending 
modes. These data are consistent with the reported coordinated amide carbonyl band of 
[Cu*5](C104)2 at 1665 cm'169(a) For comparison, free ligand 5 has this band at 1685 cm'1 
while free ligand 6 has this band at 1675 cnT1.69^ ’125^  For the Zn(II), Cd(II) and Hg(II) 
complexes of the carboxylate-armed cross-bridged ligands 7 and 8, two characteristic 
carboxyl ate bands ranging from 1586 to 1645 cm’1 were observed. This is due to the 
presence of asymmetrical stretches of carboxylate groups since Deacon and Phillips 
concluded that coordinated carboxylate groups have asymmetrical stretches ranging 
from 1500-1675 cm’1 and symmetrical stretches at lower than 1490 cm'n25(b) These are
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comparable to those reported for [Cu®(7-2H)](NaCl(>4) at 1590 and 1616 cm'169(a) The 
presence of asymmetrical stretches of carboxylate groups indicates that the two 
coordinated carboxylate groups are different in the solid-state even though the X-ray 
structure of [Zn*6] (Cl04)2 shows that these two carboxylate pendant arms are equivalent 
because of its- Ci symmetry (Figure 3.23, vide infra). The complex [Zn®(8- 
2H)](NaClC>4) (143), however, only showed a broad carboxylate band around 1617 cm'1. 
This may be a result of the overlapping of two bands. No IR absorption belonging to the 
COOH group between 1700 and 1740 cm'1 was observed for any o f these Zn(II), Cd(II) 
and Hg(II) complexes, further supporting metal coordination of their carboxylate 
groups.69(a)
2.2 Solution 'H  and ^C ^H } NMR Spectra.
Similar to Zn(II), Cd(II) and Hg(II) complexes of ligands 1-4, the !H and 13 C 
{]H} NMR spectra of all thirteen Zn(II), Cd(II) and Hg(II) complexes of ligands 5-8 
revealed only single species on the NMR time scale at room temperature. An exception 
is that both the ]H and 13C{!H} NMR spectra of [Cd-(8-2H)](NaC104) (147) in CD3OD 
showed only very broad resonances, which may imply presence of more than one 
species in intermediate exchange.
The 13C{1H} NMR spectra of all characterized Zn(II), Cd(II) and Hg(II) 
complexes of cyclam-derived ligands 5 and 7 in solution at room temperature possess 
actual or time-averaged C2 symmetry as revealed by the presence of eight resonances out 
of a total sixteen carbons in both 5 and 7. All characterized Zn(II) and Cd(II) complexes 
of cyclen-derived ligands 6 and 8 including [Cd*(8-2H)](NaC104)(144) in D2O exhibit a
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higher-order C> solution symmetry at room temperature, as their 13C{1H} NMR spectra 
featured only five carbon resonances out of fourteen total carbons in both 6 and 8 . A C2v 
symmetry also resulted in the observation o f the methylene protons in the pendant arms 
as a singlet in their *H NMR spectra.
(a) Z n ( I I )  and Cd(II) Complexes of Ligand 5 and 6 .
Although neither a satisfactory CHN elemental analyses nor X-ray structural 
analysis was obtained for the CdCClOG complex of 5, the formation of this complex 
was indicated by the presence of doublet satellites around five l3C resonances out of 
eight total (C2 symmetry) in its 13C{1H} NMR spectrum in D2O (Figure 3.2(a)). For
Figure 3.2(a) The NMR spectrum of the Cd(C104)2 complex of 5 in D2O.
1 1 1 1 1 ”3 n  m
example, the ’ Cd- C satellites around the amide carbonyl C resonance have a 
coupling constant of 9 Hz (Figure 3.2(b)). The presence of these 111,m Cd-I3C satellites 
clearly suggests that the Cd(II) center is coordinated by at least four amine nitrogen
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donors from the hexadentate 5 in D2O on the NMR timescale even if  the satellites
15 5
around the amide carbonyl C resonance are due to a J  coupling.
K
Figure 3.2(b) The carboxylate carbonyl resonance showing a doublet satellite (arrows) 
in the NMR spectrum of the Cd(C104)2 complex of 5 in D2O.
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Figure 3.3(a) Comparison of JH NMR spectra of the two Zn(II) complexes of 6 in 
D2O. Top: [Zn»6](C104)2; bottom: [Zn*6](NC>3)2.
In both D2O and methanol, [Zn*6 ](C104)2 (137) and [Zn#6](N03)2 (138) show the 
same 'H (Figure 3.3 (a) and Figure 3.3(b)) and 13C{!H} NMR spectra, indicating a 
common solution structure. The largest chemical shift difference is only 0.02 ppm in
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Figure 3.3(b) Comparison of !H NMR spectra of the two Zn(II) complexes of 6  in 
CD3OD. Top: [Zn»6](N03)2; bottom: [Zn-6](C104)2.
their proton NMR spectra and 0.02 ppm in their ^C^H} NMR spectra. Since the solid- 
state structure of [Zn®6](C104)2(137) (Figure 3.24, vide infra) shows that the Zn(II) is 
engulfed in the cavity formed by hexadentate 6 , the Zn(II) centers in both [Zn»6](C104)2 
and [Zn*6](N03)2 in either water or methanol are probably also fully coordinated. This is 
consistent with the kinetic stability of [Zn»6](C104)2 being several orders of magnitude 
higher than of the parent cross-bridged cyclen Zn(II) complex, [Zn*2(0 H2)2](C104)2 
(122) (vide infra). By contrast, the !H NMR spectrum of Cd®6(C104)2 (139) is 
significantly different from that of [Cd®6(ril-N0 3)](N0 3 ) (140) in CD3OD (Figure 
3.4(a)). This suggests their different solution structures in methanol. This difference may 
be due to the different coordination numbers at Cd(II) because the X-ray structure of 
[Cd*6(r|1 -N03)](N03) (Figure 3.25, vida infra) revealed that the Cd(II) center is seven- 
coordinated by four amino nitrogens and two carboxylate oxygens from ligand 6 as well 
as a monodentate nitrate.
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Figure 3.4(a) 'H  NMR spectra of Cd-6(C104)2 (top) and [Cd»6(V-N03)](N03) 
(bottom) in CD3OD.
Figure 3.4(b) *H NMR spectrum of [Cd*6(rj1-N 03)](N03) in CD3CN. The u u , 3Cd- 
]H coupling satellites are marked by arrows. The downfield singlet belongs to two 
methylenes of the pendant arms while the upfield singlet belongs to the bridging 
ethylene.
The 'H NMR spectra of [Cd«6(r)1-N 03)](N03) in both CD3OD (Figure 3.4(a)) 
and CD3CN (Figure 3.4(b)) show ll1,ll3Cd-1H coupling satellites around both the 
methylene in the pendant arms and the bridging ethylene signals. The 'H NMR spectrum 
of Cd*6(ClC>4)2 in CD3CN (Figure 3.5) shows similar coupling satellites around
152
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Figure 3.5 JH NMR spectrum of Cd-6(C104)2in CD3CN. The " ‘^ C d ^ H  coupling 
satellite is marked by arrows.
methylene in the pendant arms but those around the bridging ethylene resonance overlap 
with other resonances and are not detectable. These 3J  coupling constants range from 
10.6 Hz to 13.9 Hz. In the ^C l'H } NMR spectrum of a saturated solution of 
Cd*6 (C104)2 (139) in CD3CN, three sets of 111,ll3Cd-13C satellites with coupling 
constants between 3.2 to 12.1 Hz are observed. One of these appears at 176.27 ppm, the 
amide carbonyl resonance (Figure 3.6). This indicates that Cd(II) is coordinated at least
Figure 3.6 A doublet satellite appears around the amide carbonyl resonance in the 
I3C{'H} NMR spectrum of Cd*6(C104)2 in CD3CN.
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by four amine nitrogen donors from this hexadentate ligand 6 in C D 3 C N .  Surprisingly, 
the n C{1H} NMR spectrum of [ C d ^ T i ' - N O s X K N C b )  in C D 3 O D  has detectable HU 13Cd-
1 3 13 1C satellites only around its amide carbonyl resonance. The weak C{ H} NMR 
spectrum of sparingly-soluble Cd»6 (C104)2 in C D 3 O D  precludes the detection of any 
such 111,113Cd-13C satellites.
(b) Zn(II), Cd(II) and Hg(II) Complexes of Ligands 7 and 8 .
Similar to metal complexes of ligands 1 and 3, all characterized Zn(II), Cd(II) 
and Hg(II) complexes of ligands 7 and 8 provided analogous upfield resonances 
patterns. The second-most upfield resonance can be assigned to the axial proton of the 
(3-methylene in the six-membered chelate ring ((3-CHHax). A doublet of pentets (or a 
broad doublet) to the highest field belongs to the equatorial proton of the (3-methylene in 
the six-membered chelate ring ((3-CHTTe9)- [Zn*(7-2H)](NaC104)(141) and [Zn*(7- 
2H)](NaNC>3) (142) have a common aqueous solution structure because they have the 
same ]H (Figure 3.7) and NMR spectra in D2O. As shown in the solid-state
structure of [Zn*(7-2H)](NaC104) (141) (Figure 3.26, vide infra), the six-coordinate 
Zn(II) was engulfed deeply in the cavity formed by the hexadentate 6 . This structure can 
account for the several orders of magnitude higher kinetic stability of [Zn*(7- 
2H)](NaClC>4) compared to that of Zn»l(0104)2 (117) (vide infra). We expect that such a 
structure of [Zn»(7-2H)](NaC104) is also maintained in aqueous solution. This is likely 
also the case for the common aqueous solution species of [Zn*(8-2H)] (NaC104) (143) 
and [Zn*(8-2H)](NaNO3) (144). Figure 3.8 shows their *H NMR spectra in D2O. There 
is also no significant difference between the proton NMR spectra
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Figure 3.7 Comparison of 'H NMR spectra o f the two Zn(II) complexes of 7-2H in 
D20. Top: [Zn®(7-2H)](NaC104). Bottom: [Zn*(7-2H)](NaN03). The large singlet 
around § 2 is the reference CH3CN resonance.
2 .8 0
T
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Figure 3.8 Comparison of ]H NMR spectra of the two Zn(II) complexes of 8-2H in 
D20. Top: [Zn*(8-2H)](NaC104). Bottom: [Zn*(8-2H)](NaN03).
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of [Cd*(7-2H)](NaC104) (145) and [Cd*(7-2H)](NaN03) (146) (Figure 3.9) again, 
indicating a common aqueous solution species. No conclusion, however, can be dawn as 
to whether this species is six or seven coordinate at Cd(II).
t >
Figure 3.9 *H NMR spectra of [Cd*(7-2H)](NaN03) (top) and [Cd*(7-2H)](NaC104) 
(bottom) in D2O. Solvents peaks are labeled by dots.
In D20 , both Cd*(7-2H)](NaC104) (142) and [Cd*(7-2H)](NaN03) (143) exhibit 
111,113cd -13C satellites around four 13C resonances. These range from 6.0 to 12.0 Hz.
111113 13Most importantly, the ’ Cd- C satellites around the carboxylate carbon resonance 
are clearly present and give a coupling constant of 11 Hz (Figure 3.10). Even though no 
solid-state structure is available, the presence of these clearly confirms that the Cd(II) in 
both of these two cadmium(II) complexes are coordinated at least by four amine nitrogen 
donors from the hexadentate 7-2H in D20. In contrast to the relative well-resolved !H 
and ^C l'H } NMR spectra of these two Cd(II) complexes in D20 , the proton NMR 
spectrum of Cd»(7-2H)](NaC104) in CD3OD (Figure 3.11(a)) gave rather broad
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13 1Figure 3.10 The satellites around the carboxylate carbonyl resonance in the C{ H} 
NMR spectrum of [Cd®(7-2H)](NaNC>3) in D2O.
Figure 3.11(a) *11 NMR spectrum of [Cd*(7-2H)](NaClC>4) in CD3OD.
resonances. In its ^C ^H } NMR spectrum in the same solvent, only seven out of eight 
possible resonances from coordinated 7-2H are observed (Figure 3.11(b)). The missing 
resonance is probably overlapped either with the resonance at 8 62.20 or solvent peaks. 
The two 13C resonances at 5 65.68 and 52.70 (Figure 3.11(b)) from coordinated 7-2H in 
Cd*(7-2H)](NaC104) are also quite broad. The broadening of both ]H and NMR
spectra indicate a dynamic equilibrium around coordinated 7-2H in CD3OD.
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Figure 3.11(b) 13C{!H} NMR spectrum of [Cd*(7-2H)](NaC104)in CD3OD. The
resonances assigned to this complex are marked by dots.
In its proton NMR spectrum in D2O (Figure 3.12), complex [Cd»(8- 
2H)](NaC104) (147) shows satellites around both the methylene of both the pendant arm
Figure 3.12 ’H NMR spectrum of [Cd*(8-2H)](NaC104) in D20 . The " ’’^ C d -'H  
satellites are marked by arrows.
3 3  1 1 1 1 1 3  1 1
and cross-bridging ethylene. Three C resonances out of five also show ’ Cd- C 
satellites. Their coupling constants vary from these satellites vary from 6.0 to 15.3 Hz. 
Specifically, the satellites around the carboxylate carbon resonance have a coupling
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Figure 3.13 Satellites around the carboxylate carbonyl resonance in the ^C l'H } NMR 
spectrum of [Cd®(8-2H)](NaC104) in D2O.
constant of 11.3 Hz (Figure 3.13). Again, these confirm that Cd(II) in this cadmium(II) 
complex is also coordinated at least by four amine nitrogen donors from the hexadentate 
8-2H in D2O. This complex gives only very broad signals in both its proton (Figure 
3.14(a)) and i3C{'H} NMR spectra (Figure 3.14(b)) in CD3OD, indicative o f some 
intermediate dynamic exchange process.
Figure 3.14(a) !H NMR spectrum of [Cd*(8-2H)](NaC104)in CD3OD.
Figure 3.14(b) !3C {]H} NMR spectrum of [Cd*(8-2H)](NaC104) in CD3OD.
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In the eight °C { 1H} resonances of [Hg*(7-2H)](K2HgCl4) (148) in D2O (Figure 
3.15), seven including the carboxylate carbon resonance at 5 177.13 have detectable
Figure 3.15 ^C l'H } NMR spectrum of [Hg*(7-2H)](K.2HgCl4) in D2O.
Figure 3.16 Doublet satellites at the sides of both resonances in the 13C{!H} NMR 
spectrum of [Hg*(7-2H)](K.2HgCl4) in D2O.
199Hg-13C satellites with coupling constants between 16 to 36 Hz. Figure 3.16 shows 
that the two 13C resonances in the 5 51-53 indeed have these features. Again, presence of 
these satellites confirms that at least four amine nitrogen donors from 7-2H are 
coordinated to the Hg(II) center. In CD3OD, all ^C l'H } resonances (except that at 
5 49.58 overlapping with solvent peaks) have clearly detectable 199Hg-13C satellites of 
between 11 to 30 Hz. These confirm that unlike the out-of-cleft complex formed by the
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present ligand in [HgCl2(p -l)]2 (133), an inside-cavity Hg(II) complex likely exists for 
[Hg*(7-2H)](K2HgCLi). This is also consistent with the observation of metal-coordinated 
carboxylate bands in its solid-state IR (KBr) spectrum (Table 3.1). Indeed, the X-ray 
structure of [Hg-(7-2H)]2(HgCl2)3 (148A) (Figure 3.29, vide infra) supports this 
premise.
2.3 Variable-temperature TH and 13C{'li} NMR Spectral Studies in CD3OD.
All characterized Zn(II) and Cd(II) complexes of cyclen-derived ligands 6 and 8 
exhibit a higher-order C2v symmetry in solution at room temperature whereas the highest 
symmetry of their solid-state structures is only C2 (136 in Figure 2.26). This indicats 
that these Zn(II) and Cd(II) complexes undergo some rapid dynamic process on the 
NMR time-scale. Two plausible mechanisms are shown for the Zn(II) complex of ligand 
8-2H (Figure 3.17). Lowering the temperature of these samples in CD3OD may slow
F a s t  a t  r tF a s t  a t  r t
C2v symmetry
Figure 3.17(a) A possible non-dissociative mechanism for the averaged 
symmetry in the Zn(II) complex of 8-2H in CD3OD.
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8 - 2 H
Figure 3.17(b) A dissociative mechanism for the averaged C2v symmetry in the Zn(II) 
complex of 8-2H in CD3OD.
down this equilibrium (Figure 3.17) and result in a slow exchange C2 spectrum. Thus 
low temperature *FI (or ^ C l’H}) NMR studies of these complexes were carried out in 
CD3OD. Especially useful is the observed singlet assigned to the methylene protons on 
the pendant arms from coordinated 6 or 8-2H at room temperature which should become 
an AB pattern at a low temperature. To begin with, low-temperature *H NMR studies of 
both [Zn*(7-2H)](NaC104) and [Cd*(7-2H)](NaClC>4) in CD3OD were performed.
The 'h  NMR spectra of [Zn®(7-2H)](NaClC>4) in CD3OD at room temperature 
and at -80°C are shown in Figure 3.18 and these of [Cd*(7-2H)](NaC104) in CD3OD at 
room temperature and at -80°C are shown in Figure 3.19. Broadening of both proton 
spectra indicate the slowing down of some dynamic process in both of these two 
complexes. Unfortunately, we were not able to reach the slow-exchange limit.
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Figure 3.18 Variable-temperature *H NMR spectra of [Zn*(7-2H)](NaC104) in 
CD3OD at room temperature (top) and at -80°C (bottom).
V..A x
Figure 3.19 Variable-temperature !H NMR spectra of [Cd»(7-2H)](NaC104) in 
CD3OD at room temperature (top) and at -80°C (bottom).
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The 'H NMR spectra of [Zn*6 ](Cl04)2 in CD3OD at both 15°C and at -80°C are 
shown in Figure 3.20. Clearly, significant slowing of a dynamic process can again be 
seen. Again, no limiting spectrum was obtainable.
\
Figure 3.20 Variable-temperature NMR spectra of [Zn*6](ClC>4)2 in CD3OD at
15 C (top) and at -80°C (bottom).
The ]H NMR spectra of [Zn*(8-2H)](NaC104) in CD3OD at both room 
temperature and at -80°C are shown in Figure 3.21. Interestingly, the observed singlet 
belonging to the methylene protons in the pendant arms at room temperature does 
resolve into an AB pattern at -80°C. Further, we observed five carbon resonances (two of 
them are broad) from the i3C{'H} NMR spectrum of [Zn*(8-2H)](NaClC>4) in CD3OD at 
room temperature and seven sharp 13C resonances at -80°C (Figure 3.22).
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Figure 3.21 Variable-temperature NMR spectra of [Zn*(8-2H)](NaC104) in 
CD3OD at room temperature (top) and at -80°C (bottom). The resonances o f the two 
methylene protons in the pendant arms are marked by dots.
Figure 3.22 Variable-temperature ,3C{1H} NMR spectra of [Zn®(8-2H)](NaC104) in 
CD3OD at room temperature (top) and at -80°C (bottom). The resonances from this 
complex are marked by dots.
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Either a dissociative (Figure 3.17(a)) or non-dissociative (Figure 3.17(b)) 
mechanism can explain this dynamic process. Both can interconvert the Cj enantiomeric 
complex rapidly at room temperature to give averaged C2v spectra. The latter process is 
analogous to a helicity twist to attain enantiomerization without bond rupture. A Zn(II) 
center with d10 configuration has no ligand-field stabilization energy, making this an 
attractive, low activation process.
3. X-ray Structural Data.
X-ray structures of [Zn*5](C104)2(136), [Zn*6](C104)2(138), [Cd®6 (r|1~
NO3)](NO3)(140), [Zn*(7-2H)](NaC104)(141), [Zn*(8-2H)](NaC104)(143) and [Hg*(7- 
2H)]2(HgCl2)3 (148a) were determined. To data, structural data of [Zn*(8-2H)](NaC104) 
(143) has not yet been available. Crystals of complexes suitable for X-ray analyses 
typically grew when their methanol solution was diffused with diethyl ether. A summary 
of relevant bond distances and angles of these metal complexes are listed in Tables 3.2 
(a-e).
[Zn»5](0 0 4 ) 2  (136). The crystal structure of this complex is shown in Figure 3.23. 
The Zn(II) center is fully enveloped by the cross-bridged tetraamine and its two pendant 
arms with a near-octahedral N40 2 donor set. Similar to all characterized metal 
complexes of parent ligand 1, the bicyclic tetraamine frame adopts the expected as- 
folded configuration (cis-V) in this complex (Figure 2.26).69(a-)’72,77 This Zn(II) center is 
deeply engulfed in the ligand cavity as shown by the Nax-Zn-Nax (N(2)-Zn-N(2A))
166
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Figure 3.23 X-ray structure of [Zn*5](C104)2 (136) showing atomic labeling scheme.
angle of 183.87(11)° and the N(eq)-Zn-N(eq) (N(l)-Zn-N(IA)) angle of 86.36(14)°. 
Among reported 5- or 6-coordinated metal complexes of cross-bridged ligands, 
[Cu*7Na(H2 0 )C104]2(H2 0 ) has the largest Nax-Cu-Nax bond angle of 179.7(3)° 
indicating an almost perfect fit inside the ligand.69(a) This Zn(II) center is even deeper 
within the coordinated ligand cleft.
This Zn(II) structure possesses a C2 symmetry. The two Zn-N(ax) bondlengths of 
2.147 (3) A and Zn-N(eq) bond distances of 2.087 (2) A are significantly shorter than the
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Table 3.2(a) Selected Bond Distances (A) and Bond Angles (deg) in [Zn*5](C104)2
(136).
Zn(l)-0(1) 2.099(2) Zn(l)-0(1A) 2.099(2)
Zn(l)-N(l) 2.087(2) Zn(l)-N(1A) 2.087(2)
Zn(l)-N(2) 2.147(3) Zn(l)-N(2A) 2.147(3)
0(1)-Zn(l)-N (2 A) 97.41(9) 0(1 A)-Zn( 1 )-N(2) 97.41(9)
0(1)-Zn(l)-N(2) 79.71(9) 0(1 A)-Zn( 1 )-N(2 A) 79.71(9)
0(1)-Zn(l)-N(1A) 176.91(7) 0(1 A)-Zn( 1 )-N( 1) 176.91(7)
0(1)-Zn(l)-N(l) 94.35(11) 0(1 A)-Zn( 1 )-N (1 A) 94.35(11)
0(1)-Zn(l)-0(1A) 85.10(13) N (2)-Zn( 1 )-N(2 A) 183.87(11)
N(2)-Zn(l)-N(l) 85.48(9) N(2A)-Zn(l)-N(1A) 85.48(9)
N (2 A)-Zn( 1 )-N( 1) 97.36(10) N (2)-Zn( 1 )-N (1 A) 97.36(10)
N( 1 )-Zn( 1 )-N( 1 A) 86.36(14)
Zn-N bond distances in the six-coordinated Zn(II) complex of DOTAM (65 in Figure 
1.21), which range from 2.204(4) to 2.311(4) A.164 No X-ray structures of amide-armed 
cyclam complexes of Zn(II) have been updated. Comparing to the N(eq)-Zn bond 
distances of 2.185(4) A in [Zn*l(p-C1)]2C12*4CH30H  (116) and of 2.124 (5)A in 
Zn*3(p-Cl2ZnCl2) (120), this Zn(II) complex appears to be a better fit (Figure 1.57). 
This is consistent with the larger Nax-Zn-Nax angle of 183.87(11)° in [Zn*5 ](C104)2
168
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
compared to 168.4(3)° in [Zn*l(|a-Cl)]2Cl2«4CH3OH (116) and 171.1(2)° in 
Zn»3(p-Cl2ZnCl2) (120).
[Zn»6](0 0 4 ) 2  (137). The structure of this Zn(II) complex possesses a distorted 
octahedral N4 0 2 donor set (Figure 3.24) similar to that of [Zn*5](0 0 4 ) 2  (136). The
Figure 3.24 X-ray structure of [Zn*6](ClC>4)2 (138) showing atomic labeling scheme.
smaller cross-bridged cyclen derivative, ligand 6 , is a poorer f i t  for the six-coordinate 
Zn(II). This is manifested in the increased distortion of the cation out from the bicyclic 
tetraamine cleft as the N(ax)-Zn-N(ax) angle is compressed to only 159.14(10)°. Again, 
the two Zn-N(ax) bond distances of 2.172 (3) and 2.244 (3) A are slightly longer than 
the two Zn-N(eq) bond distances of 2.076(3) and 2.107(3) A. Two different Zn-O bond
C10
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distances of 2.016(2) and 2.167(2) are found here. These bond distances are similar to 
those in the six-coordinated Zn(II) complex of DOTAM.40
Table 3.2(b) Selected Bond Distances (A) and Bond Angles (deg) in [Zn*6](0 0 4 )2
(137).
Zn(l)-0(1) 2.016(2) Zn(l)-0(2) 2.167(2)
Zn(l)-N(l) 2.076(3) Zn(l)-N(3) 2.107(3)
Zn(l)-N(2) 2.244(3) Zn(l)-N(4) 2.172(3)
0(1)-Zn(l)-N(4) 117.38(10) 0(2)-Zn(l)-N(2) 118.58(9)
0(1)-Zn(l)-N(2) 78.75(9) 0(2)-Zn(l)-N(4) 77.53(9)
0(1)-Zn(l)-N(3) 100.39(11) 0(2)-Zn(l)-N(l) 96.24(10)
0(1)-Zn(l)-N(l) 157.07(10) 0(2)-Zn(l)-N(3) 158.02(10)
0(l)-Zn(l)-0(2) 86.54(10) N(2)-Zn(l)-N(4) 159.14(10)
N(2)-Zn(l)-N(l) 79.97(10) N(4)-Zn(l)-N(3) 80.79(10)
N(l)-Zn(l)-N(4) 85.35(10) N(2)-Zn(l)-N(3) 83.34(10)
N(3)-Zn(l)-N(l) 85.48(11)
[Cd*6(r|1-N0 3 )](N0 3 ) (140). This Cd(II) complex is coordinated folly by the 
hexadentate ligand 6  and a monodentate nitrate (Figure 3.25). This is the only known 
metal complex of a cross-bridged ligand with a coordination number of seven. The
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Figure 3.25 X-ray structure of [Cd*6(r|1-N0 3 )](N03 ) (140) showing atomic labeling 
scheme.
coordination geometry around cadmium can be described as the capped trigonal prism as 
the monodentate nitrate oxygen occupies the cap position. Similar to CdCl2®2 (129) and 
[Cd*2 (r|2-N0 3 )2] (131), the axial N(l)-Cd-N(3) bond angle of 137.5° and equatorial 
N(2)-Cd-N(4) bond angle of 71.8° show how poorly the Cd(II) fit inside the coordinated 
ligand cleft. Four Cd(II)-N bond distances range from 2.408 to 2.456 A, which are 
longer than two tertiary N-Cd(II) bond distances of 2.39 A in [Cd®2 (rj2-N03 )2] but 
shorter than the two tertiary N-Cd(II) bond lengths of 2.47 A in CdCl2*2. The average 
amide O-Cd(II) bond-length of 2.36 A is similar to the two shorter amide O-Cd(II) 
bondlengths o f 2.34 A in [Cd(II)DOTAM]2+ (72 in Figure 1.25).40
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Table 2.8(c) Selected Bond Distances (A) and Bond Angles (deg) in [Cd*6(r|1-
N 03)](N03) (140).
Cd(l)-N(l) 2.428(1) Cd(l)-N(3) 2.456(2)
Cd(l)-N(2) 2.408(1) Cd(l)-N(4) 2.416(1)
Cd(l)-0(1) 2.327(1) Cd(l)-0(2) 2.395(1)
Cd(l)-0(3) 2.379(1)
0(l)-Cd(l)~N(4) 143.51(5) 0(2)-Cd(l)-N(2) 103.61(5)
0(1)-Cd(l)-N(2) 98.84(5) 0(2)-Cd(l)-N(4) 141.07(5)
0(1)-Cd(l)-N(3) 138.17(5) 0(2)-Cd(l)-N(l) 145.96(5)
0(1)-Cd(l)-N(l) 71.63(5) 0(2)-Cd(l)-N(3) 68.73(4)
Q(3)-Cd(l)-N(l) 113.12(5) 0(3)-Cd(l)-N(2) 158.33(5)
0(3)-Cd(l)-N(3) 91.51(5) 0(3)-Cd(l)-N(4) 91.32(5)
0(l)-Cd(l)-0(2) 75.04(4) 0(l)-C d(l)-0(3) 102.78(5)
0(2)-Cd(l)-0(3) 80.71(5) N(3)-Cd(l)-N(l) 137.47(5)
N(2)-Cd(l)-N(l) 75.27(5) N(4)-Cd(l)-N(3) 73.50(5)
N(l)-Cd(l)-N(4) 71.89(5) N(2)-Cd(l)-N(3) 71.00(5)
N(2)-Cd(l)-N(4) 71.84(5)
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[Zn»(7-2H)](NaQ04) (141). This Zn(II) complex is iso structural to the corresponding 
[Cu*(7-2H)Na(H2 0 )C104]2(H2 0 ) (Figure 1.60). The Zn(II) center in this complex is 
also fully coordinated by four tetraamine nitrogens and two carboxylate oxygens from 7- 
2H in a near-octahedral manner (Figure 3.26). The Nax-Zn-Na* bond angle of 178.32(6)°
;Ut1?
041
Figure 3.26 X-ray structure of [Zn*(7-2H)](NaCKX) (141) showing atomic labeling 
scheme. Hydrogens bonded to carbons are omitted for clarity.
and the N(eq)-Zn-N(eq) bond angle of 83.84(6)° are also similar. Unlike both 
[Zn*5](C104)2 and [Zn«6](C104)2, the Zn-N(ax) bond distance of 2.117(2) A is slightly 
shorter than the two Zn-N(eq) bond distances of 2.158(2) A. These are within the Zn(II)- 
N bondlengths ranging from 2.110 to 2.253 A  in the six-coordinated Zn(II) complexes of 
macrocyclic tetraamine carbamoyl ligands. ’ ’ The two Zn-0 bond distances of
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2.0834(14) and 2.1103(13) A are also within Zn(II)-0 bondlengths of between 2.037 
and 2.147 A in these complexes. 137,164,165 The full structure o f [Zn*(7-2H)](NaClC>4) 
includes sodium(I) cations coordinating to carboxylate oxygens from two different 
Zn(II) complex units in either mono or bidentate mode to form an infinite polymeric 
chain (Figure 3.27). Such an infinite Zn(II) coordination network may have potential
1 Of tapplication as an nonlinear optical material.
tx s o  OOS1H
taosM  ^ ®i
Figure 3.27 Hydrogen bonding interactions in the crystal structure of 
[Zn*(7-2H)](NaC104) (141).
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Table 3.2(d) Selected Bond Distances (A) and Bond Angles (deg) in
[Zn-(7-2H)](NaC104)(141).
Zn(l)-0(1) 2.0834(14) Zn(l)-0(3) 2.1103(13)
Zn(l)-N(l) 2.1557(16) Zn(l)-N(3) 2.1598(16)
Zn(l)-N(2) 2.1172(16) Zn(l)-N(4) 2.1162(16)
Na(lA)-0(2A) 2.3143(16) Na(lA)-0(3'A) 2.5194(15)
Na(lA)-0(4'A) 2.5020(16)
0(1)-Zn(l)-N(4) 97.88(6) 0(3)-Zn(l)-N(2) 98.45 (6)
0(1)-Zn(l)-N(2) 83.22(6) 0(3)-Zn(l)-N(4) 82.74(6)
0(1)-Zn(l)-N(3) 173.95(6) 0(3)-Zn(l)-N(l) 172.33(6)
0(1)-Zn(l)-N(l) 91.79(6) 0(3)-Zn(l)-N(3) 90.02(6)
0(l)-Zn(l)-0(3) 94.66(6) N(2)-Zn(l)-N(4) 178.32(6)
N(2)-Zn(l)-N(l) 86.42(6) N(4)-Zn(l)-N(3) 86.49(6)
N(l)-Zn(l)-N(4) 92.27(6) N(2)-Zn(l)-N(3) 92.32(6)
N(3)-Zn(l)-N(l) 83.84(6) Zn( 1 )-0(3)-Na( 1 A) 156.780
[Zn*(8-2H)](NaQC>4) (143). An X-ray structure of this complex (Figure 3.28) 
shows that Zn(II) center is also fully coordinated by four amine nitrogen donors and two
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carboxylate oxygen atoms from 8-2H in a distorted-octahedral geometry. Full structural 
data is not yet available at this time.
Figure 3.28 X-ray structure of [Zn»(8-2H)](NaCKX) (143).
[Hg*(7-2H)]2(HgCl2)3 (148a). Unlike the out-of-cavity HgCU complex with parent 
cross-bridged cyclam 1 (Figure 2.39), the structure of this Hg(II) complex of 
dicarboxylate pendant-armed cross-bridged cyclam derivative (8) shows an inside cavity 
Hg(II) complex (Figure 3.29). Similar to all characterized Zn(II) and Cd(II) complexes 
of ligands 5-8, the Hg(II) center in this complex is fully enveloped by the cross-bridged 
tetraamine and its two pendant arms. Due to the larger size of Hg(II), the coordinated 
Hg(II) center does not fit well in the cavity as indicated by the Nax-Hg-Nax angle of 
157.09(14)° and the N(eq)-Hg-N(eq) angle of 72.30(14)°. This structure also features 
two independent but structurally similar Hg(II) marcobicyclic units bridged by a third 
Hg(II) through the carboxylate oxygen atoms. This bridging Hg(II) is further 
coordinated to two terminal chlorides in a distorted square planar. Further, within each
176
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C5A
C8A C7A
Figure 3.29 X-ray structure of [Hg»(7-2H)]2(HgCl2)3 (148a) showing atomic labeling 
scheme.
[Hg(II)»(7-2H)] units, an additional HgCb is chelated through two carboxylate oxygen 
atoms. This Hg(II) atom adopts a distorted tetrahedral geometry with two terminal 
chlorides occupy the remaining coordinating sites.
177
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

































































Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Cl(3)-Hg(3)-C1(3A) 180.00(6) Cl(3 A)-Hg(3)-0(3) 93.84(10)
Cl(3)-Hg(3)-0(3A) 93.84(10) C1(3A)-Hg(3)-0(3A) 86.16(10)
0(3)-Hg(3)-0(3A) 180.00(9)
The structure of this Hg(II) complex clearly indicates that the formation of the 
out-of-cavity complex [HgCl2(p-l) ] 2 (133) (Figure 2.39) is is a result of the presence of 
two secondary amine hydrogens which maintained strong transannular hydrogen 
bonding within the ligand cleft. There have been no X-ray reports on the Hg(II) 
complexes of macrocyclic polyamine with one or more carboxylate pendant-arms.
Summary of Structural Data.
Those six Zn(II), Cd(II) and Hg(II) complexes of pendant-armed cross-bridged 
ligands 5-8 feature full p4-N , p2- 0  coordination of the metal cations within the ligands 
clefts. So far, full structural data of [Zn*(8-2H)] (NaClO,*) is not yet available. A 
comparison of axial N-M-N angles and the equatorial N-M-N angles is listed in Table 
3.3. Clearly, similar to parent ligands, cross-bridged cyclam derivatives 5 and 7-2H 
provide a better fit for octahedral Zn(II) than the smaller cross-bridged cyclen 
derivatives 6  and 8-2H. This is best gauged by the axial N-Zn-N angles of 183.87° and 
178.32(16)° for the former and 159.14(10)° for [Zn*6 ](C104)2 (137). However, unlike 
Zn(II) complexes of parent ligands 1 and 2, the equatorial N-Zn-N angle which is
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86.36(14)°and 83.84(6)° for Zn(II) complexes of cyclam-derived 5 and 7-2H 
respectively is close to that of 85.48(11)° for [Zn®6](C104)2.
Comparison of the structural data o f [Zn®6](C104)2(137) and [Cd^bfq1- 
NO3)](NO3)(140) clearly shows that the increased misfit of the larger cation. Their 
respective axial N-M-N angles are Zn (159.14(10)°) and Cd (137.5°). Parallel trends in 
the equatorial N-M-N angles are also observed for Zn (85.48(11)°) and Cd (71.8°). 
Similarly, comparison on the structural data of [Zn®(7-2H)](NaC104)(141) and [Hg®(7- 
2H)]2(HgCl2)3 (148a) again demonstrated this trend as their respective axial N-M-N 
angles are Zn (183.87(11)°) and Hg (157.09(14)°) while the equatorial N-M-N angles 
are Zn (86.36(14)°) and Hg (72.30(14)°). These data affirm the design purpose of these 
cross-bridged ligands with or without pendant-arms for selective complexation of 
smaller metal ions. Similar to any other Zn(II) and Cd(II) complexes of ligands 5-8, a 
Hg(II) center has been shown to be fully coordinated by four tetraamine nitrogens and 
two carboxylate oxygens from 7 (Figure 3.29), albeit with substantial bond angle 
deviations from an idealized octahedral geometry.
Table 3.3 Structural comparison of Zn(II), Cd(II) and Hg(II) complexes of ligands 5-8.
Complex Axial N-M-N angle Equatorial N-M-N angle
[Zn«5](C104)2(136) 183.87(11) 86.36(14)
[Zn*61(C104)2 (138) 159.14(10) 85.48 (11)
[Cd*6('n1-N 03)1(N03) (140) 137.5 71.8
[Zn®(7-2H)1 (NaC104) (141) 178.32 (6) 83.84 (6)
[Hg-(7-2H)l2(HgCl2)3 (148a) 157.09(14) 72.30(14)
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CHAPTER IV
Ga(ffl), In(III) AND Cu(II) COMPLEXES OF CROSS-BRIDGED
LIGANDS 1-8
1. Ga(III) and In(III) Complexes o f Cross-bridged Ligands 1, 2 , and 8 .
H
-N\ N ^Ph NCph
;n  n N N Ph^N N Ph S'
H H
-Nn  Nr^CONH2 NCT'CONHj /b k  nC'COOH JNL N^COOH
h 2n o g ^ ]^ J ^  h 2n o c ^  N h o o g ^ ^ J 1* h o o c ^
5 6 7 8
Figure 4.1 Cross-bridged ligands studied in Ga(III), In(III) and Cu(II) complexation.
1.1. Synthesis and Characterization.
In the preparation of Ga(III) and In(III) coordination complexes, a persistent 
problem is that the precipitation of Ga(OH)3 and In(OH)3 may occur before the 
complexation process is complete.59 The combination of this and the proton-sponge 
character of our cross-bridged ligands can easily lead to protonated ligand byproducts in 
the presence of moisture or any acidic proton sources. Early attempted complexations of
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Ga(III) or In(III) salts with ligands 1 or 2 in the protic solvent methanol indeed produced 
this probem. For example, attempted complexation of InBr3 with 2 in MeOH yielded 
some white precipitate from which pure [LnBr2*2 ]Br (152) was isolable after several 
acetonitrile washings. However, Et20  diffusion into the mother, liquor yielded a 
crystalline solid from which a proton NMR spectrum in CD3CN included a singlet 
resonance at 5 10 ppm (Figure 4.2). This indicates that protonated 2 was formed in the
Figure 4.2 Proton NMR spectrum of the crystalline solid from [InBr2*2]Br synthesis in
c d 3c n .
attempted complexation. An attempted complexation of InBr3 with 1 in methanol also 
yielded a mixture of complexed and protonated 1 as seen in its ]H (Figure 4.3(a)) and 
NMR spectra in D2O. The characteristic resonance of protonated 1 at 8 2.53 in 
its proton NMR spectrum in Figure 4.3(a) can be compared with the proton NMR 
spectrum of protonated 1 (Figure 4.3(a)). A failed complexation between Ga(N03)3 
hydrate and 1 in methanol yielded mainly protonated 1 (Figure 4.3(b)). Anhydrous 
reaction conditions were thus employed to prepare Ga(III) and In(III) complexes of cross­
bridged cyclam (ligand 1) and cross-bridged cyclen (ligand 2). By avoiding moisture and 
using anhydrous acetonitrile as the reaction solvent, complexes [GaCfr'IJCl (149) (68%,
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yield), [InBr2*l]Br (150) (86%), [GaCl2*2]Cl (151) (53%), and [InBr2*2]Br (152) (60%) 
were isolated as confirmed by their CHN elemental analyses. In addition, three o f these 
four Ga(III) and In(III) complexes were also characterized by X-ray analyses. These 
represent the first well-characterized gallium(III) and indium(III) halide complexes of 
any tetraamine.
-V6
Figure 4.3(a) Top: Proton NMR spectrum of a protonated 1 in D20 . Bottom: Proton 
NMR spectrum of an attempted complexation product of InBr3 with 1 in methanol in 
D20 , in which the characteristic protonated 1 resonance is marked by a dot.
Figure 4.3(b) Proton NMR spectrum of an attempted complexation product between 
Ga(NC>3)3 hydrate and 1 in methanol (D20).
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Ligands 7 and 8 are N, N'-dicarboxylate pendant-armed derivatives of parent 
cross-bridged cyclam (1) and cross-bridged cyclen (2) respectively (Figure 4.1). Unlike 
ligands 1-6, ligands 7 and 8 contain both carboxylate acidic protons and basic amines and 
they were synthesized as TFA salts. Equivalents of base are thus necessary to neutralize 
these acidic protons in order to facilitate the formation of metal complexes. In the 
presence of NaOAc base, [Ga»(8-2H)](NC>3) (153) precipitated from the reaction mixture 
of8*TFA*H20  and Ga(NC>3)3 hydrate in MeOH after refluxing for several hours. Sodium 
acetate was chosen as the base for the following reason. Addition of a strong base such as 
sodium hydroxide into a solution containing Ga(N6)3)3 hydrate may cause the 
precipitation of Ga(OH)3 whereas the weakly coordinating of acetate to Ga(III) can avoid 
this problem.22,59 [Ga*(8-2H)](N0 3 ) is soluble in D20  and d6-DMSQ. Contrary to the 
relatively easy synthesis of [Ga*(8-2H)](N0 3 ), all attempted complexations of Ga(TII) 
salts with 7*(TFA)2 have failed so far. For example, an attempted complexation of 
Ga(N03)3 hydrate with 7*(TFA)2 under similar reaction conditions yielded only a 
polymeric or oligomeric product as indicated by its poor solubility in D20  and dg-DMSO. 
The presence of ligand 7 in this is indicated by carboxylate carbonyl stretches at 1558, 
1635, 1652, and 1685 cm'1 in its IR (KBr) spectrum (Figure 4.4). Attempted 
complexation of Ga(acac)3 with 7*(TFA)2 in the presence of a methanol solution of KOFI
1 13 1(or NaOAc) did not yield an inside-cavity complex since both H and C{ H} NMR 
spectra of the product in acidic D20  are quite similar to those of 7®(HC1)2 (Figure 4.5(a) 
and Figure 4.5(b)).
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Figure 4.4 IR (KBr) spectrum of the product of an attempted complexation of
Ga(NC>3)3 hydrate with 7*(TFA)2
2
Figure 4.5(a) Top: Proton NMR spectrum of 7 *(HC1 ) 2  in D 2 O. Bottom: Proton 
NMR spectrum of an attempted complexation product of Ga(acac)3 with 7®(TFA)2 in D 2 O 
(the singlet at 5 2.06 ppm is from CH 3 CN.).
1 ............ - ... .......... -
......... —......—. ....................... ... .
Figure 4.5(b) Top: 13C{1H} NMR spectrum of 7®(HC1)2 in D20. Bottom:
NMR spectrum of an attempted complexation product of Ga(acac)3 with 7*(TFA)2 in 
D20.
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1.2. Spectral Data.
(a) Infrared Spectra.
In their IR(KBr) spectra, all four Ga(III) and In(III) complexes o f ligands 1 and 2 
have N-H stretches appearing between 3036 and 3137 cm'1 (Table 4.1) which are 
significantly lower than those of Zn(II), Cd(II) and Hg(II) complexes o f ligands 1 and 2
Table 4.1 NH stretches in the IR spectra of Ga(III) and In(III) complexes of ligands 1 
and 2.
Complex vNH (cm'1) Complex V N H  (cm'1)
[GaCl2*l]Cl 3137 [InBr2*l]Br 3116
[GaCl2*2]Cl 3049 [InBr2*2]Br 3036
(3216 and 3286 cm'1) (Table 2.2) but similar to the N-H stretch of 3078 cm'1 in the out- 
of-cavity complex [HgCl2(p-l)]2 (Table 2.2). Complex [Ga»(8-2H)](NC>3) (152) shows 
two sharp and strong carboxylate bands at 1672 and 1692 cm'1. These two are higher than 
for the C=0 stretches of Zn(II), Cd(II) and Hg(II) complexes with ligands 7-8 (Table 
3.1). 1611 and 1645 cm'1 are the two highest frequency carboxylate bands among these 
complexes.
(b) Solution 'H and NMR Spectra.
Solution !H and NMR spectra of the four Ga(III) and In(III) complexes
of ligands 1 and 2 are discussed here. Similar to Zn(II) complexes of ligands 1 and 2 in 
D2O, all these complexes display NTT/ND exchange in D2O. In D2O, [GaCl2*l]Cl (N-D 
complex) exhibited broad signals in both its ]H and I3C{1H) NMR spectra (Figure 4.6(a)
186
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and Figure 4.6(b)), which may he caused by dynamic exchanges involving chloride, D2O
Figure 4.6(a) Proton NMR spectrum of [GaCU’lJCl (N-D complex) in D2O.
Figure 4.6(b) Top: NMR spectrum of [GaCb'lJCl (N-D complex) in D2O.
Bottom: 13C{*H} NMR spectrum of [Z m l^ -C l^ C h  (116a) in D2O.
13 1and OD‘ at the cation. For comparison, the sharp and well-resolved C{ H} NMR 
spectrum of [Zn*l(p-Cl)]2Cl2 (116a) is also shown in Figure 4.6(b). Both the 'H and 
NMR spectra of [GaC^’lJCl in D2O changed after the addition of acid. The 'H 
NMR spectrum of [GaCh’ljC l (N-D complex) in acidic D2O (pD =1.07, DCIO4) is 
shown in Figure 4.7. Unlike the usual spin pattern of the most upheld resonance of a 
doublet of pentets around 8 1.6 of a coordinated cross-bridged cyclam (ligand 1) and its 
derivatives, this spectrum shows two doublets of pentets at 8 1.84 and 1.76 (Figure 4.8). 
Since this Ga(III) complex is stable in acidic D2O (pD =1.07) for at least one year, these
187
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Figure 4.7 JH NMR spectrum of [G aC^'ljC l (N-D complex) in acidic D2O 
(pD =1.07).
Figure 4.8 Expansion of the two doublets of pentets at 8 1.84 and 1.76 in the ]H NMR 
spectrum of 0.015 M [GaCl2*l]Cl (N-D complex) in acidic D2O (pD =1.07).
two separate doublets of pentets suggest that [GaCl2*l]Cl can exist as two species in
acidic D2O in slow exchange on the NMR time scale. Consistent with this hypothesis,
there are also two sets of 13C resonances for this Ga(III) complex (Figure 4.9). For
example, the carbon P to amino nitrogens in coordinated 1 appear as two distinct peaks at
8 19.7 and 19.4 (Figure 4.10). For clarity, these two Ga(III) species will be labeled
Ga(III) complex A (!H at 8 1.84) and Ga(III) complex B ('H at 8 1.76) respectively. The
N///ND exchange also occurs for both as indicated by the fact that in a NH/ND complex
1 ^mixture, a slightly different chemical shift is observed for the two C resonances around 
8 48 and 8 41 for both species but not for the pure N-D complex (Figure 4.9). The 
assumption that complexes A and B are in slow exchange on the NMR time scale is
188
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Figure 4.9 ^C l'H } NMR spectrum of 0.015 M [GaCE'IJCl in acidic D2O (pD =1.07). 
Top: N-D complex. Bottom: a 1:1 N-H and N-D complex mixture.
I  $ > . 8
Figure 4.10 Expansion of two peaks at 5 19.7 and 19.4 in the ^ C l’H) NMR spectrum 
of 0.015 M [GaCE'ljCl (N-D complex) in acidic D2O (pD =1.07).
further supported by the changes of both ’H and 13C{1H} NMR spectra upon addition of 
KC1. As shown in Figure 4.11, the increased KC1 concentration increased the relative 
integration of the doublet of pentets at 8 1.76 while decreasing that at 8 1.84. This implies 
that the concentration of Ga(III) complex A decreased whereas that of Ga(III) complex B 
increased as the chloride anion concentration was increased. Since this increase of KC1 
concentration simultaneously increased the relative height of the 13C resonance at 8 19.7 
relative to the one at 8 19.4 (Figure 4.12), we can assign 8 19.7 and 19.4 to complex B
189
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Figure 4.11 Comparison of the changes of the two sets of proton doublet of pentets at 
5 1.84 and 1.76 with increased KC1 concentration (pD =1.07). Top: no KC1. Middle: 3 
equivalents of KC1. Bottom: 9 equivalents of KC1.
Figure 4.12 Comparison of the changes of the two l3C{]H} resonances at 8 19.7 and 
19.4 with the increase of KC1 concentration (pD =1.07). Top: no KC1. Middle: 3 
equivalents of KC1. Bottom: 9 equivalents of KC1.
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and complex A respectively. Since the relative intensity of the broader set of !3C 
resonances increased with [KC1] (Figure 4.13), one may speculate that complex A is 
more symmetrical than B. Complex A is then likely to be the more symmetrical species 
[l-Ga-(OH2)2]3+ while complex B is probably the less symmetrical [1-Ga-(0H2)C1]2+. 
Confirmation of these conjectures will require much more detailed studies of the solution 
speciation.
1
Cm* 62 <50 SK 3<i S*t SZ  SO
30 i ft
Figure 4.13 Comparison of 13C{]H} NMR spectral change of 0.015 M [GaCh’ljC l 
(N-D complex) in acidic D2O (pD =1.07) with the increase o f KC1 concentration. Top: 
no KC1. Middle: 3 equivalents of KC1. Bottom: 9 equivalents of KC1.
In D2O, [InBr2*l]Br (N-D complex) existed as a major species and a minor 
species (10%) as indicated by its ’H and ^ C f’H} NMR spectra (Figure 4.14). In order to 
confirm whether there is equilibration between these species, a comparison of the 'H 
NMR spectra of 0.030 M, 0.018 M and 0.0030 M [InBr2*l]Br in D2O (Figure 4.15) were 
recorded to demonstrate that the relative ratios of these two species indeed changed as 
exemplified by the resonances between 8 1.6 to 1.8 and from 8 2.6 to 2.9.
191
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Figure 4.14 Top: Proton NMR spectrum of [InBr2*l]Br (N-D complex) in D2O. 







Figure 4.15 Comparison of ’H NMR spectra of 0.030 M, 0.018 M and 0.0030 M 
[InBr2*l]Br in D2O. Top: 0.030 M. Middle: 0.018 M. Bottom: 0.0030.
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Figure 4.16(a) Proton NMR spectrum of [InBr2*2 ]Br (N-D complex) in D 2 O (the 
singlet resonance labeled with a dot is the CH3 OD peak.).
By contrast, both ]H and ^C ^H } NMR spectra of [GaCl2*2 ]Cl and [InBr2*2 ]Br 
(Figure 4.16(a) and Figure 4.16(b)) in D2O showed only a species with C2v symmetry on 
the NMR time scale.
Figure 4.16(b) ^C ^H }  NMR spectrum of [InBr2*2]Br (N-D complex) in D2O.
In CD3CN, all four Ga(III) and In(III) complexes give well-resolved !H and 
^ C l’H} NMR spectra except that no ^C^H } NMR spectrum of [GaCl2*2 ]Cl can be
13 1recorded due to its poor solubility. The six sharp carbon resonances in the C{ H} NMR 
spectra of [GaCl2*l]Cl (Figure 4.17) and [InB^'lJBr indicate their C2 symmetry on the
1T 1NMR time scale. The three carbon resonances in the C{ H} NMR spectrum of 
[InBr2*2 ]Br in CD3CN (Figure 4.18) confirm its Civ symmetry on the NMR time scale. 
Here, the appearance of cross-bridged ethylene as a singlet in the 'H NMR spectra of 
[GaCl2*2 ]Cl and [InBr2*2 ]Br (Figure 4.19) is also indicative o f their C2V symmetry.
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Figure 4.17 ,3C{1H} NMR spectrum of [GaCl2*l]Cl in CD3CN (the shortest
resonance at 8 30.8 is an impurity.).
Figure 4.18 NMR spectrum of [InBr2»2]Br in CD3CN.
Figure 4.19 1H NMR spectrum of [InBr2»2]Br in CD3 CN. The singlet of cross-bridged 
ethylene appears at 8 3.05.
The proton and ^C l'H } NMR resonances of [InBr2*2]Br in CD3CN (Figure 4.19 
and Figure 4.18) can be assigned by a combination of 2D [1H,1H] COSY and 2D 
[’H ^C ] HMQC NMR experiments. The 1-D proton NMR spectrum (Figure 4.19) is a 
first-order spectrum with a total of six well-resolved resonances from coordinated 2. The 
broad singlet at 8 4.49 can be assigned to NH  protons since it does not couple to any 13C
194
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Figure 4.20 A 2D [JH,13C] HMQC NMR spectrum of [InBr2*2]Br in CD3CN (only 13C 




Figure 4.21 A 2D [ ^ ‘H] COSY spectrum of [InBr2*2]Br in CD3CN.
resonances in the 2D [’Hj^C] HMQC spectrum (Figure 4.20). 2D ['H^H] COSY 
(Figure 4.21) reveals that the two multiplets at 5 3.71 and 2.84 are coupled to the N -if 
singlet at 8 4.49 so these two resonances belong to Ha and Hb (Figure 4.22). 2D []H,I3C] 
HMQC reveals that they are coupled to the ^ C l’H} resonance at 8 50.62. This carbon
195
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Figure 4.22 Solution structure of [InBr2®2]Br with a C2v symmetry. A total of six 
different resonances are expected in its *H NMR spectrum.
resonance can thus be assigned to the one bonded to Ha and Hb (position 1 in Figure 
4.22). The singlet at 5 3.05 does not show coupling to any other proton resonances so it
13can be assigned to the protons from bridging ethylene (Hf). The C resonance at 8 50.62 
showing coupling to this singlet can then be assigned to the bridging ethylene carbons
1 3(position 3 in Figure 4.22). The remaining unassigned C resonance at 8 54.65 can be 
assigned to position 2. Proton resonances at 8 3.56 and 3.05 do not couple to the singlet at 
8 4.49 so these two belong to Hc and Ha in Figure 4.22. Consistent with this, they are 
also coupled to the 13C resonance at 8 54.65 assignable to position 2.
To assign the two proton resonances at 8 3.71 and 2.84 to Ha or Hb, we can check 
the coupling constants of these resonances. The resonance at 8 3.71 has a larger coupling 
constant of 7.6 Hz with the NH proton whereas the resonance at 8 2.84 has a smaller 
coupling constant of 3.4 Hz with the same NH proton. A model of this time-averaged C2v 
In(III) complex shows that the dihedral angle between NH proton and Ha is around 180° 
and the dihedral angle between NH proton and Hb is between 0 to 45°. So the resonance 
at 8 3.71 probably belongs to the Ha protons while the resonance at 8 2.84 likely belongs
196
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to the Hb protons.
Unlike the C2v time-averaged symmetry of [Zn*(8-2H)](NaClC>4) (143) observed 
in its solution NMR spectra at room temperature, complex [Ga*(8-2H)](N0 3 ) (153) 
shows only C2 symmetry. Such symmetry is indicated by the pendant-arm methylene 
giving an AB pattern (Figure 4.23) in its proton NMR spectrum as well as the presence 
of eight instead of five 13C resonances. This indicates that at room temperature, there is 
no dynamic equilibration of this Ga(III) complex in D2O solution.
Figure 4.23 !H NMR spectrum of Ga*(8-2H)](N0 3 ) in D2O. The most downfield AB 
resonance belongs to the methylenes in the two pendant arms of 8-2H.
1.3 X-ray Structural Data.
X-ray structures of [GaCl2*l]Cl (149), [InBr2*l]Br (150), [InBr2*2]Br (152), and [Ga«(8- 
2H)](N03) (153) were solved. Their relevant bond distances and angles are listed in 
Tables 4.2(a-d) individually.
[GaCl2*l]Cl (149) This complex has the cross-bridged ligand 1 in the distorted
A
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Figure 4.24 X-ray structure of [GaC^’ljCl (149) showing atomic labeling scheme.
diamond lattice [2323]/[2323] cz's-folded ligand conformation (Figure 4.24). Within the 
ligand molecular cleft, the Ga(III) has a slightly distorted octahedral coordination sphere 
as indicated by the axial N(2)-Ga-N(4) angle of 169.3(1)° and equatorial N(l)-Ga-N(3) 
angle of 84.2(1)°. The average secondary N(ax)-Ga bond length of 2.08 A is slightly 
shorter than the average tertiary N(eq)-Ga bond length of 2.13 A. There are limited 
structural studies of Ga(III) complexes of cyclam and its derivatives in the literature. Two 
known examples [Ga(cyclam)]P04  and [(CH3)Ga(cyclam)]Cl2 (Figure 1.48) have the 
trans-IU ligand configuration. These have average amine N-Ga bond distances of 2.05 
and 2.08 A respectively.
Ga-Cl bond distances of 2.3227 (6) and 2.3184 (6) A are found in this Ga(III)
198
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complex. T h e s e  a r e  s l i g h t l y  l o n g e r  t h a n  t h e  G a - C l  b o n d l e n g t h  o f  2 . 2 6 5  ( 1 )  A r e p o r t e d  in 
s i x - c o o r d i n a t e d  [ m - G a ( C l ) 2 ( b i p y ) 2] + [ G a C l 4 ] ' . 127
Table 4.2(a) S e l e c t e d  B o n d  D i s t a n c e s  (A) a n d  B o n d  A n g l e s  ( d e g )  i n  [ G a C l 2 * l ] C l  
(149).
G a ( l ) - N ( l )  2 . 1 3 2 3 ( 1 6 )  G a ( l ) - N ( 2 )  2 . 0 7 0 ( 2 )
G a ( l ) - N ( 3 )  2 . 1 3 2 2 ( 1 7 )  G a ( l ) - N ( 4 )  2 . 0 8 8 ( 2 )
G a ( l ) - C l ( l )  2 . 3 2 2 7 ( 6 )  G a ( l ) - C l ( 2 )  2 . 3 1 8 4 ( 6 )
N ( 4 ) - G a ( l ) - N ( 2 )  1 6 9 . 3 3 ( 7 )  N ( 3 ) - G a ( l ) - N ( l )  8 4 . 1 7 ( 7 )
N ( 3 ) - G a ( l ) - N ( 4 )  8 8 . 2 0 ( 7 )  N ( 3 ) - G a ( l ) - N ( 2 )  8 3 . 9 3 ( 7 )
N ( 4 ) - G a ( l ) - N ( l )  8 3 . 8 0 ( 7 )  N ( 2 ) - G a ( l ) - N ( l )  8 8 . 2 3 ( 7 )
N ( 4 ) - G a ( l ) - C l ( 2 )  9 5 . 9 4 ( 5 )  N ( 3 ) - G a ( l ) - C l ( 2 )  9 . 4 2 ( 5 )
N ( 2 ) - G a ( l ) - C l ( 2 )  9 1 . 4 6 ( 5 )  N ( l ) - G a ( l ) - C l ( 2 )  1 7 5 . 5 9 ( 5 )
N ( 3 ) - G a ( l ) - C l ( l )  1 7 7 . 0 2 ( 5 )  N ( 4 ) - G a ( l ) - C l ( l )  9 2 . 3 7 ( 5 )
N ( 2 ) - G a ( l ) - C l ( l )  9 5 . 1 3 ( 5 )  N ( l ) - G a ( l ) - C l ( l )  9 2 . 9 8 ( 5 )
C l ( 2 ) - G a ( l ) - C l ( l )  9 1 . 4 3 ( 2 )
[InBr2*l]Br (150) T h e  X - r a y  s t r u c t u r e  o f  t h i s  c o m p l e x  ( F i g u r e  4.25) r e v e a l s  t h a t  t w o  
t e r m i n a l  b r o m i d e s  a n d  f o u r  a m i n o  n i t r o g e n s  f r o m  t h e  l i g a n d  c o o r d i n a t e  t o  t h i s  I n ( I I I )  
c e n t e r .  I t  h a s  a  d i s t o r t e d - o c t a h e d r a l  c o o r d i n a t i o n  g e o m e t r y  w i t h  a n  a x i a l  N ( 4 ) - I n - N ( 2 )  
b o n d  a n g l e  o f  1 6 4 . 2 9 ( 1 2 ) °  a n d  a n  e q u a t o r i a l  N ( l ) - I n - N ( 3 )  b o n d  a n g l e  o f  7 8 . 8 9 ( 9 ) ° .  
C o m p a r i s o n  o f  t h e s e  t w o  b o n d  a n g l e s  w i t h  t h e  a n a l o g o u s  o n e s  i n  [ G a C l 2 * l ] C l  r e v e a l s  t h a t
1 9 9
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C(12)
C ! 5 )  /  _ J d
- • ■ r A  f e »
Br(2)
Figure 4.25 X-ray structure of [InBr2*l]Br (150) showing atomic labeling scheme.
the larger In(III) does not f i t  as well as Ga(III) in the cleft formed by coordinated 1. The 
axial and equatorial In-N bond distances are 2.26 and 2.31 A respectively and the In-Br 
bond distance is 2.27 A. There is no reported crystal structures of any In(III) complex 
with a N4X2 donor set (X = halide). For comparison, [InBr3(Me3[9]aneN3)] has a N3Br3 
coordination set128 with the secondary In-N bond distances ranging from 2.338 (7) to 
2.360 (7) A and In-Br bond distances ranging from 2.5974 (11) to 2.6054 (11) A.
200
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[InBr2*2]Br (152) Compared to that of [InBr2*l]Br, the pseudo-octahedral indium(III) 
coordination sphere here is even more distorted (Figure 4.26) with an axial N(2)-In-N(4) 
bond angle of only 144.0(1)° and equatorial N(l)-In-N(3) bond angle of 76.8(1)°. Again, 
this can be attributed to the smaller cleft of the coordinated cross-bridged cyclen 2 
compared to that of cross-bridged cyclam 1. The axial and equatorial In-N bond distances 
are 2.26 and 2.31 A respectively which are similar to those of [InB^'lJBr. Compared to 
the In-Br bond distance of 2.27 A in [InBr2*l]Br, this complex has significantly longer 
In-Br distances of 2.57 A.
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C(3) N(2)
Figure 4.26 X-ray structure of [InBr2*2]Br (152) showing atomic labeling scheme.
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[Ga»(8-2H)](NC>3) (153) This structure (Figure 4.27) represents only the second X-ray 
o f Ga(III) complexes of carboxylate pendant-armed tetraamines.66 The Ga(III) center is 
















Figure 4.27 X-ray structure of [Ga*(8-2H)](N0 3 ) (153) showing atomic labeling 
scheme.
coordination sphere around Ga(III) is again a distorted octahedral with an axial N(2)-Ga- 
N(2A) angle of 164.56 (9)° and an equatorial N(l)-Ga-N(1A) angle of 86.24 (9)°. The 
axial Ga-N bond distance of 2.0780 (15) A is slightly longer than the Ga-N(eq) bond
203
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distance of 2.0461 (15) A. In the literature, a Ga(III) complex of a tricarboxylate-armed 
cyclen derivative 106 also has a N4O2 pseudo-octahedral geometry (Figure 1.52) with an 
axial N(3)-Ga-N(5) angle of 156.3 (2)° and an equatorial N(2)-Ga-N(4) angle of 105.6 
(2)°. These bond angle differences imply that Ga(III) fits better in cross-bridged ligand 8- 
2H than that in ligand 106. Here, the axial Ga-N bond distance o f 2.15 A is also 
marginally longer than Ga-N(eq) bond distance of 2.13 A. Two Ga(III)-0 bondlengths of 
1.904 (5) and 1.932 (4) A are shorter than those of 1.9421 (13) A found in [Ga®(8- 
2H)](N03).
Table 4.2(d) Selected Bond Distances (A) and Bond Angles (deg) in [Ga®(8-2H)](N0 3 ) 
(153).
Ga(l)-0(1) 1.9421(13) Ga(l)-0(1A) 1.9421(13)
Ga(l)-N(l) 2.0461(15) Ga(l)-N(1A) 2.0461(15)
Ga(l)-N(2) 2.0780(15) Ga(l)-N(2A) 2.0780(15)
0(1)-Ga(l)-N(2A) 107.90(6) 0(1A)-Ga(l)-N(2) 107.90(6)
0(1)-Ga(l)-N(2) 83.23(6) 0(1 A)-Ga( 1 )-N(2 A) 83.23(6)
0(1)-Ga(l)-N(1A) 93.60(6) 0(1A)-Ga(l)-N(l) 93.60(6)
0(1)-Ga(l)-N(l) 165.20(5) 0(1 A)-Ga(l)-N(1A) 165.20(5)
0(1)-Ga(l)-0(1A) 90.28(8) N(2)-Ga( 1 )-N(2A) 164.56(9)
N(2)-Ga(l)-N(l) 81.99(6) N(2 A)- Ga( 1 )-N( 1 A) 81.99(6)
N(2A)-Ga(l)-N(l) 86.75(6) N(2)-Ga( 1 )-N( 1 A) 86.75(6)
N(l)-Ga(l)-N(1A) 86.24(9)
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Summary of Structural Data,
X-ray structures of three Ga(III) and In(III) complexes with parent cross-bridged 
ligands 1 and 2 and the Ga(III) complex with the carboxylate derivative ligand 8  provide 
rare examples of Ga(III) and In(III) complexes of tetraamines and their derivatives. A 
comparison of their axial N-M-N angles and the equatorial N-M-N angles is listed in 
Table 4.3. similar to the trend shown in their Zn(II) complexes, cross-bridged cyclam 1 
provides a better fit for octahedral In(III) than the smaller cross-bridged cyclen derivative
2. This is best indicated by the axial N-In-N angles of 164.29 (12)° for the former and 
144.0 (1)° for the latter.
Smaller Ga(III) fits better than In(III) in the cleft of complexed 1. This is also 
shown by the axial N-Ga-N angles of 169.3 (1)° and the axial N-In-N angles of 164.29 
(12)°. Consistent with this, the equatorial N-Ga-N bond angle of 84.2 (1)° in the former is 
closer to 90° compared to that of 78.89 (9)° in the latter.
Comparison of the axial and equatorial bond angles of [Ga*(8-2H)](NOa) and the 
Ga(III) complex of a tricarboxylate-armed cyclen derivative 106 (Figure 1.52) revelaed 
that our cross-bridged cyclen provide a better fit for Ga(III) than this cyclen derivative. 
This structural difference may imply the higher kinetic stability of [Ga*(8-2H)](NC>3) 
than the Ga(III) complex of a tricarboxylate-armed cyclen derivative 106. However, the 
larger axial N-Ga-N angles of 169.3 (1)° in Ga(III) complex of parent cross-bridged 
cyclam [GaCl2*l]Cl (Table 4.3) indicated that gallium complex of the dicarboxylate 
pendant-armed cross-bridged cyclam, [Ga*(7-2H)]+, will be the most interesting target for 
further work in this field.
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Table 4.3 Comparison of Ga(III) and In(III) ‘fit’ inside cross-bridged ligand clefts
Complex Axial N-M-N angle Equatorial N-M-N angle
[GaCl2*T|Cl (149) 169.33 (7) 84.17(7)
[InBr2*llBr (150) 164.29(12) 78.89 (9)
[InBr2*21Br (152) 143.95 (12) 76.78 (12)
[Ga*(8-2H)](N03) (153) 164.56 (9) 86.24 (9)
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2. Cu(II) Complexes o f  Ligands 1-4.
2.1 Preparation and Characterization of Copper Complexes.
Seven new copper complexes of cross-bridged ligands 1-4 were synthesized and 
characterized by their IR (KBr) and UV-Vis spectral data as well as CHN elemental 
analyses. All of these Cu(II) complexes were synthesized by the reaction of CuCL or 
Cu(Cl04 )2*61120 with the specific ligand.
As reported in the literature,69(a) we had previously synthesized complex 
Cu(l)(C104)2. The reaction of 0 1 (0 0 4 )2*6 ^ 0  with 1 in MeOH afforded a blue solution 
which upon evaporating and recrystallization from 95% aq. ethanol/ether formed 
Cu(l)(C104)2. The X-ray structure of Cu(l)(C104)2 exhibits a five-coordinate Cu(II) 
geometry (Figure 1.58).69(a) Interestingly, slight variation of this procedure yielded a new 
complex Cu2(0 H)(l)2(C104)3(H20 ) (154). Here after the reaction of Cu(C1Q4)2*6H20  
with 1 in MeOH to afford a dark-blue solution, diethyl ether vapor diffusion yielded 
crystalline Cu2(OH)(l)2(C104)3(H2 0 ). This complex was characterized by CHN and 
chloride elemental analyses. Since several Cu(II) complexes of 1 show a coordination 
number of five,69(a) a possible structure of Cu2(0 H)(l)2(C104)3(H2 0 ) may be a dimeric 
Cu(II) complex bridged by a hydroxide group, in which each Cu(II) center has a 
coordination number of 5. This proposed structure is similar to the reported X-ray 
structures of Cu2(p -0 H)(tren)2(C104)3(H2 0 )129 and Cu2(p-OH)(2 ,2 '-bipyridine)4(C104)3 
(H20 ) .130
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[Cu*2(ja-Cl)]2Cl2 (155) and Cu(2 )(C104)2 (156) were synthesized in reasonable 
yields by the reaction of 2 with the respective Cu(II) salt in ethanol. These two copper(II) 
complexes were also readily formed in methanol. Recrystallization o f Cu(2)(C1C>4)2 from 
methanol yielded a methanol-coordinated [Cu(2)(CH30H)(C104)] (CIO4) complex 
(Figure 4.39, vide infra). Synthesis or recrystallization of Cu(l)(C104)2 and Cu(2)(C104)2 
from MeCN did not yield a Cu(II) complex of 2 with a coordinated MeCN in the solid 
state since no C=N stretch around 2300 cm'1 can be observed in their IR (KBr) spectra 
(Figure 4.28 and Figure 4.29).133
Figure 4.28 IR (KBr) spectrum of recrystallized (MeCN) Cu(l)(C104)2.
Figure 4.29 IR (KBr) spectrum of recrystallized (MeCN) Cu(2 )(C104)2.
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Cu(II) complexes of the N, N’-dibenzyl cross-bridged ligands 3 and 4, CuCl2*4 
(158) and Cu(3)(C104)2 (157) were also readily prepared in MeOH. The synthesis of
Cu(4)(C104)2 (160), however, was not straightforward. In an attempted synthesis, an
1 2unexpected carbonate-bridged copper(II) complex, [Cu2(p-q :r) -C03)(4 )2](C104)2 (159) 
was isolated and characterized by CHN elemental analyses and X-ray analysis. The 
formation of this complex was due to the adsorbance of CO2 from the air. One possibility 
is that ligand 4 adsorbed CO2 from air due to its high basicity. Due to the hydroscopic 
nature of 4, this liquid tertiary polyamine could have absorbed moisture from air, and 
then reacted with carbon dioxide in the presence of water.131 Another possibility is that 
this carbonate complex was formed by the absorbance of CO2 from air during the slow 
ether diffusion process. In another attempted synthesis of Cu(4 )(C1Q4)2, a mixture of 
equal equivalents of ligand 4 and Cu(C104)2*6H20  in MeOH were refluxed for one and 
half days. Solvent methanol was then removed to afford a blue solid. This was 
redissolved in MeCN to form a deep dark-blue solution. After refluxing for eight hours, 
this solution became black. Diethyl ether vapor diffusion into this solution provided a 
mixture of a white solid and a black solid. Sublimation of this residue provided colorless 
crystals. A !H NMR spectrum of these colorless crystals in CD3CN (Figure 4.30)
Figure 4.30 A *H NMR spectrum of colorless crystals obtained from an attempted 
recrystallization of Cu(l)(ClC>4)2 from refluxing MeCN (NMR solvent is CD3CN.).
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
confirmed that these crystals were acetamide. This indicated that acetonitrile was 
hydrolyzed to acetamide in the presence of a Cu(II) complex of 4. A possible mechanism 
for this process could be similar to the one shown in Scheme l . l l . 47 Acetonitrile is thus 
not a suitable reaction solvent in this case.
Cu(4 )(C1C>4)2 was eventually synthesized and characterized by CHN elemental 
analyses. Its synthetic procedure is similar to that of [Cu2(p-r| 1 :r|2-C0 3)(4)2](C104)2 
except for the pre-drying of ligand 4 and Cu(C104)2*6H2 0  under vacuum. This reduced 
the amount of moisture as well as any adsorbed CO2.
Unlike Cu(l)(C104)2 and Cu(2)(C1C>4)2, in the presence of acetonitrile both 
Cu(4)(C104)2 and Cu(3 )(C104)2 formed acetonitrile-coordinated Cu(II) complexes, 
[Cu(3)(CH3CN)](C104)2 and Cu(4 )(CH3CN)2(C104)2. The formation of 
Cu(3)(CH3CN)(C104)2 was confirmed by its IR spectral data and X-ray structure 
determination whereas the isolation of Cu(4 )(CH3CN)2(C104)2 was supported by IR 
spectral data and CHN elemental analyses.
2.2 Infrared Spectra.
In the IR (KBr) spectrum of Cu2(0 H)(l)2(C104)3(H2 0 ) (154) (Figure 4.31), a 
slightly broadened N-H stretching band at 3270 cm’1 is essentially the same as that of 
Cu(l)(ClC>4)2 (Figure 4.32).69(a) However, consistent with its composition, an additional 
very broad OH stretching band at 3537 cm'1 can be observed in the IR spectrum (KBr) of 
Cu2(0 H )(l)2(C104)3(H2 0 ) whereas a much weaker OH stretching band is found for
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Figure 4.31 The IR (KBr) spectrum of Cu2(0 H)(l)2(C104)3(H20 ).
V r |,
 "" /"
Figure 4.32 The IR (KBr) spectrum of Cu(l)(C104)2.
Cu(l )(C104)2 (Figure 4.32). Compared to the broadened and complicated perchlorate
bands of Cu(l)(C104)2 centered at 1090 cm'1, the only single strong perchlorate band for
Cu2(0 H)(1)2(C104)3(H20 ) at 1096 cm'1 is formed in the range 900-1300 cm'1. This
indicates that in Cu2(0 H)(l)2(C104)3(H2 0 ), probably no perchlorate coordinates to the 
1
metal center whereas one oxygen atom from a perchlorate in Cu(l)(C104)2 likely 
coordinates to the copper(II) center as confirmed by its X-ray structure. The presence of 
two NH stretches at 3150 and 3180 cm'1 in the IR spectrum (KBr) of [Cu*2(p-Cl)]2Cl2 
indicate the nonequivalence of the two NHs in complexed 2 at least in the solid-state.
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Figure 4.33 The IR (KBr) spectrum of Cu(3 )(C104)2.
In the IR spectrum of Cu(3 )(C104)2 (Figure 4.33), two strong and broadened
1 1 ^ 9perchlorate bands are observed at 1055 and 1097 cm' . Based on this and the fact that 
there is no solvent present in this complex according to its CHN elemental analyses, it is 
proposed that at least one of these two perchlorates is coordinated to the Cu(II) center. 
Consistent with the fact that no perchlorate coordinates to the Cu(II) center in 
[Cu(3)(CH3CN)](Cl64)2 (Figure 4.34(a)), only a strong ionic perchlorate band appears at 
1086 cm'1 within the range 900-1300 cm'1. The coordination of acetonitrile to this Cu(II) 
center is indicated by the presence of two v o n  at 2285 and 2314 cm'1 (Figure 4.34(a)). 
In the literature, Karlin has reported an acetonitrile v c =n  at 2300 cm'1 in the IR spectrum 
(nujol) of a dimeric 5-coordinated Cu(II) polyamine complex. A strong and relatively- 
sharp band at 1089 cm'1 in the range 900-1300 cm'1 can be seen in the IR (KBr) spectrum 
of Cu(4 )(CH3CN)2(C104)2 (Figure 4.34(b)). This indicates that no perchlorate is 
coordinated to the Cu(II). The observation of two vc=n bands at 2333 and 2305 cm'1 is 
indicative of the acetonitrile coordination.
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Figure 4.34(a) The IR (KBr) spectrum of [Cu(3)(CH3CN)](C104)2.
g
Figure 4.34(b) The IR (KBr) spectrum of Cu(4)(CH3CN)2(CI0 4)2.
Two relatively-strong bands at 1506 and 1496 cm'1 in the IR (KBr) spectrum of 
[Cu2(p-r| 1 :r|2-C03)(4)2](C104)2 (Figure 4.35(a)) suggest the presence of the 0 = 0  group 
whereas no such strong bands was observed in the spectrum of Cu(4 )(C104)2 (Figure 
4.35(b)). In the literature, [Cu2(p-'n1 :ti2-C03 )(L)2(H2 0 )](CF3S0 3)2 (L=l,4,7-triisopropyl- 
1,4,7-triaazacyclononane) featuring the same carbonate coordination mode has these two 
bands at 1539 and 1476 cm'1.134 This was consistent with the the X-ray structure of
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Figure 4.35(a) The IR (KBr) spectrum of [Cu2(p-ri1:ri2-C0 3 )(4)2](C104)2-
S - -
Figure 4.35(b) The IR (KBr) spectrum of Cu(4 )(C104)2-
[Cu2(p-p1 :t12-C0 3)(4)2](C104)2 (Figure 4.42, vide infra) in which a bridging carbonate 
featuring both unidentate and bidentate coordination modes was found. A strong and 
relatively-sharp perchlorate band at 1095 cm'1 was consistent with the presence of only 
ionic perchlorates in this complex.
2.3 Electronic Spectra.
Solution electronic spectra of the described copper complexes are summarized in 
Table 4.4. Except that of Cu2(0 H)(l)2(C104)3(H20 ), these d-d transitions are found as
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Tabic 4.4 Summary of electronic spectral data for the copper complexes of ligands 1-4.
Complex “^trtax
( e , M^cm'1)
Complex -^max
( e , M ',cm’1)
Cu2(0H)(1)2(C104)3 
(H20 ) in MeCN
584 nm (151), 
904 (71)
Cu2(0H)(1)2(C104) 3 
(H20 ) in water









623 nm (129) CuC12®4
in MeCN
710 nm (85)
[Cu2(p1-  p2- C 0 3)(4)2] 
(C104)2 in MeCN
660 nm (148) Cu(4)(C104)2
in MeCN
647 nm (162)
[CU2(P]-  p2- C 0 3)(4)2] 
(C104)2 in MeOH
687 nm (187) Cu(4)(C104)2
in MeOH
657 nm (94)
broad bands between 623 and 710 nrn. The electronic spectrum of Q i2(0 H)(l)2(C104)3 
(H2O) shows two bands at 584 and 904 nm in acetonitrile (Figure 4.36) and two bands at 
595 and 958 nm in water. This is significantly different from that of Cu(l)(C104)2 in 
which only a band at 567 nm can be observed in acetonitrile. This suggests that in 
solution, hydroxide remains still partially or fully coordinated to the former Cu(II) center.
s
5 0 0 1000
Wavelength (nm)
150C
Figure 4.36 The electronic spectrum of Cu2(0 H)(l)2(Cl04)3 (H2O) in acetonitrile.
In H2O, diluted [Cu*2(p-Cl)]2Cl2 (155) (0.0024 M) has a maximum at 640 nm (s= 
72 IVr'cnfi1) in its electronic spectrum (Figure 4.37(a)) while Cu(2)(C104)2 (156) has a
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similar m a x i m u m  at 6 3 5  nm (s = 7 6  M ^cm'1) (Figure 4.37(b)). This suggests that they
2+
may have a common aqueous solution species, probably [Cu(2 )(H2 0 )j .
o . « - j  jJl
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Figure 4.37(a) The electronic spectrum of [Cu*2(p-Cl)]2Cl2 in water.
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Figure 4.37(b) The electronic spectrum of Cu(2)(C104)2 in water.
In M e C N ,  CuCl2*4 has a longer wavelength d-d maximum at 7 1 0  nm compared to 
that of[Cu-3Cl]Cl(H20 ) at 6 8 0  nm. Similarly, Cu(4)(C104)2 has a longer wavelength d-d 
maximum at 6 4 7  nm compared to that of Cu*3(C1C>4)2 at 6 2 3  nm.69(a) This indicates that 
ligand 3 has a strong ligand field towards Cu(II) than ligand 4.
2 1 6
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2.4 X-ray Structural Data.
X-ray structures of [Cu*2(p,-Cl)]2Cl2 (155), [Cu(2 )(CH3 0 H)(C104)](C104) (156a), 
[Cu(3)(CH3CN)](C104)2 (157a), CuC12*4 (158) and [Cu2(p-V:D2-C 03)(4)2](C104)2 (159) 
were successfully solved. Their relevant bond distances and angles are listed in Tables 
4.5(a-e).
[Cu*2(p-Cl)]2Cl2 (155): The structure of this Cu(II) complex shows a centrosymmetric
dimeric Cu(II) complex with each Cu(ll) adopting a distorted octahedral geometry 


















Figure 4.38 X-ray structure of [Cu“2(p-Cl)]2Cl2 (155) showing atomic labeling 
scheme.
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Table 4.5(a) Selected Bond Distances (A) and Bond Angles (deg) in [Cu®2(jj,-C1)]2C12
(155) (Hydrogen bonding interactions are included.).
Cu(l)-N(l) 2.037(2) Cu(l)-N(3) 2.197(2)
Cu(l)-N(2) 2.073(2) Cu(l)-N(4) 2.050(2)
Cu(l)-Cl(l) 2.2842(8) Cu(l)-C1(1A) 2.893
N4—Cl(2) 3.362(3) N2A—Cl(2) 3.299(3)
N(4)-Cu(l)-N(2) 160.37(11) N(l)-Cu(l)-N(3) 85.35(9)
N(l)-Cu(l)-N(2) 83.87(10) N(3)-Cu(l)-N(2) 81.46(10)
N(l)-Cu(l)-N(4) 82.33(10) N(3)-Cu(l)-N(4) 83.57(10)
N(l)-Cu(l)-Cl(l) 174.13(7) N(3)-Cu(l)-Cl(l) 100.50(7)
N(4)-Cu(l)-Cl(l) 97.94(7) N(2)-Cu(l)-Cl(l) 97.21(7)
Cl( 1 A)-Cu( l)-Cl(l) 82.8 H(2A)-C1(2)-H(4) 75.1
Cu-N(ax) angle is 160.37(11)° and the N(eq)-Cu-N(eq) angle is 85.35(9)°. Among four 
Cu(l)-N distances, one N(eq)-Cu (Cu(l)-N(3)) bond distance of 2.197(4) A is 
significantly longer than the other three Cu(l)-N bondlengths which range from 2.04 to 
2.07 A. This dimer has an inversion center with very unsymmetrical bridging Cu(l)-Cl 
bond distances of 2.28 A and 2.89 A. Such long Cu(l)-N(3) and Cu(l)-Cl(l A) distances 
in trans to each other are clearly due to the Jahn-Teller distortion. For comparison, five- 
coordinate [Cu»1C1]C1(H20)3 showed Cu(l)-N bondlengths ranging from 2.00 to 2.14 A 
and Cu-Cl bond distance of 2.30 A.69(a) In the literature, there are more than thirty Cu-Cl
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bond distances longer than 3.0 A134 with the longest of 3.44 A.135(a'e) For example, a 
dimeric copper complex of diethylenetriamine with two bridging chlorides has a Cu-Cl 
bond distance of 3.02 A.135^  This is the one of several reported dichloride-bridged Cu(II) 
complexes o f polyamines. ]35(c') ,!36
[Cu(2)(CH3 0 H)(C1C>4)](CIO4) (156a): Unlike five-coordinate Cu(II) complexes of
parent cross-bridged cyclam and its derivatives 3, 107, and l l l ,69(a)’74,78 this complex of 
the smaller cross-bridged cyclen, ligand 2, has a six coordinate geometry (Figure 4.39).
C(3)
0 (2  A)
N(2) ° ^ }C(4)
0(10) N O U  C<2 014A)
CCS) cm >0(3A)





Figure 4.39 X-ray structure o f [Cu(2)(CH30H)(C104)](C104) (156a) showing atomic 
labeling scheme.
The Cu(II) atom is coordinated by four amino nitrogen donors from the macrocycle 
ligand together with one methanol oxygen and one monodentate perchlorate oxygen in a 
distorted octahedron. This is indicated by the axial N(2)-Cu-N(4) bond angle of 165.3(5)°
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Table 4.5(b) Selected Bond Distances (A) and Bond Angles (deg) in
[Cu(2)(CH3OH)](C104)2 (156a).
Cu(l)-N(l) 2.167(9) Cu(l)-N(3) 2.030(11)
Cu(l)-N(2) 2.024(12) Cu(l)-N(4) 2.079(14)
Cu(l)-0(1) 2.019(9) Cu(l)-0(2) 3.483(14)
Cu(l)-0(3) 2.741(14)
N(4)-Cu(l)-N(2) 165.3(5) N(l)-Cu(l)-N(3) 84.7(4)
N(l)-Cu(l)-N(2) 85.0(4) N(3)-Cu(l)-N(2) 84.5(5)
N(l)-Cu(l)-N(4) 84.8(5) N(3)-Cu(l)-N(4) 84.1(6)
N(l)-Cu(l)-0(1) 102.6(4) N(2)-Cu(l)-0(1) 97.3(4)
N(3)-Cu(l)-0(1) 172.6(4) N(4)-Cu(l)-0(1) 95.2(5)
N(l)-Cu(l)-0(2) 150.8(3) N(2)-Cu(l)-0(2) 66.5(4)
N(3)-Cu(l)-0(2) 98.0(4) N(4)-Cu(l)-0(2) 124.4(5)
N (l)-Cu(l)-0(3) 167.2(3) N(2)-Cu(l)-0(3) 107.8(4)
N(3)-Cu(l)-0(3) 95.7(4) N(4)-Cu(l)-0(3) 82.6(5)
0(l)-C u(l)-0(2) 76.3(4) 0(2)-Cu(l)-0(3) 41.9(3)
0(l)-C u(l)-0(3) 76.9(4)
and equatorial N(l)-Cu-N(3) bond angle of 84.7(4)°. Again, one N(eq)-Cu (Cu-N(l)) 
bond distance of 2.167(9) A is significantly longer than the other three Cu(l)-N 
bondlengths which range from 2.030(11) to 2.079(14) A. The coordinating of only one
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oxygen from perchlorate is indicated by the single 0(perchlorate)-Cu distance of 
2.741(14) A under 3.4 A. This perchlorate Cu-0(3) distance is significantly longer than 
that of 2.166(6) A in [Cu(l)(C104)]C104 (Figure 1.58). Such long Cu-N(l) and Cu-0(3) 
distances in trans sites are again due to the Jahn-Teller distortion.
The methanol 0(1)-Cu bond distance in this Cu(II) complex is 2.019(9) A. There 
is no literature data on the methanol-coordinated Cu(II) complexes of tetraamines. 
However, a numerous Cu(II) complexes with coordinated MeOH in a N40  mode are 
available.137^ '1-1 These have longer methanol O-Cu bond distances ranging from 2.24 to 
2.54 A.
[Cu(3)(CH3CN)](C104)2 (157a): This structure (Figure 4.40) has the same
[Cu(3)(CH3CN)]2+ fragment as that of [Cu(II)*3(MeCN)](PF6)2 (Figure 1.65).78 This has 
acetonitrile in the fifth coordinate position and an axial N(3)~Cu-N(4) bond angle of 
177.79(19)° and equatorial N(l)-Cu-N(2) bond angle of 88.37(19)° whereas the same 
Nax-Cu-Nax bond angle and a different Neq-Cu-Neq bond angle of 86.96(10)° were 
reported for [Cu(II)(MeCN)*3](PF6)2. The Cu(II) atom has a slightly distorted square- 
pyramidal coordination geometry as indicated by an Addison and Reedjik’s x-parameter 
of 0.1515.138 The acetonitrile and three nitrogen atoms from the cross-bridged ligand 
occupy the equatorial position while N (l) is apical. The four Cu(II)-N distances are 
within the range between 2.020(5) and 2.127(5) A.
The bond distance between the acetonitrile nitrogen atom and Cu is 2.020(5) A 
which is essentially the same as that in [Cu(II)*3(MeCN)](PF6)2. In the literature, several 
6-coordinate Cu(II) complexes of cyclam and cyclam derivatives with two coordinated
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0 2 4 )
Figure 4.40 X-ray structure of [Cu(3)(CH3CN)](C104)2 (157a) showing atomic 
labeling scheme.
acetonitriles in trans positions have been reported.50^ ’139^ ’139^  The bond distances 
between acetonitrile nitrogen and copper in these complexes are all essentially the same 
(2.6 A). Two five-coordinate Cu(II) complexes of cyclam derivatives with a coordinating 
acetronitrile have also been reported.50(k)’51(h) The Cu-N bond distances in these two 
complexes are 2.17 and 2.48 A, which are also substantially longer than that in 
[ Cu(3)(CH3CN)] (Cl 0 4)2.
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Table 4.5(c) Selected Bond Distances (A) and Bond Angles (deg) in
[Cu(3)(CH3CN)](C104)2 (157a).
Cu(l)-N(l) 2.130(5) Cu(l)-N(3) 2.127(5)
Cu(l)-N(2) 2.058(5) Cu(l)-N(4) 2.082(5)
Cu(l)-N(5) 2.020( 5)
N(4)-Cu(l)-N(3) 177.79(19) N(l)-Cu(l)-N(2) 88.37(19)
N(2)-Cu(l)-N(5) 168.7(2) N(4)-Cu(l)-N(5) 88.42(19)
N(2)-Cu(l)-N(4) 84.82(19) N(3)-Cu(l)-N(5) 92.98(19)
N(2)-Cu(l)-N(3) 93.5(2) N(l)-Cu(l)-N(5) 101.1(2)
N(l)-Cu(l)-N(4) 93.45(19) N(l)-Cu(l)-N(3) 87.97(19)
CuCl2®4 (158): The crystal structure of this Cu(II) complex is shown in Figure 4.41.
One terminal chloride and four nitrogen atoms from the macrobicycle coordinate to 
Cu(II) atom. This complex has an axial N(2)-Cu-N(4) bond angle of 167.9(3)° and 
equatorial N(l)-Cu-N(3) bond angle of 81.0(3)° whereas the Cu(II) complex of the cross­
bridged cyclam analogue, [Cu(3)C1]C1(H20 ) (Figure 1.59) has axial N(l)-Cu-N(8) bond 
angle of 176.0(2)° and equatorial N(4)-Cu-N(l 1) bond angle of 86.1(l)°.69(a) Clearly, 
Cu(II) fits better in the latter cross-bridged cyclam derivative compared to its cyclen 
analogue. Three short tertiary amine nitrogen-Cu bondlengths ranging between 2.047(8) 
and 2.080(7) A were observed. The fourth nitrogen-Cu bond of 2.197(7) A is 
significantly N(3) at the apex as indicated by an Addison and Reedjik x-parameter of only 
0.013.
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Figure 4.41 X-ray structure of CuCl2*4 (158) showing atomic labeling scheme.
The Cu(II)-Cl bond distance of 2.251(3) A is slightly shorter than that of 2.296 A 
found in [Cu(3)C1]C1(H20) (Figure 1.59).69(a) Several five-coordinate Cu(II) complexes 
of cyclen derivatives with a terminal chloride in the fifth coordination position have been 
reported.54(a)’54(e)’54(r't) Their longer Cu-Cl bond distances range from 2.37 to 2.43 A while 
the Cu-N bond distances range from 2.026 to 2.144 A.
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[Cu2(ki-t11:ti2-C 03)(4 )2](C104)2 (159): The structure of this dimeric copper complex
features r)1:r|2-bridging carbonate and ^-coordinating bicycle tetraamines 4b (Figure 
4.42). At two copper(II) centers, Cu(l) is in a distorted octahedral N4O2 environment 
whereas Cu(2) adopts a square-pyramidal geometry as indicated by its Addison and 
Reedjik’s x-parameter of 0.099. The distortion of the octahedral geometry around Cu(l) 
is indicated by the axial N(3)-Cu(l)-N(4) bond angle of only 155.70(16)° and the chelate 
0(l)-Cu(l)-0(2) bond angle of only 66.44(16)°. Unlike the structures of 155, 156a, 
157a, and 158, N(ax)-Cu(l) bondlengths of 2.399(5) and 2.421(5) A are significantly 
longer than the N(eq)-Cu(l) bondlength of 1.999(5) and 2.018(5) A and related N-Cu 
bondlengths in 155,156a, 157a, and 158. These longer bond distances in the axial
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Figure 4.42 X-ray structure of [O ^ p -p 1 :ri2-C03 )(4)2] (0 0 4 )2  (159) showing atomic
labeling scheme.
positions are again caused by the Jahn-Teller distortion along the axial N(3) and N(4)
sites.
Cu(2) in the square-pyramidal coordination geometry is coordinated by four 
nitrogen atoms from the macrobicycle and one monodenate carbonate oxygen. According 
to our standard definition, it has an axial N(7)-Cu-N(8) bond angle of 165.6(2)° and 
equatorial N(5)-Cu-N(6) bond angle of 84.13(19)°. Four amine N-Cu bond distances 
range from 2.034(5) to 2.158(5) A. Again, the amine nitrogen N(5) opposite the vacant 
sixth site has the longest bond distance of 2.158(5) A.
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Table 4.5(e) Selected Bond Distances (A) and Bond Angles (deg) in [Cu2(g-r]1:r|2-
C 03)(4)2](C104)2 (159).
Cu(l)-N(l) 2.018(5) Cu(l)-N(3) 2.421(5)
Cu(l)-N(2) 1.999(5) Cu(l)-N(4) 2.399(5)
Cu(2)-N(5) 2.158(5) Cu(2)-N(6) 2.034(5)
Cu(2)-N(7) 2.080(5) Cu(2)-N(8) 2.124(5)
Cu(l)-0(1) 1.977(4) Cu(l)-0(2) 2.028(4)
Cu(2)-0(3) 1.933(4)
N(4)-Cu(l)-N(3) 155.70(16) N(l)-Cu(l)-N(2) 86.59(19)
N(7)-Cu(2)-N(8) 165.6(2) N(5)-Cu(2)-N(6) 84.13(19)
N(2)-Cu(l)-N(4) 79.58(18) N(l)-Cu(l)-N(4) 81.57(19)
N(2)-Cu(l)-N(3) 83.41(18) N(l)-Cu(l)-N(3) 80.21(18)
N(6)-Cu(2)-N(7) 86.41(19) N(6)-Cu(2)-N(8) 82.40(19)
N(5)-Cu(2)-N(7) 83.42(19) N(5)-Cu(2)-N(8) 86.50(19)
N (l)-Cu(l)-0(1) 102.98(18) N(2)-Cu(l)-0(1) 170.15(18)
N(3)-Cu(l)-0(1) 100.36(16) N(4)-Cu(l)-0(1) 99.29(16)
N (l)-Cu(l)-0(2) 169.39(18) N(2)-Cu(l)-0(2) 103.96(18)
N(3)-Cu(l)-0(2) 101.86(16) N(4)-Cu(l)-0(2) 99.00(17)
N(6)-Cu(2)-0(3) 159.65(19) N(7)-Cu(2)-0(3) 99.60(18)
N(8)-Cu(2)-0(3) 93.98(18) N(5)-Cu(2)-0(3) 115.75(17)
0(l)-C u(l)-0(2) 66.44(16)
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The tridentate carbonate has two slightly longer chelate O-Cu bondlengths of 
1.977(4) and 2.028(4) A and a slightly shorter monodentate carbonate O-Cu bond length 
of 1.933(4) A. Such a dimeric copper complex featuring an rj’ir^-bridging carbonate is 
rare for Cu(II) polyamine complexes. The only other literature example is the complex 
[Cu2(p-ri1:r|2-C03 )(L)2(H2 0 )](CF3S03)2 (L= 1,4,7-triisopropyl-1,4,1 -triaazacyclononane) 
in which two five-coordinate copper atoms are bridged by a carbonate. It has chelating O- 
Cu bondlengths of 1.967(3) and 2.036(2) A and a monodentate carbonate O-Cu 
bondlengths of 1.967(2) A. The amine nitrogen-Cu bond distances range from 2.036(2) 
and 2.228(3) A. There is another example of a Cu(II) carbonate complex with a cross­
bridged ligand. It is a trinuclear Cu(II) complex with a p3-carbonate, [(Cu*112)3(p3C03 )] 
(C104)4(H20 )29° (Figure 4.43). Its three equivalent Cu(II) atoms have N(ax)-Cu-N(ax) 
bond angles of 169.0(2)° and equatorial N(eq)-Cu-N(eq) bond angles of 98.0(2)°. All the 
monodentate carbonate O-Cu bondlengths are 2.001(11) A.
Figure 4.43 X-ray structure of [(Cu» 112)3(g3-C03 )](C104)4(H20)2 from reference 90.
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Summary of Structural Data.
These five copper complexes of cross-bridged ligands 2, 3, and 4 showed 
coordination numbers of five or six. A summary of their axial N-Cu-N bond angles and 
equatorial N-Cu-N bond angles is listed in Table 4.6. Together with the data in Table 
1.1, five or six-coordinate Cu(II) complexes of cross-bridged cyclam and its derivatives, 
ligands 1, 3, 107, and 111 thus have the axial N-Cu-N angles ranging from 175.16(13) to 
179.7(3)° and the equatorial N-Cu-N bond angles ranging from 84.8(1) to 88.5(3)° By 
comparison, Cu(II) complexes of cross-bridged cyclen and its derivatives, ligands 1, 3, 
107, and 111 have their axial N-Cu-N angles from 155.70(16) to 167.9(3)° and equatorial 
N-Cu-N bond angles ranging from 81.0(3) to 86.59(19)°. Similar to the case for zinc, 
these structural data confirm that the smaller cross-bridged cyclen and its derivatives are 
not as good a fit for Cu(II) as cross-bridged cyclam and its derivatives . Consistent with 
this, this structural trend is paralleled in their kinetic stabilities in acidic solution (vide 
infra). The Cu(II) complex of cross-bridged cyclam is at least several orders of 
magnitude more inert than the copper(II) complex of cross-bridged cyclen.
Table 4.6 Summary of axial N-Cu-N angles and equatorial N-McuN angles in Cu(II) 
complexes of cross-bridged ligands 2, 3 and 4.
Complex Axial N-Cu-N angle Equatorial N-Cu-N angle
fCu*2(p-Cl)l2Cl2 160.37(11) 85.35 (9)
[Cu(2)(CH30H)(C104)](C104) 165.3 (5) 84.7 (4)
[Cu(3)(CH3CN)1(C104)2 177.79(19) 88.37(19)
CuC12*4 167.9 (3) 81.0 (3)
Five-coordinate Cu(II) in 
[Cu2(p-r|, :q2-C 03)(4)2l(C104)2
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3. Cu(II) Complexes of Ligands 5-8
3.1 Preparation and Characterization of Copper Complexes.
Six copper complexes of four N,N'-dipendant-armed cross-bridged ligands, 5, 6, 7 
and 8 (Figure 3.1) were synthesized and characterized hy their IR (KBr) and UV-Vis 
spectral data and CHN elemental analyses.
In the synthesis of [Cu*5](NC>3)2 (161), no purified yield can be obtained due to 
the presence of about five percent organic impurity in ligand 5. Several recrystallizations 
yielded this pure Cu(II) complex as needle-shaped crystals, on which X-ray analyses and 
CHN elemental analyses were carried out. [Cu“6](C1C>4)2 (162) and [Cu*6](NC>3)2 (163) 
were formed readily by the reaction of the respective hydrated metal salt with 6 in 
MeOH.
[Cu»(8-2H)](NaC104) (165) and [Cu»(8-2 H)](NaN03 ) (166) were synthesized by 
the same method. The reaction of Cu(C104)2*6H20  or Cu(N0 3 )2*3H20  with 8*TFA*H20 
in the presence of equivalents of aqueous sodium hydroxide yielded a blue solution. 
Diethyl ether diffusion into this solution yielded [Cu*(8-2H)](NaC104) (or [Cu®(8- 
2H)](NaNC>3)) as blue crystals. To study its kinetic stability, solution IR spectral and 
solution capillary electrophoresis studies, complex [Cu»(7-2H)](NaClC>4) 
(NaCF3COO)o.5(H20)i.5 (164) was synthesized more than ten times using the a similar 
procedure to make previous-reported [Cu*(7-2 H)Na(H2 0 )C104]2(H2 0 ).69<a) The only 
difference is the use of 7®(TFA)2 as the reactant instead of 7*(HC1)4. The formation of 
[Cu»(7-2H)](NaC104)(NaCF3COO)o.5(H2 0 )i.5 is indicated by its CHN elemental results. 
It is essentially the same as the reported [Cu»(7-2H)Na(H20)ClC>4]2(H20).69(a'1
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3.2 Infrared Spectra.
Similar to their Zn(II) and Cd(ll) analogues, typically two strong carbonyl bands 
ranging from 1595 to 1685 cm'1 were observed from the IR (KBr) spectra recorded on 
Cu(II) complexes of the carbamoyl or carboxylate cross-bridged ligands 5, 6, 7 and 8 
(Table 4.7). Again, this is due to the presence of asymmetrical stretches of carboxylate
Table 4.7 Summary of C=0 stretches in the IR spectra of Cu(II) complexes of ligands
5-8.
Complex vc=o (cm"1) Complex vc=o (cm'1)
[Cu*51(N03)2 1678 [Cu*61(C104)2 1682, 1661
[Cu*6](N03)2 1685, 1670 [Cu»(7-2H)](NaC104)
(NaCF3COO)i.5
1624, 1595
[Cu*(8-2H)](NaC104) 1624, 1595 [ Cu*(8-2H))(NaN03) 1638, 1595
groups since Phillips reviewed that coordinated carboxylate groups have the 
asymmetrical stretches ranging from 1500-1675 cm"1 and the symmetrical stretches is 
lower than 1490 cm'1.125^  However, in the IR (KBr) spectrum of [Cu«5](N03)2 (161) 
(Figure 4.44), only one strong carbonyl band is observed at 1678 cm"1. In the range of
s ..
s ..
Figure 4.44 The IR (KBr) spectrum of [Cu*5 ](N03)2 (161).
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1500 to 1800 cm'1, a medium intensity band at 1606 cm'1 probably belongs to either NH 
or OH bending. For comparison, the coordinated amide-carbonyl band of [Cu®5 ](C104)2 
appears at 1665 cm'1.69^  Even though the solid-state structure of [Cu»6 ](C104)2 showed 
three independent Cu(II) centers with different coordination geometries (Figure 4.49, 
Figure 4.50 and Figure 4.51, vide infra), the IR spectrum of this complex showed only 
two strong carbonyl bands at 1682 and 1661 cm'1 (Figure 4.45). This is probably due to 
crystal solvent loss as a result of the vacuum-drying of this copper complex before the 
spectral work.
Figure 4.45 The IR (KBr) spectrum of [Cu*6](C104)2 (162).
3.3 Electronic Spectra.
Solution electronic spectra of the described copper complexes are summarized in 
Table 4.8. These d-d transitions are found as broad bands between 620 and 647 nm in 
water. For examples, the UV-Vis spectrum of [Cu*6](C104)2 in water shows a band at
232
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
627 nm (Figure 4.46) and that of [Cu»(8-2H)](NaC104) in water has a band at 642 ran 
(Figure 4.47).

















620 nm (43) [Cu*(8-2H)] 
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Figure 4.46 The UV-Vis spectrum of [Cu®6 ](C104)2 in water.
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Figure 4.47 The UV-Vis spectrum of [Cu*(8-2H)](NaCl0 4 ) in water.
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Aqueous solution electronic spectra of complexes [Cu*6] (C1C>4)2 and 
[O 6 ](N 0 3)2 both show a band at 627 nm. However, this has an s value of 96 M '1cm '1 
and 66 M^cnT1 respectively. Such a discrepancy is probably due to their different 
aqueous solution speciation or due to instrument instability. Similarly, the UV-Vis 
spectrum of [Cu*(8-2H)j (NaC104) in water has a band at 642 nm (75 M ^cm'1) whereas 
that o f [Cu»(8-2H)](NaN03) has a band at 647 nm (57 M^cnT1).
3.4 X-ray S t r u c t u r a l  D a t a .
X-ray structures of [Qi*5](N03)2 (161), [Cu*6] (0 0 4 ) 2  (162) and [Cu*(8- 
2H)](NaN03) (166) were solved. Full structural data have not yet become available for 
[Cu*(8-2H)](NaN03). The relevant bond distances and angles of the other two Cu(II) 
complexes are listed in Tables 4.9(a-d). Interestingly, three independent Cu(II) centers 
with different coordination geometries in the X-ray structure of [Cu*6](C104)2 are found. 
These three Cu(II) centers include a five-coordinate Cu(l) with MeOH hydrogen 
bonding, five-coordinate Cu(2) center, as well as a six-coordinate Cu(3). Their bond 
distances and angles are thus listed separately in the table Tables 4.9.
[Cu*5](N03)2 (161) Similar to the X-ray structure of [Zn®S](O04)2 (Figure 3.23), 
ligand 5 in [Cu»5](N03)2 holds Cu(II) within its molecular cleft with N4O2 donors 
(Figure 4.48). Similar to all characterized metal complexes of parent ligand 1, the 
bicyclic tetraamine ligand also adopts the cA-folded ligand configuration in this copper
complex.69(a),72,7?
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Figure 4.48 X-ray structure of [Cu*5 ](N0 3 ) 2  (161) showing atomic labeling scheme.
This Cu(II) center is deeply engulfed in the cavity as shown by the N ax-Cu-Nax 
(N(2)-Cu-N(4)) angle of 174.38(8)° and the N(eq)-Cu-N(eq) (N(l)-Cu-N(3)) angle of 
86.93(9)°. For comparison, [Zn®5](C104)2 (Figure 3.23) has an obtuse Nax-Zn-Nax bond 
angle of 183.87(11)° and a N(eq)-Zn-N(eq) angle o f 86.36(14)°. The related Cu(II) 
complex of dicarboxylate pendant-armed cross-bridged cyclam, [Cu*(7- 
2H)Na(H2 0 )C104]2(H2 0 ) (Figure 1.60) has a slightly larger Nax-Cu-Nax bond angle of 
179.7(3)°.69(a)
Unlike [Zn*5](C104)2, this Cu(II) complex does not possess a Cj symmetry. This 
is explained by one Cu-N(ax) bondlength, Cu-N(3) of 2.178(2) A which is significantly 
longer than the other three Cu-N bondlengths which are between 2.043(2) and 2.061(2) 
A. Consequently, the bond distance between copper and the amide oxygen trans to N(3),
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Table 4.9(a) Selected Bond Distances (A) and Bond Angles (deg) in [Cu*5 ](N03)2
(161).
Cu(l)-N(l) 2.043(2) Cu(l)-N(2) 2.044(2)
Cu(l)-N(3) 2.178(2) Cu(l)-N(4) 2.061(2)
Cu(l)-0(1) 2.2643(18) Cu(l)-0(2) 2.0423(19)
N(2)-Cu(l)-N(4) 174.38(8) N(l)-Cu(l)-N(3) 86.93(9)
. N(l)-Cu(l)-N(2) 86.98(8) N(2)-Cu(l)-N(3) 98.50(8)
N(l)-Cu(l)-N(4) 97.44(8) N(3)-Cu(l)-N(4) 85.24(8)
N(l)-Cu(l)-0(1) 90.86(8) N(3)-Cu(l)-0(1) 177.64(8)
N(4)-Cu(l)-0(1) 95.86(7) N(2)-Cu(l)-0(1) 80.56(7)
N(l)-Cu(l)-0(2) 179.09(8) N(3)-Cu(l)-0(2) 92.28(8)
N(4)-Cu(l)-0(2) 82.93(8) N(2)-Cu(l)-0(2) 92.70(8)
Q(l)-Cu(l)-0(2) 89.93(7)
0(1)-Cu is 2.2643(18) A which is significantly longer than the other amide 0(2)-Cu bond 
distance of 2.0423(19) A. Again, this elongation is due to the Jahn-Teller distortion in an 
octahedral copper complex. Several X-ray structures of Cu(II) complexes with amide 
pendant-armed cyclam derivatives have been reported.57(a),57(l)’57^  These Cu(II) 
complexes also adopt a distorted octahedral geometry but cyclam derivatives in them all 
have a trans-III configuration. Their amide oxygen(2)-Cu bond distances range from 
2.29 to 2.36 A. The bond distances between the four equatorial nitrogen donors and 
Cu(II) vary from 2.04 to 2.15 A. In the literature, a Cu(II) complex of a bis(acetamido)-
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pendant armed dibenzocyclam has been also reported.53(d) The copper atom in this 
complex is octahedrally coordinated by this hexadentate ligand in a m -folded 
configuration. The distortion of this from full octahedral geometry is indicated by its Nax- 
Cu-Nax bond angle of 176.5(2)° and N(eq)-Cu-N(eq) bond angle of 101.3(2)°.
The Five-coordinate Cu(2) center in [Cu»6 ](0 0 4 ) 2  (162). The X-ray structure of 
this Cu(II) center (Figure 4.49) shows that it is only penta-coordinated by the 
hexadentate ligand 6 since one of two amide-pendant arms remains uncoordinated. The 
coordination geometry around copper is again a square pyramid with the longer apical
C 1 2 3 ! CHS)
N19)
□ 2 4 )
□ 21) N110)N(11)
□ 2 7 )




0 1 9 )
□ 2 6
Figure 4.49 X-ray structure of the five-coordinate Cu(2) center in [Cu*6](C104)2 (162) 
showing atomic labeling scheme.
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N(9)-Cu bondlength of 2.1763(19) A as indicated by an Addison and Reedjik’s x- 
parameter of 0 .012 .138 The other three N-Cu(II) bond distances range from 1.97 to 2.06 A 
while the coordinated amide oxygen-Cu bondlength is 1.9576(14) A. According to our 
definition, this complex has an Nax-Cu-Nax (N(1Q)-Cu-N(12)) bond angle of 165.80(7)° 
and an Neq-Cu-Neq bond angle of 87.01(7)°. In the literature, a copper complex of an 
octadentate ligand 1,4,7,10-tetrakis(2-carbamoylethyl)-1,4,7,10-tetraazacyclododecane 
also shows a square pyramidal geometry with the amide oxygen from a pendant arm in 
the apical position.54(n) The coordinated amide oxygen-Cu bond distance is 2.137(3) A 
and the four N-Cu distances are between 2.017(3)-2.072(3) A.
Table 4.9(b) Selected Bond Distances (A) and Bond Angles (deg) of the five- 
coordinate Cu(II) center in [Cu»6](C104)2 (162).
Cu(2)-N(9) 2.1763(19) Cu(2)-N(10) 2.0593(17)
Cu(2)-N(ll) 1.9686(18) Cu(2)-N(12) 2.1021(19)
Cu(2)-O(10) 1.9576(14)
N(10)-Cu(2)-N( 12) 165.80(7) N(9)-Cu(2)-N(l 1) 87.01(7)
N(10)-Cu(2)-N(l 1) 84.58(7) N(11)-Cu(2)-N(12) 87.60(7)
N(9)-Cu(2)-N(l 0) 85.91(7) N(9)-Cu(2)-N(12) 81.86(7)
N(9)-Cu(2)-O(10) 100.49(7) N(10)-Cu(2)-O(l 0) 84.82(6)
N(11)-Cu(2)-0(10) 166.53(7) N( 12)-Cu(2)-0( 10) 104.43(6)
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The Five-coordinate Cu(l) center involving MeOH hydrogen bonding in 
[Cu»6](0 0 4 ) 2  (162). Again, the X-ray structure of this Cu(II) center (Figure 4.50) 









f  Cud) 0(8) 
0 (2 ) 0115C(13)
0 1 4 )
N(6) C(12)
0(25)
0 4 3 )
Figure 4.50 X-ray structure of the five-coordinate Cu(l) center with MeOH hydrogen 
bonding in [Cu*6](0 0 4 )2  (162) showing atomic labeling scheme.
coordinate center, this uncoordinated amide oxygen is hydrogen-bonded by a methanol 
solvent. Again, the coordination geometry around this copper(II) remains a square 
pyramid as indicated by an Addison and Reedjik’s x-parameter of 0.033, the longest 
nitrogen-Cu bond distance of 2.1935(15) A (Cu(l)-N(3)) is in the apical position. Its 
Nax-Cu-Nax bond angle of 173.02(8)° is significantly larger than that o f 165.80(7)° in the
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first five-coordinate Cu(II) center whereas the Neq-Cu-Neq bond angle of 80.66(7)° is 
significantly smaller than that of 87.01(7)° in the first five-coordinate Cu(II) center.
Table 4.9(c) Selected Bond Distances (A) and Bond Angles (deg) of the five- 
coordinate Cu(II) center involving MeOH hydrogen bonding in [Cu*6](C104)2 (162).
Cu(l)-N(l) 2.0439(18) Cu(l)-N(2) 1.9696(17)
Cu(l)-N(3) 2.1935(15) Cu(l)-N(4) 1.9885(18)
Cu(l)-0(2) 2.0223(16)
N(2)-Cu(l)-N(4) 173.02(8) N(l)-Cu(l)-N(3) 80.66(7)
N(l)-Cu(l)-N(2) 87.92(7) N(2)-Cu(l)-N(3) 88.34(7)
N(l)-Cu(l)-N(4) 85.62(8) N(3)-Cu(l)-N(4) 88.00(7)
N(l)-Cu(l)-0(2) 171.06(7) N(3)-Cu(l)-0(2) 98.51(7)
N(4)-Cu(l)-0(2) 103.27(7) N(2)-Cu(l)-0(2) 83.16(7)
The Six-coordinate Cu(3) center in [Cu»6](010^2 (162). Similar to all
characterized Zn(II), Cd(II) and Hg(II) complexes of ligands 5-8, this Cu(II) center in 
[Cu*6](C104)2 is fully enveloped by the cross-bridged tetraamine and its two pendant 
arms in a distorted-octahedral N4O2 donor set (Figure 4.51). It has a Nax-Cu-Nax bond 
angle of 162.20(7)° and Neq-Cu-Neq bond angle of 87.47(7)°. Four macrobicyclic 
tetraamine nitrogen-Cu bond distances vary from 1.9625(18) to 2.172(2) A and two 
amide oxygen-Cu bonds are 2.2306(16) to 1.9542(15) A respectively. The longest
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Figure 4.51 X-ray structure of the six-coordinate Cu(3) center in [Cu*6](C104)2 (162) 
showing atomic labeling scheme.
Table 4.9(d) Selected Bond Distances (A) and Bond Angles (deg) o f the six- 
coordinate Cu(II) center in [Cu*6](C104)2 (162).
Cu(3)-N(17) 1.9625(18) Cu(3)-N(18) 2.172(2)
Cu(3)-N(19) 2.1556(19) Cu(3)-N(20) 2.0926(18)
Cu(3)-0(17) 2.2306(16) Cu(3)-0(18) 1.9524(15)
N(18)-Cu(3)-N(20) 162.20(7) N( 17)-Cu(3 )-N (19) 87.47(7)
N(17)-Cu(3)-N(20) 84.03(7) N( 19)-Cu(3)-N (20) 84.56(7)
N(17)-Cu(3)-N(18) 85.80(7) N( 18)-Cu(3)-N( 19) 80.42(7)
N( 17)-Cu(3)-0( 17) 94.65(7) N( 18)-Cu(3)-0(l 7) 76.79(6)
N(19)-Cu(3)-0(17) 156.87(7) N(20)-Cu(3)-O(l 7) 118.56(6)
N(17)-Cu(3)-0( 18) 167.62(7) N( 18)-Cu(3)-0( 18) 106.45(6)
N(19)-Cu(3)-0(l 8) 96.21(7) N(20)-Cu(3)-O( 18) 84.55(7)
0 (  17)-Cu(3)-0( 18) 86.61(6)
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macrobicyclic tetraamine nitrogen-Cu bond distance o f 2.172(2) A (Cu-N(18)) and the 
longer amide oxygen-Cu bond distance of 2.2306(16) A are not trans to each other. In the 
literature, the only Cu(II) complex of any carbamoyl cyclen derivative is the five- 
coordinate copper complex of 1,4,7,10-tetrakis(2-carbamoyl ethyl)-1,4,7,10- 
tetraazacyclododecane mentioned above.54(n)
[Cu*(8-2H)](NaN0 3 ) (166) The X-ray structure of this complex (Figure 4.52) shows 
that the Cu(II) atom is also fully coordinated by four amine nitrogen donors and two 
carboxylate oxygen atoms from 8-2H in a distorted-octahedral N4O2 donor set. Its 
structural data are not yet available.
0 4
Figure 4.52 X-ray structure of [Cu»(8-2H)](NaN0 3 ) (166).
S u m m a r y  of Structural Data.
The X-ray structure of [Cu*5 ](N03)2 shows a distorted octahedral geometry 
around copper whereas that of [Cu*6](C104)2 showed three different Cu(II) centers in
242
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either a distorted-octahedral or a square pyramidal coordination geometry. A summary of 
their axial N -Cu-N bond angles and the equatorial N-Cu-N bond angles is listed in Table 
4.10. As indicated by the N ax-Cu-Nax bond angles and the Neq-Cu-Neq bond angles of 
[Cu»5](N03)2 and the Six-coordinate Cu(3) center in [Cu»6](C1C>4)2, Cu(II) fits much 
better in the cross-bridged cyclam derivative ligand 5 than in the smaller cyclen analogue
The Nax-Cu-Nax bond angles of the three different Cu(II) centers in [Cu*6 ](C104)2 
vary from 162.20(7)° to 173.02(8)° and their Neq-Cu-Neq bond angles from 80.66(7)° to 
87.47(7)°. This indicates some degree of flexibility for this pendant-armed cross-bridged 
ligand.
Table 4.10 Summary of axial N-Cu-N angles and equatorial N-Cu-N angles in Cu(II) 
complexes of cross-bridged ligands 5 and 6 .





Five-coordinate Cu(l) center 
involving MeOH hydrogen 
bonding in [Cu»6 ](C104)
173.02(8) 80.66(7)
Five-coordinate Cu(2) center in 
[Cu*61(C104)
165.80(7) 87.01(7)
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CHAPTER V
KINETIC STABILITY STUDIES OF METAL COMPLEXES OF
CROSS-BRIDGED LIGANDS
1. Introduction
Acid-promoted dissociation studies of many main group and transition metal 
complexes of polyamines have been reported. 140(a'h) For example, Kaden et al. have 
reported the acid decomplexation studies of Ni(II), Cu(II), Co(II), Zn(II) and In(III) 
complexes of cyclam and cyclen derivatives.i40(c'b Chung reviewed the kinetics and 
mechanism of the dissociation reactions of open-chain and macrocyclic tetraamine 
copper complexes.140(a) In a very recent paper,140(b) Hermann et al. summarized the 
kinetic data on acid decomplexation of Cu(II) complexes with macrocyclic tetraamines.
As expected from the Irving-Williams series, Cu(II) complexes with nitrogen 
donor ligands are typically found to be more stable than Zn(II) complexes by several 
orders of magnitude.141 It can thus be expected that a more acidic solution is necessary to 
decomplex a copper complex compared to its zinc analogue. Due to the high basicity 
(proton-sponge activity) of our cross-bridged ligands, protonated cross-bridged ligands 
form quickly as the kinetically-controlled products in their complexation with a metal ion
77 81 84whereas the completion of a complexation process takes much longer time. ’ ’
2 4 4
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Therefore, determination of the thermodynamic stability constants of their metal
relative kinetic stability studies in acidic solution of selected metal complexes with cross­
bridged ligands. These metal ions include Zn(II), Cd(II), Hg(II), Ga(III), In(III) and 
Cu(II). The kinetic inertness of selected diamagnetic Zn(II), Cd(II), Hg(II), Ga(III) and 
In(III) complexes can be readily monitored in buffered D2O solutions by NMR 
spectroscopy whereas distinct d-d transition maxima are expected for complexed and 
decomplexed Cu(II). The kinetics of the process can thus be followed 
spectrophotometrically in the UV-Vis region (370-800 nm).
2. Results and Discussion
The ligands included in these studies are shown in Figure 5.1.
Figure 5.1 Cross-bridged ligands and other ligands used in kinetic stability studies.
2.1 Relative Kinetic Inertness of Ga(III) and In (III) Complexes
All the kinetic studies were carried out using proton NMR spectroscopy at room
O 1 O A
complexes in aqueous solution is not routine. ’ Thus we have been interested in the
1 2 Me4Cyclam tet a
h 2n o c ^
6
nC G O N H 2 n O c o o h  . n .  n C c o o h  
: ¥  h o o c J ^ J *
7 8
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temperature (22°C). [InBr2*2]Br (152) is the most labile among the four characterized 
Ga(III) and In(III) complexes of ligands 1 and 2. Among these structurally-characterized 
complexes, this indium complex should therefore have the poorest fit inside the ligand 
cavity. This poor fit is confirmed by its smaller axial N-M-N and equatorial N-M-N 
angles in its solid-state structure (Table 4.3). Figure 5.2 shows its 'H NMR spectra
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Figure 5.2 ]H NMR spectra recorded at different time periods for [InBr2*2]Br was 
dissolved in D2O. From the top to the bottom one: Spectrum one — Immediately after 
complex was dissolved in D2O; Spectrum two — 5 days later; Spectrum three — 3 
months later; Spectrum four -  6 months later.
recorded in D2O as a function of time. The ddd multiplet between 8 3.70-3.80 and the 
singlet at 5 2.96 belong to protonated 2. As indicated by the increased amount of 
protonated 2 with time, decomplexation occurred. For example, the second spectrum in 
Figure 5.2 was recorded after five days. Integration indicates that about five percent of 
protonated 2 was present.
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In contrast, no *H NMR-detectable decomplexation of [InBr2*l]Br (150) occurred 
even after this complex was kept in D2O at room temperature for twelve days and then at
Figure 5.3 *11 NMR spectra recorded after [InBr2*l]Br was dissolved in D2O. Top:
Immediately after this complex was dissolved in D2O; Bottom: After 2 days at room 
temperature then 80°C for 12 days.
Figure 5.4 'H NMR spectra recorded after [GaCl2*2]Cl was dissolved in D2O. Top: 
Immediately after this complex was dissolved in D2O. Bottom: After 46 days at room 
temperature.
80°C for additional twenty days (Figure 5.3). Similarly, no ]H NMR-detectable 
decomplexation of [GaCl2*2]Cl (151) was observed even after 46 days at r.t. (Figure 
5.4). [GaCh’ljCl (149) is also stable in D2O for months. More interestingly, this complex
247
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is even stable in acidic D2O (pD = 1.07, HCIO4) for at least one year and eight months 
(Figure 5.5). However, due to the poor solubility of both [InBr2*l]Br and [InBr2*2]Br in 
acidic D2O, no kinetic studies on the acidic decomplexation of these complexes were 
possible.
Figure 5.5 *H NMR spectra after [GaCB'ljCl was dissolved in acidic D2O (pD = 1.07, 
HCIO4). Top one: Immediately after this complex was dissolved in D2O. Bottom: After 
one year and eight months at room temperature.
1 o
Figure 5.6 !H NMR spectra after [Ga*(8-2H)](N0 3 ) was dissolved in acidic D2O (pD = 
1.07, HC1). Top one: Immediately after complex was dissolved in D2O. Bottom: After 
seven months at room temperature.
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Finally, complex [Ga*(8-2H)](N0 3 ) (153) was found to be stable in acidic D2O 
(pD = 1.07, HC1) for at least seven months (Figure 5.6).
2.2 Relative Kinetic Inertness of Zn(II), Cd(II) and Hg(II) Complexes
The kinetic studies discussed here were typically carried out at 36.8(1)°C by using 
a constant-temperature water-bath. Comparative half-lives of these pseudo-first-order 
decomplexation processes for selected Zn(II), Cd(II) and Hg(II) complexes o f ligands 1 
and 2 are shown in Table 5.1 and Table 5.2. For reference, the acid decomplexation data 
o f Z n(N 03)2*(Me4Cyclam) (168) are also included. Proton NMR spectra of these 
complexes recorded at time intervals were used to monitor their decomplexation process 
in acidic D20 . For these decomplexation studies with metal complex concentrations 
ranging between 0.020 and 0.030 M (Table 5.1 and Table 5.2), if  only protonated ligand 
was detected within the time needed to record the first ]H NMR spectrum of a 
decomplexation process, a pseudo-first order rate law is assumed and the *11 NMR 
detection limit of three percent of the initial complexed ligand is also assumed to obtain 
the half-life of this process. If an equilibrium between protonated and complexed ligand 
was reached within the time needed to record the first ]H NMR spectrum of a 
decomplexation process, a pseudo-first order rate law is also assumed to obtain the upper 
limit of the half-life of this process and the ratio of protonated to complexed ligand at the 
equilibrium is used to calculate the half-life of this decomplexation process. If no 
decomplexation was observable within the measured period, a pseudo-first-order rate law 
is assumed to obtain a lower limit of the half-life.
249
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 5.1 Acid decomplexation data for Zn(II) and Cd(II) complexes of 




Complexed L / 
Protonated L 
at Equilibrium
Time to reach 
this equilibrium
Zn(N03)2*l 2.4(1) x 103 1.0: 0.57 < 4 days
Cd(N03)2*l <3 only protonated 1 < 16 minutes
Zn(N03)2*
(Me4Cyclam)
<3 1.0: 9.1 < 7 minutes
rZn(0H2)2*21(C104)2 < 16 1.0 : 1.0 < 16 minutes
[Cd(p2-N 03)2*21 < 1 only protonated 2 < 5 minutes
[Zn*61(C104)2 1.1 x 104 1.0 : 0.38 < 8 days
[Zn]j or [Cd]i = 0.020 to 0.030 M, HOAc/NaOAc (1.0 M), 36.8(1)°C, I  = 1.0 M, 
NaCF3S 03.
Table 5.2 Acid decomplexation data for Zn(II), Cd(II), and Hg(II) complexes of 







Time to reach 
this equilibrium
Zn(N03)2' l > 1.0 x 106
Cd(N03)2*l 3.1(1) x 103 protonated 1 > 85%
[HgCl2(p-l)l2 <3 only protonated 1 <15 minutes
rCd(Ti2-N03)2-21 < 8 < 8 minutes
HgCl2*2 < 10 < 10 minutes
[Zn]; or [Cd]j = 0.020 to 0.030 M, [Hg]j = a saturated solution, MES (1.0 M), 36.8(1)°C, 
1= 1.0 M, NaCF3S 03 ( no data available).
For the Zn(II), Cd(II) and Hg(II) complexes of ligand 1, changes upon hydrolysis 
at the most upheld doublet of pentets assignable to the equatorial proton of the 13- 
methylene unit are well-resolved and allowed quantitation of the decomplexation process
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(Figure 5.7). As shown by the data in these tables, the observed relative kinetic inertness
Figure 5.7 The most upfield doublets of pentets in the JH NMR spectrum of 
Cd(N03 )2*l in buffered D2O (pD = 5.9, MES). On the left is protonated 1 and on the 
right is complexed 1.
of these complexes at pD 5.0 and 5.9 is in the expected order of Zn(II) > Cd(II) »  
Hg(II). Unlike any other Zn(II), Cd(II) and Hg(II) complexes of either ligand 1 or 2, the 
decomplexation of [HgCl2(p -l)]2 occurred immediately after it was dissolved in D2O as 
indicated by the presence of protonated 1 in all proton NMR spectra of this complex in 
D2O. Within 15 minutes, complex [HgCl2(p -l)]2 was completely decomplexed in 
buffered acidic D2O (pD =5.9, buffer MES (4-morpholineethanesulfonic acid 
monohydrate)). The half-life of this decomplexation is thus less than 3 minutes if  we 
assume the ]H NMR detection limit of three percent. Under the same conditions, 
Cd(NC>3)2*l has a pseudo-first-order reaction half-life of 3.1(1) x 10 minutes (Figure 
5.8) which was obtained from three parallel runs (R2 > 0.990) whereas Zn(N0 3 )2*l has a 
half-life of > 1.0 x 106 minutes. The slight deviation of kinetic data in the end time in 
Figure 5.8 is probably due to the approaching to the equilibrium between complexed and 
protonated ligand. At a pD of 5.0 (HOAc/NaOAc), only protonated 1 was detected for 
Cd(N0 3 )2*l as soon as this complex was dissolved whereas Zn(NC>3)2*l has a half-life of
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y = 0.000222x + 0.085808 
Ra -  0.994463
0.8  - 
0.6  - 




Figure 5.8 A typical kinetic plot of ln(Co/C) vs time (t) in the acid decomplexation of 
Cd(N03)2’l  in buffered D20 . [Cd]i = 0.020 M, pD = 5.9, MES (1.0 M), 36.8(1)°C,
/  = 1.0 M, NaCF3S 03.
0.25





Figure 5.9 A typical kinetic plot of ln(Co/C) vs time (t) in the acid decomplexation of 
Zn(N03)2*l in buffered D20 . [Cd]; = 0.020 M, pD = 5.0, HOAc/NaOAc (l.O M), 
36.8(l)°C, I  = 1.0 M, NaCF3S 03.
2.4(1) x 103 minutes which was also obtained from three parallel runs (R2 > 0.990) 
(Figure 5.9). This is consistent with their solid-state structural trend. The exo­
coordination mode of the Hg(II) complex undoubtedly renders it significantly less inert 
than the fully endo-coordinated Zn(II) and Cd(II) analogues. As Zn(II) fits much better 
than the larger Cd(II) inside cross-bridged cyclam (ligand 1) (Table 2.8), Zn(N03)2»l is 
found to be at least 800 times kinetically more inert than Cd(N03)2*l (Table 5.1).
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Thermodynamically, the ratio of complexed to protonated ligand 1 at equilibrium is 1.0 : 
0.57 in the acid decomplexation product o f Zn(N03 )2*l whereas only protonated 1 was 
detected in the acid decomplexation product o f Cd(NC>3)2®l. Complex [HgCl2(p -l)]2 
completely decomplexed at pD =5.9. Therefore, Zn(N03)2*l is at least twenty times more 
stable thennodynamically than the Cd(II) and Hg(II) complexes of 1.
The equilibrium between complexed and protonated Me4Cyclam was reached in 
seven minutes as indicated by the 'H NMR spectra of Zn(N03)2*(Me4Cyclam) run in 
buffered D2O (pD = 5.0). The major species is protonated Me4Cyclam (90%) as indicated 
by the major methyl singlet at 5 2.58 belonging to protonated ligand and the minor 
methyl singlet at 8 2.54 belonging to complexed ligand (the middle spectrum in Figure 
5.10). More clearly, the ratio of the singlet at 8 2.58 to the singlet at 8 2.54 decreased in 
the spectrum in a less acidic solution (pD =5.9, MES). The upper limit of the half-life for
v__
3.5 2,<iB 2.04
Figure 5.10 Comparison of ]H NMR spectra of Me4Cyclam in buffered D2O (pD =5.0, 
HOAc/NaOAc) (Top spectrum), Zn(N03)2*(Me4Cyclam) in buffered D2O (pD =5.0, 
HOAc/NaOAc), (Middle spectrum), and Zn(N03)2 • (Me4Cyclam) in buffered D2O (pD 
=5.9, MES), (Bottom spectrum). The singlet with the dot belongs to complexed 
Me4Cyclam.
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this process at pD =5.0 is thus calculated at three minutes. Therefore, the zinc complex of 
cross-bridged cyclam, Zn(NC>3)2*l, is at least 800 times more inert than this Zn(II) 
Me4cyclam analogue.
Figure 5.11 The two most downfield doublet of doublets in the *H NMR spectrum of 
[Zn(OH2)2*2](C104)2 in buffered D2O (pD =5.0, HOAc/NaOAc). The left doublet belongs 
to protonated 2 and the right dd belongs to complexed 2.
For complexes of ligand 2, changes at the most downfield doublet of doublets 
upon decomplexation are well-resolved in buffered D2O (pD =5.0) (Figure 5.11). As 
shown in Table 5.1, compared to Zn(N0 3 )2*l, [Zn(OH2)2*2](C104)2 is at least 150 times 
more labile. The proton NMR spectrum recorded in 16 minutes after [Zn(OH2)2*2] 
(0104)2 was dissolved in D2O indicated that the equilibrium between complexed and 
protonated ligand 2 was reached. The ratio of complexed to protonated ligand 2 is 1.0 to
1.0. The half-life of this acid decomplexation is thus less than 16 minutes. By contrast, 
the spectrum recorded as soon as [Cd(r|2-N0 3 )2*2 ] was dissolved in this solution showed 
only protonated 2 (Figure 5.12). Therefore, [Zn(0 H2)2#2 ](C104)2 is at least fifteen times 
thermodynamically more stable than [Cd(r| -N03 )2*2 ],
In 1.0 M MES buffer solution (pD =5.9), however, the strong proton resonances 
from the buffer MES overlapped with this most downfield doublet of doublets from 2. 
For example, the proton NMR spectrum of [Cd(rj2-N0 3 )2“2] in this buffer shows mainly 
the resonances from MES (relatively strong) and protonated 2 between 8 2.7 and 4.0
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Figure 5.12 *H NMR spectrum of [Cd(rj2-N03)2®2] in buffered D2O (pD =5.0, HOAc/
NaOAc). It is the same as that of protonated 2 in this buffer.
Figure 5.13 'H NMR spectrum of [Cd(r|2-N0 3 )2*2] in buffered D2O (pD =5.9, MES). 
The resonances with asterisks belong to the buffer MES whereas those with dots are 
assigned to protonated 2.
(Figure 5.13). Therefore, the relative integrations between the buffer and protonated 2 in 
the proton NMR spectra as well as the I3C{*H} NMR spectra of these Cd(II) and Hg(II) 
complexes were used to determine the progress of this decomplexation process. Since the 
two proton NMR spectra of HgCl2*2 recorded after it is kept in this buffer for 10 minutes 
and 2 days showed the same integration ratio of the resonance at 8 3.89 from MES to that 
of the singlet at 8 2.78 from protonated 2 (Figure 5.14 and Figure 5.15) and protonated 2
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Figure 5.14 *H NMR spectram of HgCl2*2 in buffered D2O (pD =5.9, MES) recorded 
14 minutes after this complex was dissolved. The resonances marked with asterisks 
belong to protonated 2. The integration values are shown below the scale.
z . n3 . o
Figure 5.15 ’H NMR spectrum of HgCl2*2 in buffered D2O (pD =5.9, MES) recorded 
163 minutes after dissolving. The integration values are shown below the scale.
is the only major species in its decomplexation product as indicated by its proton and 
NMR spectrum in this buffer, this decomplexation half-life is shorter than 10 
minutes. Similarly, the half-life of acid decomplexation of [Cd(rj -NC>3)2*2] in buffered 
D2O (pD =5.9, MES) is shorter than 8 minutes. Because Cd(N0 3 )2*l has a half-life of
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3.1(1) x 103 minutes in the same buffer, its kinetic inertness is at least 300 times higher 
than analogous Cd(II) and Hg(II) complexes of cross-bridged cyclen 2 (Table 5.1).
Since the equilibrium between complexed and protonated ligand 2 reached a 1.0 
to 1.0 ratio in buffered D2O (pD =5.0, HOAc/NaOAc), an additional experiment was 
carried out to see whether complex [Zn(0 H2)2“2 ](C104)2 can be formed from protonated 
2 and Zn(C104)2*6H2 0  under these conditions. To protonated 2 in buffered D2O (pD 
=5.0, HOAc/NaOAc), two crystals of Zn(C104)2*6H2 0  were added. After this solution 
was kept in a 36.8(1)°C bath for 49 minutes, the proton NMR spectrum of this solution 
was significantly changed (Figure 5.16) as both complexed and protonated ligand 2 were 
detected in a 1.3:1.0 ratio. A second 'H  NMR spectrum run after this solution was kept at 
36.8(1)°C for 28 days showed no further changes. This indicates that the equilibrium 
between complexed and protonated ligand 2 was reached within 49 minutes at 36.8°C. 
This suggests the possibility of obtaining thermodynamic stability constant of this 
complex by potentiometric titration.
Wa_^ _AA/a"VajvTTTVo
Figure 5.16 Comparison of ]H NMR spectra of protonated 2 in buffered D2O (pD 
=5.0, HOAc/NaOAc) (Top spectrum), protonated 2 plus two crystals of Zn(C104)2®6H20  
after 49 minutes at 36.8(1)° (Middle spectrum) and 28 days (Bottom).
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Figure 5.17 Top: !H NMR spectrum of [Zn*6](C104)2 in buffered D2O (pD -5.0,
HOAc/NaOAc) at equilibrium; Bottom: Spectrum of a mixture of [Zn*6](C104)2 in 
buffered D2O (pD =5.0, HOAc/NaOAc) at equilibrium and excess protonated 6 .
Ligand 6 is the dicarbamoyl pendant-armed cross-bridged cyclen. Changes in the most 
downfield singlet assignable to the methylene protons from the pendant arms upon 
decomplexation are well-resolved and allowed quantitation of the [Zn*6](C104)2 
decomplexation process (top spectrum in Figure 5.17). The comparison of the proton 
NMR spectra of this complex before and after the addition of protonated ligand enabled 
us to assign the singlet at 5 4.00 to complexed 6 and the singlet at 3.61 to protonated 6 
(Figure 5.17). Since the kinetic data collected near the equilibrium deviated from the 
pseudo-first order behavior (Figure 5.18(a)), only the first three data points were used to 
calculate this half-life (Figure 5.18(b)). From this, we can confirm that indeed this zinc 
complex is at least 600 times more inert than the Zn(II) complex of parent cross-bridged 
cyclen 2 (Table 5.1). To further show that the acid decomplexation of this complex also 
follows a pseudo-first-order rate law, a more acidic D2O solution (pD =4.2) was used. 
Consistently, the first seven data points collected also show a pseudo-first-order reaction 
behavior (Figure 5.19).
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y = 0.000041 7069x 0.0203398937
= 0.95256396570.3
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Figure 5.18(a) A kinetic plot of ln(Co/C) vs time (/) in the acid decomplexation of 
[Zn*6](C104)2 in buffered D20 . [Zn]i = 0.020 M, pD =5.0, HOAc/NaOAc (1.0 M), 
36.8(1)°C,/=  1.0 M, NaCF3S 0 3.
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Figure 5.18(b) A kinetic plot of ln(Co/C) vs time (f) in the acid decomplexation of 
[Zn«6](C104)2 in buffered D20  excluding two data points collected after 3000 minutes. 
[Zn]j = 0.020 M, pD =5.0, HOAc/NaOAc (1.0 M), 36.8(1)°C,/ =  1.0 M, NaCF3S 03.
y = 0.0003236X + 0.0128072
R = 0.99335220.3 
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Figure 5.19 A kinetic plot of ln(Co/C) vs time (t) m the acid decomplexation of 
[Zn»6](C104)2 in buffered D20 . [Zn]; = 0.020 M, pD =4.2, HCOOH/HCOONa (1.0 M), 
36.8(1)°C,/=  1.0 M, NaCF3S 03.
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In order to compare our data with Springborg’s reported kinetic data (Table 
1.3),76 the decomplexation of Zn(N0 3 )2*l in acidic D2O (5 M HC1) was carried out at 
room temperature (22°C). Within 11 minutes, Zn(N0 3 )2*l was completely decomplexed 
in this medium (Figure 5.20). Since only relative noisy ’H NMR spectra were recorded 
(Figure 5.20), a detection limitation of five percent is used. The half-life of this acid
Figure 5.20 Top: ]H NMR spectrum of Zn(NC>3)2*l in acidic D2O (5 M HC1)
obtained 11 minutes after the complex was dissolved. Middle: 'H  NMR spectrum of
Zn(N03 )2*1 in acidic D2O (5 M HC1) obtained 92 minutes after the complex was 
dissolved. Bottom: ]H NMR spectrum of protonated 1 in acidic D2O (5 M HC1).
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decomplexation process is thus less than three minutes. For comparison, under similar 
conditions, Springborg’s Zn(II) complex of a homologous trimethylene-cross-bridged 
tetraamine, [Zn*114]2+ was reported to have a half-life of 72 minutes (Table 1.3).88
Unlike the out-of-cavity HgCl2 complex of cross-bridged eye]am 1 which 
decomplexed in D2O within minutes, no detectable decomplexation was observed for the 
Hg(II) complex of the dicarboxylate pendant-armed cross-bridged cyclam derivative 7, 
[Hg’(7-2H)](K2HgCl4) (148), in D20  after 48 days (Figure 5.21).
Figure 5.21 Top: ^C^H } NMR spectrum of [Hg»(7-2H)](K2HgCl4) (148) after it
was kept in D20  for 48 days. . Bottom: NMR spectrum of [Hg®(7-
2H)](K2HgCl4) (148) immediately after it was dissolved in D20.
Complex [Zn*(7-2H)](NaC104) was also found to be stable in acidic D2Q (pD =
5.0, HOAc/NaOAc, 1= 1.0 M, NaCFsSCb) at 36.8° for at least 79 days as indicated by the 
unchanged NMR spectra in Figure 5.22. The presence of only complexed 7-2H is 
further supported by its b C{’H} NMR spectrum (Figure 5.23). The half-life of this 
acidic decomplexation is thus longer than 1800 days (2.6 x 106 minutes). Therefore, the 
kinetic inertness of this complex is at least 1000 times that of Zn(N03 )2*l (118). Such 
dramatically-increased kinetic inertness is a direct result of the added dicarboxylate 
pendant arms.
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Figure 5.22 Top: *H NMR spectrum of Zn*(7-2H)](NaC104) in acidic D2O (pD =
5.0, HOAc/NaOAc) as soon as it was dissloved in this solution. Bottom: !H NMR
spectrum of Zn*(7-2H)](NaC104) in acidic D2O (pD = 5.0, HOAc/NaOAc) after 70 days. 
The strong resonance at 5 2.15 belongs to the buffer.
!•?»<■> 1*0 t-70 )6(1 150 1*40 130 120 1 io IOO <>«» >»<> 70 “ >> <4 0 .31* 20
<rp"' *
Figure 5.23 ^C^H } NMR spectrum of Zn®(7-2H)](NaC104) in acidic D2O (pD = 5.0,
HOAc/NaOAc) after 70 days (only resonances of complex Zn*(7-2H)](NaC104), acetic 
acid, and NaCF3S03  were detected).
It can thus be concluded that the kinetic stabilities of these complexes follow this 
order: [Zn«(7-2H)](NaC104) > [Zn*6](C104)2 > Zn(N03)2*l »  Cd(II) complex of
ligand 1, Zn(II), Cd(II) and Hg(II) complexes of ligand 2, and Zn(N0 3 )2*(Me4Cyclam) >
[HgCl2(p-l)]2-
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2.3 Preliminary Results on Relative Kinetic Inertness of Cu(II) Complexes
The kinetic studies for all Cu(II) complexes were carried out in 5 N HC1 at room 
temperature (22°C) by UV-Vis spectroscopy. Comparative pseudo-first-order half-lives 
are shown in Table 5.3. Since all copper complexes o f cross-bridged ligands show d-d 
maxima ranging from 595 to 647 nm in water except that Cu2(0 H)(l)2(C104)3 has a band 
at 595 nm and an additional band at 958 nm, we assumed that the d-d transitions of those
Table 5.3 Acid decomplexation data for Cu(II) complexes of cross-bridged ligands and 







6.5(5) x 102 [Cu*(7-2H)](NaC104)
(NaCF3COO)o.5(H20 ) 1.5
> 2.5 x 104
[Cu*2(p-Cl)l2Cl2 «  1.0 [Cu*(8-2H)](NaC104) «  1.0
[Cu*61(C104)2 «  1.0 Cu(tet a)(C104)2 2.4(2) x 103
* Detailed reaction conditions are included in the experimental section of this chapter.
W a v e l o n g t N  < s ' *  s-b-s  >
Figure 5.24 The electronic spectrum of Cu2(0 H)(l)2(C104)3 (H2O) in aqueous 5N 
HC1 ([Cu]j = 0.020 M).
Cu(II) complexes (Table 5.3) in 5 N HC1 would be in a similar range. Indeed, 
Cu2(0H)(1)2(C104)3 (154) has a band at 587 nm and an additional band at 958 nm in 5N 
HC1 (Figure 5.24). Since the decomplexation product CuClx2'x has broad bands used to 
monitor the around 905 nm (Figure 5.25), the decrease in the absorbance of the band at
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W a v e i e n g t H
Figure 5.25 The electronic spectrum of 0.00905 M CuCl2 in aqueous 5N HC1. The 
spike at 798 nm is due to the instrument.
y = 0.00102361 53x +  0 .2609338942
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Figure 5.26 A plot of -InA vs time (t) in the acid decomplexation of 
Cu2(0H)(l)2(Cl04)3 in 5N HCl. [Cu], = 0.020 M.
587 nm was kinetic process. A half-life o f 6.5(5) x 102 hours was then calculated from the 
data obtained from three parallel runs (R2 > 0.985) (Figure 5.26). For comparison, under 
similar conditions, the Cu(II) complex of Springborg’s homologous trimethylene-cross­
bridged tetraamine, [Cu*114]2+, has a half-life of 8.4(1) x 102 hours (Table 1.3).88 
Complex [Cu«(7-2H)](NaC104)(NaCF3COO)o.5(H2 0 )i.5 (164) has a d-d transition band at 
623(2) nm in 5 N HCl (Figure 5.27) which is very similar to its maximum at 620 nm in 
water. However, this copper complex is so stable in 5 N HCl that the data collected 
during six months from three parallel runs did not result in any significant change. Due to 
this long period of data collection, the maximum absorbance of this copper complex in
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Figure 5.27 The electronic spectrum of [Cu*(7-2H)](NaC104)(NaCF3COO)o.5(H2 0 )i.5
in aqueous 5N HCl ([Cu] = 0.016 M).
water was used as a reference standard. All absorbance data collected during this period 
were corrected using the absorbance of this copper complex in water as a reference and 
shown in Table 5.4(a-c). Using the lowest absorbance of 0.590 in these tables and the 
highest starting absorbance of 0.775, the low-limit of its acid decomplexation half-life 
can be estimated to be 2.5 x IQ4 hours.
In 5N HCl, by contrast, copper complexes of cross-bridged cyclen 1 and its 
pendant-armed derivatives 6 and 8 decomplexed so fast that no band from 500 to 700 nm 
in the spectra were observed within 3 minutes (Figure 5.28, Figure 5.29, and Figure 
5.30). Instead, only a strong broad band around 905 nm belonging to the decomplexation
Table 5.4(a) Acid decomplexation data for [Cu*(7-2H)](NaC104)(NaCF3COO)o.5 

















288 0.775 2060 0.666 0.862
552 0.765 0.765 2566 0.590 0.685
816 0.747 0.743 4248 0.730 0.777
1224 0.763 0.773
* ----------------No data available
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Table 5.4(b) Acid decomplexation data 

















288 0.763 2061 0.599 0.775
553 0.747 0.747 2565 0.603 0.700




* ----------------No data available.

















289 0.764 2060 0.602 0.779
552 0.752 0.752 2565 0.629 0.730
817 0.770 0.765 3141 0.600 0.794
823 0.775 0.770 4248 0.698 0.743
1224 0.759 0.769
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Figure 5.28 The electronic spectrum of [Cu*2(p-Cl)]2Cl2 after 2 minutes in aqueous 
5NHC1 ([Cu]j = 0.011 M).
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Figure 5.29 The electronic spectrum of [Cu*(8-2H)](NaC104) after 2 minutes in
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Figure 5.30 The electronic spectrum of [Cu*6](C104)2 after 3 minutes in aqueous 5N 
HCl ([Cu]i = 0.011 M).
product CuClx2"x appeared. Further, spectra recorded about 60 minutes later were almost 
the same (Figure 5.31 and Figure 5.32). The half-lives of [Cu*2(p-Cl)]2Cl2 (155), 
[Cu*(8-2H)](NaC104) (165), and [Cu*6 ](C104)2 (162) are thus all far less than an hour. 
For comparison, the decomplexation of the most-stable isomer in the Cu(II) complex of 
the ligand tet a, red-isomer Cu(tet a)(C104)2, in 5N HCl was also monitored by the d-d 
transition band at 518 nm. A half-life of 2.4(2) x 104 hours was then calculated from the 
data obtained from three parallel runs (R2 > 0.970) (Figure 5.33). This is significantly 
longer than previously reported half-life of 528 hours in 6.1 N HCl at 25°C in the
literature. ] 40(f)
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Figure 5.31 The electronic spectrum of [Cu»(8-2H)](NaC104) after 63 minutes in










Figure 5.32 The electronic spectrum of [Cu*6](Cl04)2 after 52 minutes in aqueous 5N 
HCl ([Cu]i = O.Ol l M).
0.0002996023x -«- 0.284 1 640682
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Figure 5.33 A kinetic plot of -InA vs time (t) in the acid decomplexation of red-isomer 
Cu(tet a)(Cl04)2 in 5N HCl. [Cu]i = 0.051 M.
It can therefore be concluded that the kinetic inertness of these complexes follow 
the order: [Cuft7-2H)](NaCl0 4 )(NaCF3COO)o.5(H20 )i.5 > red-isomer Cu(tet a)(Cl04)2 > 
Cu2(0 H)(l)2(Cl0 4)3 »  [Cu*(8-2H)](NaCl0 4), [Cu*6](Cl04)2, and [Cu*2(p-Cl)]2Cl2.
268
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3. Experimental for Kinetic Studies.
(1) Zn(II), Cd(II), Hg(II), Ga(III) and In (III) Complexes
Proton NMR spectra of these complexes recorded at time intervals were used to 
monitor their decomplexation process in either D2O or acidic D2O. The pD of a D2O 
solution can be calculated using the empirical formula pD -  pH (meter reading) + 
0.40.48(e) Acidic D2O include buffered solutions, HCIO4 or HCl in D2O (pD =1.07), and 5 
M HCl in D2O. A solution containing one of the complexes was kept in a sealed NMR 
tube or small vial with a cap and parafilm. Zn(II), Cd(II) and Hg(II) complexes with 
concentrations between 0.020 and 0.030 M were generally used for these studies. For 
complexes of ligand 1, changes upon , hydrolysis at the most upheld doublet o f pentets 
assignable to the equatorial proton of the p-methylene unit are well-resolved and allowed 
quantitation of the decomposition process. For complexes of ligand 2, changes upon 
decomplexation at the most downfield doublet of doublets is well-resolved between 
complexed and protonated ligand 2 and allowed quantitation of the decomposition 
process. Samples were kept in thermostated baths at 36.8(1)°C throughout the studies on 
zinc, cadmium and mercury complexes in buffered D2O solutions. For a pD of 5.0, a 1.0 
M acetic acid/sodium acetate buffer system was used, while for pD 5.9, a 1.0 M MES (4- 
morpholine-ethanesulfonic acid) buffer was used. Sodium trifluoromethylsulfonate was 
used to maintain all solution ionic strengths at /  = 1.0 M according to the literature 
method.142 Three parallel experiments were carried out for any collected kinetic data on 
the Zn(II), Cd(II) and Hg(II) complexes of ligands 1 and 2. However, if no detectable 
decomplexation of a complex occurred after it was dissolved in a buffer for at least
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several days, two parallel experiments were carried out. If the decomplexation is 
complete immediately after a complex was dissolved in a buffer, two parallel 
experiments were also carried out. The *H NMR detection limit of three percent is 
assumed for the metal complexes used for these studies with concentrations between 
0.020 and 0.030 M. For Zn(II), Cd(II) and Hg(II) complexes of other cross-bridged 
ligands, only a single kinetic run was collected for each complex. Likewise for the 
Ga(III) and In(III) complexes. If D2O, HCIO4 in D2O (pD =1.07), or 5 M HCl in D2O was 
used as the decomplexation medium, the kinetic studies were carried out at air- 
conditioned room temperature (22(3)°C).
(2) Cu(II) Complexes
Decomplexation kinetics were followed by monitoring changes in the d-d 
transitions of the UV-Vis region (450-650 nm). In order to make our data comparable to 
the literature data,76 5 N HCl in deionized water was used as the acid source. All Cu(II) 
complexes of cross-bridged ligands were made according to the synthetic procedure 
described in the experimental part. The 5N HCl solution containing each of these 
complexes was kept in a small vial and sealed with parafilm. Kinetic data were generally 
collected from at least three parallel runs. However, for very fast decomplexations, only 
one experiment was carried out. The copper complexes used for these studies have 
concentrations between 0.011 and 0.018 M except for Cu2(0 H)(l)2(C104)3(H2 0 ) (154) 
which was either 0.0020 or 0.0030 M. The reference complex Cu(tet a)(C104)2 was 
synthesized according to the literature method.143 A concentration of 0.051 M was used 
for this acid decomplexation study.
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Experimental Section:
General Methods and Materials.
Unless indicated otherwise, 1-D ]H and ,3C{]H} NMR spectra were recorded at 
360.13 and 90.56 MHz respectively (Bruker AM-360). Acetonitrile was generally used as 
an internal standard for NMR spectra in D2O solutions; the methyl resonance was set at 
8 2.06 and 8 1.70 for ]H and ^C l'H } spectra respectively. Proton COSY, gCOSY, NOESY, 
gHSQC, and HMQC NMR experiments were performed at 400 or 500 MHz (Varian 
Inova-400 or 500). 1I3Cd NMR spectra were recorded at 90 MHz (JEOL FX90Q). 
Variable-temperature *H and 13C{!H} NMR spectral studies were carried out at 400 MHz 
(Varian Inova-400) in which a methanol chemical shift thermometer (0.03% conc. HCl in 
MeOH) was used to monitor the temperature of the probe. IR spectra were recorded as 
KBr pellets on a Nicolet MX-1 FT Spectrophotometer. Elemental analyses were obtained 
from the University of New Hampshire University Instrumentation Center or Atlantic 
Microlab. Inc., Norcross, GA. Reactions were run under a nitrogen atmosphere with 
magnetic stirring in standard Schlenk glassware. Bulk solvent removal was by rotary 
evaporation under reduced pressure and trace volatile removal from solids was by 
vacuum pump. Solvents except for acetonitrile were used as purchased. Acetonitrile was 
dried over a CaH2/KOH mixture.
Cross-bridged ligands 1-4 (Figure 1.36) were prepared as described 
previously.19,69 In the synthesis of Ga(III) and In(III) complexes o f ligands 1 and 2,
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ligands 1 and 2 were kept under nitrogen after being sublimated under vacuum. Cross­
bridged ligands 5, 6, 7, and 8 were prepared according to our group's methods.19,69,125(a) 
Ligand 5 was synthesized only once by a slight modification of our group's method. 
However, the resulting 5 was only about 95% pure and was used for complexation with 
metal salts. Because of the synthetic routes,69,125<a-) ligand 7 was made as 7 ®(TFA)(H2 0 )o.5 
and ligand 8 was isolated as 8®(TFA)2(H20). In the synthesis of ligand 8 , by the avoiding 
of any moisture from air and trace water from solvents, ligand 8 was isolated as 8®(TFA)2 
as indicated by its CHN elemental results. Standard aqueous 1.0N NaOH solution and 
standard 0.505N KOH solution in methanol were purchased from Aldrich. Metal salts 
were obtained commercially and used without further purification. Anhydrous GaCl3 and 
anhydrous InBr3 were stored in a N2-filled glovebox. Recrystallizations of any metal 
complexes were carried out in closed containers without special precautions to exclude 
moisture or air.
[Zn*l(OH2)(p-Cl)ZnCI3] (115): To a MeOH solution (4 mL) of ZnCl2 (70.9 mg, 0.520 
mmol), 0.056 mL of deionized H2O was added. To this clear solution, a MeOH solution 
(3 mL) of 1 (56.2 mg, 0.248 mmol) was added. This solution became cloudy after stirring 
for 1 minute and was then refluxed for 14 hours. The white precipitate was centrifuged 
out and washed by MeOH (2x4 mL). Removal of residual solvent yielded 95.7 mg (75%) 
of a white solid. IR (KBr): 3434 (vOH), 3264, 3252 cm'1 (vNH). ‘H NMR in D20  (0.043 M 
solution): 5 3.51 (2H, broad t, J  ~ 8 Hz, NH), 2.80-3.22 (18H, m), 2.56-2.70 (2H, broad 
m), 2.16-2.32 (2H, m, p-CHHax\  1.56 (2H, broad dp, J  = 17.0, 2.8 Hz, $-CHegH); 
13C{’H} data in D20  (0.043 M solution): 5 59.83, 58.37, 51.21, 48.46, 41.32, 21.81.
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Anal. Calcd. for Zn2Cl4Ci2H28N40 : C, 27.88; H, 5.46; N, 10.84%. Found: C, 27.98; H, 
5.35; N, 10.70%.
[Zn*l(p.-Cl)]2Cl2*4 CH3 0 H (116): To a refluxing solution of ligand 1 (52 mg, 0.23
mmol) in 4 mL of methanol was added a methanol solution of ZnCl2 (31 mg, 0.23 mmol) 
in 5 mL methanol. This was refluxed overnight to give a clear solution. After cooling to 
room temperature, diethyl ether diffusion into this solution yielded 63 mg (75%) of clear 
X-ray-quality crystals. CHN elemental analyses were carried out on these crystals after 
vacuum-drying. IR (KBr): 3216 cm_1(v>jH). *H NMR data for the [Z n (l)(p -C l)]2Cl2 
complex in D2O (0.050 M solution): 8 3.51 (2H, broad t, J  ~ 9 Hz, NTT), 2.79-3.22 (18H, 
m), 2.61-2.68 (2H, broad m), 2.16-2.32 (2H, m, p-CHtf«*), 1.56 (2H, broad dp, J  -  16.9, 
2.8 Hz, f5-CffegH); in CD3OD (0.017 M solution): 5 3.69 (2H, broad t, J  ~ 9 Hz, N//),
3.48 (2H, tt, J =  13.2, 3.0 Hz), 3.18-3.29 (4H, m), 3.14 (2H, td, J =  12.1, 5.9 Hz), 2.72-
3.07 (10H, m), 2.48 (2H, dd, J  = 11.7, 3.6 Hz), 2.30 (2H, dtt, 16.6, 13.4, 3.3 Hz, 
p-CH //^), 1.56 (2H, broad dp, J  = 16.9, 2.9 Hz, p-CZL9H); in CD3OD (0.050 M 
solution at 500 MHz): 8 3.77 (2H, broad t, J ~  9 Hz, NH), 3.52 (2H, tt, J  — 13.2, 3.0 Hz), 
3.22-3.32 (4H, m, including AA' of AA'XX'), 3.16 (2H, td, J  -  12.8, 5.5 Hz), 2.92-3.06 
(4H, m), 2.88 (2H, d,J~13H z), 2.82 (2H, d, J ~  12 Hz), 2.70-2.78 (2H, XX' of AA'XX');
2.48 (2H, dd, J =  11.7, 3.6 Hz), 2.30 (2H, dtt, 16.6, 13.4, 3.3 Hz, p-CH tf„), 1.56 (2H, 
broad d p ,7 = 16.9, 2.9 Hz, $-CHegli); in CD3OD (0.017 M N-D complex): 3.47 (2H, td, 
J  = 13.1, 2.9 Hz), 3.18-3.29 (4H, m), 3.14 (2H, td, J  = 13, 5.3 Hz), 2.72-3.06 (10H, m),
2.48 (2H, ddd, J  = 12.0, 3.8, 1.1 Hz), 2.29 (2H, dtt, 19.7, 13.4, 3.2 Hz, p-CH tf«), 1.56 
(2H, broad dp, J  -  16.9, 2.9 Hz, p -C i/egH); in CD3OD (0.050 M N-D complex at 500
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MHz): 3.52 (2H, td , J =  13.3, 2.8 Hz), 3.22-3.32 (4H, m, including AA' of AA'XX'), 3.16 
(2H, td, J=  12.8, 5.3 Hz), 3.01 (2H, td, J =  13.5, 4.3 Hz), 2.90-2.96 (2H, m), 2.87 (2H, 
broad d ,7  = 12.5 Hz), 2.81 (2H, broad d , J  = 12.5 Hz), 2.69-2.78 (2H, XX' of AA'XX'),
2.48 (2H, broad dd, 7 =  12.0, 4.0 Hz), 2.31 (2H, dtt, 16.5, 13.0, 3.0 Hz, p-CHH^), 1.53 
(2H, broad dp, J =  16.5 Hz, 3.0 Hz, p-Ctf^H ); in CD3CN: 5 3.65 (2H, tt, J  = 12.7, 3.0 
Hz), 3.47 (2H, td, J=  12.8, 2.7 Hz), 3.41 (2H, td, J  = 12.2, 6.8 Hz), 3.15 (2H, br m, shift 
dependent on amount of water in solvent, NZ7), 3.02-3.15 (2H, AA' of AA'XX', cross- 
bridging CH2CH2), 2.81-2.91 (4H, m), 2.72 (2H, dp, J =  12.6, 1.6 Hz), 2.55-2.66 (4H, m 
including XX' o f AA'XX'), 2.23 (2H, dd, J  = 3.8, 1.5 Hz), 2.04-2.20 (2H, dtt
overlapping with water peak, J  = 16.7, 13.4, 3.3 Hz, p-C H //fl;c), 1.42 (2H, dp, J  = 16.6,
2.8 Hz, p-Gtf^H); ' ^ { ’H} data in D20  (0.050 M solution): 8 59.86, 58.40, 51.22, 48.49, 
41.34, 21.82; in CD3OD (0.017 M solution): 8 59.99, 59.84, 52.03, 48.67 (overlapped 
with the methanol peaks), 42.55, 22.76; in CD3OD (0.050 M solution at 125.7 MHz): 
8 60.04, 59.77, 51.98, 48.49, 42.60, 22.66; in CD3OD (0.017 M N-D complex): 5 59.99,
59.83, 52.02, 48.57 (overlapped with the methanol peaks), 42.44, 22.74; in CD3OD 
(0.050 M N-D complex at 125.7 MHz): 8 60.05, 59.74, 51.98, 48.35, 42.51, 22.63; 13C 
data in CD3CN: 5 59.17, 58.95, 51.49, 47.70, 42.13, 22.63. Anal. Calcd. for 
ZnCl2(C12H26N4)*0.5H2O: C, 38.78; H, 7.32; N, 15.07%. Found: C, 39.06; H, 7.19; N, 
14.99%.
Zn*l(C104)2(117): To a solution of ligand 1 (82 mg, 0.36 mmol) in 5 mL methanol was 
added a 2 mL methanol solution of Zn(C104)2*6H20  (141 mg, 0.38 mmol). After 1 day of 
refluxing then cooling, diethyl ether vapor diffusion yielded 164 mg (92%) of colorless
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crystals. IR (KBr): 3286 ca i\vm d .  !H NMR in D20  8 3.50 (2H, broad t, J=  9 Hz NH), 
2.81-3.19 (18H, m), 2.61-2.66 (2H, broad m), 2.16-2.32 (2H, m, (3-CHHm), 1.56 (2H, dp, 
J  = 17.1 Hz, 2.8 Hz, p-CHHeq)\ in CD3OD (0.020 M): 5 3.91 (2H, broad t, J =  8 Hz, 
NH), 3.19 (2H, tt, J  = 13.1, 2.9 Hz), 2.83-3.16 (16H, m), 2.61-2.70 (2H, m), 2.24- 
2.41 (2H, m, p-CH H ^ ), 1.60 (2H, broad dp, J  -  16.9, 3.0 Hz, p-CH e(?H); in CD3CN: 
8 3.35 (2H, broad s, NH), 3.19 (2H, tt, J =  13.2, 2.9 Hz), 2.64-3.13 (16H, m), 2.52-2.62 
(2H, m), 2.07-2.21 (2H, m, p-CHH«), 1.51 (2H, broad dp, J=  16.8, 2.8 Hz, p-CHe?H); 
13C{]H} data in D 20: 8 59.88, 58.42, 51.22, 48.51, 41.34, 21.81; in CD3OD: 61.00, 
59.20, 52.39, 49.94, 42.47, 22.77; in CD3CN: 8 60.02, 59.10, 51.64, 48.57, 42.09, 22.27. 
Anal. Calcd. for [Z nC C ^eN ^K C lO ^: C, 29.38; H, 5.34; N, 11.42%. Found: C, 29.76; 
H, 5.51; N, 11.44%.
Zn«l(NC>3)2 (118): To a solution of ligand 1 (226 mg, 0.998 mmol) in 2 mL methanol 
was added a methanol solution (4 mL) of Zn(N03 )2*6 ^ 0  (304 mg, 1.02 mmol). After a 
day of reflux, a clear solution was obtained. Diethyl ether was diffused in at room 
temperature to give 408 mg (98%) of colorless crystalline product. IR (KBr): 3255 cm'1 
(vnh). ’H NMR data in D20: 8 3.51 (2H, br t, J  -  8 Hz, NH), 3.13 (2H, tt, J =  13.1, 2.9 
Hz), 2.80-3.04 (16H, m), 2.60-2.65 (2H, broad m), 2.16-2.32 (2H, m, p-CHHax), 1.56 
(2H, dp, J  = 16.9, 2.8 Hz, p-CHHe?); in CD3OD (0.020M): 8 4.10 (2H, broad s, NH), 
3.22 (2H, tt, J=  13.2, 2.8 Hz), 3.10-3.21 (2H, m), 2.85-3.07 (14H, m, including 4H, AA' 
and BB' of AA'BB'), 2.61-2.65 (2H, br m), 2.22-2.41 (2H, m, p-CH H ^ ), 1.58 (2H, broad 
dp, J =  16.8, 2.9 Hz, p-CHe?H); in CD3CN: 8 3.88 (2H, broad s, NH), 3.23 (2H, tt, J -
13.3, 3.0 Hz), 3.04-3.15 (2H, AA' of AA'XX'), 2.81-3.03 (14H, m), 2.70-2.81 (2H, XX'
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of AA'XX'), 2.52-2.56 (2H, m), 2.17 (2H, dtt, J  = 16.4, 13.1, 3.3 Hz, p-CHtf**), 1.50 
(2H, broad dp, J =  16.8, 2.9 Hz, $-CHeqH); ^C ^H } in D20: 5 59.90, 58.43, 51.24, 
48.53, 41.35, 21.83; in CD3OD: 5 61.04, 59.74, 52.24, 48.93, 42.35, 22.79; in CD3CN: 
5 60.34, 59.47, 51.52, 48.65, 41.82, 22.38. Anal. Calcd. for Zn(Ci2H26N4)(N03)2: C, 
34.67; H, 6.30; N, 20.21%. Found: C, 34.56; H, 6.31; N, 19.96%.
ZnCl2®3 (119): In a glovebox, 45 mg (0.33 mmol) of anhydrous ZnCl2 and 134 mg 
(0.330 mmol) o f ligand 3 were transferred into a Schlenk flask. This sealed flask was 
then evacuated for about half an hour. Under N2 protection and with stirring, 15 mL of 
MeCN (anhydrous) was added into the Schlenk flask to form a cloudy solution. After this 
was refluxed for 3 days, the white precipitate was centrifuged off and washed with dry 
benzene (2x8 mL) and acetone (2x8 mL). The removal of residual solvents in vacuo gave 
158 mg (88%) of ZnCl2*3 as a white powder. *H NMR data in D20 : 5 7.33-7.47 (10H, m, 
phenyl), 4.24 and 3.93 (4H, AB, J  = 14.2 Hz, CH2Ph), 2.58-3.46 (20H, m), 2.16-2.25 (2H, 
m, p-CHJ/„), 1.67 (2H broad d , J ~  17 Hz, p-CHHeq)\ in d6-DMSO: 5 7.28-7.42 (10H, 
m, phenyl), 4.37 and 3.99 (4H, AX, J  -  14.1 Hz, C/fcPh), 3.23-3.44 (8H, m, overlapped 
with the water signal), 2.78 (2H, broad t, J  ~ 14 Hz), 2.43-2.66 (6H, m, overlapped with 
DMSO), 2.30 (4H, broad t, J ~  9Hz), 2.10 (2H, broad q , J ~  14 Hz, p-C fitf^), 1.50 (2H, 
broad d ,J ~  17 Hz, fi-CHegE); 13C{1H> in D 20: 5 133.35, 131.79, 129.21, 128.90, 58.77,
58.06 (two resonances overlapped), 54.26, 50.70, 42.78, 22.37; in d^-DMSO: 5 132.60, 
132.26, 128.01, 127.93, 58.14 (two resonances overlapped), 57.33, 52.98, 48.97, 41.88, 
22.00. Anal. Calcd. for ZnCl2C26H38N4: C, 57.52; H, 7.06; N, 10.32%. Found: C, 57.33; 
H, 6.85; N, 10.14%.
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Zn®3(fi-Cl)2-ZnCl2 (120): In a glovebox, 53 mg (0.19 mmol) of anhydrous ZnCl2 and 79 
mg (0.19 mmol) o f ligand 3 were transferred to a Schlenk flask. The sealed flask was 
evacuated for about half an hour. Under N2 protection, 15 mL of anhydrous MeCN was 
added and the resulting cloudy solution was refluxed for 3 days. Then the white 
precipitate was centrifuged off and washed by toluene (5 mL) and ethanol (8 mL). The 
removal of residual solvents in vacuo gave 120 mg of Zn»3(p-Cl2)ZnCl2 (92%) as a white 
powder. ]H NMR data in D 20 : 5 7.34-7.49 (10H, m, phenyl), 4.24 and 3.94 (4H, AX, J  = 
14.0 Hz, C/fcPh), 2.58-3.45 (20H, m), 2.10-2.29 (2H, m, p-CHHax, overlapped with the 
CH3CN peak), 1.67 (2H broad d, J ~  18 Hz, (3-CHHeg); in d6-DMSO: 5 7.29-7.43 (10H, 
m, phenyl), 4.35 and 3.97 (4H, AX, J  = 14.2 Hz, C i/2Ph), 3.20-3.42 (8H, m, overlapped 
with water signal), 2.80 (2H, broad t, J  ~ 14 Hz), 2.44-2.66 (6H, m, overlapped with the 
DMSO peaks), 2.32 (4H, broad t, J ~  11 Hz), 2.11 (2H, broad q, J ~  16 Hz, p-CHHax),
1.50 (2H, broad d, J ~  17 Hz, p-CHei?H); '^ { 'H }  in D20: 5 133.35, 131.80, 129.20, 
128.90, 58.77, 58.11, 58.01, 54.26, 50.69, 42.82, 22.38; in d6-DMSO: 132.61, 132.11,
128.02, 127.96, 58.07, 57.26, 57.23, 52.93, 48.97, 41.81, 21.91. Anal. Calcd. for 
Zn2Cl4C26H38N4: C, 45.98; H, 5.64; N, 8.25 %. Found: C, 46.14; H, 5.60; N, 8.28%.
ZjiCI2®2 (121): An amount of 41 mg (0.21 mmol) of ligand 2 and 29 mg (0.21 mmol) of 
ZnCl2 were placed in a Schlenk flask. Under N2 protection, 10 ml of absolute MeOH was 
added and this solution was refluxed for 10 hours forming a clear solution with a small 
amount of white precipitate which was centrifuged off from the methanol solution. Et20  
vapor diffusion into this solution yielded needle crystals. These crystals were washed by 
acetone and dissolved in MeOH. Et20  vapor diffusion into this solution yielded 44.5 mg
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needle-like crystals (64%). This complex is not soluble in MeCN and CHCI3. IR (KBr): 
3186 cdT^vnh)- 'H NMR in D20  (0.02 M solution, MeOH as internal reference): 8 3.78 
(2H, broad s, NH), 3.52-3.61 (4H, m), 2.95 (4H, s, cross-bridging CH2CH2), 2.93-3.01 
(4H, m), 2.89 (4H, td, J  = 11.9, 6.4 Hz), 2.76 (4H, br dddd, J  = 15, 11, 9, 4 Hz); in 
CD3OD (0.0066 M solution): 8 3.92 (2H, broad s, NH), 3.54 (4H, ddd, J=  14.5, 9.3, 7.1 
Hz), 3.17 (4H, td, J=  11.6, 7.3 Hz), 2.93 (4H, s, cross-bridging CH2CH2), 2.81 (4H, dd, J  
= 11.9, 6.1 Hz), 2.69-2.79 (4H, m); in D20  (0.02 M N-deuterated complex, both MeOH 
and MeCN as internal references): 8 3.56 (4H, dd, J  = 14.5, 6.2 Hz), 2.94 (4H, s, cross­
bridging CH2CH2), 2.84-2.98 (8H, m), 2.74 (4H, ddd, J =  14.9, 11.4, 6.5 Hz); in CD3OD 
(0.0066 M solution): 8 3.54 (4H, dd, J  = 14.8, 7.2 Hz), 3.15 (4H, td, J =  11.7, 7.4 Hz),
2.93 (4H, s, cross-bridging CH2CH2), 2.82 (4H, dd, J=  11.7, 5.9 Hz), 2.74 (4H, ddd, J  = 
14.6, 11.6, 5.9 Hz); in d6-DMSO: 8 4.09 (2H, broad s, NH) 3.27-3.44 (4H, m, overlapping 
with the H20  peak), 3.02-3.15 (4H, m), 2.77 (4H, s, cross-bridging CH2CH2), 2.39-2.67 
(8H, m, overlapping with the DMSO peak); 13C{1H} NMR of N-deuterated complex in 
D20  (0.02 M solution): 8 56.36, 50.67, 50.34; in CD3OD (0.0066 M N-deuterated 
complex): 8 57.26, 51.77, 51.21; in d6-DMSO: 8 55.45, 49.62, 49.34. Anal. Calcd. for 
ZnCl2(C 10H22N4): C, 35.90; H, 6.63; N, 16.74%. Found: C, 35.86; H, 6.79; N, 16.55%.
[Zn*2 (OH2)2] (€ 104)2 (122): A MeOH solution (4 mL) of ligand 2 (56.8 mg, 0.287 mmol) 
was mixed with a MeOH solution (6 mL) of Zn(C104)2e6H20  (109.8 mg, 0.295 mmol). 
This reaction mixture was refluxed for one day to afford a clear solution. Et20  vapor 
diffusion into this solution yielded 106 mg (80%) of colorless crystals. IR (KBr): 3198, 
3173 cm'^VNH)- *H NMR in D20  (MeOH as internal reference): 8 3.76 (2H, broad s, NiT),
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3.52-3.61 (4H, m), 2.95 (4H, s, cross-bridging CH2CH2), 2.93-3.00 (4H, m), 2.89 (4H, td, 
J=  11.7, 6.5 Hz), 2.76 (4H, br dddd, J =  16, 12, 7 ,4  Hz); in CD3OD: 6 4.22 (2H, broad s, 
NH), 3.53-3.69 (4H, m), 3.00 (4H, s, cross-bridging CH2CH2), 2.93-3.03 (4H, m), 2.79-
2.89 (8H, m); N-deuterated complex in D20  (MeOH as internal reference): 3.56 (4H, dd, 
J  = 11.7, 6.5 Hz), 2.95 (4H, s, cross-bridging CH2CH2), 2.93-3.00 (4H, m), 2.88 (4H, td, 
J  = 11.8, 6.7 Hz), 2.75 (4H, ddd, J  = 14.8, 11.6, 6.3 Hz); N-deuterated complex in 
CD3OD: 8 3.54-3.66 (4H, m), 2.99 (4H, s, cross-bridging CH2CH2), 2.93-3.03 (4H, m), 
2.77-2.93 (8H, m); in CD3CN: 5 3.43-3.60 (6H, m), 2.79-2.96 (10H, m), 2.64 (4H, br 
dddd, J  = 16, 12, 7, 4 Hz); n C{1H} in D 20: 6 56.42, 50.69, 50.50;D20  (N-deuterated 
complex, MeOH as internal reference): 8 56.40, 50.70, 50.38; in CD3 CN: 
8 56.75, 51.27, 50.86; in CD3OD: 57.38, 51.68, 51.56; in CD3OD (N-D complex): 57.39, 
51.55, 51.53. Anal. Calcd. For ZnCl2CioH22N408«2.5H20: C, 23.66; H, 5.36; N, 11.04%. 
Found: C, 23.55; H, 5.32; N, 10.94%.
Zn®2 (N03)2 (123): To a solution of ligand 2 (105 mg, 0.528 mmol) in 5 mL of MeOH 
was added a MeOH solution (6 mL) of Zn(N03 )2*6H20  (157 mg, 0.528 mmol). The 
resulting clear solution was refluxed for two hours. Et20  vapor diffusion into this clear 
solution yielded 174 mg (85%) of colorless crystals. IR (KBr): 3199, 3173 cm"'(vNH). !H 
NMR in D20: 8 3.78 (2H, broad s, NTT), 3.52-3.62 (4H, m), 2.94 (4H, s, cross-bridging 
CH2CH2), 2.93-3.00 (4H, m), 2.88 (4H, td, J =  11.8, 6.5 Hz), 2.74 (4H, br dddd, J  = 16, 
12, 7, 4 Hz); N-deuterated complex in D20: 8  3.56 (4H, dd, J=  14.6, 6.4 Hz), 2.94 (4H, s, 
cross-bridging CH2CH2), 2.93-3.00 (4H, m), 2.88 (4H, td, J =  11.8, 6.7 Hz), 2.75 (4H, 
ddd, J  = 14.7, 11.5, 6.3 Hz); in CD3OD: S4.10(2H, broad s, 'NH), 3.53-3.62 (4H, m),
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2.96 (4H, s, cross-bridging CH2CH2), 2.90-2.98 (8H, m), 2.74-2.87 (4H, m); N-deuterated 
complex in CD3OD: 5 3.59 (2H, dd, 5.3, 1.8 Hz), 3.55 (2H, t, 3.8 Hz), 2.96 (4H, s, cross­
bridging CH2CH2), 2.89-2.99 (8H, m), 2.73-2.88 (4H, m); in CD3CN: 5 3.50-3.61 (4H, 
m), 3.46 (2H, broad s, N/7), 2.82-2.96 (12H, m), 2.65 (4H, dddd, J =  16, 12, 7, 4 Hz); 
!3C{1H} in D20  (N-D complex): 5 56.43, 50.72, 50.39; in CD3OD (N-D complex): 8 
57.57, 51.38, 51.29; in CD3CN: 8 57.56, 51.02 (include two overlapping resonances); 
Anal. Calcd. For Zn(N0 3)2CioH22N4»0 .5H20 : C, 30.28; H, 5.84; N, 21.18%. Found: C, 
30.62; H, 6.30; N, 20.94%.
ZnCh'4 (124): Method one: To a solution of ligand 4 (133 mg, 0.350 mmol) in absolute 
MeOH (5 mL), a MeOH solution (6 mL) of ZnCl2 (47.8 mg, 0.351 mmol) was added 
dropwise. The resulting solution was refluxed for 15 hours to yield a very cloudy solution. 
This white precipitate was centrifuged out and dried in vacuo to give a white powder 
(102 mg) which was washed with CHCI3 . Evaporation of this CHCI3 extract solution 
yielded pure ZnCl2*4 (47.3 mg, 26%). Crystals suitable for X-ray analysis were grown by 
ether vapor diffusion into a chloroform solution of this complex. *H NMR in CDCI3 . 
8 7.28-7.38 (10H, m, phenyl), 4.62 (4H, s, C772Ph), 4.15 (4H, br td, J  = 12, 6 Hz), 3.61- 
3.67 (4H, m), 2.86 (4H, s, cross-bridging CH2CH2), 2.53-2.64 (8H, m); in D20  (a 
saturated solution): 7.45-7.54 (10H, br m, phenyl), 4.12 (4H, s, Ci^Ph), 3.68 (4H, dd, J -
15.3, 6.1 Hz), 3.14-3.23 (4H, m), 2.99 (4H, br s, cross-bridging CH2CH2), 2.94-3.06 (4H, 
m), 2.76-2.88 (4H, m); 13C{JH} in CDCI3 . 8 135.95, 131.14, 128.56, 127.85, 61.13, 56.01,
55.84, 52.41; in D20: 134.96, 131.60, 129.33, 129.07, 59.45, 55.81, 55.52, 51.07. Anal.
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Calcd. for Z11CI2C24H34N4: C, 55.99; H, 6 .66 ; N, 10.88%. Found: C, 55.44; H, 6.74; N, 
10.79%. Anal. Calcd. for ZnCl2C24H34N4(H20)o.5: C, 55.03; H, 6.73; N, 10.70%.
Method 2: 103 mg (0.272 mmol) of 4 and 37 mg of ZnCl2 (0.27 mmol) were weighed in a 
glovebox. The sealed flask was taken out of the glovebox and kept in vacuo for about 
half an hour. Under N2 protection, 10 mL of absolute MeOH was added into the Schlenk 
flask by using a syringe to form a clear solution that was refluxed for 10 hours. A white 
precipitate formed was centrifuged from this MeOH solution and washed by MeOH (5 
mL). The removal of residual solvents in vacuo gave a white powder (110.1 mg, 77%). 
]H NMR spectrum of this white powder in CDCI3 showed only the same lH NMR 
spectrum as that of ZnCl2*4.
CdCla®! (125): To a refluxing suspension of CdCl2 (112 mg, 0.611 mmol) in 8 mL 
methanol was added a solution of ligand 1 (139 mg, 0.612 mmol) in methanol (8 mL). 
After refluxing overnight, a clear solution was formed. At room temperature, diethyl 
ether was diffused in to yield 154 mg (61%) of colorless crystals. IR (KBr): 3248, 3220 
cm'1 ( v n h )- !H  NMR in D20  (0.1 M solution, MeOH and MeCN as internal reference): 
8 3.48 (2H, broad s, NH), 3.21 (2H, tt, J =  13.0, 2.6 Hz), 2.79-3.12 (16H, m), 2.40-2.55 
(2H, m), 2.26 (2H, dtt, J =  15.9, 13.1, 2.7 Hz, p-Ctf«H ), 1.57 (2H, broad d, J =  17 Hz, 
p-CHe(?H); in D20  (N-D complex): 3.19 (2H, td, J  -  13.1, 2.4 Hz), 2.80-3.12 (16H, m), 
2.41-2.57 (2H, m), 2.27 (2H, dtt, J  = 16.8, 13.1 , 2.7 Hz, p-GH^H), 1.57 (2H, broad d, J  
= 17 Hz, p-GH^H); in CDCl3: 8 3.69 (4H, tt, J  = 13.1, 2.8 Hz), 3.64 (2H, td, 7 =  10.4, 
2.1 Hz), 3.52 (2H, td, J=  13.0, 4.5 Hz), 3.08 (2H, ddd, J =  13.4, 7.6, 4.4 Hz), 2.91-3.04 
(4H, m), 2.58-2.88 (8H, m), 2.19-2.30 (2H, m), 2.11 (2H, qp, J  -  13.1, 2.7 Hz), 1.57 (2H,
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broad dp, J=  16.6, 2.7 Hz); ^C^H } data of N-D complex in D20: 5 59.79, 58.59 (n iCd, 
U3Cd satellites, J  = 7.3 Hz), 49.86 (H1Cd, 113Cd satellites, J  = 11.3 Hz), 49.35 (u lCd, 
113Cd satellites, J = 1  Hz), 40.94, 22.94 (m Cd, H3Cd satellites, V  = 7.3 Hz); in CDCl3: 
5 58.61 (n iCd, 113Cd satellites, J  = 5 Hz), 58.37, 49.90 (1HCd, 113Cd satellites, J  = 9.3 
Hz), 48.24 (lu Cd, 113Cd satellites, J  = 5.3 Hz), 41.24, 23.26 (n iCd, H3Cd satellites, 3J  =
6.6 Hz). U3Cd{1H} NMR chemical shift of 0.10 M CdCl2*l in D20 : 5 326 (ref. to 3M 
CdSC>4 in D20 : -3 ppm). Anal. Calcd. for CdCl2(C12H26N4) : C, 35.18; H, 6.40; N, 13.68%. 
Found: C, 34.79; H, 6.55; N, 13.34%.
Cd*l(NC>3)2 (126): A solution of Cd(N03 )2*4H20  (58.1 mg, 0.188 mmol) in 2 mL of 
methanol was mixed with a methanol solution (8 mL) of ligand 1 (44.7 mg, 0.197 mmol). 
The resulting solution was refluxed overnight to afford a clear solution. Et20  vapor 
diffusion into this yielded 74.2 mg (85%) of colorless crystals of the complex. IR (KBr): 
3259 cm'1 (vNH). *H NMR in D20  (0.03 M): 5 3.74 (2H,broad s, NH), 2.88-3.15 (16H, 
m), 2.78 (2H, td, J  = 12.9, 5.0 Hz), 2.54-2.62 (2H, m), 2.17-2.35 (2H, m. $-CHmH), 1.60 
(2H, broad dp, J=  17 Hz, 3 Hz, fi-CHegH); in CD3CN: 5 3.15 (2H, tt, J=  13.1, 2.9 Hz), 
2.66-3.11 (18H, m), 2.31-2.40 (2H, m), 2.13-2.27 (2H, m, overlapped with the water 
peak), 1.51 (2H, broad dp, J  = 16.9, 2.8 Hz, p-Ctf^H ); in CDC!3: 5 3.34 (2H, tt, J =  13.3,
2.4 Hz), 2.84-3.21 (12H, m), 2.65-2.81 (6H, m), 2.31 (2H, dd, J  = 12.2, 4.3 Hz), 2.07 (2H, 
br qp, J=  13, 3 Hz, p-C i/^H ), 1.52 (2H, broad d ,J =  17 Hz, p-Ctf^H ); ^ C l’H} in D 20: 
5 60.27, 58.70 (n iCd, n3Cd satellites, J  = 6.6 Hz), 49.99, 49.97 (H1Cd, 113Cd satellites, J  
-  10.6 Hz), 41.02, 22.93 (11!Cd, 113Cd satellites, 3J =  8.6 Hz); in CD3CN: 5 60.38, 59.71 
(lu Cd, 113Cd satellites, J  = 6.4 Hz), 50.60 (u lCd, 113Cd satellites, J  = 10.2 Hz), 50.00
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(lu Cd, 113Cd satellites, J  = 7.0 Hz), 41.89, 23.77 (1HCd, 113Cd satellites, 3J =  7.6 Hz); in 
CDCh: 8 59.46, 58.64 (1HCd, U3Cd satellites, J  = 6.6 Hz), 50.12 (m Cd, 113Cd satellites, J  
= 10.6 Hz), 48.97 (u lCd, ,13Cd satellites, J  = 6.6 Hz), 41.23, 23.17 (u lCd, U3Cd 
satellites, 3J  = 8.0 Hz). ’^Cdf'H} NMR chemical shift of 0.10 M Cd(N0 3 )2*l in D2O: 
8 262 (ref. to 3M CdSC>4 in D2O: -3 ppm). Anal. Calcd. for CdCi2H26N606: C, 31.14; H, 
5.66; N, 18.16%. Found: C, 31.08; H, 5.67; N, 18.01%.
Cd»l(Cl()4)2 (127): To a solution of Cd(ClC>4)2*6H20  (60 mg, 0.14 mmol) in 2 mL of 
methanol was added a methanol solution (6 mL) of ligand 1 (33 mg, 0.14 mmol). The 
resulting solution was refluxed overnight to afford a clear solution. Et20  vapor diffusion 
into this yielded 59 mg (63 %) of colorless crystals. IR (KBr): 3284 cm'1 ( v n h ) -  *H NMR 
(0.13M) in D 2 O (MeOH internal reference): 8 3.72 (2H br s, NH), 2.88-3.19 (16H, m), 
2.78 (2H, td, J  = 12.9, 5.0 Hz), 2.54-2.63 (2H, m), 2.28 (2H, dtt, J  = 16.2, 10.7, 4.9 Hz, 
P-CiTfljcH), 1.63 (2H, br d, J  = 17 Hz, p-CT/^H); in CD 3 CN: 8 3.41 (2H, br, NH), 3.11 
(2H, tt, J  = 13.2, 2.5 Hz), 2.72-3.07(16H, m), 2.47-2.56 (2H, m), 2.12-2.27 (2H, m, 
P -C //axH), 1.56 (2H, br dp, J  = 18, 3 Hz, p-CH^H); ^ { ‘H} in D 20  (MeOH internal 
reference): 8 60.29, 58.72 (1HCd, 113Cd satellites, J  = 6.0 Hz), 50.03, 49.96, 41.02, 22.92 
(m Cd, n3Cd satellites, 3J  = 8 Hz); in CD 3 CN: 8 60.18, 59.14 (m Cd, U3Cd satellites, J  = 
6 Hz), 50.18 (lu Cd, H3Cd satellites, J  = 11 Hz), 49.79 (H1Cd, 113Cd satellites, J = 1  Hz), 
41.45 (lu Cd, 113Cd satellites, J  = 4 Hz), 23.20 (n iCd, n3Cd satellites, 3J  = 8 Hz). 
113Cd{1H] NMR chemical shift of 0.13 M Cd(C104)2*l in D20 : 8 267 (ref. to 3M CdS04 
in D20 : -3 ppm). Anal. Calcd. for Cd(C104)2(C,2H26N4): C, 26.81; H, 4.87; N, 10.42%. 
Found: C, 26.66; H, 4.82; N, 10.00%.
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CdCl2®3 (128): Amounts of 73.6 mg (0.402 mmol) of CdCl2 and 164 mg (0.403 mmol) 
of ligand 3 were dried in vacuo overnight in a Schlenk flask. Then under N2 protection 
and with stirring, 10 mL of MeCN (anhydrous) was added by a syringe to form a cloudy 
solution. After this solution was refluxed for 3 days, the white precipitate was centrifuged 
off and washed with more MeCN (2x10 mL). Drying of the residue gave 182 mg (77%) 
of CdCl2*3 as a white powder JH NMR in CDCI3: 5 7.22-7.37 (10H, m, Ph), 4.65 and
4.39 (4H, AB, J  = 14.6 Hz), 3.93 (2H, br t , J =  12 Hz), 3.60-3.74 (4H, m), 2.78-2.93 (6H, 
m), 2.51-2.67 (6H, m), 2.23 (2H, broad dd, J=  13, 2 Hz ), 1.92 (2H, broad q, J  = 14 Hz),
1.54-1.70 (2H, m, overlapped with the solvent peaks); ,3C{1H} in CDCI3: 5 132.81,
132.58 (1HCd, m Cd satellites, V= 6 Hz), 128.18, 128.04, 59.61 (m Cd, 113Cd satellites, J  
= 8 Hz), 58.95, 56.23, 54.41 (u lCd, 113Cd satellites, J  = 5 Hz), 49.50 (11]Cd, n3Cd 
satellites, .7= 11.9 Hz), 42.88, 24.69 (1HCd, 113Cd satellites, J  = 6 Hz). Anal. Calcd. for 
CdCl2(C26H38N4): C, 52.94; H, 6.49; N, 9.50%. Found: C, 53.18; H, 6.28; N, 9.52%.
CdCl2*2 (129): A mixture of CdCl2 (43.0 mg, 0.235 mmol) and ligand 2 (47.1 mg,
0.238 mmol) was dried in vacuo for 1 hour. Then under N2 protection, 23 mL of 
anhydrous MeOH was added to this mixture. The resulting solution was refluxed for 2 
days to afford a clear solution. Et20  vapor diffusion into this clear solution yielded 54.9 
mg (61%) of colorless crystals. IR (KBr): 3248 cm'1 ( v n h ) -  ' H  NMR of N-D complex in 
D2O (0.045 M solution): S 3.56 (4H, dd, J  = 15.1 Hz, 6.2 Hz), 2.87 (4H, s, cross-bridging 
CH2CH2, u lCd, 113Cd satellites, 3/ =  25 Hz), 2.80-3.04 (8H, m), 2.73 (4H, br ddd, J =  15, 
12, 5 Hz); in CD3OD (0.022 M): 8 3.90 (2H, broad s, NH), 3.46-3.58 (4H, m), 3.28-3.38 
(4H, m, overlapped with the methanol peaks), 2.86 (4H, s, cross-bridging CH2CH2, m Cd,
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113Cd satellites, 3J =  11.6 Hz), 2.65-2.77 (8H, m); N-H complex in CD3OD  (0.022 M N-D 
complex): 5 3.47-3.57 (4H, m), 3.24-3.38 (4H, m, overlapped with the methanol peaks),
2.86 (4H, s, cross-bridging CH2 CH2, 1HCd, 113Cd satellites, 3J =  11.6 Hz), 2.65-2.76 (8H, 
m); in CD3 CN: 8 3.38-3.57 (8H, m), 3.00 (2H, s, NH), 2.75 (4H, s, cross-bridging 
CH 2 CH2, 1HCd, 113Cd satellites, 3J =  10.6 Hz), 2.50-2.65 (8H, m); 13C{1H} in D 20  (0.045 
MN-D complex): 5 57.15 (n iCd, H3Cd satellites, J  = 8.6 Hz), 50.64, 48.14 (m Cd, 1,3Cd 
satellites, J  = 14.6 Hz); in CD3OD (0.022 M N-D complex): 8 57.82 (m Cd, 113Cd 
satellites, J  -  9.9 Hz), 51.60, 49.44 (overlapped with the methanol signals); in CD 3 CN: 
5 57.45 (m Cd, n3Cd satellites, 9 Hz), 51.72, 49.20 (1HCd, 113Cd satellites, J  = 13 Hz). 
Anal. Calcd. for CdCl2C,oH22N4: C, 31.47; H, 5.81; N, 14.68%. Found: C, 31.41; H, 5.85; 
N, 14.49%.
Cd®2(C104)2 (130): Absolute MeOH (15 mL) was added to a mixture of
Cd(C104)2*6H20  (255 mg, 0.608 mmol) and ligand 2 (121 mg, 0.0610 mmol). The 
resulting cloudy solution was refluxed for 2 days to afford a clear solution. Et2 0  vapor 
diffusion into this yielded 226 mg (68 %) of colorless crystals. IR (KBr): 3260 cm'1 ( v n h )- 
!H NMR of N-deuterated complex in D 20  (MeOH internal reference): 5 3.52-3.63 (4H, 
m), 2.72-2.99 (12H, m), 2.88 (4H, s, cross-bridging CH 2 CH2); !H NMR of N-deuterated 
complex in CD3 OD: 5 3.53-3.68 (4H, m), 2.76-3.01 (12H, m), 2.93 (4H, s, cross-bridging 
CH 2 CH2); in CD3 CN: 8 3.40-3.64 (6H, m, including br NH), 2.74-2.94 (8H,m), 2.80 (4H, 
s, cross-bridging CH 2 CH2), 2.61-2.72 (4H, m); 13C{1H} in D 20  (N-D complex, MeOH 
internal reference): 8 57.60 (m Cd, n3Cd satellites, J  = 7 Hz), 50.69, 47.86 (m Cd, n3Cd 
satellites, J =  14.6 Hz); in CD3 OD (N-D complex): 5 58.62 (H1Cd, 113Cd satellites, J -  8.6
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Hz), 51.74, 48.81; in CD3CN: 5 57.81 (ln Cd, 113Cd satellites, J  ~ 10 Hz), 51.25, 48.48 
(m Cd, 113Cd satellites, J=  15.2 Hz). Anal. Calcd. for CdCl2C,oH22N40 8»2H20: C, 22.01; 
H, 4.80; N, 10.27%. Found: C, 21.84; H, 4.78; N, 10.14%.
[Cd*2(T|2-N0 3 )2] (131): Amounts of 22.6 mg (0.0732 mmol) of Cd(N03 )2*4H20  and
14.5 mg (0.0731 mmol) of 2 were dissolved together in 7 mL of MeOH to form a clear 
solution. This was refluxed for 23 hours. Needle-like crystals formed after Et20  vapor 
diffusion into this MeOH solution. After drying in vacuo, 17.6 mg (54%) of these crystals 
were obtained. IR (KBr): 3292 cm'1 ( v n h ) ,  1442, 1298 cm'1 (br, v n o ) ;  *H NMR of N- 
deuterated complex in D20  (0.020 M solution, MeOH internal reference): 5 3.52-3.65 
(4H, m), 2.71-3.00 (12H, m), 2.88 (4H, s, cross-bridging CH2CH2); N-H complex in 
CD3OD (0.020 M solution): 5 4.11(2H, broad t, J  = 10 Hz, NH), 3.55 (4H, dddd with 
shoulders due to coupling to 111)113Cd, J =  16.4 Hz, 11.4 Hz, 5.1 Hz, 1.9 Hz), 2.84-2.95 
(8H, m), 2.90 (4H, s, cross-bridging CH2CH2), 2.79 (4H, dddd, J=  17.4 Hz, 11.4 Hz, 5.4 
Hz, 3.2 Hz); N-deuterated complex in CD3OD (0.020 M solution): 5 3.54 (4H, ddd with 
shoulders due to coupling to m ’113Cd, J =  14.4 Hz, 4.4 Hz, 1.8 Hz), 2.84-2.95 (8H, m),
2.90 (4H, s, cross-bridging CH2CH2), 2.78 (4H, ddd, 7 =  17.2 Hz, 11.1 Hz, 5.8 Hz); in 
CD3CN: 5 3.43-3.56 (4H, m), 3.09 (2 H, broad s, NH), 2.94 (4H, td, J  -  12.2 Hz, 6.7 Hz), 
2.58-2.85 (8H, m), 2.79 (4H, s, cross-bridging CH2CH2); ^ { 'H }  in D20  (0.020 M N-D 
complex, MeOH internal reference): 5 57.57 (1HCd, 113Cd satellites, J  ~ 8 Hz), 50.69,
47.93 (1HCd, 113Cd satellites, J  = 14 Hz); in CD3OD (0.020 M N-D complex): 5 58.62 
(lu Cd, li3Cd satellites, 9 Hz), 51.47, 49.11 (overlapped with the solvent peaks). Anal. 
Calcd. for CdCi0H22N6O6*0.2Et2O: C, 28.86; H, 5.38; N, 18.69%. Found: C, 28.81; H,
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5.37; N, 18.69%. The presence of Et20  in the sample for CHN analyses was supported by 
its and 13C{!H} NMR spectra in CD3CN.
CdCl2®4 (132): Amounts of 61.8 mg (0.337 mmol) of CdCL and 125.9 mg (0.333
mmol) of ligand 4 were dried in vacuo overnight in a Schlenk flask. Then under N2 
protection and with stirring, 15 mL of anhydrous MeCN was added to give a cloudy 
solution. After this cloudy solution was refluxed for 3 days, the white precipitate was 
centrifuged off from the solution and washed with MeCN (2x6 mL) and dried to give
117.9 mg (63%) of CdCl2*4 as a white powder. 'H NMR in CDCl3: 5 7.31-7.40 (10H, m, 
phenyl), 4.47 (4H, s, Ctf2Ph), 4.05 (2H, t, J  = 13.3 Hz), 4.03 (2H, t, J  = 11.6 Hz), 3.61- 
3.71 (4H, m), 2.80 (4H, s, cross-bridging CH2CH2, m Cd, 1,3Cd satellites, V -  11.6 Hz), 
2.60-2.71 (8H, m); 13C{]H} in CDCh: 8 135.39 (m Cd, H3Cd satellites, 3J  = 5.3 Hz), 
130.61, 128.75, 128.04, 61.20, 56.77, 55.99, 47.13 (H1Cd, 1,3Cd satellites, J  = 14 Hz). 
Anal. Calcd. for C d C ^ ^ N ^  C, 51.30; H, 6.10; N, 9.97%. Found: C, 51.41; H, 5.93; 
N, 9.85%.
[HgCl2(p-l)]2 (133): To a solution of 1 (32.5 mg, 0.144 mmol) in absolute MeOH (5 
mL), a MeOH solution (7 mL) of HgCl2 (38.0 mg, 0.140 mmol) was added dropwise. The 
resulting solution was refluxed for five days to yield a clear solution. The diffusion of 
Et2 0  vapor into this solution yielded block-shaped crystals (47.3 mg, 68%). IR (KBr): 
3078 cm’1 (vNH). *H NMR of N-D complex in D20: 8 3.34 (2H, td, J=  13.0, 2.6 Hz), 3.23 
(2H, broad dd, J -  15, 4 Hz), 2.82-3.13 (14H, m), 2.58 (2H, ddd, J =  12.5, 4.0, 1.1 Hz), 
2.30 (2H, dtt, J  = 17.1, 12.5, 2.6 Hz, p-C77flJH), 1.62 (2H, broad dm, J  = 17.4 Hz,
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P-GF/ei?H); in CDsOD: 5 3.52 (2H, td, J  = 13.1, 2.8 Hz), 3.23-3.3 (2H, m, overlapped 
with solvent), 2.92-3.12 (10H, m), 2.75-2.86 (2H, m), 2.69 (2H, broad d, J =  13 Hz), 
2.24-2.44 (4H, m), 1.52 (2H,br dp, J =  17, 3 Hz); ^C i'H } in D20: 5 60.88, 58.68, 51.06,
50.02, 40.82, 23.60; in CD3OD (at 125.7 MHz): 6 60.63, 59.70 (,99Hg satellites, J =  42 
Hz), 50.76 (199Hg satellites, J  = 28 Hz), 50.12 (199Hg satellites, J  - 2 1  Hz), 41.41, 24.42 
(199Hg satellites, V  = 25 Hz). Anal. Calcd. for HgCl2(C12H26N4): C, 28.95; H, 5.26; N,
11.25%. Found: C, 28.96; H, 5.23; N, 11.14%.
HgCl2*2 (134): Amounts of 54 mg (0.199 mmol) of HgCl2 and 44 mg (0.222 mmol) of 
2 were weighed in a glovebox and transferred into a Schlenk flask. Under nitrogen 
protection, 10 mL of anhydrous MeOH was added. This solution was refluxed for 12 
hours to yield a clear solution from which clear needle-like crystals grew after Et20  vapor 
diffusion. Removal of residual solvent from these crystals afforded 80.5 mg of HgCl2*2 
(86%). IR (KBr): 3240 cm'1 ( v n h ) -  !H NMR of N-deuterated complex in D 2 O  (MeOH 
internal reference): 6 3.73 (4H, dd, J  = 13.6, 5.6 Hz, 199Hg satellites, J  ~ 53 Hz ), 2.95 
(4H, s, cross-bridging CH2CH2), 2.73-3.03 (12H, m); in CD3OD (500 MHz): 6 3.60 (4H, 
dd, J=  14.8, 6.5 Hz; ,99Hg satellites, J ~  41 Hz), 3.24 (4H, dt, J=  12, 7 Hz), 2.88 (4H, s, 
cross-bridging CH2CH2, 199H g  satellites, V =  44 Hz), 2.72 (4H, ddd, J = 15.0, 11.8, 5.2 
Hz), 2.63 (4H, dd, J -  12.0, 5.5 Hz, 199Hg satellites, /  = 55 Hz); in CD3CN: 6 3.44-3.56 
(4H, m), 3.37 (4H, dt, J =  11,7 Hz), 2.96 (2H, NH), 2.76 (4H, s, cross-bridging CH2CH2, 
m Hg satellites, V = 40 Hz), 2.41-2.65 (8H, m); 13C{'H} in D20  (MeOH internal 
reference): 6 57.72 (199Hg satellites, J  = 42.9 Hz), 49.57, 47.02 (199Hg satellites, J  ~ 40 
Hz); in CD3OD (at 125.7 MHz): 6 58.51 (199Hg satellites, J  = 46 Hz), 51.60, 48.62 (199Hg
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satellites, J=  40 Hz); in CD}CN: 5 57.40, 51.11, 47.51. Anal. Calcd. for HgCl2CioH22N4: 
C, 25.57; H, 4.72; N, 11.93%. Found: C, 25.60; H, 4.82; N, 11.73%.
(HgCl2y ( 2 )4 (135): Amounts of 52.5 mg (0.193 mmol) of HgCl2 and 38.0 mg (0.192 
mmol) of 2 were weighed in air and transferred into a Schlenk flask. This mixture was 
kept in vacuum for 12 minutes. Then under nitrogen protection, 14 mL of anhydrous 
MeOH was added to form a clear solution. This solution was refluxed for 11 hours to 
yield a solution from which a mixture of clear crystals and a white precipitate fell out 
when cooled to room temperature. After standing under nitrogen for 4 days, the mixture 
of clear crystals and the white precipitate were separated from this solution and dried 
(36.1 mg). This mixture was redissolved in MeOH and ether vapor diffusion into this 
solution still yielded a mixture of clear crystals and a white precipitate. An X-ray 
structural determination of these crystals revealed that they have the composition of 
(HgCl2)6«(2)4. IR (KBr): 3262 cm'1 (b, vNH). *H NMR in CD3CN  (NH/ND complex 
mixture): 5 3.52-3.67 (4H, m), 3.09-3.30 (5.2-5.5 H, m, including NH), 2.81 (4H, s, 
cross-bridging CH2CH2, l99Hg satellites, 3J =  40 Hz), 2.57-2.70 (8H, m), 2.21(3H, 1:1:1 
triplet, HOD, J =  1.0 Hz); in d6-DMSO: 6 4.34 (2H, broad t , J =  9.6 Hz; NH), 3.27-3.49 
(4H, m, overlapped with solvent peaks), 3.07 (4H, dt, J  = 11.4, 6.6  Hz), 2.76 (4H, s, 
cross-bridging CH2CH2, 199Hg satellites, V =  41 Hz), 2.49-2.67 (8H, m, overlapped with 
solvent peaks); ^C ^H } in CD3CN: 5 57.54, 50.46, 50.34, 47.17; in d6-DMSO: 5 56.10 
(199Hg satellites, J  -  44 Hz), 49.06 (199Hg satellites, J  = 11 Hz), 45.63 (199Hg satellites, J  
= 5 Hz).
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[Zn®5](€ 104)2 (136): To a MeOH solution (5 mL) of 5*(H20)o.5 (46.3 mg, 0.132 mmol) 
which was about 95% pure, a MeOH solution (6 mL) of Zn(C104)2*6H2 0  (50.3 mg, 
0.135 mmol) was added. This resulting solution was refluxed for 27 hours to form a very 
cloudy solution. This solution was then centrifuged to remove the white precipitate. Et20 
vapor diffusion into this supernatant yielded 52.9 mg of a white solid, which was 
recrystallized from acetone and washed by CHCI3. Then it was redissolved in MeCN and 
ether diffused into this solution to form pure [Zn®5](C104)2 as needle-shaped crystals 
(15.6 mg, 20%). IR (KBr): 3442, 3337, 3293 and 3232 cm'1 (vOH and  vNH), 1673, 1659 
cm'1 (vc=o), 1590 cm'1 (w, NH2 bending). !H NMR in CD3CN: 8  7.31(2H, s, N i/2), 6.94 
(2H, s, NH2), 3.66 (2H, br A of AB in C/fcCONH2 arms), 3.47 (2H, B of AB in 
C//2CONH2 arms), 3.35-3.44 (2H, m) 3.15-3.29 (4H, m), 3.08 (4H, broad td, J =  12.9,
2.4 Hz), 2.59-2.87 (10H, m), 2.17-2.31 (2H, m, (3-CHLQ, 1.68 (2H, dp, J=  17.6, 2.5 Hz, 
P-Ci7e(?H); 13C{'H} data in CD3CN: 5 176.88, 62.13, 60.68, 59.71, 58.53, 52.35, 51.52, 
23.80. Anal. Calcd. for ZnCia^NeCMClCL^: C, 31.78; H, 5.33; N, 13.90%. Found: C, 
31.99; H, 5.39; N, 13.78%.
[Zn*6](C104)2 (137): A mixture of ligand 6 * ^ 0  (74.1 mg, 0.224 mmol) in MeOH
(5mL) and Zn(C104)2*6H2 0  (84.0 mg, 0.226 mmol) in MeOH (2 mL) was refluxed for 
one day. After cooling to room temperature, needle-shaped crystals (53.0 mg) grew out 
and were centrifuged from this solution. Ether was diffused into the supernatant to 
produce another 27.2 mg of colorless crystals. The combined yield was 62%. IR (KBr): 
3413, 3370, 3296, 3241 cm'1 ( v n h  o r o h ) ,  1682(s), 1663(s) cm'1 (vc=o stretches) 1597 
(medium) cm'1 (OH or NH2 bending). *H NMR of N-deuterated complex in CD3OD:
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5 3.94 (4H, s, GH2COND2), 3.32-3.49 (8H, m), 3.11 (4H, s, cross-bridging CH2CH2),
3.05 (4H, dd, J  -  12.1, 4.8 Hz), 2.94 (4H, td, J =  12.3, 7.1 Hz); in CD 3 OD (-80°C at 400 
MHz): 5 3.97 (4H, broad s, CJ72COND2), 2.50-3.70 (20H, m); in D 20  (400 MHz): 5 3.98 
(4H, s, CH2COND2), 3.38 (8H, br dd, J  = 9.4, 3.0 Hz), 3.07 (4H, s, cross-bridging 
CH2CH2), 2.89-3.06 (8H, m); in CD3 C N  (partially N-deuterated complex): 5 7.42 (1.5H, 
s, NH2), 7.08 (1.5H, s, NH2), 3.86 (4H, s, CH2CONE2), 3.21-3.38 (8H, m), 2.99 (4H, s, 
cross-bridging CH2CH2), 2.96-3.04 (4H, m), 2.81 (4H, td, J  = 12.1, 7.7 Hz); '^ { 'H }  
NMR in CD3 OD (N-D complex): 5 177.90, 63.08, 61.73, 57.81, 50.58; in D 20  (N-D 
complex): 5 177.09, 62.27, 60.98, 56.73, 49.98; in CD 3 C N  (partially N-deuterated 
complex): 5 177.49 (N-H complex), 177.40 (N-D complex), 62.84 (N-H complex), 62.80 
(N-D complex), 61.49, 57.30 (N-H complex), 57.28 (N-D complex), 50.01. Anal. Calcd. 
for ZnCl2C]4H28N6Oio: C, 29.16; H, 4.89; N, 14.57%. Found: C, 29.23; H, 4.98; N, 
14.31%.
[Zn*6](NC>3)2 (138): A mixture of ligand 6 * ^ 0  (67.1 mg, 0.203 mmol) and
Zn(N0 3 )2*6H20  (62.4 mg, 0.210 mmol) in MeOH (22 mL) was refluxed for 16 hours. 
After cooling to room temperature, this solution was diffused with Et20  vapor to yield
90.4 mg (89%) of colorless crystals. IR (KBr): 3331, 3129 cm"1 (vnhoi-oh), 1683 (s), 1656 
(s) cm'1, (vc=o stretches), 1601 (medium) cm'1 (OH or NH2 bending). *H NMR of N- 
deuterated complex in CD3OD: 5 3.95 (4H, s, C/fcCOND2), 3.32-3.49 (8H, m), 3.10 (4H, 
s, cross-bridging CH2CH2), 3.03 (4H, dd, J  = 12.6, 4.0 Hz), 2.94 (4H, td, J =  12.2, 7.2 
Hz); in D20: 5 3.98 (4H, s, CiL2COND2), 3.37 (8H, br dd, J  = 9.3, 2.9 Hz), 3.07 (4H, s, 
cross-bridging CH2CH2), 2.88-3.09 (8H, m); in CD3CN (partially N-deuterated
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complex): 5 7.97 (1.6H, s, NH2), 7.22 (1.6H, s, NJ/2), 3.88 (4H, s, Cfl>CONH2), 3.16-
3.39 (8H, m), 2.97 (4H, s, cross-bridging CH 2 CH 2 ), 2.91-3.06 (4H, m), 2.82 (4H, td, J  =
12.3, 7.6 Hz); 13C{]H} NMR in CD3OD (N-D complex): 8 177.90, 63.08, 61.71, 57.83, 
50.59; in D20  (N-D complex): 5 177.09, 62.26, 60.97, 56.73, 49.89. Anal. Calcd. for 
ZnC14H28N80g: C, 33.51; H, 5.62; N, 22.33%. Found: C, 33.36; H, 5.51; N, 22.56%.
Cd(C104)2*6 (139): To a MeOH solution (5mL) of Cd(C104)2»6H20  (78.4 mg, 0.187
mmol), a solution of ligand 6®H20  (55.5 mg, 0.168 mmol) in MeOH (15 mL) was added. 
This resulting solution was refluxed for 1.5 days. After cooling to room temperature, this 
solution was diffused with Et20  vapor to yield 72.1 mg (67%) of colorless crystals. IR 
(KBr): 3430, 3353, 3299, 3240 cm'1 ( v N H o r O H ) ,  1689 (s), 1658 (s) cm"1, (vc=o stretches), 
1606 (medium) cm'1 (OH or NH2 bending). !H NMR of N-deuterated complex in CD 3 OD: 
8 3.76 (4H, s, CF/2COND2), 3.24-3.37 (4H, m, overlapped with methanol peaks), 3.15 
(4H, broad dd, J  = 16.0, 5.2 Hz), 2.95 (4H, s, cross-bridging CH 2 CH 2 ), 2.89-3.06 (4H, 
m), 2.82 (4H, broad dd, J  = 12.2, 4.7 Hz); NH complex in CD3 C N  (saturated): 5 7.13 
(2H, s, N i/2), 6.85 (2H, s, N i/2), 3.69 (4H, s, C //2CONH2, m Cd, 113Cd satellites, J  = 10.9 
Hz), 3.03-3.21 (8H, m), 2.83 (4H, s, cross-bridging CH 2 CH 2 , H1Cd,113Cd satellites, J  =
14.9 Hz), 2.91 (4H, td, J =  12.1, 6.7 Hz), 2.77 (4H, ddd, J  = 12.4, 4.2, 1.3 Hz); I3C{]H} 
NMR in CD 3 OD  (N-D complex): 8 176.92, 63.25, 61.02, 58.31, 48.23; in 
CD3 CN: 8 176.27 (in Cd,ll3Cd satellites, J  = 12.1 Hz), 62.49, 60.58 (11!Cd,113Cd satellites, 
J  ~ 3 Hz), 57.54 (H1Cd,113Cd satellites, J  = 15.9 Hz), 47.50. Anal. Calcd. for 
CdC14H28N60 2(C104)2(H20): C, 26.20; H, 4.71; N, 13.10%. Found: C, 26.59; H, 4.95; N, 
12.67%.
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[Cd*6(r|^NOa)](NO3) (140): A mixture of ligand 6*H20  (89.8 mg, 0.272 mmol) and
Cd(N03 )2*4H20  (84.4 mg, 0.274 mmol) in MeOH (9 mL) was refluxed for two days. 
After cooling to room temperature, needle-shaped crystals (65.9 m) grew out and were 
centrifuged from solution. This solution was then diffused with Et2 0  vapor to produce 
another 9.5 mg of colorless crystals. The combined weight of crystalline product is 75.4 
mg (49%). IR (KBr): 3348, 3304, 3151 cm'1 (vNH o r  o h ) ?  1656 (s), 1650 (s) cm'1 (vc=o), 
1611 cm'1 (medium, OH or NH bending). !H NMR of a saturated N-deuterated complex 
in CD 3 OD\ 5 3.71 (4H, s, C//2COND2, H1Cd, 1,3Cd satellites, J  = 11.1 Hz), 3.21-3.33 (4H, 
m, overlapped with solvent peaks), 3.02-3.15 (8H, m), 2.94 (4H, s, cross-bridging 
CH 2 CH 2 , m Cd, 113Cd satellites, J=  14.1 Hz), 2.74-2.83 (4H, m); N-H/N-D complex in 
CD3 CN: 8 6.95 (0.74H, s, NH 2), 6.66 (1.0H, s, NH 2), 3.65 (4H, s, CH2 CONH2, in Cd, 
113Cd satellites, J  = 11.6 Hz), 2.98-3.18 (12H, m), 2.83 (4H, s, cross-bridging CH2CH2, 
in Cd, 113Cd satellites, J  -  13.9 Hz), 2.71 (4H, broad dd, J =  11.2, 4.4 Hz); 13C{]H} in 
CD3 OD (a saturated N-D complex): 8 177.04 (n iCd, 113Cd satellites, J  = 11.3 Hz) , 63.41, 
61.11, 58.29, 48.57. Anal. Calcd. for CdC14H28N80 4(H20 )o.5: C, 30.14; H, 5.24; N, 
20.09%. Found: C, 29.95; H, 5.25; N, 19.96%.
[Zn*(7-2H))(NaC104) (141): Method 1: To a MeOH solution (6 mL) of 7*(TFA)2
(105.6 mg, 0.185 mmol), a MeOH solution (6 mL) of Zn(C104)2®6H20  (72.6 mg, 0.195 
mmol) was added. This resulting solution was refluxed to form a very cloudy solution. To 
this cloudy solution, 0.75 mL of an aqueous NaOH (0.9864 N) solution was added and 
the reaction mixture was refluxed for 1.5 days. The white precipitate was then 
centrifuged off from this reaction solution. Et20  vapor diffusion into this supernatant
293
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
yielded 55.3 mg (56%) of a white solid. Method 2: To a 95% aqueous EtOH solution 
(25 mL) of7*(TFA)2.s (231.8 mg, 0.350 mmol), a 95% aqueous EtOH solution (8 mL) of 
Zn(C104)2*6H2 0  (131.8 mg, 0.354 mmol) was added. This mixture was stirred at room 
temperature for 1 hour to form a very cloudy solution. To this cloudy solution, 1.08 mL 
of an aqueous NaOH (0.970 N) solution was added and refluxed for 30 hours. This 
resulting 95% aqueous EtOH solution was then centrifuged off from the white precipitate. 
Et20  vapor diffusion into this supernatant yielded 165.3 mg (88%) of a white solid. IR 
(KBr): 3568, 3363 cm'1 (vOH), 1616, 1592 cm'1 (vc=0). *H NMR in D20: 8 3.40-3.57 (4H, 
m, including A of AX from CH2COO arms), 3.30 (2H, AA' of AA'XX'), 2.97-3.18 (8H, 
m, including X of AX from CH2COO arms), 2.88 (2H, td, J  = 13.0, 2.8 Hz), 2.72-2.86 
(4H, m), 2.65 (2H, dd, J =  13.4, 4.3 Hz), 2.45 (2H, dd, J =  14.8, 4.4 Hz), 2.20-2.35 (2H, 
m, p-CHi7ax), 1.66 (2H, dp, J=  17.1, 3.0 Hz, $-CHeqH); in CD3OD: 8 3.46-3.57 (4H, m, 
including A of AB in CH2COO arms), 3.34 (2H, AA' of AA'XX'), 3.20 (2H, td, J =  12.6,
2.7 Hz), 3.02-3.09 (4H, m, including B of AB in CH2COO arms), 2.94-3.01 (4H, m), 2.88 
(2H, td, J =  13.7, 4.6 Hz), 2.76 (2H, XX' of AA'XX'), 2.60 (2H, dd, J =  13.2, 3.9 Hz),
2.39 (2H, dd, J  = 15.0, 4.4 Hz), 2.25-2.43 (2H, m), 1.63 (2H, dp, J  = 17.2, 2.9 Hz, 
p-C/f^H ); CD3CN: 8 3.63 (2H, dd, 16.9, 1.4 Hz, A of AX from CH2COO arms), 3.25-
3.40 (4H, m), 3.17 (2H, td, J=  12.9, 2.8 Hz), 3.03 (2H, td ,J=  12.9, 2.7 Hz), 2.94 (2H, d, 
J  = 12.4 Hz), 2.70-2.89 (4H, m, including X of AX from CH2COO arms), 2.45-2.58 (4H, 
m), 2.25 (2H, dd, J=  14.5, 4.2 Hz), 2.11-2.23 (2H, m, overlapped with DOH peak), 1.66 
(2H, dp, J  = 17.2, 2.9 Hz, p-C f/e9H); in CD3OD (-80°C at 400 MHz): 8 3.39-3.64 (6H, 
m), 3.04-3.22 (6H, m), 2.76-3.01 (6H, m), 2.61-2.70 (4H, m), 2.31-2.46 (4H, m), 1.62 
(2H, broad d, J  = 15.2 Hz, $-CHeqH); 13C{]H} data in D20: 8 178.95, 64.28, 59.85,
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58.87, 58.17, 52.60, 50.97, 23.32; in CD3OD: 177.94, 65.48, 60.69, 59.50, 59.39, 53.35, 
51.69, 24.40; in CD3CN: 8 177.85, 64.52, 59.69, 59.53, 58.45, 53.19, 51.09, 24.12. Anal. 
Calcd. for ZnCi6H28N404NaC104(H20 )o.5: C, 35.77; H, 5.44; N, 10.43%. Found: C, 35.59; 
H, 5.67; N, 10.05%.
[Zir(7-2H)](NaN03)3 (142): To a MeOH solution (6 mL) of 7*(TFA)2 (106.3 mg,
0.186 mmol), was added a MeOH solution (6 mL) of Zn(N03)2*6H20  (62.3 mg, 0.209 
mmol). This resulting solution was refluxed to form a slightly cloudy solution. To this 
solution, aqueous NaOH (0.970 N, 0.77 mL) was added and refluxed for 1.5 days. A 
small amount of white precipitate was then centrifuged off to yield a clear supernatant. 
Et20  vapor diffusion into this supernatant yielded 91.7 mg (71%) of a white solid. IR 
(KBr): 3430 cm'1, 3263 cm'1 (vOH), 1618, 1596 cm'1 (vc=o)- ]H NMR in D20: 5 3.40-3.57 
(4H, m, including A of AX from CH2COO arms), 3.30 (2H, AA’ of AA'XX'), 2.97-3.18 
(8H, m, including X o f  AX from CH2COO arms), 2.89 (2H, td, J =  13.0, 2.8 Hz), 2.72-
2.86 (4H, m), 2.65 (2H, dd, J  = 13.4, 4.3 Hz), 2.45 (2H, dd, J =  14.8, 4.4 Hz), 2.20-2.35 
(2H, m), 1.66 (2H, dp, J=  17.1,3.0 Hz, p -C ife(?H); 13C{]H} data in D20: 8 179.01, 64.28,
59.87, 58.90, 58.19, 52.61, 50.99, 23.35. Anal. Calcd. for Z n C ^ g ^ C X ^ a N C ^ s  
(NaOH)o 5(H20)o.5: C, 27.86; H, 4.31; N, 14.21%. Found: C, 27.94; H, 4.02; N, %.13.89.
[Zn«(8-2H)](NaC104) (143): To a MeOH solution (10 mL) of 8«TFA«H20  (113.3 mg, 
0.265 mmol), was added 0.818 mL of an aqueous solution of NaOH (0.970 N) to form a 
clear solution. A MeOH solution (6 mL) of Zn(C104)2*6H20  (100.4 mg, 0.270 mmol) 
was then added. After refluxing for 2 days, this MeOH solution was centrifuged off from
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some precipitate. Et2 0  vapor diffusion into this supernatant yielded 106.4 mg (71%) o f a 
white crystalline solid. IR (KBr): 1617 cm'1 (broad) (vc=o). *H NMR in D20\ 8 3.63 (4H, 
s, CH2COO), 3.20-3.37 (8H, m), 3.03 (4H, s, cross-bridging CH2CH2), 2.89-3.08 (8H, m); 
’H NMR in CD3OD (400 MHz): 8 3.61 (4H, s, CH2COO), 3.20-3.41 (8H, m), 3.07 (4H, s, 
cross-bridging CH2CH2), 2.91-3.15 (8H, m); in CD3OD at -80°C (400 MHz): 8 3.65 (4H, 
AB, CH2COO), 3.24-3.48 (8H, m), 2.72-3.19 (12H, m); °C {1H} data in D20: 8 179.03, 
64.94, 61.10 (br), 56.83, 49.95; in CD3OD: 8 177.85, 66.11, 61.77 (broad), 57.85, 50.80; 
CD3OD at -80°C: 8 178.59, 65.62, 63.93, 59.12, 58.55, 56.89, 49.78. Anal. Calcd. for 
ZnCi4H24N40 4 (NaC104)i.5: C, 29.95; H, 4.31; N, 9.98%. Found: C, 30.05; H, 4.68; N, 
9.81%.
[Zn*(8-2H)](NaNO3) (144): To a clear solution of Zn(N0 3)2*6H20  (60.8 mg, 0.204
mmol) in MeOH (6 mL), a MeOH solution (6 mL) of 8*TFA®H20  (82.8 mg, 0.193 mmol) 
was added to form a clear solution. An amount of 0.60 mL aqueous NaOH (0.970 N) was 
then added to form a clear solution. After refluxing for 2 days, this MeOH solution was 
centrifuged off from some white precipitate. Et20  vapor diffusion into this supernatant 
yielded 47.9 mg (38%) of a white crystalline solid. IR (KBr): 1645, 1611 cm'1 (vc=o). *H 
NMR in D20: 8 3.63 (4H, s, CH2COO), 3.21-3.38 (8H, m), 3.03 (4H, s, cross-bridging 
CH2CH2), 2.89-3.08 (8H, m); 13C{*H} data in D20: 8 179.08, 64.94, 61.12, 56.84, 49.97. 
Anal. Calcd. for ZnCi4H24N404  (NaN0 3)3(H20 )i.5: C, 25.49; H, 4.13; N, 14.86%. Found: 
C, 25.20; H, 3.92; N, 15.00%.
296
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
[Cd*(7-2H)](NaC104) (145): To a MeOH solution (7 mL) of Cd(C104)2*6H20  (61.0 mg, 
0.145 mmol), a MeOH solution (7 mL) of 7 ®(TFA)2 (76.5 mg, 0.134 mmol) was added to 
form a clear solution. To this solution, 0.553 mL of an aqueous NaOH (0.970 N) solution 
was added and refluxed for one and a half days. The MeOH solution was diffused with 
EtaO vapor to yield 60.3 mg (76%) of a white solid. IR (KBr): 1633, 1586 cm'1 (vc=o). JH 
NMR in D20\ 8 2.85-3.48 (18H, m, including AX of CH2COO), 2.70 (2H, XX' of 
AA'XX'), 2.51 (2H, br dd, J  -  13, 3 Hz), 2.43 (2H, dd, J=  15.2, 2.7 Hz), 2.26-2.45 (2H, 
m), 1.70 (2H, dp, J=  17.7, 3.0 Hz, p-C/f^H ); in CD3OD (400 MHz): 8 3.32-3.49 (6H, m, 
overlapped with solvent peaks), 2.98-3.21 (8H, m), 2.87 (4H, broad s), 2.66 (2H, broad 
AA' or XX' of AA'XX'), 2.26-2.48 (6H, broad m), 1.66 (2H, broad d, J  = 17.2 Hz, 
(3-CJT^H); ^C^H } data in D20: 8 178.66 (H1Cd, m Cd satellites, J  = 12.0 Hz), 64.40 
(m Cd, 113Cd satellites, J  = 8.6 Hz), 59.48, 59.46, 58.58, 51.75, 49.78 (in Cd, 113Cd 
satellites, J  = 11.3 Hz), 24.02 (1HCd, H3Cd satellites, J  = 6.0 Hz); in CD3OD (100.5 
MHz): 5 178.24, 65.68 (broad), 60.20, 59.66, 52.70 (broad), 50.53, 25.08. Anal. Calcd. 
for CdC16H28N404(NaC104)(H20 ): C, 32.39; H, 5.10; N, 9.44%. Found: C, 32.41; H, 5.10; 
N, 9.53%.
[Cd®(7-2H)](NaNO3) (146): To a MeOH solution (6 mL) of Cd(N03)2*4H20  (37.4 mg, 
0.121 mmol), a MeOH solution (6 mL) of 7®(TFA)2 (60.6 mg, 0.106 mmol) was added to 
form a clear solution into which aqueous NaOH (0.970 N, 0.44 mL) was added and 
refluxed for sixteen hours. This MeOH solution was then centrifuged off from some 
white precipitate. Et20  vapor diffusion into this supernatant yielded 49.2 mg (78%) of a 
white solid. IR (KBr): 1619, 1594 cm'1 (vc=o). ]H NMR in D20: 8 2.85-3.48 (18H, m),
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2.70 (2H, AA' or XX' of AA'XX'), 2.51 (2H, dd , J  = 13.4, 2.4 Hz), 2.43 (2H, dd ,/== 15, 
3 Hz), 2.26-2.50 (2H, m), 1.70 (2H, dp, J -  17.7, 3.0 Hz, p -C i^ H ); 13C {!H} data in D 20: 
5 178.66 (lu Cd, 113Cd satellites,/ =  11.9 Hz), 64.39 (H1Cd, 113Cd satellites, / =  8.6 Hz), 
59.47, 59.44, 58.59, 51.73, 49.78 (m Cd, n3Cd satellites, J  = 10.6 Hz), 24.02 (H1Cd, 
113Cd satellites, J  = 6.6  Hz). Anal. Calcd. for CdCi6H28N404(NaN03) (NaOH)(H20 ): C, 
32.25; H, 5.24; N, 11.75%. Found: C, 32.66; H, 5.25; N, 11.61%.
[Cd*(8-2H)](NaC104) (147): To a clear mixture of 8*TFA*H20  (89.0 mg, 0.208 mmol) 
and Cd(C104)2*6H20  (94.8 mg, 0.226 mmol) in 15 mL MeOH, 0.64 mL of an aqueous 
solution of NaOH (0.970 N) was added to form a cloudy solution. After refluxing for 7 
hours, some white precipitate was centrifuged off. Et20  vapor diffusion into this 
supernatant yielded 73 mg (61%) of a white crystalline solid. IR (KBr): 1615, 1595 cm'1 
(vc=0). ]E  NMR in D20: 5 3.48 (4H, s, CH2C 0 0 2, H1Cd, H3Cd satellites, J  = 11.6 Hz), 
2.94-3.26 (12H, m), 2.89 (4H, s, cross-bridging CH2CH2, in Cd, 113Cd satellites, J  = 13.7 
Hz), 2.81 (4H, broad dd, J  = 12.1, 4.4 Hz); in CD3OD: 5 2.51-3.71 (very broad m); 
13C{]H} data in D20  (MeCN external reference): 8 179.23 (n iCd,H3Cd satellites, J  =
11.3 Hz), 64.95 (in Cd, 113Cd satellites, J  = 6.0 Hz), 60.58, 57.32, 47.63 (m Cd, ll3Cd 
satellites, J  = 15.3 Hz); in CD3OD: 8 176-180 (broad signals), 55-68 (broad signals). 
Anal. Calcd. for CdCi4H24N404(NaC104)(H20 )1.5: C, 29.28; H, 4.74; N, 9.76; Cl, 6.27%. 
Found: C, 29.31; H, 4.70; N, 9.65; Cl, 5.96%.
[Hg®(7-2H)](K2HgCl4) (148): To a MeOH solution (10 mL) of HgCl2 (86.4 mg, 0.318
mmol), a MeOH solution (7 mL) of 7»(TFA)2 (82.3 mg, 0.144 mmol) was added to form
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a clear solution. A volume of 0.44 mL of a MeOH solution of KOH (0.505 N) was added 
into this solution to form a clear solution. This was refluxed for 27 hours, then 
centrifuged to remove some white precipitate. Et20  vapor diffusion into this supernatant 
yielded 104.5 mg (75%) of a white crystalline solid. IR (KBr): 1611, 1590 cm'1 (vc=o). 
NMR in D20: 8 2.80-3.51 (20H, m), 2.66 (2H, dd ,7  = 15, 3 Hz), 2.57 (2H, dd, J=  13, 3 
Hz), 2.31-2.50 (2H, m), 1.73 (2H, broad d, J =  17.7 Hz, fi-CHeqR); in CD3OD: 8 3.10-
3.40 (12H, m, overlapped with methanol solvent peaks, including AB of CH2COO arms), 
2.89-3.07 (4H, m), 2.73 (2H, dd, J  = 12.2, 3.7 Hz), 2.65 (2H, dt, J =  12.7, 2.7 Hz), 2.47 
(2H, dd, J=  14.9, 2.5 Hz), 2.17-2.41 (4H, m), 1.62 (2H, broad d ,J =  16.4 Hz, p-C i/^H ); 
^C^H} data in D20: 8 177.13 (199Hg satellites, J  = ~ 34 H z ), 63.64 (199Hg satellites, J  = 
31.2 Hz), 60.78 (199Hg satellites, J  ~ 31 Hz), 60.69, 57.75 (199Hg satellites, J  = 35.8 Hz), 
50.18 (199Hg satellites, J  = 16.6 Hz), 49.50 (199Hg satellites, J  = 29.9 Hz), 24.34 (199Hg 
satellites, J ~  25.9 Hz); in CD3OD: 8 177.30 (199Hg satellites, J ~  19 Hz), 65.17 (199Hg 
satellites, J  = 17.9 Hz), 61.15 (199Hg satellites, J  =11.3 Hz), 60.03 (199Hg satellites, J  
=17.9 Hz), 57.94 (199Hg satellites, J  =29.9 Hz), 50.72 (199Hg satellites, J  =23.2 Hz),
49.58 (overlapped with solvent peaks), 25.53 (199Hg satellites, 7=21.9 Hz). Anal. Calcd. 
for Hg2C32H56N80 8Hg3Cl6: C, 19.98; H, 2.93; N, 5.83, Cl, 14.75%. Found: C, 20.35; H, 
3.23; N, 5.69; Cl, 14.21%.
[GaCl2*l]Cl (149): Anhydrous GaCb (42 mg, 0.24 mmol) and ligand 1 (47 mg, 0.21
mmol) were transferred into a Schlenk flask in a glovebox with a nitrogen atmosphere. 
Then the Schlenk flask was sealed and taken out of the glovebox. Under N2 protection, 
dry acetonitrile (8 mL) was added through a syringe. This cloudy MeCN solution was
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refluxed for 2 days to give a white precipitate which was isolated by filtration, washed 
with MeCN, and dried to give 58 mg (68%) of the product as a white powder. X-ray 
crystals were grown by slow evaporation of an acetonitrile solution of the complex. IR 
(KBr): 3577, 3379 cm'1 (vOH), 3137 cm'1 (vNH), 1643 cm'1 (OH bending). JH NMR data 
in D20: 5 5.37 (br s, NH), 2.91-3.86 (20H, hr m, a-CH2), 2.26-2.51 (2H, hr m, p - C H Hax),
1.70-1.82 (2H, br dm, J=  17 Hz, P -C //egH);in acidic D20  (0.15 M N-D complex) (pD 
=0.67, HC104): 3.11-3.73 (18H, br m), 3.01 (2H, br d, J  = 12 Hz), 2.28-2.52 (2H, br m, 
p -C BHax), 1.84 (1H, dp, J  = 17.5, 3.0 Hz, fi-CHegR  of Ga(III) Complex A), 1.76 (1H, 
dp, J  = 17.2, 2.8 Hz, p -C //e?H ofGa(III) Complex B ) ; in CD3CN: 5 4.28 (2H, br s, NT/), 
3.81 (2H, tt, J =  13.4, 3.0 Hz), 3.60 (2H, td, J=  13.1, 3.0 Hz), 3.32-3.53 (4H, m), 2.90- 
3.21 (8H, m), 2.77-2.87 (2H, dm, J =  12.4 Hz), 2.70 (2H, dd, J =  12.6, 4.8 Hz), 2.10-2.33 
(2H, m overlapping with solvent peak, p -C H /7 flX), 1.62 (2H, dm, J ~  16.9 Hz, p-C f/^H ); 
^C^H } data in D20  (N-D complex): 5 59.85 (br), 57.83 (br), 50.91 (br), 47.87 (br), 
41.05 (br), 19.61 (br); in acidic D20  (0.15 M N-D complex) {pD =0.67, HCIO4): 60.04 
(Complex A), 59.76 (br, Complex B), 58.12 (Complex A), 57.75 (br, Complex B), 51.09 
(from both Complexes A and B), 48.23 (Complex A), 47.83 (Complex B), 41.11 (both 
Complexes A and B), 19.65 (Complex B), 19.41 (Complex A); in CD3CN: 8 60.02, 58.43, 
51.32, 48.44, 42.21, 20.75. Anal. Calcd. for GaCl3(Ci2H26N4)*0 .5H2O: C, 35.03; H, 6.61; 
N, 13.62%. Found: C, 34.94; H, 6.54; N, 13.39%.
[InBr2*l]Br (150): Anhydrous InBr3 (72 mg, 0.20 mmol) and ligand 1 (46 mg, 0.20
mmol) were transferred into a Schlenk flask in a glovebox with a nitrogen atmosphere. 
Then the Schlenk flask was sealed and taken out of the glovebox. Under N2 protection,
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dry acetonitrile (11 mL) was added through a syringe. This cloudy MeCN solution was 
refluxed for 2 days to give a white precipitate which was isolated by filtration, washed 
with M eCN , and dried to give 65 mg of the product. Diffusion of ether into the filtrate 
gave an additional 38 mg of the product as needle crystals for a combined yield o f 86%. 
IR (KBr): 3587, 3415 cm'1 (v0H), 3116 cm'1 (vNH), 1635 cm'1 (OH bending). ]H NMR 
data in D30  (0.18 mM): 5 5.18 (br s with shoulders at 5.32 and 5.26, NiT), 3.64-3.78 (2H, 
tm,J =  13.6 Hz), 3.56 (2H, td, J  -  12.8, 2.1 Hz), 2.92-3.49 (14H , m), 2.73 (2H, br dd, J  
= 13.1, 4.3 Hz), 2.26-2.48 (2H, m , p -C H Hax), 1.69-1.89 (2H, dm with shoulder at 1.81, J  
= 17.1 Hz, p - C / / e?H); in CD3CN: 5 4.14 (2H, br s, Nfl), 3.67 (2H, tt, J =  13.5, 2.9 Hz), 
3.57 (2H, td, J=  13.1, 2.4 Hz), 3.39 (2H, td, J=  13.2, 5.3 Hz), 3.16-3.33 (4H, m), 2.96- 
3.12 (4H, m), 2.83-2.93 (2H, dm, J=  13 Hz), 2.57-2.66 (2H, dm, J -  11 Hz), 2.26 (2H, 
dtt, J  = 16.4, 13.1, 3.0 Hz, p -C H Hax), 1.68 (2H, dp, J=  17.6, 3.0 Hz, p-GH^H); ^C ^H } 
data in D2O (N-D complex): 5 60.05 (minor), 59.12 (minor), 5.95, 57.40 (minor), 56.28,
50.31 (minor), 49.79, 49.43 (minor), 49.05 (minor), 48.35, 40.88, 40.33 (minor), 21.43,
21.31 (minor), 21.21 (minor); in CD3CN: 5 59.33, 57.33, 50.22, 49.05, 41.78, 22.16; in 
d6-DMSO: 5 57.72, 55.63, 48.48, 47.66, 40.13, 20.53. Anal. Calcd. for 
InBr3(C,2H26N4)*0.5H2O: C, 24.43; H, 4.61; N, 9.50%. Found: C, 24.35; H, 4.30; N, 
9.28%.
[GaCl2*2 ]Cl (151): Under nitrogen protection, a cloudy solution of a mixture of
anhydrous GaCfi (69 mg, 0.39 mmol) and ligand 2 (82 mg, 0.41 mmol) in acetonitrile (15 
mL) were refluxed to give a white precipitate. A fter filtration and drying, 136.5 mg of a 
white precipitate was obtained. An amount of 39 mg of this white precipitate was
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dissolved in MeOH (18 mL) to form a clear solution. Ether diffusion into this solution 
yielded 23 mg of white crystalline solid (53%). IR (KBr): 3049 cm'^VNH)- *H NMR in 
D20  (N-D complex): 5 3.77 (4H, dd, J  = 14.3, 7.0 Hz), 3.30 (4H, dd, J =  12.2, 6.4 Hz), 
3.25 (4H, s, cross-bridging CH2CH2), 3.06-3.21 (4H, br m), 2.99 (4H, ddd, J=  14.8, 11.3, 
6.9 Hz); in CD3CN: 5 4.58 (br s, N/7) 3.68 (4H, d t ,J  = 14.9, 8.3 Hz), 3.54 (4H, ddd, J  =
12.0, 11.2, 8.1 Hz), 3.08 (4H, s, cross-bridging CH2CH2), 3.00-3.12 (4H, br m), 2.81 (4H, 
dddd, J  = 14.8, 11.0, 6 .8 , 3.9 Hz); ^C ^H } NMR of N-deuterated complex in D 20 : 
8 54.97 (br), 51.60 (br), 49.16 (br). Anal. Calcd. for GaCl3(C,oH22N4)H20 : C, 30.61; H, 
6.16; N, 14.28%. Found: C, 30.59; H, 6.14; N, 14.31%.
[InBr2*2 ]Br (152): Under nitrogen protection, a cloudy solution of a mixture of
anhydrous InBr3 (57 mg, 0.16 mmol) and ligand 2 (32 mg, 0.14 mmol) in acetonitrile (15 
mL) were refluxed to give a white precipitate. This was filtered off, washed with more 
acetonitrile, and dried to give 44 mg of the product. Diffusion of diethyl ether into the 
filtrate gave an additional 10 mg of the product for a combined yield of 60%. Crystals 
suitable for X-ray analyses were obtained from slow evaporation of an acetonitrile 
solution of the product. IR (KBr): 3036 citT ^ vnh). *H NMR in D20  (N-D complex): 
8 3.80 (4H, dd, J =  15.0, 7.3 Hz), 3.49 (4H, td, J  = 12.3, 7.4 Hz), 3.19 (4H, s, cross­
bridging CH2CH2), 3.11 (4H, br dd, J=  12.1, 6.3 Hz), 2.98 (4H, ddd, J  -  15.1, 11.8, 6.3 
Hz); in CD3CN: 8 4.49 (2H, br s, NH) 3.71 (4H, ~dt, J  = 15.4, 7.6 Hz), 3.56 (4H, td, J  =
12.0, 7.5 Hz), 3.05 (4H, s, cross-bridging CH2CH2), 2.98 (4H, br dd, J =  12.4, 6.1 Hz), 
2.84 (4H, dddd, J  = 15.0, 11.6, 6.3, 3.4 Hz); 13C { 1H} NMR of N-deuterated complex in
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D 20: 5 54.03, 49.74, 49.69; in CDSCN: 5 54.65, 50.62, 50.23. Anal. Calcd. for 
InBr3(CioH22N4): C, 21.73; H, 4.01 ;N , 10.13%. Found: C, 21.67; H, 4.09; N, 10.05%.
[Ga*(8 -2 H)](N0 3 ) (153): To a MeOH solution (14 mL) of 8*TFA»HaO (66.4 mg, 0.155
mmol), a solution of Ga(N03)3 hydrate (38.6 mg, 0.15 mmol) in MeOH (6mL) was added 
to form a clear solution. Anhydrous NaOAc (46.3 mg, 0.55 mmol) in MeOH (7mL) was 
then added in two portions. After refluxing for 2 days, a white precipitate formed and was 
centrifuged off. This white precipitate was dried (41.9 mg, 62%) and dissolved in a H2O 
(2.6 mL) / MeOH (3.2 mL) mixture. EtaO/MeOH (1:1) vapor diffusion into this 
H20/MeOH solution yielded crystals suitable for X-ray analyses. IR (KBr): 1692 (s), 
1672 (s) cm’1 (vc=o), 1363 (s), 1351 (s), 1339 (s), 1299 (s), 1284 (s) cm'1 (broad) (vN03). 
]H NMR in D20: 5 4.04 (4H, AB, CH2COO), 3.57-3.85 (10H, m), 3.38-3.54 (6H, m), 
3.18-3.31 (4H, s, cross-bridging CH2CH2); 13C{’H} data in D20: 5 174.89, 64.07, 63.67, 
57.11, 57.09, 54.87, 51.78; in d6-DMSO: 5 169.92, 63.65, 61.92, 56.21, 55.35, 54.06, 
50.25. Anal. Calcd. For GaC 14^ 4^ 0 4 ^ 0 3 ): C, 37.86; H, 5.45; N, 15.77%. Found: C, 
37.82; H, 5.45; N, 15.75%.
Cu2(0 H)(l)2(C1 0 4)3(H2 0 ) (154): To a solution of ligand 1 (110.3 mg, 0.487 mmol) in
methanol (8 mL) was added a 12 mL methanol solution of Cu(C104)a*6H2 0  (184.0 mg,
0.497 mmol). A dark-blue methanol solution formed. After one day of refluxing, diethyl 
ether vapor diffusion into this solution yielded 85.5 mg (38%) of blue crystals. Electronic 
spectrum (CH3CN): Lmax(e) = 584 nm (151 M '1cm'1), 904 (71); (H20): A,max(s) = 595 nm 
(93 M 'W 1), 958 (69). IR (KBr): 3537 (br vOH), 3270 (vNH), 1096 (strong, va 04) cm '1.
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Anal. Calcd. for Cu2(0 H)(Ci2H26N4)2(C104)3 (H20): C, 31.57; H, 6.07; N, 12.27; Cl,
11.65%. Found: C, 31.84; H, 6.27; N, 12.05, Cl, 11.21% .
[Cu®2(p-C1)]2Q 2 (155): To a mixture of 28 mg (0.14 mmol) of ligand 2 and 19 mg
(0.14 mmol) of CuCl2, 5 mL of absolute EtOH was added to form a dark-blue solution. 
This solution was refluxed overnight. Et20  vapor diffusion into this solution yielded blue 
crystalline solid (40 mg, 85%). X-ray crystals were obtained from diethyl ether vapor 
diffusion into a MeOH solution of it. Electronic spectrum (H20): Xmax (s) = 275 nm 
(3,620 M 'W 1), 640 nm (72 M 'W '1). IR (KBr): 3448 (br, v0H), 3180, 3150 cm'1 (vNH). 
Anal. Calcd. for C uC12(C 1oH22N 4)(H 20 ) o.25: C, 35.61; H, 6.72; N, 16.61%. Found: C, 
35.57; H, 6.42; N, 16.47%.
Cu(2)(C104) 2 (156): To a solution of ligand 2 (36.8 mg, 0.19 mmol) in 5 mL absolute 
ethanol was added Cu(C104)2*6H20  (68.8 mg, 0.19 mmol). After refluxing for half an 
hour, some blue crystalline solid formed and was centrifuged off from a dark-blue 
solution. This dark-blue solution was then diffused with Et20  to yield needle-shaped 
crystals (64.2 mg, 72%). Crystals suitable for X-ray analyses were grown out from a 
methanol solution. The X-ray structure of these crystals showed a Cu(II) complex with a 
composition of [Cu(2)(CH3 0 H)(C104)](C104) (156a). Electronic spectrum (H2O): A,max (s) 
= 635 nm (76 M '1cm'1). IR (KBr): 3425 (br, v o h ) ,  3299 cm"1 (slightly br, vNH), 1104 cm'1 
(br, VC104); IR of crystals grown from MeOH (KBr): 3420 (br, V o h ) ,  3314, 3282 (slightly 
br, v N h ) ,  1098 cm'1 (very br, vcio4)- Anal. Calcd. for [Cu(C 1 oH22N4)](H20)o.5(C104)2: C, 
25.57; H, 4.94; N, 11.93%. Found: C, 25.76; H, 5.19; N, 11.58%.
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Cu(3)(C104)2 (157): To a solution of ligand 3 (70 mg, 0.172 mmol) in 2 mL methanol
was added a methanol solution (4 mL) of Cu(C104)2*6H20  (56 mg, 0.151 mmol). A 
cloudy pale-blue solution was formed. After 2 days of refluxing followed by cooling, a 
dark blue solid formed and was separated from this methanol solution and dried to yield 
96 mg (81%) of a blue solid which is soluble in MeCN and DMF, slightly soluble in 
MeOH, and insoluble in CHCI3 and t-butanol. Blue crystals suitable for X-ray analyses 
were obtained by the slow evaporation of a MeCN solution containing this solid. The X- 
ray structure of these crystals showed a Cu(II) complex with a composition of 
[Cu(3)(CH3CN)](C104)2 (157a). Electronic spectrum (CH3CN): Xmax(e) = 340 nm (12400 
M '1cm'1), 623 (129); (a saturated solution in CH3OH): A,max= 324, 648 nm. IR (KBr) of 
the blue solid: 1097 cm'1 (broad, vckm), 1055 (strong and broad, vckm)- IR (KBr) o f X- 
ray-crystals: 2314 ( v o n ) ,  2286 ( v o n ) ,  1086 cm'1 (strong, VC104)- Anal. Calcd. for 
CuC26H38N4(C104)2: C, 46.68; H, 5.72; N, 8.37%. Found: C, 46.33; H, 5.85; N, 8.26%.
CuCl2*4 (158): To a solution of ligand 4 (202 mg, 0.533 mmol) in absolute MeOH (6
mL), a MeOH solution (5 mL) of CuCl2 (72.8 mg, 0.541 mmol) was added. A cloudy 
blue solution formed was refluxed for 9.5 hours to yield a dark-blue solution and some 
brown precipitate. This dark-blue solution was centrifuged off from the brown precipitate 
and diffused with diethyl ether to give dark blue crystals (191.6 mg, 68%). Electronic 
spectrum (CH3CN): Lmax(£) -  710 nm (85 M^cm'1). IR (KBr) of the blue-crystals: 3398 
cm'1 (br, vOH). Anal. Calcd. for CuC12C24H34N4 (H20): C, 54.28; H, 6.83; N, 10.55%. 
Found: C, 54.07; H, 7.04; N, 10.36%.
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Unexpected synthesis of [Cu2(p-ri1 :r|2-CC>3)(4)2] (0 0 4 ) 2  in an attempted synthesis of 
Cu(4 )(C 1 0 4 ) 2  (159): To a solution of ligand 4 (107 mg, 0.283 mmol) in 4 mL methanol
was added a methanol solution (6 mL) of Cu(C104)2*6H2 0  (108 mg, 0.291 mmol). A 
cloudy pale-blue solution was formed. After 1.5 days of refluxing, a dark-blue solution 
formed was separated from a brown precipitate. Diethyl ether vapor diffusion into this 
solution yielded blue crystals suitable for X-ray analyses as well as some colorless 
crystals. The blue crystals (66.8 mg, 40 %) were collected manually. Electronic spectrum 
(MeOH): Xmax(e) = 295 nm (9986 M 'W 1), 687 (187); MeCN: Xmax(e) = 660 nm (148 
M '1cm'1). IR (KBr) of the blue-crystals: 3420 (br, voh), 1506, 1496 (strong, vc=o)), 1095 
cm-1 (strong, vocw)- IR (KBr) of the brown precipitate: 2500 cm'1 (br). Anal. Calcd. for 
Cu2C48H68N8(C03 )(C104)2(H2 0 )i.5: C, 50.30; H, 6.12; N, 9.58%. Found: C, 50.09; H, 
5.91; N, 9.51%.
Cu(4 )(C1 0 4 ) 2  (160): A mixture of ligand 4 (69.7 mg, 0.184 mmol) and
Cu(C104)2*6H20  (75.4 mg, 0.203 mmol) were dried in vacuum for about an hour. Then 
under nitrogen, 10 mL of methanol was added to this mixture. A cloudy pale-blue 
solution was formed immediately. After one day of refluxing, a dark-blue precipitate 
(64.7 mg, 51%) was separated from a dark blue solution. Some of this dark-blue 
precipitate was dissolved in MeCN to form a dark-blue solution. Diethyl ether vapor 
diffusion into this solution yielded blue block-shaped crystals. Electronic spectrum 
(CH3OH) of the dark-blue precipitate: Xmax (e) = 301 nm (3735 M '1cm'1), 657 nm (94) M' 
'em '1). Electronic spectrum (CH3CN) of the blue crystals: Xmax (e) = 304 nm (1184 M' 
’em'1), 647 nm (162 M '1cm'1). IR (KBr) of the dark-blue precipitate: 1108 cm'1
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(strong, vCio4), 1091 (strong, Voo4)- IR (KBr) of the blue crystals: 2333 (v c =n ), 2305 
(von), 1102 cm'1 (strong, vcio4), 1089 cm'1 (strong, vcio-d- Anal. Calcd. for the dark-blue 
precipitate, ^ 24^ 4^ ( 0 0 4 )2( ^ 0 )2.5: C, 42.02; H, 5.73; N, 8.17%. Found: C, 41.98; H, 
5.57; N, 7.91%. Anal. Calcd. for the dark-blue crystals, CuC24H34N4(C104)2(CH3CN)2: C, 
46.51; H, 5.58; N, 11.62%. Found: C, 46.30; H, 5.60; N, 11.31%.
[Cu*5](N03) 2 (161): A mixture of 5*(H20)o.5 (136.9 mg, 0.392 mmol) and
Cu(N03 )2*3H20  (95.8 mg, 0.397 mmol) in MeOH (16 mL) was refluxed for 17 hours to 
form a dark-blue MeOH solution and some bluish brown precipitate. This MeOH 
solution was then centrifuged off from the bluish brown precipitate. Et2 0  vapor diffusion 
into this MeOH solution yielded 138.7 mg of a blue crystalline solid, which was 
dissolved in ^O /M eO H  mixture (1:1) and diffused by acetone vapor to form blue 
crystals. Electronic spectrum (H20): A.max (s) -  286 nm (1348 M^cm'1), 625 (34). IR 
(KBr): 3285, 3139 cm'1 (voh and vnh), 1678 (s) (vc=o), 1604 (medium) cm '1. Anal. Calcd. 
for CuC,6H32N602(N03)2 H20: C, 35.19; H, 6.28; N, 20.52%. Found: C, 34.93; H, 6.24; 
N, 20.32%.
[Cu»6 ](C1 0 4)2  (162): A mixture of ligand 6®H20 (16.8 mg, 0.0508 mmol) and
Cu(C104)2 ®6H20  (22.1 mg, 0.0596 mmol) in MeOH (11 mL) was refluxed for 1 day. 
After cooling to room temperature, this solution was diffused with Et20 vapor to yield 
21.0 mg (72%) of blue crystals. Electronic spectrum (CH3CN): A,max (s) = 637 nm (89 M '1 
cm'1); H20: Xmax (e) = 627 nm (96 M 'W 1). IR (KBr): 3439, 3359, 3309, 3256 cm'1 (v0H 
and vnh)„ 1682(s ), 1661 (s) cm'1 (vc=o), 1612 (medium), 1593 (medium) cm'1 (vc=o or
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NH2bending). Anal. Calcd. for CuC12C14H28N6Oio: C, 29.25; H, 4.91; N, 14.62%. Found:
C, 29.09; H, 5.19; N, 14.59%!
[Cu»6](N0 3 )2 (163): A mixture of ligand 6*H20  (65.5 mg, 0.198 mmol) and
Cu(N0 3 )2*3H20  (48.4 mg, 0.200 mmol) in MeOH (9 mL) was refluxed for 26 hours. 
After cooling to room temperature, this clear dark-blue solution was diffused with Et20  
vapor to yield 58.7 mg (58%) of blue crystals. Electronic spectrum (H20): Xmax(e) = 627 
nm (66 M‘1cm'1). IR (KBr): 3293, 3138 (broad) ( v q h  and v n h ) ,  1685 (s), 1670 (s) cm'1 
(vc=o), 1619 cm'1 (vc=o or NH2 bending). Anal. Calcd. for CuCi4H2gN6 0 2(N03)2 (H20)o.s: 
C, 33.04; H, 5.74; N, 22.02%. Found: C, 33.44; H, 5.82; N, 21.92%.
[Cu-(7-2H)](NaC104)(NaCF3COO)o.5(H20 ) L5 (164): To a cloudy mixture of
7*(TFA)2*H20  (289.9 mg, 0.4926 mmol) and Cu(C104)2*6H20  (182.5 mg, 0.4926 mmol) 
in 95% aqueous ethanol solution (36 mL), an aqueous solution of NaOH (0.9864 N, 2.00 
mL) was added to form a slightly cloudy blue solution which was refluxed for 2 days. 
After a small amount of precipitate was centrifuged off, Et20  vapor diffusion into this 
solution yielded 217.5 mg (71%) of blue crystals. Electronic spectrum (H20): Xmax (s) = 
620 (43 M 'W 1); (5 M HC1): Lmax(s) = 623 nm (47 M 'W '1). IR (KBr): 3422 (br) (vOH), 
1624 (br, s), 1595 (br, s)(vc=o). Anal. Calcd. for CuC16H2gN40 4 (NaC104)(NaCF3COO)o.s 
(H20)i.5: C, 32.86; H, 5.03; N, 9.02%. Found: C, 32.94; H, 5.26; N, 9.13%.
[Cu*(8-2H)](NaC104) (165): To a MeOH solution (5 mL) of Cu(C104)2-6H20  (57.0
mg, 0.154 mmol), a mixture of a MeOH solution (7 mL) of 8»TFA*H20  (64.3 mg, 0.150
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mmol) and an aqueous solution of NaOH (0.970 N, 0.460 mL) was added to form a clear 
blue solution which was refluxed for 2 hours. After some precipitate was centrifuged off, 
diethyl ether vapor diffusion into this yielded 79.6 mg (98%) of a blue crystalline solid. 
Electronic spectrum (H2O): Lmax (s) = 642 nm (75 M’Vrn"1); CH3CN: Lmax(s) = 736 nm 
(84 M 'W 1). IR (KBr): 3422 (br) (vOH) cm"1, 1624 (s), 1595 (s) (vc=o) cm"1. Anal. Calcd. 
for CUC14H24N4O4 (NaC104)(H20 )2.5: C, 30.95; H, 5.38; N, 10.31%. Found: C, 30.89; H, 
5.03; N, 10.12%.
[Cu*(8-2H)](NaN03) (166): To a blue MeOH (25 mL) solution of Cu(N03)2*3H20
(53.6 mg, 0.222 mmol) and 8®TFA»H20  (89.0 mg, 0.208 mmol), an aqueous solution of 
NaOH (0.970 N, 0.64 mL) was added to form a clear blue solution which was refluxed 
for 8 hours. After some precipitate was centrifuged off, Et20  vapor diffusion into 3/5 of 
this MeOH solution yielded 26.5 mg (38%) of blue block-shaped crystals. Electronic 
spectrum (H20): Lmax(s) = 647 nm (57 M^cm"1); CH3CN (a saturated solution): Lmax (A) 
= 270 nm (A = 0.950), 760 (A = 0.037). IR (KBr): 1638 (s), 1595 (s) (vc=o) cm"1. Anal. 
Calcd. for CUCMH24N4O4 (NaN0 3)2(H20 )o.5: C, 30.30; H, 4.54; N, 15.14; F, 0 %. Found: 
C, 30.60; H, 4.15; N, 14.85, F, < 0.25%.
[Ni(p-Cl)*l]2Cl2 (167): To a solution of ligand 1 (36.1 mg, 0.159 mmol) in 8 mL of
methanol was added a methanol solution of NiCl2 (21.2 mg, 0.163 mmol) in 8 mL 
methanol. This was refluxed for three days to give a red solution. After cooling to room 
temperature, solvent was removed to yield a light red solid. This solid was washed by 
toluene and dried to yield [Ni*l(p-Cl)]2Cl2 (39.0 mg, 76%) as indicated by its CHN
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elemental analyses. Crystals suitable for X-ray analyses were obtained from slow 
evaporation of a MeOH solution of the product. Electronic spectrum (CH3OH): Xmax (e) = 
360 nm (37 M 'W ) ,  541 (13), 910 (17); (H20): Zmax = 515, 850 nm. IR (KBr): 3379 (br, 
v0H), 3240 and 3203 cm'1 (vNH). Anal. Calcd. for NiCl2(Ci2H26N4)*0 .5H2O: C, 39.49; H, 
7.46; N, 15.35%. Found: C, 39.65; H, 7.30; N, 15.12%.
Zn(N0 3 )2®(Me4Cyclam) (168): To a solution of ligand 9 (235.4 mg, 0.918 mmol ) in 2
mL of MeOH was added a MeOH solution (5 mL) of Zn(N03 )2*6H20  (281.1 mg, 0.945 
mmol). The resulting clear solution was refluxed for 1 day. Et20  vapor diffusion into this 
clear solution yielded 398.3 mg (97%) of colorless needle-like crystals. ]H NMR in D 20: 
5 3.19 (4H, td, J  = 12.8, 1.5 Hz), 2.49-3.07 (12H, m), 2.55 (12H, s, CHi), 2.33 (2H, qm, J  
= 14.2 Hz), 1.72 (2H, dp, J  = 16.8, 2.0 Hz); in CD3CN: 5 3.27 (4H, broad t, J  = 12.9 
Hz), 2.55-2.84 (12H, m), 2.51 (12H, s, CH3), 2.16-2.33 (2H, qm, including one H20  
peak), 1.61-1.71 (2H, m); 13C{]H} in D20: 5 61.12, 56.84, 44.19, 21.32; in CD3CN: 
8 62.07, 57.91, 45.72, 22.79; Anal. Calcd. for Zn(N0 3)2Ci4H32N4: C, 37.72; H, 7.23; N, 
18.85%. Found: C, 37.63; H, 7.16; N, 19.26%.
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A p p e n d ix
Appendix Table Selected Bond Distances (A) and Bond Angles (deg) in
[Ni*l(p-Cl)]2Cl2 (Hydrogen bonding interactions are included.).
Ni(l)-N(l) 2.090(3) Ni(l)-N(l A) 2.090(3)
Ni(l)-N(2) 2.095(3) Ni(l)-N(2A) 2.095(3)
Ni(l)-Cl(l) 2.4793(8) Ni(l)-C1(1A) 2.4793(8)
Ni(lA)-Cl(l) 2.4794(8) H(N1)—C1(2A) 2.27(6)
N(l)-Ni(l)-N(1A) 172.67(13) N(l)-Ni(l)-N(2A) 84.68(10)
N(l)-Ni(l)-N(2) 89.99(10) N(1A)-Ni(l)-N(2) 84.68(10)
N (2 A)-Ni( 1 )-N (2) 86.64(14) N(1A)-Ni(l)-N(2A) 89.99(10)
N(l)-Ni(l)-C1(1A) 95.24(8) N( 1 A)-Ni( 1 )-Cl( 1 A) 90.24(8)
N (2 A)-Ni( 1 )*C1( 1 A) 178.25(7) N(2)-Ni( 1 )-Cl( 1 A) 95.11(8)
C1(1A)-Ni(l)-Cl(l) 83.15(4) Ni( 1 )-Cl(l )-Ni( 1 A) 96.85(4)
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Appendix Figure Structure of the [Ni(p-Cl)*l]22+ dimer in [Ni(ja-Cl)®l]2Cl2 (167) 
showing atomic labeling scheme. Hydrogens bonded to carbons are omitted for clarity.
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